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Abstract
Age-related cataract is the leading cause of blindness worldwide and a major 
public health problem. The two most common types of age-related cataract are nuclear 
and cortical cataract. Nuclear and cortical cataracts are complex diseases, meaning 
both genetic and environmental factors play a role in their pathogenesis. In addition, it 
is increasingly clear that pathogenesis of age-related cataracts is intertwined with 
systemic factors related to ageing. Holistic approaches taking into account the systemic 
nature of the cataract risk factors are needed. High-throughput technologies have 
enabled detailed studies of the molecular changes and biological pathways underlying 
a variety of complex traits but their use in age-related cataract research is long 
overdue. 
The current thesis describes the implementation of various “omics” platforms to 
answer questions related to genetic and environmental risks such as: 1) What are the 
genetic variants (both common and rare) that underlie the pathogenesis of the common 
forms of age-related cataract: nuclear and cortical cataract?; 2) Do nuclear and cortical 
share genetic risk factors?; 3) What are the effects of diet on cataract formation and 
progression and are these effects mediated through circulating metabolites or the gut 
microbiome?
The work presented in this thesis resulted in, among others: the identification of 
six new genetic loci for age-related nuclear cataract; determining that dietary vitamin C 
protects not only against cataract formation but also against cataract progression; and 
suggesting that gut bacteria may play a role in the pathogenesis of cataract. Omics 
data can be useful for elucidating the biological pathways underling cataract. However, 
various factors that lead to reduction in power to identify effects, such as mismatches 
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Chapter 1: Introduction 
1.1. Overview 
Age-related cataract (ARC) is an ophthalmic condition that arises from the 
interplay of genetic and environmental factors. The work discussed within this thesis 
aims to elucidate some of the genetic factors underlying ARC and, through the use of 
high-throughput technologies, the mechanisms behind the association between ARC 
and diet, one of ARCs environmental determinants. 
In order to show the importance of studying ARC, I will start this chapter by 
discussing the global impact of cataract on eye health. Next, I will define what ARC is 
and how it is measured. In order to understand the biological mechanisms underlying 
ARC formation, it is helpful to understand the anatomical, physiological and 
developmental characteristics of the human lens, the part of the eye that cataract 
affects. After addressing what we know about cataract biology, I will focus on the 
genetic and environmental risk factors for ARC development and progression. 
1.2. Cataract as a public health problem 
Age-related cataract is a major public health problem and a leading cause of 
blindness worldwide1. According to the latest summary statistics, the number of blind 
due to cataract worldwide rose from 12.3 million in 1990 to 20 million in 20101,2. 
Cataract related blindness is not distributed evenly around the world as illustrated by 
data collected between the late 1990 and 2010: in North America  and West Europe *
cataract accounts for 12.7% and 13.8% of blindness respectively, while in East Sub-
Saharan Africa cataract accounts for 36.7% of blindness and in Southeast Asia for 
42.0%3-5. Cataract-related blindness can be avoided by surgically removing the lens 
and replacing the affected lens with an artificial one. A valuable resource of information 
of cataract related blindness and severe visual impairment after the year 2010 comes 
from the rapid assessment of avoidable blindness (RAAB) studies6. RAAB uses 
cluster-based randomised door-to-door survey and visual acuity testing strategy to 
assess the prevalence and causes of blindness in a survey area, divided into segments 
with sample size of 50 participants over the age of 506. The RAAB is ideally designed 
for obtaining a total sample size of between 2000 and 5000 individuals. However, the 
studies provide predominantly raw prevalence which makes comparison between 
 high income *
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countries difficult. The findings of those studies are summarised in Table 1.1.  
Although overall the worldwide prevalence of cataract-related blindness is 
decreasing and the rates of cataract surgery are increasing7, there are still a lot of 
areas with high prevalence of cataract related blindness. And given an increasing 
elderly population in many countries the above mentioned positive changes do not 
happen fast enough. Moreover, lack of ophthalmologists in developing countries and 
the significant costs of treatment and care in the industrialised countries pose 
significant issues to the national healthcare systems7. In the USA alone it is estimated 
that direct medical costs for cataract treatment are an estimated $6.8 billion per year8. 
In UK for the year 2010 the estimated cost of cataract treatment (referral and surgical 
treatment) and ongoing social and personal care for those who are partially sighted or 
blind due to cataract was over £995 million9. Ninety percent of visually impaired people 
live in developing countries where such high spending levels are not possible. For 
example, in Nigeria the median direct cost of cataract surgery equals more than 50 
days income for 70% of the local population10.
Table 1.1. Summary of results from the rapid assessment of avoidable blindness studies 
This table summarises the results from the rapid assessment of avoidable blindness studies 
that were published after 2010. For each world region the lowest and highest raw prevalences 
(%) measured are presented, followed by the country where this was measured. AFR(N)/ME – 
Africa (North) and the Middle East; AFR(S) – Africa (Subsaharan); AMR – Latin America; EAS/
SEA – East and South-East Asia; EUR – Europe; ME - SAS -South Asia. N – number of studies 
conducted per region. The figure for this table come from the studies cited in the references list 
with numbers:11-24.
Cataract will likely continue to be a major public health problem, even as we are 
approaching the end of the World Health Organisation (WHO) VISION 2020 initiative, 
cataract-related blindness cataract-related visual impairment
Region N Lowest Highest Lowest Highest
AFR(N)
/ME
4 41.0 (Saudi Arabia) 58.6 (Saudi Arabia) 45.0 (Saudi Arabia) 71.0 (Saudi Arabia)
AFR(S) 3 39.8 (Zambia) 55.0 (Burundi) 43.0 (Burundi) 82.7 (Madagascar)
AMR 1 63.0 (Mexico) 68.0 (Mexico)
EAS/
SEA
4 51.4 (Maldives) 81.8 (Cambodia) 59.5 (China) 94.1 (Cambodia)
EUR 2 21.2 (Hungary) 58.2 (Moldova) 35.3 (Hungary) 70.2 (Moldova)
SAS 7 56.0 (India) 74.6 (India) 51.4 (India) 82.4 (India)
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which targeted the eradication of cataract-related blindness. There are several reasons 
for this phenomenon. The first two are the higher life-expectancy worldwide and the 
sustained population growth in areas with high cataract prevalence. There is also an 
increase in prevalence of several of the risk factors for developing cataract, such as 
diabetes and obesity. Last but not least, there is still a limited access to treatment in 
poor countries, particularly sub-Saharan Africa. In this situation, cataract prevention or 
non-surgical interventions may prove to be a better way forwards.
1.3. Age-related cataract: definitions and assessment
ARC is defined as slow and progressive loss of transparency (opacification) 
within the clear lens of the eye as the eye ages. The opacity interferes with the 
passage of light causing impaired visual acuity and glare due to scatter. ARC is a 
complex trait caused by the interplay of genetic and environmental factors25-27. ARC 
generally affects people above the age of 50. The lens shows a number of zones of 
optical discontinuity in which transparent regions are separated by bands of increased 
light-scatter and reflection28. The age-related opacification of the lens has different 
morphological presentation at the different zones, resulting in the three most common 
types of ARC: nuclear cataract, cortical cataract, and posterior subcapsular cataract 
(PSC) (Figure 1.1.). Nuclear cataract affects the fibres at the centre of the lens (the 
fetal nucleus) and presents as uniform clouding, and coloration of the lens from grey-
white and light-blue (opalescence) in its early stages to yellow-brown (brunescence) 
and deep blackish-brown (cataracta nigra) in the advanced stages28,29. Nuclear 
cataract affects the central vision and is the most common indication for cataract 
surgery. 
Cortical cataract affects the fibres in the lens cortex and presents as radial 
spokes28-30. The spokes start in inferonasal quadrant of the lens as a small numbers of 
opaque fibre bundles that grow and spread both along individual fibres and also to 
adjacent fibres28,31. This results in centripetal and circumferential spoke growth at the 
equator28,31. Cortical cataract affects the peripheral vision causing glare and dazzle, 
particularly in dim light when the pupil is large, but, in later stages, it in can also affect 
the central vision. PSC cataract affects the posterior cortex just under the posterior 
capsule and forms web-like structures, thus also affecting central vision28-30. PSC 
cataract is due to defective fibre production by the epithelium that results in migration of 
metaplastic cells from the lens equator to the posterior pole and in failure of lens 
growth28.
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Figure 1.1: Types of age-related cataract
In this figure black and white lens images from participants in the TwinsUK (A) and the 
Rotterdam study (B) cohorts are presented. The images exemplify the tree types of age-related 
cataract: nuclear cataract (a), cortical cataract (b) and PSC cataract (c).For comparison lens 
images from unaffected eyes are also included. 
PSC has a disproportionate effect on vision as it develops centrally at the back of 
the lens, at the nodal point where rays of light converge. The three types of cataract 
can present alone or in combination and they are typically bilateral but commonly 
asymmetrical30.
Cataracts are detected, either by direct visualisation or by using optical 
equipment, with or without lens photography, and one of the following systems can be 
employed: ophthalmoscopy (direct/retroilllumination), photography (Scheimpflug or 
retro-illumination); optical degradation of projected retinal images; fluorimetry; and laser 
quasielastic light scattering32. The second and third are used most in research and will 
be discussed here. The slit lamp contains a high-intensity light source that can be 
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with a biomicroscope. All types of cataract can be detected using a slit lamp but only 
single section of the lens is visible at any one time which, when used in combination 
with photography, can be limiting. During retro-illumination the lens and photographic 
camera are parallel and light beam is shone straight in the eye, so that the lens is 
illuminated only by light reflected from the back of the eye. The reflected light is tilted 
by a mirror system and captured by a camera. This technique is particularly good for 
detection of cortical and PSC cataracts. Scheimpflug photography is used for detecting 
nuclear cataracts, as it provides depth of focus across the whole lens. A light beam hits 
the ocular lens straight in the visual axis, while the camera records the image under an 
oblique angle allowing depth of focus through the lens.
Table 1.2. Characteristics of existing subjective cataract grading systems
SLT/SLD — standard lens photos/diagrams used for comparison; N — number of SLP/SLD 
used for comparison; AREDS — Age-Related Eye Diseases Study grading system33; JAP-
CCESG — Japanese Cooperative Cataract Epidemiology Study Group classification system34; 
LOCS II/III — Lens Opacities Classification System versions II and III35,36; Oxford — Oxford 
Clinical Cataract Classification and Grading System37; Wilmer — Wilmer Grading System38; 
WHO — Simplified Cataract Grading System (http://www.who.int/iris/handle/10665/67221); 
Wisconsin — Wisconsin System for Classification of Cataracts from Photographs39; $ — 
original; & — modified; NC - nuclear cataract; CC - cortical cataract.
Once the lens is visible or lens photographs are obtained, cataract severity is 




types N of SLP/SLD SLP/SLD
AREDS decimal 3x cataract type AREDS stnadard photos
JAP- 
CCESG integer
2x NC and CC; 
1x PSC JAP-CCESG standard photos
LOCS II decimal 4x NC and PSC; 5x CC LOCS II lens photos 
LOCS III decimal 6x cataract type LOCS III lens photos 
Oxford$ integer 10x NC,  
5x CC and PSC
Diagrams only; NC: brunescence/white scatter;  
CC: 1/5 pie segments; PSC: concentric segments;Oxford& decimal
WHO integer 4 x cataract type NC photos; diagrams: CC 1/8 pie segments; PSC ⌀
Wilmer integer
4 x NC and CC; 
⌀ PSC
NC photos, a CC 1/8 pie diagram, PSC dimensions 
(slit lamp calibration beams)
Wisconsin$ integer
4 x cataract type Wisconsin standard lens photos 
Wisconsin& decimal
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Objective densitometry systems exist but are rarely used. The main characteristics of 
the existing subjective cataract grading systems are presented below (Table 1.2.). The 
various grading systems produce different prevalence measures but studies, where two 
or more grading systems were compared, showed that calibration between systems is 
easily achievable and that grading systems produce results that are to some extent 
comparable40-42.  
1.4. Anatomy and embryonic development of the lens
The human lens is a transparent, avascular, non-innervated, biconvex structure 
(~10 mm in diameter) in the anterior segment of the eye, which continues grow 
throughout adulthood43. Together with the cornea, the lens helps focus the light on the 
retina and by altering its shape through the process of accommodation it can fine-tune 
the eye’s focus. The human lens has three histological compartments: lens capsule, 
lens epithelium, and lens fibres (Figure 1.2)43.
The lens capsule is a basement membrane, rich in collagen type-IV, laminin and 
fibronectin43. It has structural and signalling functions, and allows the passage of small 
molecules both into and out of the lens43,44. The lens epithelium is a simple cuboidal 
epithelium that regulates the lens osmolarity and the transport of molecules from the 
aqueous humor, and gives rise to the lens fibres. The fibres cells form the bulk of the 
lens mass and are long (4μm diameter and up to 12 mm length), thin, transparent cells 
that, when mature, are devoid of organelles and nuclei and connected to each other by 
adherens and gap junctions45. The lens fibres stretch lengthwise from the posterior to 
the anterior poles forming honeycomb-like onion-layered structures (Figure 1.2). They 
are continuously produced; until early childhood the lens grows asymptotically and after 
that point the growth becomes linear46.
The healthy human lens is transparent to visible light and nearly transparent in 
the long-wavelength region but absorbs strongly in the UV and short-wavelength 
regions47. The lens transparency is due to the lack of organelles and to its special 
protein and membrane organisation. The lens has the highest protein content of any 
other tissue in the body (about 38% of the total mass) and up to 90% of which are 
crystallins; small-sized (<10nm in diameter) closely-packed water-soluble proteins28,48. 
Lens proteins also have a long half-life and are characterised by long-term stability, 
which is due to the inhibition of degradative enzymes and a shift that cause ubiquitin to 
bind to proteins under stress and, protect them from, rather than tagging them for, 
degradation49. The minimisation of scatter is further enhanced by the tight packing of 
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lens fibre cells and changes in the concentrations of lipids in the membrane: high 
cholesterol ratios; low percentage of phosphatidylcholine; higher percentage of 
phosphatidylglycerol, lysophosphatidylglycerol, and gangliosides50-53. The lack of 
organelles results in anaerobic glycolysis being the only way ATP is produced in the 
lens fibres, with only 30% of ATP derived from the aerobic oxidation in the lens 
epithelium43.
Figure 1.2. The structure of the adult human lens
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lenticular histological components (A); and a slit lamp biomicroscopy image (B) revealing the 
lens zones of optical discontinuity. Figure 1.2.A is adopted from Harding et al. 200254, while 
figure 1.2.B. is adopted from et al. Augusteyn55 2010. 
Given the unique anatomical characteristics of human lens, it is perhaps not 
surprising that Mendelian mutations in genes encoding for structural lens proteins have 
been implicated in the formation of congenital cataracts in both animal models and in 
humans. Such genes include: crystallins (CRYA, CRYB and CRYG families), collagens 
(eg. COL11A1 and COL4A1), aquaporins (eg. major intrinsic lens fibre protein (MIP) 
and APQ1), gap-junction proteins (eh. GJA3 and GJA8)56-64.  
To understand the anatomy and function of the lens, it is necessary to follow its 
embryonic development. Although disruption of normal lens development may lead to 
congenital cataract formation, it is unclear to what extent developmental events impact 
lens ageing. In human, lens development starts at embryonic day 22 with the formation 
of the lens placode from surface ectoderm cells that are adjacent to neural plate65. The 
placode starts envaginating and forms the lens vesicle65. Synthesis of crystallins, the 
structural lens proteins, starts at about embryonic day 30 and by embryonic day 33 the 
lens is fully separated from the optic vesicle66. After this point the lens cells start 
elongating towards the anterior of the lens vesicle and thus form the embryonic 
nucleus65. The cells of the anterior portion of the lens vesicle give rise to the lens 
epithelium, which in turn gives rise to additional secondary fibres located toward the 
equatorial region of the lens. Studies in various vertebrate animal models have shown 
that, from cellular and molecular prospective, lens morphogenesis can be divided into 
four phases: formation of lens placode from prospective lens ectoderm (PLE); 
invagination of the lens placode and formation the lens pit and lens vesicle; primary 
lens fibre cell differentiation; and fibre cell maturation that includes cytoskeletal 
modifications and organelle degradation67. Various genes do play a role at these 
stages. The most important of those, and their role in congenital cataract formation, will 
be discussed below.
During the first phase, the lens epithelium is established from multipotent 
placodal precursors which are induced to form the lens placode. PLEs arise from 
epithelial cells under the controls of bone morphogenetic proteins (BMPs), fibroblast 
growth factors (FGF) and Wingless integrator proteins (WNT)/β-catenin signaling68. 
The transition from PLE to placodal precursors cells and the establishing of lens 
identity starts with the action of two lysine acetyltransferases: CBP and p30069. They 
modify core histone proteins thereby initiating the expression of key lens TFs, such as 
Pax6, Six3 and Sox2-Oct1, that play role in the formation of the lens placode67,69. The 
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induction of the lens placode is dependent on signals coming from different sources 
and all those signals converge on Pax6 (Figure 1.3.), as discussed below. At gastrula 
stages, sustained exposure to autocrine bone morphogenetic proteins (Bmp2, Bmp4 
and Bmp7), a subset of the TGF-β superfamily of growth factors, is required and 
sufficient to induce lens placodal cells70,71. In mice, targeted deletions of different 
components of the BMP pathway lead to disturbed lens formation72. At slightly later 
stages, BMP activity has been suggested to be required for crystallin expression in 
primary lens fibre cells and BMP receptor signalling also regulates both cell survival 
and proliferation during lens placode formation73. At this placode stage, paracrine 
signals from the prospective retina and from retinoic acid are also important67. The 
retinoic acid signalling also continues to play a role during the next phase of 
development when the lens placode invaginates to form the lens pit and lens vesicle67. 
Inhibition of cellular retinal binding protein (CRBP)-1 in mouse led to failure of lens 
placode invagination, and inactivation of retinaldehyde dehydrogenase led to disrupted 
lens vesicle formation74. 
The most important players at the first phase, however, is probably Pax6 (Figure 
1.3.). Pax6 regulates a lot of different key lens development TFs, such as Six3, Sox2-
Oct1, Sox1175-77. The functions of those will briefly be discussed below. Furthermore, 
Pax6 inhibits the WNT/β-catenin signalling which is a prerequisite for lens placode 
formation78. Apart from regulating the expression of a variety of different transcription 
factors, Pax6 can regulate its own activity using a positive feedback loop and is further 
regulated by a whole array of upstream proteins from different signalling pathways: 
Pygo2 (Wnt-independent lens induction); Raldh2, Rx (retinoic acid signalling); Hes1, 
Lhx2 (Notch signalling); Nf1 (ERK signalling); Mab21l2, Bmp4, and Bmp7(TGF-β); Fgfs 
(Fgf singling); Meis1 and Pknox1 (PI3K-Akt-mTOR)79.
The effects of Pax6 mutations on eye development have been extensively 
studied. Pax6 knock-outs do not develop ocular structures and die in the neonatal 
period80. Heterozygote mice present with: microphthalmia (small eye), delay in lens 
placode formation, a smaller than normal lens, vacuolated lens fibres, and, importantly, 
cataracts in adults81,82. Humans with mutations in PAX6 present with microphthalmia, 
aniridia (lack of iris) and aphakia (lack of lens), with only one study reporting congenital 
cataract83,84. 
An important target and co-regulator of Pax6 is Six3. In mice and chicks, Six3 is 
initially expressed in PLE and the ectoderm overlying the optic vesicles; followed by 
expression in the lens placode and is, during differentiation, localised to the lens 
epithelium85-87. In humans the predominant phenotype caused by mutations in this 
gene is lack of forebrain development, while in animals, ectopic eyes and ectopic 
 31
Chapter 1: Introduction 
lenses have been reported88.
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Figure A), adopted from Cveki et al (2017)77, illustrates how Pax6 directly regulates the 
expression of components of six signal transduction pathways (FGF, Hedgehog-Hh, Notch, 
retinoic acid-RA, TGF-β/BMP and Wnt) which are upstream of Pax6. Figure B), adopted from 
Lang (2004)88, shows some of the downstream targets of Pax6. 
A group of key lens development TFs, under Pax6 regulation, is the Sox gene 
family of TFs (eg. Sox1, Sox2, Sox3, and Sox11). Sox genes are involved in the 
developmental processes leading to cell fate decisions and, dependent on tissue-
specific partnering, activate a trans network of genes, including crystallins (murine γ F-
crystallin, chicken δ1-crystallin genes)89-91. In absence of both Pax6 and Sox2 lens 
development is not initiated92. Similarly, in absence of Bmp4 which is upstream from 
both Pax6 and Sox2, Sox2 expression is not up-regulated, and the lens does not 
form93. Furthermore, it has been shown that Pax6 expression is stabilised and 
maintained by Sox2 activity and that Oct-1, a Sox2 co-factor, is needed for this 
process94,95. Interestingly, Oct-1 has been shown to be an oxidative and metabolic 
stress sensor96. Pax6 and Sox2 together activate the transcription of lens specific 
MAFs (L-Maf and c-Maf) and which in terns bind to α A-crystallin and γ F-crystallin 
promoters respectively97-99. Disruption of the mouse c-mad gene led to failure of lens 
differentiation and elongation and a small hollow lenses phenotype100. In the lens, Sox1 
and Sox3 have the same expression patterns as Sox2 and they overlap with Sox2 in 
terms of crystalline expression90. Mutations in all three genes caused microphthalmia in 
animal models and in humans but only Sox1 mutant mice developed cataract101,102. 
Finally, Sox11 is important for lens placode invagination79. 
In vertebrates, including humans, FoxE3 is another important member of the 
Pax6 regulatory network. In the mouse lens, FoxE3 expression is first detected at E9.5 
but following lens vesicle formation, FoxE3 expression ceases in lens fibre cells but 
persists in the anterior epithelial cells103,104. FoxE3 is essential to lens vesicle closure 
and subsequent separation of the lens vesicle from the ectoderm, although the 
underlying mechanisms have not been extensively studied105. It is also involved in the 
maintenance of central lens epithelial cell proliferation via the upregulation of Mki67, 
Pcna and Pdgfra expression and the maintenance of equatorial lens epithelial cell 
phenotype via the exclusion of Prox1-induced Cdkn1c expression103. This prevents 
early cell cycle exit and premature lens epithelial cell differentiation into lens fibre 
cells105. Homozygous loss of function mutation in the human FOXE3 present with a 
fusion between lens and cornea and an arrest of development of anterior epithelial and 
lens fibre cells, and congenital cataract106,107.
Pax6 also regulates the expression of Prox1, Ptx3, Otx1, Otx2, Creb-2, AP-2a, 
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Eya1, Eya2. Prox1 seems to be driving γ D-crystallin expression and lens fibre 
differentiation while Ptx3 is involved in maintenance of the anterior epithelium of the 
lens79. Mutations in Otx1/2 cause defects with varying severity including aphakia, 
microphthalmia and aniridia108,109. Furthermore, as implied by low levels of α A-
crystallin in Otx knockout lens remnants, mutations in Otx1/2 cause delay in or failure 
of lens development progression110. Creb-2 is as an essential survival factor for anterior 
epithelial cells111. In mutant Creb-2 mice, anterior epithelial cells undergo p53-
dependent apoptosis at approximately stage E14.5, followed by resorption of the 
developing lens111. AP-2a is important for lens vesicle separation79.It has also been 
shown to bind to Pitx3 regulatory regions and to the promoter of MIP112,113. Both Eya1 
and Eya2 transcripts have been detected in the developing lens and are prosed to play 
roles in lens placode development114.
Following the first two phases of lens development there is a shift in regulatory 
pathways that lead to the initiation of the differentiation of primary lens fibres and 
epithelium cells67. Although the BMP, FGF and Notch pathways still play important roles 
in this phase, a variety of other regulatory pathways get activated. For example, vitreal 
factors such as insulin-like growth factors, platelet-derived growth factor and epidermal 
growth factor have been shown to potentiate lens cell proliferation, and later cell 
differentiation115. Another example is the members of B-cell lymphoma 2 (Bcl-2) family. 
Chick embryo experiments have shown that pro-apoptotic members of Bcl-2 are up-
regulated in the lens and anti-apoptotic members are down-regulated at the time that 
organelle loss commences116. Mice exhibiting lens-specific Bcl-2 over-expression 
showed abnormal lens fibre cell differentiation, inducing cataracts, microphakia, 
vacuolization, lens fibre cell disorganisation and inhibition of lens fibre cell 
denucleation117. The expression of another important apoptosis regulator, p53 has 
detected in lens epithelium cels and in the lens fibres, and temporally distinct patterns 
of p53-dependent apoptosis have also been identified during mouse lens 
development118,119. The amount of p-53 signalling may be under the control of 
phosphatidylinositol 3-kinase120. Finally, tumour necrosis factor (TNF) related 
molecules and their signalling components have been shown to be expressed in the 
developing lens suggesting that TNF-related signalling (potentially TNFα-mediated cell 
signalling cascades) might be involved in regulating organelle loss in lens fibre cells 
and/or lens fibre cell differentiation121. Last but not least, cell–cell signalling plays an 
important role in fibre differentiation as shown by studies of human cataracts where 
mutations in EPHA2, encoding a receptor tyrosine kinase, were associated with 
autosomal dominant congenital cataracts and age-related cortical cataracts122,123. 
Furthermore, analyses of wild-type and Efna5−/− lenses indicated that Ephrin–A5/
 34
Chapter 1: Introduction 
EphA2 signalling regulates N-cadherin/β-catenin interactions, and thus adhesion and 
structure of the fibre cells124.
1.5. The biology of age-related cataract formation
Understanding the biology of ARC is complicated by the lack of good animal 
models and the difficulties in obtaining, and working with, human lens material125. 
Consequently, studies trying to explore the molecular causes underlying the vast 
majority of epidemiological associations for ARC risk factors has not been particularly 
fruitful. That said, a plethora of cumulative age-related biochemical and biophysical 
lens changes that can cause lens opacification has been identified (Figure 1.4.). The 
age-related changes may start as early as the prenatal period and affect both the 
nucleus and the cortex. The age-related opacification is further increased by oxidative 
stress due to molecular-, photo- and UV-oxidation28,126,127. The oxidation-related 
changes are proposed to be similar to those affecting the other organs in the body. As 
opposed to other organs such as the brain, age-related changes in the lens are easier 
to see and measure. Thus cataract is proposed as a marker of oxidative ageing. This 
role is further backed up by the association of cataract with other markers of ageing 
and oxidation (e.g. telomere length, systemic inflammation)128,129.
Osmotic homeostasis and microcirculation: The lens is avascular but its 
microcirculation system is very important for the function of the lens because it 
generates a flux of ions and water that circulates through the lens130. In ageing, or as 
result of dehydration, the amount of water entering the lens nucleus via the epithelium 
and cortex is reduced131-134. In the lens cortex, however, an age-related increase in 
sorbitol and fructose can increase the osmotic pressure, leading to the uptake of water 
and lens edema130,135,136. Animal studies also suggest a link between lens opacities 
and changes of extracellular fluid volume137. The age-related degeneration of the 
vitreous humor, may result in molecule gradient disturbances, including an increase in 
oxygen concentration close-to and in the lens138. Furthermore, cataract is inevitable 
consequence of vitrectomy. Hypertension-related inflammation and endothelial 
dysfunction may alter osmotic homeostasis in the lens128. Finally, Mendelian mutations 
in gap-junction proteins (GJA3, GJA8, etc.), which disturb lens structure and thus 
microcirculation, cause congenital cataracts60,64; but more subtle changes (e.g. 
variation in expression) may be involved in ARC.
Glucose Metabolism: The activity of many enzymes involved in glucose 
metabolism decreases with age while the concentration of advanced glycation end 
products (AGEs) increases, which results in increasing glycosylation of crystallins, the 
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formation of high-molecular weight (HMW) aggregates and clouding43. Furthermore, 
apart of the effects of UV absorption, the brown pigmentation in advanced cataract may 
be partially due to a Maillard reaction where a sugar molecule binds to lysin and 
increases protein cross-linking139. Changes in glucose metabolism due to obesity, T2D 
or other components of the metabolic syndrome may therefore lead to the development 
of diabetic cataracts, which, in the majority of cases, are not morphologically 
distinguishable from primary ARC but may differ molecularly140,141.
Figure 1.4: Ageing-related changes within the lens
This figure, adopted from Harding et al., 200254, summarises the age-related changes known to 
occur in the lens. Glc –glucose; G6P – glucose 6-phosphate; MDA – malondialdehyde; SH – 
disulphide anions.
Proteins and changes related to protein metabolism: Due to the lack of 
organelles, the protein and cell membrane replacement and repair mechanisms are 
limited or lacking altogether, and the lens is dependent on molecular transport from the 
aqueous humor and lens epithelium43. Also with age there is a shift from protein 
degradation through the proteasome system of degraded to degradation by 
proteases43,142,143. As the lens ages, there is an increase in water–insoluble proteins, 
which is associated with high levels of yellow chromophores28. The chromophores give 
the lens a yellow coloration, which leads to shift in colour perception and increase in 
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the formation of oxygen radicals43,47. During the lens lifespan, crystallins are truncated 
through proteolysis and modified molecularly, resulting in protein unfolding, 
destabilisation and conversion from L- to D-isomers28,144. The most common molecular 
modifications are: thiolation, deamidation, glycation, carbamylation, cys-methylation, 
phosphorylation, acetylation, intermolecular S-S cross-linking, and aldehyde-amino 
acid reactions28,144. In addition, similar processes affect the cytoskeletal and membrane 
proteins an lead to their loss43. With ageing the oxidative damage of proteins 
increases28,126,127, and the levels of enzymes involved in the oxidative stress response 
and in ubiquitin conjugation decrease43,142,145. These mechanisms result in the 
formation of HMW insoluble aggregates, the levels (>10 times increase between the 
ages of 20 and 60) and complexity of which increase with age146. An additional source 
of protein oxidation may come from alcohol consumption. Alcohol metabolism via 
cytochrome CYP2E1 has been hypothesized to generate free radicals causing 
aggregation of the lens proteins, resulting in subsequent lens opacities147,148
Lipids and changes related to lipid metabolism: During ageing there is an 
increase of lenticular lipid content (from 4.1 to 14.5 mg), mainly due to an increase of 
oxidation-prone sphingolipids and gangliosides149. There is also less cholesterol and 
phospholipids (0.6-0.8 mg to 0.5 mg) in the deeper layers of the nucleus and the 
cortex51,52,150. The changes in lipids, together with the loss of membrane proteins, 
results in loss of membrane potential and an increase of Na+ and Ca2+ ions, at about 
approximately 50 years of age — the time when cataract formation starts151. Alcohol 
may augment those processes, and in addition, disrupt calcium homeostasis152,153. 
Furthermore, a more systemic lipid dysregulation may also play a role. Obesity-related 
increases in leptin and high triglycerides and decreased HDL have been implicated in 
increasing oxidative stress which may contribute to cataract formation154-156. The age-
related changes that affect lipid composition can be used as an oxidative stress marker 
of ageing beyond the eye51. 
Changes in antioxidants: A stable redox environment in the lens is achieved by 
additional scavenger molecules and repair systems located in cell membranes (e.g. 
vitamin E) and the cytosol (reduced glutathione (GSH), ascorbic acid, lutein and 
zeaxanthin, cysteine, methionine, glutathione reductase, glutathione peroxidase, 
thioredoxin and thioltransferase)157. Estrogens, which have been implicated in causing 
the sex-specific differences in cataract formation, have anti-oxidative properties, too143. 
Similar to other parts of the body, the concentration of all these antioxidants drops with 
age which leads to increased oxidative stress and protein damage158. The effect of 
smoking on cataract, apart from increasing oxidative stress and the accumulation of 
heavy metal ions159-161, may also be related to depletion of antioxidants126. 
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The drop with age in the concentration of GSH, the most important antioxidant 
molecule of the lens, is especially pronounced and once cataract develops the rate of 
GSH decrease is faster28. The ageing lens nucleus loses its ability to produce GSH; the 
synthesis of GSH in the cortex and lens epithelium slows down as does the GSH 
transport to the nucleus28. The role of dietary antioxidants is very important for 
maintaining a stable redox environment, partly through interaction with GSH. In the 
absence of GSH, ascorbic acid, which is the second most abundant antioxidant in the 
lens, can cause oxidative lens damage through its first oxidation product 
(dehydroascorbic acid)28. Decrease in vitamin C concentration, on the other hand, 
causes an increase in angiotensin-converting enzymes and impacts the proliferation, 
migration and epithelial-mesenchymal-transition of lens epithelial cells, thus causing 
PSC cataract158,162. Vitamin E, apart from scavenging galactose- and aminotriazole-
indused radicals, is also important for GSH homeostasis as it is involved in GSH 
recycling163.
All the animal models and in vitro experiments described in this section suggest 
that disruption of many pathways can all lead to the same end point, that of cataract. It 
is therefore highly likely that numerous environmental and genetic factors will add up to 
the complex trait that is ARC.
1.6. Genetics of age-related cataract 
Age-related cataract shows familial aggregation and heritability studies for all 
cataract types have been performed164-166. In the TwinsUK cohort, additive genetic 
factors explained 48% [95%CI: 42%-54%] of nuclear cataract variance, with the 
remaining variance due to environmental factors and age167. Sib-pair analysis in the 
SEEP found nuclear cataract heritability of 55%, however after adjustment for 
confounders the heritability fell to 36% [95%CI: 21.0%-50.3%]168. Results of 
commingling analysis in BDES, suggested that a single gene of major effect could 
account for 35% of nuclear cataract164. However, such a gene has not been found, and 
the majority of age-related eye diseases show polygenic inheritance which raises 
significant doubt about these results. In the TwinsUK cohort, cortical cataract was 
similarly heritable compared to nuclear cataract with heritability of clinically graded 
cataract being 53% [95%CI: 45%-60%] and that of digitally graded cataract being 58% 
[95%CI: 51%-64%]169. Moreover, the best fitting model suggested a major non-additive 
genetic contribution (ie. dominant genetic effects)169. In the SEEP, the adjusted 
heritability of cortical cataract was again found to be lower (24%)170. The differences in 
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estimate between the twin- and family-studies are due to the fact the twin studies are 
known to overestimate heritability171. Due to the rarity of PSC cataract in population-
based studies, accurate heritability analysis for this trait is difficult. 
As opposed to congenital cataract, where over 39 genetic loci and 26 genes have 
been described, very little is known about the genetics of ARC172. Two genes, GALK1 
and FTL, have been reported in connection to familial forms of adult-onset cataract. 
Homozygous mutations in GALK1, a gene encoding for an enzyme important for 
galactose metabolism, cause a mild phenotype characterised by development of 
cataract postnatally173,174. The cataract arises because of osmotic swelling of the lens 
due to galactitol accumulation. Interestingly, in Asians, a low frequency variant in 
GALK1 was associated with ARC175. Both dominant and recessive mutations in FTL 
cause iron storage defects which lead to cataract but the penetrance of the different 
mutations is so varied that cataract may not develop until the 5th decade of life176,177. 
There have also been plenty of predominantly underpowered candidate gene studies 
that looked at single nucleotide polymorphisms (SNPs) and copy number variants 
(CNVs) in genes linked to: oxidative stress response (e.g. GSTM1, OGG1, XDP, 
XRCC1, PARP1); congenital cataracts (CRYAA, MIP, GJA3, HSF4, SLC16A12); 
signalling pathway (e.g. estrogens); structural or cytoskeleton lens proteins64,178-205. 
These studies mostly did not distinguish between cataract types and the associations 
they identified have generally not been replicated and often reflect publication bias and 
questionable methodologies.
The first gene robustly associated with a common form of ARC, cortical cataract 
in particular, was EPHA2 and this gene has been linked to both congenital and late-
onset cataracts122,123,206,207. The EPHA2 locus was initially described using sib-pair 
linkage analysis and, subsequently, both rare and common coding variants in EPHA2 
were associated with age-related cortical cataract in European and in Asian candidate 
gene/variants studies26,122,208-210. EPHA2 encodes for a tyrosine kinase receptor, 
important in development and apoptosis, including UV radiation-induced apoptosis211. 
EPHA2 binds ephrin-A family ligands leading to contact-dependent bidirectional cell-
cell signalling, and participates in the cross-talk between RAS-PI3K-ACT and RAS-
MAPK signalling pathways, upstream of ERK1/2122,212, thus promoting cell 
differentiation. 
More recently, a meta-analysis of genome-wide association studies (GWAS) in 
Asian cohorts found two loci (CRYAA, KCNAB1) to be associated with age-related 
nuclear cataract27. CRYAA encodes for the most abundant structural protein of the lens 
and mutations in this gene cause congenital cataracts57,213,214. KCNAB1 encodes 
voltage-gated potassium channel, not previously linked to cataract215. Finally, two 
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studies explored the association between any cataract and SNPs at exome-wide and 
genome-wide level. A Korean exome-wide study of small sample size (N=249) found 
only one variant to be suggestively associated with cataract (rs7136356 within 
B3GNT4; P=6.5x10−5) and 13/20 most strongly associated SNP to be within 
glycosylation-associated genes216. A case-control GWAS in 7,397 individuals from the 
eMERGE network followed by age-of-onset analysis in cases only, found 45 variants to 
be suggestively associated with cataract217. Neither study used replication nor made 
statements on age correction for their analyses. In the latter cohort, gene-by-gene and 
gene-by-environment analyses were also attempted with doubtful significance218,219.
1.7. Epidemiology and risk factors
The prevalence of ARCs is dependent on age, sex, and ethnicity. Socioeconomic 
status affects access to treatment but its effect on cataract formation is uncertain220. 
Comparing the prevalence estimates from different studies is further complicated by 
the variety of grading systems used42 and differences in study design and reporting: 
different age ranges; reporting “any” cataract instead of by type; separating pure and 
mixed cataracts; combining estimates with those for cataract surgery. Nevertheless 
there are certain trends, as discussed below, emerging from published studies166,221-230. 
As opposed to prevalence, the data on incidence and progression of ARC are more 
limited but the incidence patterns resemble those for prevalence231-238. Finally, 
progression of cataracts seems not to be dependent on age or sex but some ethnic 
differences have been observed231-233. These differences, however, may reflect the 
different grading systems used rather than true ethnic differences.
1.7.1. Differences in prevalence between cataract types.
Nuclear cataract is the most prevalent type of cataract , followed by cortical *
cataract, while PSC cataracts are comparatively rare. To illustrate the variation, in the 
Beaver Dam Eeye Study (BDES) overall 17.3% of people had nuclear cataract and 
16.3% had cortical cataract221. In the Blue Mountains eye study (BMES) slightly older 
population on average, 53.3% of women and 49.7% of men had nuclear cataract and 
25.9% of women and 21.1% had cortical cataract223. In India, up to 48% had nuclear 
 except for individuals of African decent where cortical cataract is more common than nuclear *
cataract
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cataract and up to 21% had cortical cataract, while the Beijing Eye Study (BES) found 
the prevalence of any nuclear lens opacity to be 82.0% and that of any cortical lens 
opacity to be10.3%227,239. Some of these differences may reflect different grading 
systems. 
Figure 1.5: Increase in prevalence and incidence of cataract with age
This graph, adopted from Moreau at al. 2012240, illustrates the increase in prevalence (in %) of 
cataract as function of age (in years) for both sexes in for people of European (A) and African 
(B) ancestry (B). BDES – Beaver Dam Eye Study; BMES – Blue Mountains Eye Study; VIP – 
Visual Impairment Project; SEE – Salisbury Eye Evaluation.
1.7.2. Age and ethnicity
As with other age-related conditions, increasing age is by far the strongest known 
risk factor for cataract and both the prevalence (Figure 1.5.) and the incidence of 
cataract, including by type, increase with age166,221-232.
Partially because of differences in healthcare provision, cataracts tend to be more 
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lower than 50 years of age in Asians, Africans and Hispanics222,224,227,241,242. The reason 
for this is not clear but, given that genetic risk factors for age-related disease are 
usually largely shared across ethnic groups, greater lifetime exposure to environmental 
risk factors (eg. UV light, low antioxidant diets, biomass cooking fuels) is a likely 
contributor.
1.7.3. Sex
Irrespective of ethnic origin, cortical cataracts are more common in women than 
in men, while PSC cataract affects equally both sexes. The effect of sex on nuclear 
cataract is less clear. Several population based studies found that, after adjusting for 
age and various other confounders, female sex was associated with increased 
prevalence and incidence of both nuclear and cortical cataracts166,221,243. In contrast 
two other population based studies, the BMES and Barbados Eye Study (BAES), 
reported cortical cataracts only to have higher adjusted female prevalence223,244. Long-
reproductive life span (early menarche and/or late menopause) and the use of 
hormone replacement therapy (HRT) seem to have protective effect against 
cataractogenesis but the evidence is conflicting245-249. For example, in the BDES later 
age of menopause and longer HRT use were associated with decreased risk, while the 
Salisbury Eye Evaluation Project (SEEP) found a protective effect for nuclear cataract 
but not for cortical cataract and only in subgroup analysis245,247. The Nurses Health 
Study (NurHS), however, failed to find any association between current HRT and the 
presence of any type of lens opacity247. In the BMES, HRT use was not associated with 
5-year or 10-year incidence of any of the types of cataract but the use of contraceptives 
protected against cortical cataract (5-year incidence)248,249. Finally, a meta-analysis of 
these and other studies concluded that HRT use decreased the risk of developing any 
type of cataract for both population-based and case-control studies; and that current 
HRT use protected against nuclear cataract only250. In Asian women, inconsistencies 
similar to those in European women exist, with some studies finding a protective effect 
while others reporting increased risk251,252. 
The sex specific differences in cortical cataract risk mimic those in longevity and 
in other age-related traits (hypertension, cardiovascular (CVD) and neurodegenerative 
diseases, etc.)253-255. Sex-specific differences have been proposed to be biological in 
nature and driven by sex hormone levels143. In particular, low androgen, high estrogen 
and low testosterone levels seem to have protective effect in various conditions143. 
Furthermore, as exemplified by CVD, after menopause the risk is equal in both sexes 
or, as is the case with hypertension, women are at a higher risk than men256. These 
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findings do not imply that hormone imbalance does not play a role in disease aetiology 
in men but rather that, apart from baseline differences in concentration, there might be 
a difference in threshold effects between the sexes. It is known that prostate cancer 
patients treated with androgen inhibitors, have elevated incidences of diabetes, CVD 
and, interestingly, cataract 257,258. Regarding molecular mechanisms, it is unclear how 
exactly the sex hormones exert their effects in the lens but the receptors for all of them 
are present in both the animal and the human lens259,260. One possibility is through 
anti-oxidant effects (estrogen) or through the suppression of antioxidant defences 
(androgens, testosterone)261,262. Estradiol, the predominant form of estrogen, has been 
shown to protect cultured human lens epithelial cells (LEC) against oxidative 
stress263,264. Another possible mechanism in LEC relates to mitochondrial health. It has 
been demonstrated that estradiol causes rapid activation of extracellular signal-
regulated kinase (ERK1/2), a member of the mitogen-activated protein kinase (MAPK) 
survival signalling pathway, and that ERK2 silencing causes a dramatically increased 
membrane depolarisation of mitochondria 265,266. In mice, estrogen has also been 
shown to protect lenses against TGF-β induced cataract267,268. Finally, similarly to the 
results of epidemiological studies, the use of HRT in animal models of cataract and of 
other disease showing sex-specific effects has yielded conflicting results268,269. 
1.7.4. Tobacco smoking 
Tobacco smoke is a complex chemical mixture which can adversely affect human 
health through several mechanisms, discussed below. Tobacco smoking (smoking 
status, pack-years) has been extensively studied as a risk factor for ARC and some of 
the studies that explored the relationship between smoking and cataract will be 
discussed here. 
 The observation that smoking increases cataract risk was first noted in case 
control studies270,271. Later, several studies used case-control design to specifically look 
at different cataract subtypes. The Lens Opacities Case Control Study (LOCCS) found 
increased risk for nuclear cataract only, as did the Age-Related Eye Disease Study 
(AREDS)272,273. A Greek hospital-based study found association between smoking and 
both nuclear and PSC cataracts274. Further evidence was provided by prospective and 
cross-sectional population based studies. For example, The Reykjavik Eye Study 
(RES), a cohort study of comparable size, found association between smoking and 
nuclear cataract only while The Physicians Health Study (PHS) found increased 5-year 
incidence of nuclear and PSC cataracts in heavy smokers275,276. Finally, a recent meta-
analysis concluded that smoking statistically significantly increases the risk of nuclear 
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cataract (ORcohort [95%CI] = 1.7 [1.5-1.9], ORcase-control [95%CI] = 1.9 [1.5-2.4]), and that 
there was a marginally significant association with PSC but no association with cortical 
cataract277.
Dose-response and reversibility effects were also demonstrated. For example, 
the City Eye Study and Framingham Eye Study, found that heavy smokers had 
increased risk of nuclear cataract compared to light smokers278,279. In PHS, compared 
to smokers, past smokers had a statistically significant reduction in risk of cataract 
diagnoses and cataract extraction280. The effect, however, was primarily due to lower 
total cumulative dose, except for cataract surgery were there was a small dose-
independent effect280. Unlike cataract formation, the effects of smoking on cataract 
progression are not well understood. Only one study of modest size, the Chesapeake 
Bay Eye Study (CHBES), looked at progression and suggest that odds of progression 
increased for smokers versus ex- and non-smokers; and 18% increase in risk for each 
pack year of smoking281. 
Tobacco smoking also increases the risk of cataract formation in non-European 
populations, although this is predominantly based on results in Asian populations, as 
studies in African and Latin-American populations are scarce282,283. Similarly to the 
majority of studies in European ancestry populations, in individuals of Chinese ancestry 
smoking increases the risk of nuclear cataract formation only238,243,284. Studies in ethnic 
Indians285,286 and Malaysians287, found similar effects for nuclear cataract but, unlike 
the previous studies, they also found association between cortical cataract and 
smoking. For example, an Indian cross-sectional population based study, found that 
smoking increased the odds of nuclear and cortical cataracts, but not of PSC 
cataract285, while cross-sectional association between smoking and all the cataract 
types was reported by the Singapore Malay Eye Study (SiMES)287.
The molecular mechanisms behind the association between nuclear cataract and 
smoking are not extensively studied but it is assumed that the smoking-related 
increase in oxidative stress is responsible for the increase in nuclear cataract risk. It is 
well established, both in vitro and in vivo, that cigarette smoke induces reactive oxygen 
species (ROS), which in turn cause oxidative damage to lipids, proteins, and DNA288. In 
many cases, the initially generated reactive intermediates convert cellular constituents 
into second-generation reactive intermediates (e.g., acrolein, 4-hydroxynonenal) 
capable of inducing further cytotoxic and genotoxic damage, resulting in chain reaction 
of free radicals288. ROS are capable of activating numerous redox sensitive signaling 
pathways that modulate cellular responses, such as inflammation, which may itself 
result in the formation of endogenous oxidative species288. Further to the oxidative 
properties of cigarette smoke, smoking-related increase in the concentration of heavy 
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metals in the lens, has also been proposed to play role in cataractogenesis160,289-292. 
Those heavy metals are also prosed to increase oxidative stress damage by catalysing 
Fenton reactions290. 
Another possible mechanism for the effect of smoking on cataract is through 
epigenetic changes affecting crystallin expression or the expression of genes with 
antioxidant roles293-295. The field of lens epigenetics is relatively new but the ways in 
which smoking cases epigenetics changes have been extensively studied in other 
conditions. Smoking has been consistently shown to trigger genome-wide epigenetic 
changes in methylation levels296,297. For example gene enrichment analysis have 
shown smoking related epigenetic changes (either hyper- of hypomethylation of CpG 
cites) to be more common in genes associated with coronary heart disease risk factors 
(hypertension, lipid levels), pulmonary traits and cancer298. Another example is multiple 
sclerosis where smoking-associated hypomethylation has been detected at the aryl 
hydrocarbon receptor gene CpG299. The aryl hydrocarbon pathway is known to exert 
environmental control on the immune response and, in particular, on neuronal 
inflammation 299. 
1.7.5. UV radiation
Studies looking at a link between exposure to UV radiation, especially UV-B, and 
cataract formation had varying degrees of success. UV radiation has repeatedly been 
reported as a risk factor for cortical cataract formation but the picture for the other types 
of cataract is less clear300-304, and defining exposure or disentangling the roles of the 
different light wavelengths is tricky.  
The first study to look at the relationship between UV radiation exposure and 
cataract in two population-based surveys (the Model Reporting Area for Blindness 
Statistics and the National Health and Nutrition Examination Survey 1971–1972) noted 
that the ratio of cataract cases to controls was significantly higher in areas with large 
amounts of sunlight for people aged 65 and older305. A later study, using the Medicare 
claims data, found that the odds of cataract surgery were also higher in southern than 
in the northern states306. Moreover, The Alienor Study found subjects in the upper 
quartile of lifetime ambient UVR exposure to be at increased risk for cataract 
extraction307.
Contrary to those findings, case-control studies have mostly failed to find an 
association272,308-311 but this can be due to small sample-size, the ways used to 
calculate exposure, and selection bias. An exception is the RES where more than 4 
hours outdoor daily exposure before the age of 50 was associated with increased risk 
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of moderate and severe cortical cataract312. Interestingly, a cross-sectional population-
based study of Finnish individuals approximately at the same latitude as Reykjavik, 
albeit much older (≥70 years), did not find an association313. Studies from Australia 
showed that the risk of cataract increases with higher UV radiation dose in populations 
of both Aboriginal314,315 and European descent316. These results have been supported 
by several other studies316-322.   
As UV radiation increases with increase in altitude, a positive association 
between altitude and cataract formation can be expected. Indeed, several studies have 
found increased cataract prevalence at higher altitudes323-327 but there have also been 
some conflicting results. A study in Punjabis found less cataract in people living in the 
regions at higher than at lower altitude, and a study in Nepal found that cataract 
prevalence was negatively correlated with altitude but positively correlated with sunlight 
exposure328,329. The first study was of moderate size but the difference in altitude 
between the sampling locations was small, and cloud cover, which seems to have a 
protective effect330, may have biased the results. The discrepancy in the second one is 
more interesting but may point to population specific high-altitude adaptation 
differences331,332.  
The cataractogenic effects of UV-light have been studied in animal models and 
those studies suggest that UV light can cause lens damage in various ways. UV light 
(both UVA and UVB) has oxidative properties333. Lenses of mice who were exposed to 
UV light showed increase in oxidative stress markers334. GSH level and glyceraldehyde 
3-phosphate dehydrogenase activity decreased while mixed disulfides concentration, 
thioltransferase and thioredoxin activity increased334. UV-B irradiation caused changes 
in lens proteins such as side chain oxidation and polypeptide cleavage of γD-crystallin 
and βL-crystallin; and formation of cross-linked βL-crystalline aggregates335. These 
changes led to the occurrence of amorphous crystalline aggregates and of amyloid 
fibres335. Furthermore, AGEs are proposed to be important contributors during cataract 
development due to their cross-linking properties333. UVA radiation excites kynurenine 
to photo-oxidised ascorbate and reduces ascorbate which in turn can forms AGEs336. 
UVA seems also to increase apoptosis in animal models. Exposure of high doses of 
UV-light induced apotheoses in rodent LEC and the LEC’s phagocytic capabilities were 
lost337,338. The apoptosis caused intracellular calcium ion (Ca2+) elevation, inhibited 
Ca2+-ATPase activity and decreased the expression of PMCA1, a plasma membrane 
calcium, with a role in calcium homeostasis339. This suggests that PMCA1 may play 
important roles in UVB-induced cell apoptosis339. Finally, UVB exposure in mice was 
associated with intraocular inflammation and increase in concentration of circulating 
Interleukin-1b and interleukin-6340. 
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1.7.6. Dietary factors and alcohol consumption
The majority of epidemiological studies, discussed below, explored the 
relationship between cataract and diet focusing on specific dietary factors (e.g. vitamin 
C) and data on diet types or intake of food groups is less studied. As opposed to 
macronutrients and vitamins, the role of dietary minerals in cataract formation is poorly 
understood341-345, with only iron, calcium, zinc and coper proposed to have some 
effect272,330,341,343,346.
Regarding alcohol consumption, the different studies show inconsistent direction 
of effect per cataract type. For example, in the NurHS, the odds of nuclear opacity 
increased by 30% for each 10g increase in total alcohol intake, after adjustment for age 
and vitamin C intake, but there was no statistically significant relationship between 
alcohol intake and cortical cataract153. Conversely, in the BMES cohort moderate 
alcohol consumption was associated with reduced prevalence of cortical cataract but 
there was no association with nuclear cataract347. There results of the different studies, 
however, are not always consistent and several studies report no association for any of 
the cataract types166,225,348,349. Similarly, studies that focused on cataract extraction can 
be divided into those that find alcohol is a risk factor350 and those that either find no 
association341,351,352 or a protective effect353. Furthermore, a recent meta-analyses 
failed to show any association between alcohol consumption and ARC354,355. Similarly 
to the evidence from the epidemiological studies, there is lack of molecular evidence 
for a causative role of ethanol on cataract formation. It seems that, while alcohol-
derived sugars play a role in certain types of cataracts (eg. galactosemic356 or diabetic 
cataracts140), they probably do not in the common forms of ARC.  
Macronutrients: The results of several small studies have proposed high 
carbohydrate intake to be associated with an increased risk of developing cortical 
cataract357-359. However, several larger studies found no cross-sectional or longitudinal 
association between carbohydrate intake and cataract343,360,361, while a small Greek 
hospital case-control study even found carbohydrates to protect against any 
cataract362. Finally, a recent meta-analysis study, found only a marginal association 
(OR [95%CI] of 1.4 [0.99-1.9]) between carbohydrate intake and cortical cataract363. It 
has been suggested that an association between carbohydrates and cataract could be 
driven by fibre intake, however fibre seems not to influence the risk of cataract, except 
possibly of PSC343,361,364.
 Another way to approach the problem of whether carbohydrates influence 
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cataract pathogenesis is to use the glycemic load as a predictor. The glycemic load is 
the weighted average of the glycemic indices of individual foods, multiplied by the 
percentage of energy as carbohydrate365. The glycemic index is the incremental area 
under the glucose response curve after a standard amount of carbohydrate from a test 
food relative to that of a control food (either white bread or glucose) is consumed366. In 
AREDS, dietary glycemic index was associated with a higher prevalence of all pure 
nuclear opacities358. The BMES found a nominally significant association between the 
glycemic index and 10-year incidence of cortical cataract but not between the glycemic 
load and the incidence of other cataracts360. Several other studies either failed to find 
effect of glycemic load/index on cataract or found marginal effects, without dose-
response associations357,367. An Italian case-control study found an association 
between glycemic load and cataract extraction, while, a much bigger study using 
combined data from the NurHS and the Health Professionals Follow-Up Study did not 
find an association between glycemic load and cataract extraction368,369. Wu et al., after 
performing meta-analysis, concluded that there was association between higher 
glycemic index and nuclear cataract risk (OR [95%CI] of 1.23 [1.03-1.46]) and a 
significant dose-response relationship between carbohydrate intake and the risk of 
cortical cataract363.
Very few studies looked at the association between protein intake and cataract. A 
retrospective analysis in the BMES, indicated that subjects who consumed a median of 
99.2g of protein per day had a 50% reduction in risk of prevalent nuclear cataract 
compared with those in the first quantile (62.3g) of protein intake343. In the same 
population, high protein consumption was associated with PSC incidence only361. A 
similar cross-sectional effect was found in Chinese subjects359. In EPIC, however, high 
intake of protein was associated with increased risk of cataract formation370. High 
protein intake was also associated with higher risk of cataract in an Indian study328.    
Finally, although various studies explored the relationship between fat intake and 
cataract, relatively few associations have between reported. The EPIC study reported 
increased risk of any cataract with elevated blood levels of cholesterol364, while the 
prospective SUN cohort had decreased risk for any cataract in people who consumed 
high levels of polyunsaturated fatty acids (PUFAs)371. The BMES found cross-sectional 
protection of PUFAs for cortical cataract343 and, also that omega-3 PUFAs were 
protective against nuclear cataract incidence361. Conversely, in the NurHS (Boston 
Area) high total intake of PUFA resulted in 2.3-fold increased risk of nuclear cataract 
but this could have been driven by a strong negative association between linoleic acid 
intake and nuclear cataract372,373.
Vitamins and carotenoids: The role micronutrients play in cataract formation 
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has also been studied. Given that, as discussed later, oxidative stress is proposed to 
play an important role in cataract pathogenesis, studies have mostly focused of the 
effects of dietary antioxidants (vitamins C, E, and A, carotenoids) and vitamins in 
general. 
Three strategies have been deployed when studying the effect of vitamin C on 
cataract formation. These are measuring: dietary vitamin C intake272,374-378; serum 
vitamin C concentrations375,376,378-380, and vitamin C supplementation375,377,381. 
Randomised clinical trials of supplement have also been performed382-384. These 
studies sometimes have conflicting results, as discussed below, but in most studies, 
vitamin C intake does seem to protect against nuclear cataract formation. Furthermore, 
vitamin C has also been found protective against cataract progression385,386. The 
LOCCS looked at all three types of cataract but found vitamin C intake to be protective 
against nuclear cataract formation only272. Similar results were obtained by a Spanish 
case-control study376, while an American-Italian clinical trial found protective effect at 
baseline for both nuclear and PSC cataracts380. Inverse association between vitamin C 
intake and cataract formation have also been found in population based studies. The 
NurHS found that intake of vitamin C was associated with lower prevalence of nuclear 
opacities only  and a protective effect of long term (>10 years) intake of vitamin C 
supplements375. The BMES explored the association between incidence of cataract 
and vitamin intake, and found that vitamin C intake or combined antioxidants (vitamins 
C and E, β-carotene, and zinc) reduced cataract incidence377. However, other 
prospective cohort studies and randomised clinical trials have found no effect 
overall374,379,382-384,387 or protective effects only in subgroups374,387. Somewhat 
surprisingly, given the rest of the literature, two Danish population based studies found 
long term vitamin C supplementation to increase cataract risk388,389. With the exception 
of two studies376,378, vitamin C intake seems not to be associated with cortical cataract. 
Finally, a meta-analysis of 20 studies for vitamin C intake and 10 studies for serum 
ascorbate, concluded that vitamin C intake reduced the risk for any cataract (RR 
[95%CI] = 0.81 [0.71-0.94]), as well as for nuclear and PSC cataracts390. The 
association between vitamin C intake and cataract was primarily driven by the case-
control studies, and the studies in Americans and Asians. An inverse relationship 
between cataract and serum ascorbate was found irrespective of study design or 
geographic location (RR [95%CI] of 0.70 [0.56–0.88])390. 
Ascorbate (vitamin C) is found at high levels in the lens where it is capable of 
quenching oxygen and, in addition, acts as a strong reductant and scavenger of 
ROS391-393. Ascorbate has been shown to decrease membrane damage in diabetic rats 
and photoperoxidation of lens membranes394,395. Furthermore, ascorbic acid prevents 
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light-induced damage to cation pumps in the lens; plays a role in lens development and 
maintenance of transparency during development; and has been shown to protect the 
rat lens against selenite-induced cataract396. Lenticular levels of ascorbate declined 
with age and the ratio of ascorbate to dehydroascorbate decreased in cataractous 
lenses compared to clear lenses396. Finally, aside from its reducing properties, ascorbic 
acid is also essential for collagen synthesis and has anti-inflammatory properties397.
Vitamin E encompasses a family of molecules known as tocopherols, of which α-
tocopherol (highly concentrated in olives and sunflower seeds) is the most biologically 
active. It is also the major tocopherol in the European diet, whereas γ-tocopherol (soy, 
corn) is the major tocopherol in the American diet163. Compared to both vitamin C and 
A, the role of vitamin E in cataractogenesis is more uncertain and the majority of 
studies did not find an association between dietary vitamin E and cataract or, when 
they did, it was only in univarable analyses343,374,376,398,399. A recent meta-analysis of 27 
studies, however, concluded that vitamin E intake was protective against cataract 
formation (OR [95%CI] = 0.73 [0.58-0.92]), as were supplementation and serum 
levels400. The pooled odds in this analysis was calculated using the odd ratios for 
different types of cataracts and any cataract together which may not be optimal. 
Vitamin E supplementation and vitamin E plasma levels appear to have protective 
effects375,379,381,385,386. In the NurHS, high levels of vitamin E in plasma and duration of 
vitamin E supplementation were inversely associated with reduced risk of nuclear 
cataract cross-sectionally375. Moreover, in the same cohort duration of vitamin E 
supplementation decreased the 5-year incidence of nuclear cataract386. Similarly, 
Robertson et al. found supplemental vitamin E to be associated with reduced risk of 
cataract, while Vitale et al. found high levels of plasma tocopherol to be associated with 
reduced risk of nuclear cataract379. Meta-analysis also found tocopherol in plasma to 
be inversely associated with cataract (OR [95% CI] = 0.75 [0.58-0.96])401. Similarly to 
vitamin C, in randomised clinical trials, vitamin E supplementation alone or in 
combination with other vitamins failed to find an effect302,382,383,402,403. Finally some 
studies have reported an increased risk of cataract in association with vitamin E intake. 
In the MVIP and  BMES cohorts, vitamin E intake was associated with an increase in 
PSC cataract risk166,377. Furthermore, in BMES, high vitamin E levels were also 
associated with increased prevalence of cortical cataract, and of any cataract377. 
Vitamin E functions as a lipid antioxidant and a free radical scavenger, and may 
help to maintain GSH levels and to reduce protein–protein linkages in the lens404,405. 
There is evidence suggesting that vitamin C recycles vitamin E from α-tocopheryl thus 
pointing to synergetic relationship between the two vitamins396. The delaying or 
preventive effect of vitamin E on cataractogenesis has been shown in galactose 
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cataract mouse models but, just as with the epidemiological studies, vitamin E 
supplementation in mice models of idiopathic ARC showed mixed results396. Moreover, 
a recent study in humans has suggested that there is no correlation between the 
concentration of vitamin E in lens and blood (plasma or red blood cells) and, thus, that 
plasma α-tocopherol may not be a clinically relevant marker for cataract risk406.
As discussed below, the role of other vitamins in protecting against cataract 
formation has been addressed trough epidemiological studies but, as opposed to 
vitamin C and E, the molecular effects of all those vitamins on cataract formation are 
very poorly understood.
Vitamin A is a group of unsaturated organic compounds that includes retinol, 
retinal, retinoic acid, and several provitamin A carotenoids (α-carotene, β-carotene, and 
β-cryptoxanthin). The majority of studies that explored the effect of vitamin A have 
shown an inverse association with cataract, except for a study in the EPIC cohort 
where high intake of vitamin A was associated with increased risk of “any” cataract364. 
As with vitamins C and E, supplement trials of vitamin A have largely failed to find an 
effect382. To illustrate this, the BMES showed dietary vitamin A to protect against 
nuclear cataract formation343, while in the BDES that was true only for men407. In the 
same cohort, participants who supplemented with vitamin A had a reduced risk of 
cortical cataract346. In the POLA study, higher plasma retinol level was associated with 
decreased relative risk for nuclear cataract, mixed cataract, and cataract extraction408. 
In a cross-sectional study of the North India subset of INDEYE, blood levels of retinol 
had a protective effect against nuclear cataract only and that was also true for β-
carotene409. In the South India subset of INDEYE, retinol protected against PSC (and 
“any” cataract)378. Gale et al. found that α-carotene decreased the risk of nuclear 
cataract in British women (aged 66-75 years) living in Sheffield410. Finally, meta-
analyses on the effect of dietary, supplemental and plasma antioxidants on cataract 
found retinol , dietary β-carotene and plasma α-carotene to be inversely associated *
with cataract401,411.
The B vitamins are water soluble organic compounds that play important roles in 
metabolism but only vitamins B1-3, B9 and B12 have been studied in relation to 
cataract. Cumming et al found 3 of the B vitamins to be inversely associated with 
nuclear cataract343. Similar results but in men only were obtained in the BDES 
cohort407. Jacques et al. found the intake of the three B vitamins was inversely 
associated with nuclear cataract progression; and that dietary B9 (folic acid/folate) was 
protective against nuclear cataract formation375,386. In the AREDS cohort niacin 
 dietary, supplemental and plasma*
 51
Chapter 1: Introduction 
protected against incident (10 years) nuclear cataract412. Sen et al. found decreased 
blood levels of folate and vitamin B12 (cyanocobalamin) in cataract patients compared 
to controls413. Moreover, a combination of niacin and riboflavin protected against 
nuclear cataract formation (44% reduction in prevalence) in a supplementation trial, 
albeit in a poorly nourished population414. Regarding the other two types of cataract, 
the association between dietary intake of vitamins of the B group and cortical cataract 
is unclear and there seems to be no association between these vitamins and PSC 
cataract. Indeed, The LOCCS was the only study to find an inverse association 
between riboflavin and niacin and, in this case, pure cortical cataract272. Finally, in 
AREDS cohort vitamin B12 was associated with decreased risk of incident cataract412.
The role of vitamin D in relation to cataract is poorly studied and that of vitamin K 
not at all. In a secondary analysis of a randomised trial of the Mediterranean diet , high 
intake of dietary vitamin K1 was associated with a reduced risk of cataract surgery in 
Spanish men and women (mean age at baseline of 66.3 years)415. The Korea National 
Health and Nutrition Examination Survey suggested that high serum 25-hydroxyvitamin 
D levels are protective against cataract in men but not in women345. In the Carotenoids 
in Age-Related Eye Disease Study (CAREDS), an ancillary study of the Women's 
Health Initiative, serum 25-hydroxyvitamin D levels were not associated with nuclear 
cataract either416.
Finally, carotenoids are more than 400 organic pigments that are produced 
predominantly by plants. The major carotenoids in the eye are lutein and zeaxanthin 
and they likely protect against cataract formation. The majority of studies on 
dietary417,418 or plasma409,410,419,420 carotenes report estimates that, although not 
statistically significant, point to protective effects overall or in subgroups. The couple of 
studies that do report statically significant protective effect are discussed here. In the 
BDES dietary lutein, and in the AREDS and CAREDS studies a combination of dietary 
lutein and zeaxanthin, were inversely associated with nuclear cataract374,421. A Finish 
population-based study found that individuals with high plasma lutein (> 0.27μmol/L) 
and zeaxanthin (>0.041μmol/L) were protected against nuclear cataract formation422. 
Similarly, in the CAREDS cohort, plasma lutein plus zeaxanthin were inversely 
associated with lower nuclear cataract risk421. Gale et al., reported an inverse 
association between plasma lycopene and cortical cataract410. In INDEYE, both plasma 
lutein and zeaxanthin were inversely associated with “any” cataract378. Finally, meta-
analyses of studies that looked at plasma antioxidants concluded that lutein (OR 
[95%CI]: 0.75 [0.65-0.87]) and zeaxanthin (OR [95%CI]: 0.70 [0.60-0.82]) but not 
lycopene (OR [95%CI]: 0.86 [0.65-1.15]) protect against cataract formation; and that 
there was a dose-response relationship401,423. 
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Analogous to the macula, lutein and zeaxanthin are the only carotenoids present 
in the human lens but at substantially lower concentration in the lens relative to the 
macula424. The molecular mechanisms behind their association with cataract are not 
well studied but, similarly to the macula, they are hypothesised to serve as high energy 
blue light filters and as functional antioxidants424.
In summary, diet seems to have stronger effect on nuclear opacities than on the 
other types of cataract and, not surprisingly, all dietary effects seem much stronger in 
malnourished as opposed to well-nourished populations. In addition, the relationship 
between cataract and metabolic syndrome (discussed later), may partially be mediated 
by dietary factors. Although studying separate nutrients have been successful, little 
attention has been given to diets as a whole364,425-428. Each nutrient can be confounded 
by other nutrients and other confounders of a “healthy” diet as a whole, so measures of 
the overall diet may be a better measure of its effects, and studies in, for example, 
cardiovascular disease have recently concentrated on dietary indices rather than 
individual subcomponents429-431. Given the few studies to date that looked at entire 
diets or dietary indexes, I intend to study the role of diet on cataract formation in 
TwinsUK.
1.7.7. Type 2 Diabetes and metabolic syndrome 
Diabetes and cataract occur more often together than by chance, and T2D is 
associated with increased risk of developing cataract432,433. In the NurHS presence of 
T2D was associated with higher risk of developing PSC, but neither diabetes nor 
measures of adiposity were related to the prevalence of cortical and nuclear 
opacities434. BDES reported an increased prevalence of PSC in diabetics but there was 
also an association with cortical cataract435. In the same cohort, T2D was associated 
both with increase in 5-years incidence and with progression of cortical and PSC 
cataracts436. In the MVIP cohort, T2D duration was cross-sectionally associated with 
cortical and nuclear cataract but not with PSC cataract166. Other studies, that explored 
the association between T2D and cortical284,437-439, nuclear438,440,441 and PSC284 
cataract, found similar results. Furthermore, T2D is also found to be a risk factor for 
cataract formation in individuals of non-European descent; and diabetics with Asian 
and African descent have a slightly higher risk than non-diabetics284,437. Finally, meta-
analysis of T2D in cataract, involving 8 population-based studies, concluded that the 
risk of cortical cataract and PSC cataract (OR [95% CI]: 1.68 [1.47-1.91]) and 1.55 
[1.27-1.90] respectively) but not of nuclear cataract (OR [95% CI] = 1.36 [0.97-1.90]) 
was significantly higher in T2D patients432. In addition to T2D diagnoses, impairments 
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in glucose tolerance442-444 and fasting glycaemia440, high glycated haemoglobin283,443,444 
and poor glycaemic control283,408,439,445,446 may also increase cataract risk.
From a molecular biology prospective, there can be several links between diabetes 
and cataract, again including oxidative stress. As a consequence of impaired glucose 
metabolism in diabetes, the activity of aldose reductase (the enzyme responsible for 
fructose formation from glucose) increases447. That then leads to increased activity of 
the sorbitol pathway and intracellular sorbitol accumulation in the lens; resulting in 
osmotic stress447. Imbalances in glucose metabolism, in the absence of T2D, that lead 
to osmotic stress may similarly be a driving force in the development of cortical 
cataract. Accumulation of AGEs is also increased in both diabetic and ARC43,447. More 
importantly, diabetes increases oxidative stress and oxidative stress is the one of the 
main drivers behind ARC447. Thus, recently, the NRF2-Keap1 signal transduction 
pathway, one of the main cellular defence mechanisms against oxidative stresses, has 
been proposed as a target for prevention of both age-related and diabetic cataracts448. 
Given the role of T2D in cataract, a question about the role of metabolic 
syndrome of cataract formation arises. Metabolic syndrome is defined as a cluster of 
risk factors for cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2D) which 
occur together more often than by chance alone449. These risk factors are: 
hypertension, dyslipidemia (raised triglycerides and lowered high-density lipoprotein 
cholesterol), raised fasting glucose, and central obesity449. Even though CVD, T2D and 
their underlying risk factors have been associated with eye diseases450, the relationship 
between metabolic syndrome and the ageing eye has only recently been 
addressed450-452. Other lines of evidence connecting metabolism with ocular health are 
the eye manifestations (e.g. cataract, glaucoma) of inherited metabolic disorders453.   
In population-based cross-sectional studies, metabolic syndrome was associated 
with increased cataract prevalence454,455, albeit only in certain subgroups of 
participants. An increased risk of cataract surgery was observed in a hospital-based 
case-control study456 and in a prospective cohort457. A population-based incidence 
study in BMES showed that the presence of metabolic syndrome at baseline was 
associated with statistically significant increase in 5-year-incidence of cortical cataract, 
suggestive increase in PSC and no change for nuclear cataract458. The same study did 
not find any increase in 10-year-incidence for any of the cataract subtypes458. An earlier 
larger study in the same population, however, did find an increase in risk of all three 
cataract subtypes for cortical, nuclear and PSC respectively440. The association 
between metabolic syndrome and cataract is present in Asian populations, too. In the 
SiMES cohort, cortical cataract was also significantly associated with metabolic 
syndrome459. The study did not find an association with nuclear cataract or PSC 
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cataract but this could have been partially due to fewer affected individuals in those 
groups459. While a Korean population based study found association between 
metabolic syndrome and cortical cataract in women but not in men and the inverse was 
true for nuclear cataract460. Finally, a dose–response relationship was also observed 
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Age-related cataract is a complex trait and to prevent or delay its onset, or to 
develop new therapies for cataract, a better understanding of the genetic and 
environmental factors and of how these factors interact is required. In addition, it is 
increasingly clear that pathogenesis of ARC is intertwined with systemic factors related 
to ageing and holistic approaches taking into account the systemic nature of the 
cataract risk factors are needed. High-throughput 'omics' technologies have recently 
become available and affordable, and are enabling detailed studies of the molecular 
changes and biological pathways involved in ageing processes461. Their use in ARC 
research is long overdue. Utilisation of omics is likely to improve our capability to 
identify accurately molecular mechanisms leading up to cataract formation in the 
ageing eye. This current thesis describes the implementation of various Omics 
platforms to:
Aims: This thesis aims to explore the genetic variants underlying the 
pathogenesis of the common forms of ARC. In addition the role of diet on cataract 
formation and progression is also explored.
Hypotheses:
There exist genetic variants associated with age-related nuclear cataract.
There exist genetic variants associated with age-related cortical cataract.
Age-related nuclear and cortical cataracts share genetic risk factors.
Cataract progression is heritable. 
Dietary factors are associated with cataract progression.
Healthy diet is inversely associated with at least one ARC type.
There exist metabolite, measured in blood, that are associated with healthy diets 
and those are inversely associated with cataract severity for at least one ARC type.
There exist gut microbes that are associated with healthy diets and those are 
inversely associated with cataract severity for at least one ARC type.
The association between healthy diet and ARC is mediated by the effects of 
metabolites or the gut microbes.
Objectives: 
1. Explore whether nuclear and cortical cataract share genetic risk 
factors 
2. Identify common genetic variants associated with ARC by performing 
genome-wide association studies and the meta-analysis of those studies 
3. Identify whether low frequency and rare genetic variants from whole-
genome sequencing data are associated with ARC 
4. Estimate the heritability of cataract progression. 
5. Determine what nutritional factors underlying cataract progression.
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6. Identify correlation of dietary scores with cataract severity and explore 
related metabolome or microbiome signatures 
7. Determine if the dietary effects are mediated through circulating 
metabolites or the gut microbiome
The findings of this thesis will be presented as follows. In Chapter 3 the cohorts 
that contributed data to the analysis presented in this thesis will be introduced. The 
data collection I have performed in two of the cohorts (TwinsUK and the Rotterdam 
Study) will also be described. In Chapter 4 I explore whether the two most common 
types of ARC share genetic risk factors with each other or with other age-related 
diseases. This is done by using various methods for calculating heritability. Then, the 
role that common and rare genetic variants play in nuclear and cortical cataract 
formation is determined by GWAS and burden tests. The common variant analyses 
were done using two cohorts of European ancestry — TwinsUK and Rotterdam Study, 
while the rare variant analyses were done using TwinsUK data only. In Chapter 5 multi-
ethnic meta-analysis of nuclear cataract GWAS are presented. In Chapter 6 the 
following is explored: 1) the effect of micronutrients intake on cataract progression; 2) 
whether the effect of diets on cataract formation might be mediated through changes in 
blood metabolites or the gut microbiome. In the final chapter (Chapter 7), the findings 
reported in each chapter are drawn together and the overall implications of this thesis 
are discussed.
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3.1. Introduction 
To aid the understanding and interpretation of the analysis and results presented 
in the later chapters of this thesis, the cohorts which provided data used in the thesis 
will be introduced in the present chapter. Here the focus will be on the methods and 
quality control (QC) steps that were undertaken in order to obtain the various omics 
datasets that I have used for my analysis. Unless stated otherwise, the data has been 
provided to me in its final QCed form by my colleagues from the Department of Twin 
Research and Genetic Epidemiology or from the studies that took part in the 
International Cataract Genetics Consortium. 
In addition to the above, I will describe my efforts in terms of data collection for 
two of the cohorts — TwinsUK and the Rotterdam Study; and I will present basic 
summary statistics for the phenotypes I obtained through those efforts. 
  
3.2. Twins UK 
3.2.1. Cohort description
The TwinsUK cohort is an adult unselected twin registry of over 13,500 British 
twins (including a small sample of parents and siblings, number of individuals 
(N)=1,883) recruited from the general population, through national media campaigns in 
the United Kingdom, and representative to the broader population in terms of disease-
related and lifestyle characteristics (http://www.twinsuk.ac.uk)462-465. The registry was 
initiated in 1993 and is still actively recruiting participants. At present over 9,000 twins 
are actively participating. The twins have a mean age of 55 year (range: 16-100 years) 
and the ratio of monozygous to dizygous twins is approximately 1:1. The twins are 
predominantly female (80%) of white British ancestry (80%) for historical reasons: the 
original aim of the registry was to allow investigation of osteoporosis and osteoarthritis, 
conditions with higher prevalence in women463. Since then, the TwinsUK studies have 
focused on the genetic basis of complex diseases (cardiovascular, metabolic, 
musculoskeletal, and ophthalmologic diseases), which has broadened to include the 
complex healthy ageing process. In addition twins of ethnically diverse backgrounds 
are now actively recruited. Clinical, physiological, behavioural and lifestyle data is 
collected at either twin visits to the DTR or via self-administered questionnaires, which 
volunteers complete either once or twice a year via the post or email (Figure 3.1., 
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Table 3.1.). Longitudinal data is available for a wide range of the phenotypes. All the
Figure 3.1. Phenotypes available in the TwinsUK cohort
This 
figure  summarises the different phenotypes available in the TwinsUK cohort. The ✝ symbol *
denotes phenotypes measured in all participants. WCC — white blood cell count; DXA — Dual-
energy X-ray absorptiometry; CV — cardiovascular; ECG — electrocardiogram; IBS — 
inflammatory bowel disease;  OA – osteoarthritis; OB & GYN — obstetrics and genealogy; SF36 
 adopted from http://www.twinsuk.ac.uk/data-access/cohortdata-description/*
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—The Short Form (36) Health Survey; GHQ — General Health Questionnaire; SES — 
socioeconomic status.
studies in the TwinsUK cohort were performed with the approval of the Guy’s and St 
Thomas’ Ethics Committee, and participants signed a written informed consent in 
accordance with the Declaration of Helsinki.
3.2.2. Omics data
Apart of the detailed phenotyping, a strength of the TwinsUK cohort is the 
availability of data from several ‘omics’ technologies (Table 3.1.). These include 
genome-wide scans of single nucleotide variants, next-generation sequencing, exome 
sequencing, epigenetic markers (both chip and sequencing), gene expression (arrays 
and RNA sequencing), telomere length measures, metabolomics (Metabolon and 
nuclear magnetic resonance (NMR) platforms), and gut flora microbiome.
Genotyping and imputation of single nucleotide polymorphisms (SNPs) : *
The genotyping QC, imputation and post-imputation QC for the TwinsUK cohort were 
performed by Dr. Massimo Mangino, Dr. Pirro Hysi, Dr. Nicole Soranzo and Dr. 
Abhishek Nag. TwinsUK participants were genotyped using a combination of four 
Illumina arrays (HumanHap300, HumanHap610Q, 1M‐Duo and 1.2M-Duo). The probe 
intensity data was normalised and pooled for each of the three arrays separately (with 
1M‐Duo and 1.2M-Duo 1M pooled together). For each dataset the Illluminus calling 
algorithm was used to assign genotypes466. No calls were assigned if an individual's 
most likely genotype was called with less than a posterior probability threshold of 0.95. 
Validation of pooling was achieved via a visual inspection of 100 random, shared SNPs 
for overt batch effects. Finally, intensity cluster plots of significant SNPs were visually 
inspected for dispersion biased no calling, and/or erroneous genotype assignment. 
SNPs exhibiting any of these characteristics were discarded. The following exclusion 
criteria were applied to each of the three datasets separately. Samples were excluded 
if sample call rate was lower than 98%, heterozygosity across all SNPs was equal to or 
higher than 2 standard deviations (SD) from the sample mean; evidence of non‐
European ancestry as assessed by principal component analysis (PCA) in comparison 
to HapMap3 populations; observed pairwise identity by descent (IBD) probabilities 
suggestive of sample identity errors. Furthermore, misclassified monozygotic and 
dizygotic twins were corrected based on IBD probabilities. Variants were excluded if: 
 includes small indels*
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the p‐value  for deviation from Hardy‐Weinberg Equilibrium (HWE)*
Table 3.1. Summary of available Omics data in the TwinsUK cohort 
The table summarises the TwinsUK omics data gathered through various studies. The number 
(N) of samples measured and the platforms used for each omics type are listed. UK10K — UK 
10,000 genomes project; GOT2D — Genetics of T2D consortium; HLI — Human Longevity Inc.; 
MuTHER — Multiple Tissue Human Expression Resource; ESRC — Economics and Social 










Illumina 7x 1,800 UK10K
Illumina 30x 2,000 TwinsUK/HLI
Illumina 4x 325 GOT2D
Exome sequencing Illumina 4x 925 GOT2D
Transcriptomics
Illumina HT12 array 850 (Blood/Adipose/Skin) MuTHER
RNA-seq 800 (4 tissues)/ 130 (3 time-points) MuTHER/SystemoTwin
Micro RNAseq 180
Epigenetics 
Illumina 450K array 900 xBlood/600 xAdipose/400 xSkin Epitwin/MuTHER
Illumina 27K array 170
Epitwin
MeDIp Seq 4,000
Illumina EPIC 500 ESRC
Metabolomics Biocrates 1,200
Metabolome 6,400/ 2,050 (3 time points) TwinsUK/HLI





Microbiome 16S (x10K) from Gut 5,494 (2,731) Flora
16S salivary/urinary
Metagenomes 1,250 BGI/HLI
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Research Council; NMR — nuclear magnetic resonance; $ datasets with N>100 only; * untyped 
twins from MZ-twin pairs were added as copies of the typed co-twin’s genotypes.
was less than 1x10-6; the minor allele frequency (MAF)* was less than 0.01; SNP call 
rate was less than 97% for SNPs with MAF≥5% or less than 99% for SNP with MAF 
between 1% and 5%. Alleles of all three datasets were aligned to HapMap3 forwards 
strand.
Figure 3.2. Summary of genotyping platforms used in the TwinsUK cohort
This figure shows the breakdown of people genotyped on each array in the final merged 
TwinsUK data-set of genotypes, as well as the overlap in number of samples between arrays. 
None of the samples were genotyped on all three arrays. Light blue circle — Illumina 317,000 
SNPs array; Light red circle — Illumina 610,000 SNPs array; Light green circle — Illumina 
1,000,000 Duo and 1,200,000 Duo arrays. 
The data from the three platforms was merged keeping individuals typed at the 
largest number of SNPs when an individual was typed with two different arrays (Figure 
3.2.). Prior to merging, the following pairwise comparisons among the three datasets 
were performed and, further SNPs and samples were excluded to avoid spurious 
genotyping effects. Samples and SNPs were excluded if: the concordance at duplicate 
samples was lower than 99%; the concordance at duplicate SNPs was less than 99%; 
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pairwise dataset comparisons with array as the phenotype; the SNP HWE p‐value  was*
1x10-6; observed pairwise IBD probabilities were suggestive of sample identity errors. 
The final dataset contained 5697 individuals and 918,282 SNPs.
Figure 3.3. Quantile-quantile plots for pairwise array comparisons 
This figure, courtesy of Dr. Manigino, shows the quantile-quantile (QQ) plots for models where 
genotyping array was used as binary phenotype and genetic variants were used as predictors. 
These analyses were done in unrelated individuals only. Black and green dots denote p-values 
prior and after the exclusion of discordant SNPs and individuals respectively. A) 317K versus 
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The TwinsUK cohort has been imputed against three different reference panels: 
HapMap3, 1000 Genomes (1000G) project, and the Haplotype Reference Consortium 
(HRC) panel. In the present thesis only data imputed against the 1000 Genomes 
reference panel was used. Therefore, the imputation and QC procedures only for this 
particular dataset will be presented here. The 918,282 SNPs that passed genotyping 
QC were imputed against the full (world) panel of individuals (Phase 3, version 2014) of 
the 1000G project. The “HRC/1KG Imputation Preparation and Checking Tool” (version 
4.2.5, http://www.well.ox.ac.uk/~wrayner/tools/) was used to check input data for 
accuracy relative to 1000G inputs prior to imputation. This process identified errors in 
the original data, including incorrect REF/ALT designations, incorrect strand 
designations, extreme deviations from expected allele frequencies, and palindromic (A/
T and G/C) SNPs with allele frequency near 0.5 that are often the source of imputation 
errors. The problematic variants identified were fixed or removed. Imputation was done 
on the Michigan Imputation Server  using Eagle version 2.3 for haplotype phasing  and * †
IMPUTE2 for imputation467,468. No central post-imputation QC was performed. The 
steps I took to assure the SNPs I have used are well imputed are described in the next 
chapter (Chapter 4, Section: 4.3.3. Statistical analysis, Subsection: GWAS results QC). 
Whole-genome sequencing data (provided by UK10K project): To determine 
the role of rare genetic variants in cataract formation, I have made use of the whole-
genome sequencing data, which is also available for a subset of the TwinsUK cohort 
(N=1800 ). DNA from whole blood was whole-genome sequenced at low coverage ‡
(median coverage: 6x) as part of the UK10K project . The 1800 individuals (one twin §
per pair) were selected by the TwinsUK data management team to maximise overlap 
with a number of existing genomic resources in addition to availability of a wide range 
of phenotypes and environmental exposure data. The sequencing was performed using 
Illumina Genome Analyzer and Illumina HiSeq 2000 platforms and all variants passed 
strict QC as discussed in detail elsewhere469 and are briefly summarised below.
The sequencing was performed at both the Wellcome Trust Sanger Institute and 
the Beijing Genomics Institute. DNA (1-3μg) from PBMCs was sheared to 100-1000 bp 
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end DNA library preparation469. Following size selection (300-500 bp insert size), DNA 
libraries were sequenced using the Illumina HiSeq platform as paired-end 100 base 
reads according to manufacturer’s protocol469. Sequencing reads that failed QC were 
removed using the Illumina GA Pipeline469. Data and data generated at each of the two 
sequencing centres were aligned to the GRCh37 human reference separately by the 
respective centres469. Single nucleotide and insertion deletion (indels) polymorphism 
calls over all samples and all-sample and all-site genotype likelihood probabilities were 
generated using samtools and bcftools respectively469. Sites were filtered out if: their 
variant quality score log odds ratio values corresponded to less than 99.5% and 97% 
sensitivity for SNPs and indels respectively; had p-value for deviation from HWE of 
1x10-6; showed batch effects between sequencing centres or participating cohorts469. 
Samples were filtered out if: there was high overall discordance to the array genotypes 
(> 3%); heterozygosity rate was more than 3SD from population mean suggesting 
possible contamination; the read depth per sample was low (below 4x mean read 
depth)469.
Metabolomics single-time-point (N=6,400) and longitudinal measurements 
(N=2,050)470,471: In Chapter 6 I make use of the TwinsUK metabolomics data. This 
data, in its fully QCed form, was generously shared with me by Dr. Jonas Zierer and Dr. 
Cristina Menni. Briefly, blood samples were collected after a minimum of six hours of 
fasting. After coagulation (4°C for 40 min), samples were centrifuged at 3,000 rpm for 
10 minutes and the top clear yellow layer (either plasma or serum ) was aliquoted as *
0.5 to 1 ml aliquots into 1.5 ml micro-centrifuge tubes. The tubes were stored at -45°C 
until metabolomics profiling. Untargeted metabolite profiles from blood were generated 
by Metabolon Inc. as follows. After being isolated, metabolites were separated using 
ultra-performance LC and GC, spiked with injection standards of fixed concentrations 
and then helium-loaded into an 5% phenyldimethyl silicone  MS column. The following †
mobile phases were used: water, 95% methanol containing 0.1% formic acid, or 6.5 
mM ammonium bicarbonate. Samples were then vaporised (60℃ to 340℃ over for 17 
minutes) and underwent electron ionisation, followed by acceleration, deflection and 
detection. The MS values were then compared to a reference library that used 
molecular weight, retention time and in-source fragment values in order to identify the 
metabolites as known chemical compounds. Metabolon Inc. provided relative 
concentrations of metabolites per sample. These were then quantile-normalised and 
any data points that were greater than 4 standard deviations from the mean were 
 plasma without fibrinogens *
 stationary phase†
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removed. 
For a subset of TwinsUK participants, metabolites (from serum) were available 
from multiple collections (over a maximal 18-year period). The metabolites were 
measured again using the Metabolon platform but this time a newer detection platform 
was employed, that did not include GC and that afforded a better detection of lipid 
subspecies. Detailed description of the methods used is available elsewhere471. The 
effect of all technical covariates was accounted for prior the data release to us by 
Metabolon Inc. Missing relative concentrations were imputed using the minimum value 
of the run-day. The data was scaled by run-day median and inverse-normalised. 
Metabolites with more than 20% missing values were excluded. 
Microbiome: In Chapter 6 I also make use of the TwinsUK Microbiome data. 
This data was in its fully QCed form, was generously shared with me by Dr. Matt 
Jackson and Dr. Jordana Bell. Briefly, participants collected delivered a home-collected 
faecal sample (15mL conical tube, at 4°C for 1-2 days) to their annual TwinsUK clinical 
phenotyping visit. Samples were then frozen and stored at -80 C before being shipped 
to Cornell University on dry ice for sequencing. DNA was extracted from the 100mg of 
faecal sample (MoBio Power Soil® DNA isolation kit, MoBio Laboratories Ltd, 
Carlsbad,CA). The V4 hypervariable region of the 16S rRNA gene was PCRed using 
515F and 806R primers472 in duplicates (2.5U Easy-A high-fidelity enzyme, 1 x buffer 
(Stratagene, La Jolla, CA), 10-100 ng DNA template, and 0.05 mM of each primer). 
The following PCR conditions were used: 3 minutes of denaturation at 94°C; 25 cycles 
— 45 seconds of denaturation at 94°C C; annealing — 60 seconds at 50°C; extension 
— 90 seconds at 72°C; final extension — 10 minutes at 72°C. The PCR duplicates 
were combined, purified using the Mag-Bind® magnetic bead purification system 
(EZPure, Omega Bio-Tek, Norcross, GA) and quantified using the QuantiT PicoGreen 
dsDNA assay kit (Invitrogen, Carlsbad, CA). Aliquots were combined to yield a final 
concentration of approximately 15 ng per μl. 
Paired-end sequencing was performed on the Illumina MiSeq platform at Cornell 
Biotechnology Resource Center Genomics Facility, following the manufacturer’s 
protocols. The matched pair reads were joined using fastq-join and reads exceeding 
275bp in length were discarded. Sequences containing unreadable barcodes, 
ambiguous bases or low quality reads (Phred quality score ≤25) were discarded, 
resulting in 81,634,331 quality-filtered sequences. Quantitative Insights Into Microbial 
Ecology (QIIME 1.7.0) was used to analyse the remaining sequences. Closed 
reference clustering was used to determine operational taxonomy units (OTUs) at 97% 
sequence identity against the Greengenes v13_5 taxonomy database. OTUs that were 
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observed in fewer than 25% of individuals were not considered for further study. This 
threshold was applied to focus on associations within abundant OTUs where data 
sparsity would be less influential on analyses. Of the total 9,840 OTUs, 16% passed 
this threshold (data sparsity) resulting in a final set of 2118 OTUs. These OTUs were 
further collapsed into taxonomies (N=560) at the family (N=124), genus (N=283 
variables) and species (N=153) levels where only fully classified taxa were considered 
within each level.
OTU counts were converted to relative abundances and log10 transformed. Even 
though standard collection and sample processing were used PCA analyses revealed 
the following confounders: sequencing run, sequencing depth, who extracted the DNA, 
who loaded the DNA, and sample collection method. The transformed abundances 
were then used as the response in a model with those confounders as covariates. The 
resulting residuals from this model were used for any subsequent analysis.
3.2.3. Data collection in the TwinsUK cohort 
As part of their PhD work, PhD students at the Department of Twin research and 
Genetic epidemiology are required to participate in clinical examination data collection. 
This is usually done for a day each week for 2 years. In addition to that, due to 
personnel shortage, I performed all data collection for the ophthalmologic component of 
the twin visit for a period of six months on full time basis. During this period, two new 
machines for eye measurements were introduced: Visionix VX120 — a combined all-in-
one device for performing a whole variety of eye tests; and the Optovue iFusion system 
that performs optical coherence tomography scans and fundus retinal imaging. This 
required the development of new data collection protocols. The protocols I developed 
can be found in Appendix I. I was also responsible for the training of research nurses 
and students who later joined the department on how to use the machines and 
implement the protocols. The data collected during the 6 months period and later in my 
PhD contributed to both scientific articles and conference abstracts (see publications 
arising from this thesis: page 7 and Appendix II).
In the period from 01/09/2014 to 28/02/2015 I have measured 734 individuals 
(98.3% white British, 77.8% women, mean age (±SD) of 62.3±11.7). The key 
ophthalmic parameters measured in the white British individuals (N=708) are 
summarised in Table 3.2. and distribution plots are presented in Figure 3.4. As there 
was a high correlation between left and right eyes for all measurements (Pearson 
correlation coefficient >0.7), the mean of both eyes is presented in the table. 
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Table 3.2. Summary of ophthalmic parameters in TwinsUK participants measured 
between September 2014 and February 2015
This table summaries key ophthalmic parameters in the 708 white British individuals measured 
by me between September 2014 and February 2015. The mean of both eyes is presented. 
Values for men and women are given separately. SD — standard deviation; SphE — spherical 
equivalent; IOP — intraocular pressure; RNFLT — retinal nerve fibre layer thickness;  GCCT — 
ganglion cell complex thickness
Parameter Men Women
Number of individuals 52 571
SphE (mean±SD) -0.24±0.35 0.17±0.93
IOP (mean±SD) 12.95±0.50 13.48±0.10
Corneal thickness (mean±SD) 520.33±9.14 536.88±1.63
Average RNFLT (mean±SD) 93.88±1.27 95.88±0.36
Superior RNFLT (mean±SD) 114.89±1.70 117.34±0.52
Nasal RNFLT (mean±SD) 73.89±1.56 74.15±0.42
Inferior RNFLT (mean±SD) 116.22±2.14 120.44±0.14
Temporal RNFLT (mean±SD) 70.52±1.14 71.61±0.33
inner GCCT (mean±SD) 94.2±1.06 94.90±0.29
superior GCCT (mean±SD) 93.40±0.97 94.30±0.30
inferior GCCT (mean±SD) 95.00±1.07 95.48±0.31
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3.3. The Rotterdam Study 
3.3.1. Cohort description
The Rotterdam Study (RS) is a Dutch prospective population based study (N= 
14,926) focusing on cardiovascular, neurological, ophthalmological, endocrine and 
psychiatric diseases in the elderly473-475. The study sampled white Dutch individuals 
(100%) from both sexes (60% women) living in Ommoord (a suburb of the city of 
Rotterdam) during three independent waves of enrolment (Figure 3.5.), resulting in 
three cohorts (RSI, RSII, and RSIII)473. The participants in each cohort were examined 
at multiple time points at regular intervals from 1991 to present (eg. baseline: RSI-1, 
RS2-1, RS3-1; first follow-up: RSI-2; RSII-2; RSIII-2; etc.). All individuals were first 
interviewed at home (2 h) and then had an extensive set of examinations (a total of 5 h) 
including imaging (of heart, blood vessels, eyes, skeleton and later brain) and on 
collecting biospecimens that enabled further in-depth molecular and genetic analyses. 
All of the participants in the Rotterdam study have signed written informed consent and 
the Medical Ethics Committee of Erasmus Medical Centre has approved the study.
At baseline (RDSI; 1989-1993), 7,983 individuals (78% response rate) were 
enrolled (age range: 55-106). The Rotterdam study II started enrolling in 2000 
(N=3,011; 67% response rate; age 55 years or older), while the Rotterdam study III, a 
further extension of the cohort from 2006 onwards, enrolled slightly younger individuals 
(N=3,932, aged 45–54 years, 65% response rate)473-475. Since summer of 2016, 
another extension RSIV has started that includes all participants aged 40 years and 
over475. The recruitment of this extension is expected to be completed in 2019 and 
yield around 4000 new participants475.
As part of the ophthalmic examination, assessment of cataract was carried out 
only in a subset of the Rotterdam Study cohorts (Rotterdam study I: visits 3 and 4, 
Rotterdam study II visit 2, and Rotterdam study III visit 1). In the current thesis only 
data from the Rotterdam study I visit 3 was used. From now on throughout this 
thesis the RSI-3 is referred as RSI-III.
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Figure 3.5.Diagram of examination cycles of the Rotterdam Study
 This figure is adapted from Hofman et al., Eur J Epidemiol 2011476 and show the examination 
cycles of the Rotterdam Study.
Similarly to the TwinsUK cohort, the Rotterdam study has omics data available 
(genome-wide (array and sequencing): genotyping, transcriptomics, and methylation; 
as well as metabolomics, proteomics and microbiome data475. In this thesis, I have 
made use of only the genome-wide array, that was subsequently imputed to the 1000G 
reference panel. The genotyping and imputation procedures used in the Rotterdam 
study are shown below. This data has been provided to me by Prof. Dr. Caroline Klaver 
and her team who are responsible for the ophthalmologic studies within the Rotterdam 
Study. 
Genotyping and imputation of single nucleotide polymorphisms (SNPs) : *
DNA was extracted from blood leucocytes according to standard procedures. 
Genotyping of SNPs was performed using the Human 610 Quad Arrays Illumina (RSI‐
III). Samples with low call rate (< 97.5%), with excess autosomal heterozygosity (> 
0.336), or with sex‐mismatch were excluded, as were outliers identified by the identity-
by‐state (IBS) clustering analysis (outliers were defined as being > 3SD from 
population mean or having IBS probabilities > 97%). A set of genotyped input SNPs (N 
= 530,683) with call rate > 98%, with MAF > 0.01, and with HWE p-value >1x10-6 was 
used for imputation. Imputation was conducted against the in European Ancestry panel 
 includes small indels*
 73
Chapter 3. Cohorts description.  
Data collection in the TwinsUK and Rotterdam studies 
of individuals (Phase 1, version 2012) of the 1000G project using an algorithm 
implemented minimac, after phasing using MACH468,477. As with TwinsUK, no central 
post-imputation QC was performed. The steps I took to assure the SNPs I have used 
are well imputed are described in the next chapter (Chapter 4, Section: 4.3.3. 
Statistical analysis, Subsection: GWAS results QC). 
3.3.2. Data collection in the Rotterdam Study 
As part of the third follow-up of the Rotterdam Study (January 1998 to December 
1999), 3,600 participant attended an eye test. During the eye test lens images were 
taken (N=15,599) for both eyes using an analogue camera. Nuclear cataracts were 
assessed using Slit Lamp/Scheimpflug (1 image per eye), while cortical and PSC 
cataracts (2 images per eye) were assessed using Neitz CT-R camera (Kowa Optical, 
Torrance, CA). In the latter case, one of the images was taken at higher depth to permit 
better focus on the posterior lens, adjacent to the posterior lens capsule. After being 
taken the images were developed, mounted on slides and stored. At the time the 
quality of the images was not evaluated and cataracts were not graded. As part of my 
PhD I had the task to scan/digitise all those images, evaluate their quality and perform 
cataract grading. The grading procedures I used will be detailed later in this thesis 
(Chapter 4; Section 4.3.2.Phenotyping). Here I will focus on the procedures followed 
when scanning the images and on the quality score I developed in order to determine 
whether the images were of high enough quality to be reliably graded.  
 Image scanning: On each slide the participant’s study number, the date on 
which the photo was taken and the participants sex were noted. This information was 
used to find the participants in the central database and to create a barcode that the 
scanner could read. The barcode included information of the participant’s study number 
and sex, the date of visit, and the type of photo (Scheimpflug/retroillumination) taken. 
The barcodes were read in a particular order that followed the order in which the slides 
were mounted on the scanner feeder trays. The slide with lens images (3 x eye when 
possible ) were then scanned on a Hasselblad Flextight X5 Scanner using the following *
standard settings: 16MB RGB standard; 36x24 full size frame; auto levels; 26% 
scanning resolution; output PPI=3000, output file format = .tiff. The images were 
automatically named using the information from the barcode. Finally, images were 
converted to grey scale using Apple Automator.
 1) some images were extremely dark, thus the scanner could not detected that a slide was *
present; 2) a few individuals had one or more of their lens photos missing
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Table 3.3. Quality scores for RSI-III cataract images 
This table summarises the parameters used to assign a quality score to an RSI-III lens image. 
The number of eyes (N) that fall in each category are also listed. Eye where the lens had been 
surgically removed are included in the N presented here.
Image quality assessment: In all cases, both eyes were dilated prior to taking 
the photograph to permit the whole lens to be visible. When assessing the images, 
however, I discovered that no standard conditions were used. For example sometimes 
Parameter Points Meaning N
Images of the lens nucleus 
Brightness: 












































Other problems leading obscured lens nucleus: 
reagents on slide; artefact on slide; lens is not 
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images were taken in full-light conditions or before the pupil was fully dilated. In 
addition photos of aphakic and pseudophakic eyes were also taken. These issues did 
not substantially affect the grading of cortical and PSC cataracts but they were 
problematic when assigning nuclear scores because the use of objective grading 
systems, such as the CNDS grading system, requires standard lighting and positioning 
of the lens. Therefore, I crated a scoring system (Table 3.3.) and scored each photo 
using this system. Images with a total score higher than 0 were deemed unacceptable 
and were not used in any subsequent analysis. In addition, prior to the analysis, I 
excluded individuals with bilateral cataract surgery or with mislabeled photos .*
3.4. International Cataract Genetics Consortium 
3.4.1. The Age‐Related Eye Disease Study (AREDS)
Cohort description: AREDS is a USA-based long‐term prospective multi-centre 
study of the clinical course of age‐related macular degeneration (AMD) and age‐related 
cataract, that included a clinical trial of high‐dose vitamin supplements for AMD and 
cataract382,420. After signing informed consent according to the Declaration of Helsinki, 
the AREDS participants (N=4,757, age at enrolment (1992-1998): 55 to 80 years; 57% 
women; 96.7% white) were enrolled on the basis of fundus photographs graded by a 
central reading centre, best‐corrected visual acuity and ophthalmologic evaluations and 
had to be free of any illness or condition that would make long‐term follow‐up or 
compliance with study medications unlikely or difficult. Lens images were taken using 
slit lamp and cataract were graded using the AREDS system478.  
Genotyping and Imputation: All AREDS participants were genotyped at the 
Centre for Inherited Disease Research. For AREDS1a‐1b three chips were used for 
this genotyping: Affymetrix 100K, Illumina 100K and Illumina 300K. SNPs were 
abstracted from each of the chips and genotypes on more than one chip were checked 
to ensure that the calls were the same. Individuals not of European descent were 
removed. For AREDS 1c, genotyping of SNPs was performed using the Illumina 
HumanOmni2.5‐4v1_B chip array. For the analysis presented in Chapter 5 only 
individuals genotyped on the HumanOmni2.5‐4v1_B chip array were used. For all 
studies, samples with low call rate (<98%), with low mean confidence scores over all 
non‐missing genotypes, with chromosome anomalies, or with sex‐mismatch were 
 the information noted on the slide was different than that in the central data base*
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excluded. No samples exhibited excess heterozygosity rates (1.5 interquartile ranges 
above or below the upper/lower quartile ranges). Cryptic relatedness was detected by 
estimating IBD sharing and kinship coefficients among all possible pairs and one 
member of each pair exhibiting a sibling or closer relationship was dropped from the 
analysis. SNPs were dropped from the analysis if they exhibited more than 1 blind 
duplicate error, more than 1 HapMap control error or more than 1 error in HapMap 
control trios, a genotype call rate < 99%, minor allele frequency < 0.01, or HWE p-value 
< 10‐4. No batch effect, sex‐specific differences in allelic frequency (> 0.2) or 
heterozygosity (> 0.3) were detected. Imputation was performed with IMPUTE2 against 
1000G world samples from phase I integrated variant set (v3, release March 2012). 
Imputed variants were aligned the to plus strand of NCBI build 37, for each imputed 
SNP a measure of imputation quality were calculated (info score) was calculated. No 
central post-imputation QC was performed. The steps I took to assure the SNPs I have 
used are well imputed are described in the next chapter (Chapter 4, Section: 4.3.3. 
Statistical analysis, Subsection: GWAS results QC).   
3.4.2.The Beaver Dam Eye Study (BDES)
Cohort description: BDES is a population based study of age related ocular 
disorders. All individuals (N = 5925) who were between 43 and 84 years of age as 
determined by a private census of the township, and resided in the city or township of 
Beaver Dam, Wisconsin, USA, in 1987-8, were eligible to take part in the study479. Of 
the 5925 eligible people identified, 4926 (83.1% response rate) were examined at 
baseline (1988-90). These people were white (99%) and 56% were female. The cohort 
was re-examined at 5- (N = 3722), 10- (N = 2962), 15- (N = 2375), and 20-year (N = 
1913) follow-ups. Physical examinations and lens photography were conducted both at 
baseline and at follow-up. Medical histories and information on demographic and 
behavioral characteristics were ascertained at baseline, using a standardized 
questionnaire administered in conjunction with the physical examinations. Lens 
photographs were taken using a Topcon SL5 Slit Lamp camera (Paramus, New Jersey) 
with specially designed fixation targets for photographing the nuclear region of the lens. 
In the BDES cataracts were graded using the original Wisconsin grading system39.  
Genotyping and Imputation: BDES samples were genotyped using Illumina 
HumanExome BeadChip (San Diego, CA, USA) at the Genetic Resources Core Facility 
at Johns Hopkins Institute of Genetic Medicine480. Genotypes were called using the 
Illumina GenTrain clustering algorithm in GenomeStudio. All samples had a call rate > 
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98% but individuals with sex inconsistencies (N = 15) and Mendelian errors (N = 2) 
were excluded. Cryptic relatedness and unexpected duplicates were determined by 
identifying pairs of individuals with IBD sharing > 20%, representing first and second-
degree relatives. The individual from each relative pair with the lower quality score (n = 
85) was excluded. Six individuals did not cluster with HapMap European ancestry 
controls (CEU), and were excluded. Of the 242,901 genotyped variants, variants that 
fell in the following categories were excluded: non-autosomal variants (N = 5,465), 
SNPs with a call rate<98% (N = 6,121), and monomorphic variants (N = 138,061)480. 
Variants were aligned the to plus strand of NCBI build 37 and imputed against the 
1000G world samples from phase I integrated variant set (v3, release March 2012); 
using an algorithm implemented minimac, after phasing using MACH468,477. For the 
analysis presented in this thesis I have used this cohort as a replication cohort, 
focusing only on the subsets of variant that were taken forwards for replication as part 
of the meta-analysis of GWAS of nuclear cataract project (see Chapter 5).  
3.4.3. The Beijing Eye Study (BES)
Cohort description: BES is a population-based cross-sectional study of Chinese 
individuals residing in rural areas (Yufa, Daxing District) south of and in urban areas 
north of Beijing (Haidian District)239. The Medical Ethics Committee of the Beijing 
Tongren Hospital approved the study protocol and all participants gave informed 
consent. At the baseline survey in 2001, a total of 5,324 individuals (40 years of age or 
older) were eligible to participate in the study, of which 4,439 individuals (83.4% 
response rate) were recruited. In 2006, all survey participants were re-invited and 
3,251 participants (73.2% response rate) were recruited239. Participants underwent a 
series of examinations including: refractometry; pneumotonometry; biomicroscopy 
assisted by slit-lamp; optical coherence tomography of the anterior segment; 
photography of the cornea, lens, optic disc, macula and fundus; blood sampling for 
laboratory tests; blood pressure measurements, as well as determinations of 
anthropomorphic parameters239. They were also asked to complete a questionnaire 
which included questions on socioeconomic parameters, and awareness and treatment 
of ocular and general diseases.
In BES, the degree of nuclear cataract was assessed in 6 grades using the 
AREDS grading system, which is an extension of the Wisconsin System39,478. Digital 
photographs of the lens were obtained using the slit lamp. A single grader under the 
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supervision of senior ophthalmologists and researchers performed the lens grading. 
The nuclear cataract grading from the 2006 follow-up study was used243. 
Genotyping and Imputation: DNA was extracted from blood leucocytes 
according to standard procedures. Genotyping was performed using Illumina 
Human610-Quad BeadChip and Illumina OmniExpress arrays. Samples were excluded 
based on: call-rates of < 95% and excessive heterozygosity; cryptic relatedness; 
gender discrepancies; and discordant ethnic memberships as defined using PCA 
analysis .SNPs were excluded based on high rates of missingness (> 5%); 
monomorphism; or gross departure from HWE p-value < 1x10-6.
3.4.4. The Blue Mountains Eye Study (BMES)
Cohort description: BMES is a population-based survey of vision and common 
eye diseases in the Blue Mountains, west of Sydney, Australia481. Following a door-to-
door census of the region, all permanent residents aged 49 years or older were invited 
to take a detailed eye examination481. From a total of 4,433 eligible residents, 3,654 
(82.4%) gave informed consent, attended the baseline eye examination and were 
interviewed between 1992 and 1994. During 1997-99 (BMES II A); 2,335 participants 
(75.1% of survivors) returned for examinations after 5 years. During 1999-2000, 1,174 
(85.2%) new participants took part in an Extension Study of the BMES (BMES IIB). At 
each examination, a detailed assessment of eye disease and other general health 
measures was conducted. Participants were also asked to attend fasting blood tests 
after each examination (except 15-year) and complete a detailed questionnaire about 
the types of food they consumed. At the follow-up exams, a test of memory and 
cognition (Mini Mental State Examination), questions about quality of life (Short Form 
36) and visual functioning were also conducted. 
Eye conditions were assessed at each examination by taking a series of 
photographs of the eye. Photographs of the retina were used to assess the presence of 
diseases like macular degeneration or diabetic eye damage. Stereo photographs of the 
optic nerve were taken to assess changes that, together with an automated test of the 
field of vision, indicate the presence of glaucoma. Two types of photographs were 
taken of the lens inside the eye to grade the presence of the different types of cataract. 
All of these photographs were graded using the Wisconsin grading system39.
Genotyping and Imputation: Participants of the BMES were genotyped using 
the Illumina Human 670‐Quadv1 custom genotyping array at the Wellcome Trust 
Sanger Institute, Cambridge as part of WTCCC2, and 2,761 had genotyping data 
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available. QC procedures in the WTCCC2 excluded SNPs with Fisher information 
measure < 0.98, genotype call rate < 0.95, MAF < 0.01 or HWE p-value < 1x10-6. 
Samples were excluded if they were identified as outliers on call rate, heterozygosity, 
ancestry and average probe intensity based on a Bayesian clustering algorithm. 
Samples were also removed if they exhibited discrepancies between inferred and 
recorded sex or cryptic relatedness with other WTCCC2 samples (pairwise IBD > 
0.05). Imputation was than carried out against the European Ancestry panel of 
individuals (Phase 1, version 2012) of the 1000G project using IMPUTE. No central 
post-imputation QC was performed. The steps I took to assure the SNPs I have used 
are well imputed are described in the next chapter (Chapter 4, Section: 4.3.3. 
Statistical analysis, Subsection: GWAS results QC).
3.4.5.The India Eye Study (INDEYE)
Cohort description: INDEYE is a population-based study of people aged 60 
years and older from a mix of rural and urban areas in North India (Gurgaon district, 
Haryana state) and South India (Pondicherry union territory and Cuddalore district in 
Tamil Nadu). The INDEYE study is aimed at estimating the age- and sex-specific 
prevalence of early and late AMD and of lens opacities, and at investigating 
associations of these conditions with tobacco use, exposure to biomass cooking fuels, 
outdoor work, and dietary factors227,482. Based on a randomly selected clusters where 
8% of the total population per cluster would be aged 60 years and older, a total of 
7,518 people (3586 from 29 cluster in North India and 3932 from 30 cluster in South 
India) were invited to take part in the study (2005-2007). In both locations the mean 
age of participants was 62 years and 52% were women. Participants were examined 
by an ophthalmologist either at their homes or during a hospital or ophthalmic centre 
visit. Informed written consent was obtained from all participants before enrolment. 
Information was read to people who were illiterate in the presence of a local witness, 
and a thumb impression of the participant signified assent. The study complied with the 
guidelines in the Declaration of Helsinki, and ethics approval was received from the 
Research Ethics Committees of the All India Institute of Medical Sciences, Aravind Eye 
Hospital, London School of Hygiene and Tropical Medicine, Queens University Belfast, 
and the Indian Council for Medical Research.
Genotyping and Imputation: In the current thesis only samples from the South 
India were used. The INDEYE has no genome-wide genotype data and was used only 
for replication purposes. Variants were genotyped using TaqMan. 
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3.4.6. Singapore Cohorts (SCES, SiMES, SINDI)
Detailed information for the Singapore cohorts is provided below. For the 3 
cohorts in Singapore, ethics approval was obtained from the SingHealth Centralised 
Institutional Review Board. All study participants were provided with written informed 
consent in adherence to the Declaration of Helsinki.  
Cohort description: The Singapore Chinese Eye Study (SCES-610 and SCES-
OmniExpress) is a population-based cross-sectional epidemiological study on eye 
diseases in Chinese (age range: 40-80+; 50.6% were female) residing in Singapore. 
Using age-stratified random sampling strategy, 4605 ethnic Chinese residents in the 
southwestern part of Singapore were eligible from the sampling frame (N = 6,752), of 
which 3,353 (72.8% response rate) participants were recruited between February 2009 
and December 2012483. 
The Singapore Malay Eye Study (SiMES) is a population-based cross-sectional 
epidemiological study on eye diseases for Malays aged between 40 and 80 years old 
residing in Singapore484. Details of the SiMES design, sampling plan and methodology 
have been reported elsewhere. In brief, between August 2004 and June 2006, a total of 
4,168 Malay residents in the south-western part of Singapore were identified through 
age-stratified random sampling and were invited to participate in the study, of which 
3,280 (78.7% response rate, 51.8% women) underwent a detailed ocular examination. 
The Singapore Indian Eye Study (SINDI) is a population-based cross-sectional 
epidemiological study on eye diseases for ethnic Indians aged between 40 and 80+ 
years old residing in Singapore. The study was conducted between March 2007 and 
December 2009. Using age-stratified random sampling, 4,497 ethnic Indian residents in 
the south-western part of Singapore were eligible from the sampling frame (N = 6,350), 
of which 3,400 participants (75.6% response rate; age: 57.8 ± 10.1 years; 49.5% 
women) were recruited483.
In the Singapore cohorts, the severity of nuclear cataract was assessed using 
the Wisconsin Cataract Grading System, based on lens photographs and followed a 
decimalized system (decimal scores from 0.1 to 5.0)39. In brief, lens photographs were 
taken using a digital slit-lamp camera (model DC-1 with DF-21 flash attachment; 
Topcon, Tokyo, Japan) and grading was performed through comparison with four 
standard photographs at the University of Sydney42.
Genotyping and Imputation: For all studies, the Illumina Human610-Quad 
Beadchips (Illumina Inc.) were used for genotyping27. A first round of SNP QC was 
performed to obtain a cleaned set of genotypes for sample QC by excluding SNPs with: 
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high missingness (> 5%); gross departure from HWE p-value < 10−6; and were 
monomorphic27. Samples were excluded based on: call-rates of less than 95% and 
excessive heterozygosity; cryptic relatedness; gender discrepancies; and discordant 
ethnic memberships as defined using PCA analysis27. A final round of SNP QC was 
applied to the remaining samples on autosomal SNPs using the same three criteria 
earlier, and an additional restriction of minor allele frequency > 5%. Genome-wide 
imputation of SNPs was performed on post-QC set of genotype data, using minimac 
with 1000G Phase 1 version 3 release (world panel). The same SNP QC procedure 
was performed on the imputed SNPs, except for the MAF threshold which was relaxed 
to 1%.
3.4.7. South London Case Control Study (SLCCS)
Cohort description: SLCCS is a case-control study, aimed at recruiting a 
replication sample for studies of the genetics of age-related eye diseases in South 
London. Study participants were recruited from the Princess Royal University Hospital, 
Orpington, and St Thomas’ Hospital in London. Cataract cases were defined as having 
significant nuclear cataract (grade >= 3 on the LOCS III clinical grading system), 
controls were individuals without significant cataract (as assessed by treating 
physician, usually without LOCS III grades) and attending the eye department for other 
reasons (e.g. patients with glaucoma, age-related macular degeneration or other 
conditions). The SLCCS had no exclusion criteria on the grounds of age, gender, or 
ethnic origin, but for this study subjects identified as being of Northern European origin 
on principal component analyses were included.
Genotyping and Imputation: The SLCCS study was genotyped using Illumina 
OmniExpress Exome Array and imputed against the 1000G world samples from phase 
III integrated variant set (2014 release).The genotyping and imputation procedures 
used were exactly the same as the ones used for the TwinsUK cohort (this chapter; 
Section 3.2.2. Omics data). For the analysis presented in this thesis I have used this 
cohort as a replication cohort and I have not performed any genome-wide analysis; 
focusing only on the subsets of variant that were taken forwards for replication as part 
of the meta-analysis of GWAS of nuclear cataract project (see Chapter 5).  
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4.1. Overview
The aim of this chapter is two address the first three objectives of the current 
thesis: 
1. Explore whether nuclear and cortical cataract share genetic risk 
factors
2. Identify common genetic variants associated with ARC by performing 
genome-wide association studies 
3. Identify whether low frequency and rare genetic variants from whole-
genome sequencing data are associated with ARC
In Chapter 1 (section 1.7. Epidemiology and risk factors), the environmental risk 
factors associated with ARC have been discussed in detail. The different studies 
presented show that, apart from age, nuclear and cortical cataracts are unlikely to 
share much in terms of associated epidemiological risk factors. However, there is a 
general lack of studies focusing on answering questions related to causation, thus 
making it difficult to know whether nuclear and cortical cataract are different forms of 
the same disease or two totally unrelated diseases that happen to manifest in the same 
organ . Answering this question is important not only from a mechanistic perspective *
but also because it can elucidate the need for different prevention or treatment 
strategies for the two different types of cataract. In terms of genetic studies, if the two 
types of cataract would share a substantial amount of genetic risk, then easily 
obtainable phenotypes such as “any cataract” or cataract surgery could be used in 
genetic analysis as opposed to a more detailed and time consuming grading of cataract 
by type. In Chapter 4, I explore whether nuclear and cortical cataract share genetic risk 
factors employing methods that use either phenotypic data only (classical heritability 
calculation) or genotypic data (amount of trait-shared phenotypic variance explained by 
the effect of a set of genetic variants). 
Two of the analyses employed in answering the question of shared heritability 
(LD-score regression and polygenic risk scores) require the use of results from 
genome-wide association analysis (GWAS). GWAS are a standard tool for discovery of 
genetic loci associated with common diseases. However, as pointed out in Chapter 1 
 PSC cataract has a low prevalence, and a population-based sample of 2,556 TwinsUK *
participants with cataract data (mean age of 62) lacks the number of affected individuals needed 
for meaningful analysis. Therefore, the thesis focuses on the two most common types of 
cataract  — nuclear and cortical cataracts.
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(section 1.6. Genetics of age-related cataract), apart of linkage analysis and candidate 
gene/variants studies, GWAS had not been employed in cataract genetics at the time 
the work on this thesis commenced (October 2013). My aim was, therefore, to explore 
the role common variants play in the pathogenesis of cataract by performing GWAS in 
two European cohorts — TwinsUK and the Rotterdam Study). Moreover, the first ever 
published GWAS of cataract studied Asian individuals only27. Therefore, in this chapter 
the findings from the first two GWAS in European ancestry cohorts will be discussed 
while in the following chapter (Chapter 5) I will focus on meta-analysis of GWAS. 
In addition to genome-wide array data, the TwinsUK cohort also (Table 3.3.) has 
genome-wide sequencing data available. This data is used here to address the 
question from objective 3, namely whether low frequency and rare genetic variants, not 
surveyed by classical GWAS analysis, play a role in cataract formation.
 
4.2. Introduction
In this chapter three different analysis strategies have been employed to answer 
the above stated aims. These strategies are introduced in more detail below.  
4.2.1. Shared heritability: definition and estimates
One way to answer the question of whether two traits share genetic risk factors is 
to calculate the amount of shared heritability between the two traits where heritability is 
defined as the proportion of phenotypic variance (VP) that is explained by genetic 
factors. In this chapter, shared heritability is estimated both by using phenotypic data 
only and by using the estimates of the effect of SNPs on the traits. The first case is 
known as classic heritability modelling where the variance and covariance observed 
between related individuals is used to partition VP  of a trait as follows:  
VP = VA + VD + VC + VE,
where: VA, also known as narrow sense heritability (h2), is the variance explained 
by additive genetic factors (the combined direct effect of all genetic variants); VD is the 
variance explained by the effect of alleles on the trait by allele interaction at the same 
(dominance (D)) or different loci (epistasis); the sum of VA and VD is known as broad 
sense heritability (H2); VC is the variance explained by common (C) environmental 
factors — all environmental exposures shared between individuals of the same 
population; VE is the variance explained by unique (E) environmental factors that apply 
only to single individuals in the population (VE includes measurement error)485. In case 
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of two- or multi-trait analysis VP is the phenotypic variance shared between traits and 
VA is the proportion of shared phenotypic variance that is explained by shared genetic 
factors between the traits.
The most powerful model for calculating heritability uses twins and assumes that 
monozygotic (MZ) twins share all of their genetic and common environmental factors 
and that any discordance is caused by unique environmental exposures. Dizygotic (DZ) 
twins, however, share on average half of their alleles and thus half of the genetic 
factors, but all common environmental factors. As a result, DZ discordance is attributed 
to the unshared half of their genetic components and the unique environmental 
exposures. 
Heritability is a population-specific but not a constant measure (can change with 
time) that can predict the statistical power of gene mapping studies as high heritability 
reflects a high correlation between phenotype and genotype; and high shared 
heritability reflects high sharing of genetic factors485. However, heritability makes no 
claim about the architecture of a trait (number of associated loci, strength of effect the 
associated loci) and it makes certain assumptions (no or minimal gene-by-environment 
interactions, equal sharing of VC for both MZ and DZ twin pairs, no trait-related 
selective assortment) that might not hold true in all cases485,486. 
Heritability, as well as shared heritability, can also be estimated using unrelated 
individuals but in this case both genetic and phenotypic data are required. One way to 
do that is to fit a penalised linear mixed effect model that treats the effect of SNPs as 
random and the variance explained by all the SNPs together is estimated: 
where: y is the phenotype, μ is the mean term, z is a allele frequency dependant 
penalty for m number of SNPs, u is the additive effect at each SNP and ε is the error 
term487. This method is implemented in the GCTA software488. Another method, also 
applied in this chapter, is the LD-score regression which regresses the GWAS 
summary statistics against the LD-score in order to calculate heritability: 
where: Χ2 is the summary statistics given the LD-score (Σkr2kj); N and M are the number 
of individuals SNPs respectively and h2 is the heritability489.  
Yet another method that can be used to explore sharing of genetic factors is to 
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calculate a polygenic risk score for a trait and use it to predict another trait. This score 
is a sum of trait-associated alleles across many genetic loci, weighted by their effect 
size. The score is calculated using GWAS results or a meta-analysis of GWAS 
summary results as an initial training sample, and the markers are ranked by their 
evidence for association, usually their p-values490. An independent replication sample is 
then analysed by constructing, for each subject, a polygenic score consisting of the 
weighted sum of its trait-associated alleles, for some subset of top ranking markers490.  
4.2.2. Genome-wide association analysis 
When studying the genetics of moderately heritable common multifactorial 
diseases in population-based cohorts the method of choice is GWAS. In GWAS a 
dense set of single nucleotide polymorphisms (SNPs) across the genome is genotyped 
to survey the common genetic variation for a role in disease or to identify the heritable 
quantitive traits that underlie disease491. GWAS is a comprehensive, hypothesis-free, 
and, when population stratification is controlled for, unbiased approach491. In statistical 
terms, there are broadly two types of models that are widely employed: asymptotic 
tests (Wald test, score test, log-likelihood ratio test (LRR)) and linear mixed effect 
models. All of those test are based on a classical linear regression: Y = α + β1X + β2C 
+ ε for quantitative traits or logit(Y)= α + β1X + β2C + ε for binary traits. In the first case 
Y is the population mean of the trait and β is the degree of change in Y for every 1-unit 
of change in the predictor variable X, while in the second it is the probability of being a 
case [Pr(Y=1)] and β1 is the log odds ratio for X. In both cases α is an intercept, X is 
the genotype/allele count, β2C estimates the effect of a covariate and ε is the error 
term492. In its simplest form (without covariates), the statics for the various tests is 
denoted as follows: 
These models treat the effect of the predictor variable as fixed and assume that: 
1) linearity: the response variable is a linear combination of the parameters (regression 
coefficients) and the predictor variables; 2) homoscedasticity: the values of the 
response variable have the same variance in their errors, regardless of the values of 
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the predictor variables; 3) independence of errors:  the errors of the response variables 
are uncorrelated with each other; 4) lack of perfect multicollinearity in the predictors: 
the predictors are not strongly correlated with each other. In addition, the models 
assume that the response variables have normally distributed errors. If that is not the 
case, generalised linear models where the errors are permitted to follow other 
distributions than the normal distribution would be preferred. For common variants 
(MAF > 5%), all those test give very similar results.  
Finally, random effect (u) can also be introduced in the model: Y = α + β1X + β2C 
+  u + ε; u ~ N (0, 𝜎g K) where K is a kinship matrix. In genetic epidemiology models 
random effects are introduced to control for population structure that is due either to 
true genetic structure (including family relatedness) or to pseudo structure introduced 
as result of sampling or genotyping procedures (using different genotyping arrays, 
batch effects, etc.)492.
Using GWAS has led to the identification of 33,674 unique SNP-trait 
associations , however, GWAS have certain limitations. First, the observed effects of *
variants are usually small and, because GWAS relies on linkage disequilibrium (LD), 
finding the causative variant or gene is not straightforward. The sentinel variant is more 
often than not a proxy for the casual variant and usually in high LD with a number of 
other variants493,494. Some of those variants may have causative effect but they may 
themselves be just proxies too. If a small set of likely causative variants (a.k.a credible 
set) is identified through fine mapping, the function of those may still be difficult to 
predict. This is because associated variants usually do not fall within a well-established 
cis-regulatory element such as a known promoter, and thus challenge predictions of 
their impact on regulatory elements, like disruption of transcription factor binding or 
function of a long non-coding RNA (lncRNA)493,494. Association signals tend to cluster in 
gene-rich areas where a number of genes are located within the same LD block, 
adding another level of difficulty to causative gene identification. Cell-type specific 
regulation may be of help here but for a lot of complex diseases the relevant cell types 
are not well established. Furthermore, because of chromatin looping that places 
regulatory enhancer elements in proximity to the promoters of genes that may be quite 
distant on the physical map, a causal variant may influence expression of distant 
genes493,494. The various strategies that can be used to solve those problems are 
discussed in more details and applied in the next chapter (Chapter 5), which deals with 
a meta-analysis of GWAS in over 19,000 people. Due to the small overall-sample size 
many of the loci resulting from the GWAS presented in this chapter are likely to be 
 GWAS catalogue (2017-04-03): https://www.ebi.ac.uk/gwas/ *
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false-positive, and thus, no in depth fine-mapping was attempted here but possible 
candidate genes were short-listed on the basis of published literature.    
4.2.3. Analysis of low-frequency and rare genetic variants
Due to the small effects of variants identified by GWAS, much of the genetic 
variance of common traits is still unexplained495. One of the proposed methods to deal 
with this problem is the inclusion of low frequency (MAF<5%) and rarer (MAF<1%) 
genetic variants with moderate effects that are poorly detected by available genotyping 
arrays but are obtainable using sequencing495. Traditional regression models are not 
suitable for dealing with rare variants, and a variety of aggregate (“set-based”, 
“collapsing”) tests have been proposed as an alternative496-506. Those tests can be 
divided into non-adaptive and adaptive burden tests, variance component tests, and 
combined and exponentially combined tests507. Burden tests, such as the cohort allelic 
sums test (CAST) and the combined and multivariate collapsing (CMC) method, 
collapse information for multiple genetic variants into a single genetic score and test for 
association between the genetic score and a trait of interest496,497,503. CAST assumes 
the presence of any rare genetic variant increases the risk, while CMC categorises 
variants within MAF categories and gives different weights for each category496,497. 
Alternative methods employing continuous weight functions are also available502,508. 
Burden tests are powerful when a trait is explained by a large proportion of causal 
variants with the same direction of effect but lose power in the presence of both trait-
increasing and trait-decreasing variants or a small fraction of causal variants. The 
adaptive burden tests are similar to the burden tests but are robust in the presence of 
null variants and allow for variants with different direction of effects. This is done by 
estimating the effect of each variant in advance and taking the direction of the effect 
into account (e.g. aSum)509 in the burden calculations, by using the betas as weights 
(e.g. EREC)510, or by using permutation-based frequency threshold (e.g. VT)499 or 
kernel-based adaptive weighting (KBAC)511. The next class of tests, the variance-
component tests, evaluate the distribution of genetic effects (weighted or unweighted 
aggregated score test statistics) for a group of variants within a random-effects model 
(C-alpha, SKAT, SSU)498,500-502. Of the three tests SKAT (SNP-set (Sequence) Kernel 
Association Test) is the most commonly used. This test affords the use of covariates 
(including kinship matrix), flexible choice of weights and a resampling procedure for 
empirical p-value calculation500,502. Finally, the burden and variance-component tests 
can be combined to produce a single p-value504-506. This p-value is obtained either by 
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taking the difference between the p-value from the two tests or by combining them in a 
linear or an exponential manner504-506. During my master-degree thesis project and one 
of my first-year PhD rotations, I explored the utility of different tests in the context of 
common and rare conditions  and found the different tests tend to give very different *
results from each other, and very inflated p-values. Of all the tests, the use of SKAT 
resulted in the lowest amount of inflation and in this chapter I will present the results I 
obtained using this test.  
4.3. Materials and Methods
Detailed cohort description of the TwinsUK and the Rotterdam Study cohorts, 
together with detailed description of data collection, genotyping and genotype 
imputation procedures, are presented in Chapter 3. Here I will focus on phenotyping, 
QC procedures and describing the various statistical analyses used to obtain results in 
the present chapter.   
4.3.1. Analysis overview
The analysis presented in this chapter can be divided into three parts where Part 
I is heritability analyses, Part II is the GWAS and part III is gene-based analysis of low-
frequency and rare genetic variants. Part I and II are interconnected in terms of 
datasets used. In addition, in the Rotterdam Study, only GWAS were performed. An 




The TwinsUK cataract data was provided to me by the members of the eye-
research team. My contribution to the data collection for the Rotterdam study is 
described in Chapter 3 (section 3.3.2. Data collection in the Rotterdam study). I also 
performed the cataract grading for this cohort as described below. 
TwinsUK: All subjects were unaware of eye research interests at the time of 
enrolment. Cataracts were assessed in all individuals over the age of fifty, as a part of a 
complete ophthalmological examination during the following periods (January 1998 – 
July 1999, May 2006 – September 2010). Digital black-and-white Scheimpflug and 
 age-related cataract (subset of the TwinsUK sequencing data); Silver-Russell syndrome *
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Retroillumination lens photographs of dilated eyes were taken in dark conditions using
Figure 4.1.Analysis overview
This figure presents an overview of the analysis presented in Chapter 4. N — number of people; 
N* — number of people after exclusion of low quality images; 1000G — data imputed to the 
1000 Genomes panel; WGS — whole genome sequencing data; LDSR — linkage 
disequilibrium score regression; GCTA — Genome-wide Complex Trait Analysis; PRS — 
polygenic risk score; LFRGV — low frequency and rare genetic variants; GWAS — genome-
wide association analysis; ICGC — international cataracts genetics consortium; RSI-III — 
Rotterdam study I, follow-up III.  
the Case2000 camera (Marcher Instruments Ltd, Worcester, UK). Only the right eye in 
each person was assessed, except if that eye was aphakic/pseudophakic. Cataracts 
were not assessed in participants who had bilateral cataract surgery or were 
uncomfortable with being dilated. The total number of TwinsUK participants with 
gradable cataract photos was 2,556.
Nuclear cataract was graded using an objective, densitometry-based grading 
system that measures the pixel density at the centre of the lens nucleus (central 
nuclear dip score (CNDS))167,512. This score (range: 0-255) measures the amount of 
white scatter (or opalescence) in the lens, but not of brunescence due to images being 
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in grey scale. In TwinsUK the nuclear cataract grading was done automatically by 
software inbuilt in the camera. Subsets of TwinsUK images were also graded using the 
Modified Oxford grading system169 and a CNDS of ≥ 70 wad previously calculated as 
equivalent to clinically significant cataract according to that system.
Cortical cataract was graded subjectively using modified Modified Oxford grading 
system169.
Figure 4.2.Nuclear cataract grading in RSI-III
 
This figure shows a snapshot of the nuclear cataract grading set up: A) a lens image with the 
operator-defined measurement window in yellow; B) the density function read out from A) with a 
green arrow pointing to the the central nuclear dip measurement point. The coordinates of that 
point are shaded in grey; In this case the central nuclear dip score is 94.9.
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at the time of enrolment. As part of the third follow-up of the Rotterdam Study (January 
1998 to December 1999), 3,600 participants attended an eye test. During the eye test 
lens images were taken (N=15,599) for both eyes using an analogue camera. Nuclear 
cataracts were assessed using Slit Lamp/Scheimpflug (1 image per eye), while cortical 
and PSC cataracts (2 images per eye) were assessed using Neitz CT-R camera (Kowa 
Optical, Torrance, CA).
The grading of nuclear cataract was designed to closely follow that of the 
TwinsUK cohort, but was semi-automated. Each image was loaded separately in 
ImageJ (https://imagej.nih.gov/ij/) and a macro designed by Dr. Zoë Forkin was 
launched. The macro plots the grey pixel density function across the lens in an 
operator-specified measurement window. The operator then locates the central nuclear 
dip and registers the density value at its lowest point in a separate excel spreadsheet 
(Figure 4.2.). Nuclear cataract in this cohort was not graded using any other system, 
thus it could not be determined which grades were equivalent to clinically significant 
cataract. 
Similarly to TwinsUK, cortical cataract for the RSI-III cohort was also graded 
using the Oxford grading system. Clinically significant cortical cataract, according to 
that system, is defined as ≥ 5% of lens area affected by cortical spokes. 
4.3.3. Statistical analysis 
Heritability analysis: Classical heritability analyses were carried out in 1232 
twin pairs (620MZs and 612DZs) using univariate models and bivariate Cholesky 
decomposition modelling implemented in OpenMx (https://openmx.ssri.psu.edu/). Two 
different models were explored. In the first model, both nuclear and cortical cataract 
were treated as quantitative traits but the cortical cataract scores were not normalised. 
As the heritability modelling assumes that variables are normally distributed, a second 
model where the quantile normalised cortical cataract scores were used was explored. 
In this case, to make the nuclear scores comparable to the cortical scores, the nuclear 
scores were adjusted for age and sex, and used the residuals.
Two different methods, GCTA and LD-score regression, were used to calculate 
SNP-based bivariate heritability. In order to make the GCTA and LD-score regression 
analyses comparable, the GCTA relatedness matrix was calculated using the SNPs 
implemented in the LD-regression score program (N=1,027,466, high quality HapMap3 
SNPs). In addition, as GCTA is unable to handle twin data, bivariate heritability analysis 
were carried in 1155 individuals (one twin per pair) and nuclear and cortical cataract 
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were treated either as both quantitative or as both case-control traits, in the latter case 
the disease prevalences detected in TwinsUK were used: 22% for nuclear and 16% for 
cortical cataract.
Polygenic risk scores: For each SNP, the reference allele, beta coefficient and 
p-value from the GWAS meta-analysis of nuclear cataract, excluding the TwinsUK 
cohort were extracted. Detailed information about this meta-analysis is presented in 
Chapter 5. The extracted SNPs were then pruned for linkage disequilibrium using 
PLINK (pairwise cut-off of r2  ≤ 0.25 within 200 kB window, and a MAF cut-off of 5%). 
Polygenic risk scores for nuclear cataract were calculated with PLINK at the following 
p-value thresholds: < 0.0001, <  0.001, < 0.01, < 0.05, < 0.1, < 0.5. The effect of the risk 
score on cortical cataract was calculated by using a linear model adjusting for age and 
sex. Risk scores with uncorrected p-value <0.05 for association were considered 
statistically significant. Variance explained (r2) was calculated using logistic regression 
with and without covariates. In all cases family structure was taken into account.
As the results from the cortical cataract meta-analysis were not available to me, 
I could not calculate the effect of cortical cataract risk score on nuclear cataract.
Genome-wide association analysis: The cataract scores for nuclear and 
cortical cataracts in the two cohorts were not normally distributed and, given that the 
GWAS linear models work optimally for normally distributed data, all cataract scores 
were transformed. The nuclear score was normalised using natural logarithm. In 
addition, to permit meta-analysis at a later stage (Chapter 5), the transformed scores 
were standardised (subtracting the mean and dividing by the standard deviation). Due 
to the high percentage of people having a score of zero, the cortical cataract scores are 
not easily transformable. Cortical cataract score were therefore treated as binary trait 
with a case-control status cut-off of 0.25 which is equal to 5% of lens area affected by 
cortical spokes.
In GWAS, confounding due to population structure causes inflation of the test 
statistics and high-false positive rates. In homogeneous cohorts, such as TwinsUK and 
RSI-III (Figure 4.2.), excluding ancestry outliers as described above is usually enough 
to prevent inflation. In more heterogeneous cohorts, adjusting for genetic principal 
components is recommended. The TwinsUK cohort consists of related individuals 
which creates structure in the data that needs to be accounted for. Therefore, in 
TwinsUK, GWAS analyses were performed using a linear mixed effect model 
implemented in GEMMA513,514 that includes a relatedness matrix  within the random *
 the matrix was calculated using standardised genotypes to account for the fact that lower *
minor allele frequency tend to have larger effects
 94
Chapter 4: Different genetic variants are associated 
 with nuclear and cortical cataract 
effect term:
where Y is a vector of phenotype values; W is a matrix of fixed effect covariates; A a 
matrix of the corresponding coefficients for this covariates, including intercept; x is a 
vector of SNP genotypes (or allele dosage probabilities in the case of inputed variants); 
β is a vector of SNP effect sizes; U is a matrix of random effects; E is a matrix of errors; 
K is a relatedness matrix, I is identity matrix, Vg is a symmetric matrix of genetic 
variance components; and Ve is a symmetric matrix of environmental components. 
Both the genetic and environmental effects are normally distributed. 
In RSI-III, GWAS was performed using a standard linear and logistic regression 
models implemented in MACH2QTL and MACH2DAT515:
y = WA + βX + E
odds(y) = exp(WA + βX + E)
where Y is a vector of phenotype values; W is a matrix of fixed effect covariates; A a 
matrix of the corresponding coefficients for this covariates, including intercept; X is a 
vector of allele dosage posterior probabilities for each SNP; β is a vector of SNP effect 
sizes; and E is a matrix of errors.
All models included age and sex as covariates and in the case of nuclear 
cataract, a model using smoking status as a covariate was also explored. The 
percentage of non-, ex- and current smokers in TwinsUK were: 55.8, 29.6, and 14.6 
respectively. The percentage of non-, ex- and current smokers in RSI-III were: 44.2, 
2.5, and 53.3 respectively. 
GWAS results QC: I performed QC of the summary statistics from the separate 
GWAS using a protocol developed by the Genetic Investigation of Anthropometric 
Traits (GIANT) Consortium516. First, I confirmed that variants aligned to the positive 
stand of build GRCh37/hg19 and that the frequencies of both the imputed and 
genotype variants did not deviate significantly from those reported by the 1000G 
(Pearson correlation coefficient larger than 0.7). Then, variants were excluded if they: 
had low imputation scores (< 0.30); deviated from HWE (p-value < 1x10-4); effect sizes 
that were outliers in from the distribution of effects (below the 0.1 and the above the 
99.9 percentiles); SNPs with sample size less than 30 and minor allele count less than 
6. In addition to these exclusions, as the 2012 version of 1000G is less reliable for 
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insertion-deletion polymorphism, those variants were excluded from the RSI-III 
analysis.
Figure 4.3. Principale component plots for TwinsUK and RSI-III 
This figure shows the results of the principale component analysis for TwinsUK (A) and RSI-III 
(B) together with the 1000 Genomes project populations. For the purposes of a clearer 
presentation the South Asian, Amerindians and Afro-Americans have been excluded from the 
plot. Both TwinsUK and RSI-III cluster with the European ancestry populations (on top of the 
British and Utah Residents with Northern and Western European Ancestry and slightly apart 
from the Finnish and Tuscany clusters). PC – principale component; AFR  – African ancestry 
populations; EAS – East Asian Ancestry populations; EUR – European ancestry populations.  
Analysis of low-frequency and rare genetic variants (LFRV): Of the 1800 
individuals with genome-wide sequencing data, 905 (100% female) had cataract 
phenotypes. Similarly to the GWAS analysis, nuclear cataract was treated as 
quantitative trait and cortical cataract was treated as binary trait, and all analyses were 
adjusted for age. Low frequency and rare variants are much more susceptible to 
subtler effects of population substructure than common variants517-519. This can partially 
explain the higher inflation factors seen when such variants are analysed. The other 
reason being that LFRV effects are more likely to be sampled from the tails of the 
effects distribution. Thus, even though the 1800 individuals are unrelated and ethnically 
white British, a kinship matrix was used in the analysis. These resulted in substantially 
reducing the inflation of the test statistics. Exome-centric aggregate analyses were 
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conducted for both types of cataract using SNP-set (Sequence) Kernel Association Test 
(SKAT) implemented in EPACTS software :*
where Q is a variance-component score statistic that equals a weighted linear kernel 
function times the difference between the phenotypic value of an individual and the 
predicted mean value for the phenotype as function of the covariates502:
  quantitative traits
binary traits 
The kernel function (K = GWG’) measures the genetic the similarity between 
individuals.  The weights (W) per variant are drown from a beta distribution function
where a1 and a2 are pre-specified parameters evaluated at the sample MAF for the j-th 
variant in the data502. 
Synonymous changes and sets where the signal came from less than 3 variants 
were excluded. Genes known to consistently generate false positive signals were also 
excluded520. All variants were annotated against the human genome build GRCh37/
hg19 and NCBI human RefSeqGenes (19,821). All genes with p-value < 2.52x10-6 
were considered significantly associated with cataract after Bonferroni correction for 
multiple testing (0.05/19,821).
Result visualisation: Plots were created using STATA14 and ggplot2 under R 
(https://www.r-project.org/). Regional association plots were created using LocusZoom 
(http://locuszoom.org/) as follows: the hg19/1000 Genomes (November 2014) 
European reference panel was used as an LD-reference panel for TwinsUK, while 
hg19/1000 Genomes (March 2012) was used an LD-reference panel for RSI-III.
4.4. Results
In TwinsUK, cataract was measured in 2556 predominantly female (98%) twins, 
with mean age at eye visit of 62 years (range: 50-83 years). Monozygotic (MZ) and 
dizygotic twin (DZ) were equally represented (MZ:DZ ratio = 0.8). In RSI-III lens 
photographs  were available for 2,773 participants, who were also predominantly †
female (66%) but, in contrast to the TwinsUK sample, were on average 10 years older 
(mean age at eye visit of 71.9 [61-100 years]). After excluding RSI-III individuals with 
 http://genome.sph.umich.edu/wiki/EPACTS*
 aphakic and pseudophakic eyes†
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bilateral cataract surgery and with poor quality photographs, nuclear and cortical 
cataracts were graded in 1,589 and 2,434 individuals respectively. The excluded RSI-III 
individuals were on average older (4.6 years, p-valuet-test < 0.0001) than the included
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This figure shows the distribution of nuclear cataract before (A) after (B) transformation, and the 
distribution of cortical cataracts (C) in TwinsUK and RSI-III. In TwinsUK only one eye per person 
was available, while in RSI-III the eye with the higher cataract score was used. CNDS - central 
nuclear dip score; std - standardised; ln- natural logarithm.  
individuals but did not differ from the latter in terms of sex or smoking status (p-valuez-
test > 0.05). Cataract scores summary statistics (Table 4.1.) and score distributions 
(Figure 4.4.) for both cohorts are presented below. Both nuclear and cortical cataract 
scores were significantly higher (p-value < 0.001 from Mann-Whitney rank-sum and 𝛘2 
tests respectively) in RSI-III than in TwinsUK. Theses differences may be due to the 
fact that RSI-III individuals were older but may also be due to differences in cameras, 
graders, etc.
Table 4.1: Summary statistics for nuclear and cortical cataract scores
This table summarises the nuclear and cortical cataract scores for the TwinsUK and RSI-III 
cohorts. Nuclear cataract: CS - % of people with clinically significant cataract as compared 
against the Modified Oxford Grading System. * Nuclear cataract in the Rotterdam study was 
graded using CNDS only, thus it could not be determined which CNDS cut-off in this study was 
equivalent to a clinically significant cataract as measured by a clinically relevant grading 
systhem. Cortical cataract: the % of people with score of 0 is reported as well as summary 
statistics for individuals with non-zero scores. IQR - interquartile range.  
4.4.1. Heritability analysis
Before focusing on bivariate heritability modelling, I first calculated the univariate 
heritability for nuclear and cortical cataract (Table 4.2). In the adjusted model, the 
heritability of nuclear cataract was 0.64 [95%CI: 0.60-0.68] and that of cortical cataract 
was 0.65 [95%CI: 0.61-0.69]. The rest of the variance for both nuclear and cortical 
cataract was explained by environmental factors: 0.36 [95%CI: 0.32-0.40] and 0.35 
[95%CI: 0.31-0.39] respectively. 
These heritability estimates were higher than the ones previously obtained167,169. 
Nuclear cataract scores Cortical cataract scores
cohort mean (SD) range CS (%) 0 (%)  > 0 CS (%)
median range IQR
TwinsUK 62.1 (18.1) 34.5-229.2 22.0 57.9 0.15 0.02-5.0 0.4 16.3
RSI-III 89.6 (36.9) 30.3-229.8 NA* 54.6 0.25 0.01-4.5 0.5 25.6
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The observed difference could be explained as follows. First, the heritability in the 
present thesis was calculated in larger sample (620MZ and 612DZ) which affords an 
increase in power compared to the Hammond et al. studies167,169. This is also 
exemplified by the tighter confidence intervals obtained here. Second, when the effects 
of strong environmental contributors are removed from a heritability model, the 
heritability estimates usually increase. In terms of nuclear cataract, this means 
comparing heritability calculated from raw cataract scores167 with the heritability 
calculated from the residuals of a linear regression with log-transformed CNDS as a 
dependent variable and age and sex as predictors. While for cortical cataract the 
comparison is between a liability model with age as a latent variable169 and a linear 
regression model with age and sex as covariates. Last but not least, using normally 
distributed residuals in modelling affords more accurate estimates than using row 
variables.
Table 4.2: Univariate heritability analysis not nuclear and cortical cataract 
Model-fitting results for univariate analysis of nuclear and cortical cataract against the full (ACE) 
model. Intraclass correlation coefficient (ICC); -2 log-likelihood (-2LL); df – degrees of freedom; 
AIC — Akaike information criterion used to evaluate the most parsimonious model; diffLL – 
difference between the log-likelihood estimates of the models; diffdf – difference in number of 
degrees of freedom between models; A — additive genetic component, C — common 
environment, E unique environment and measurement error. 
Next, I performed classic bivariate heritability analysis (Table 4.3). In this sample 
the two traits were weakly correlated (rs= 0.13). Additive genetic factors explained 34% 
of variance in the unadjusted nuclear score and 56% of variance in the unadjusted 
ICC MZ ICC DZ Model -2 LL df AIC diffLL diffdf p-value
Nuclear cataract
0.65 0.36 ACE 19797.09 2440 14917.09 - - -
AE 19799.58 2441 14917.58 2.49 1 1.1E-01
CE 19843.95 2442 14961.95 46.87 1 7.6E-12
E 20215.91 2442 15331.91 418.82 2 1.1E-91
Cortical cataract
0.66 0.41 ACE 6483.98 2440 1603.98 - - -
AE 6491.52 2441 1609.52 7.54 1 6.0E-03
CE 6522.66 2442 1640.66 38.68 1 5.0E-10
E 6939.80 2442 2055.80 455.82 2 1.1E-99
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cortical cataract scores, with the remaining variance being explained by unique 
environmental factors (AIC = 16523.54) (Table 4.3.). Similarly to the correlation above, 
in this model nuclear and cortical cataract scores shared 13% of phenotypic variance 
and 32% of this shared variance could be attributed to genetic factors (p-value = 0.03). 
Using the age- and sex-adjusted quantitative traits significantly changed the results and 
yielded a larger heritability estimate (Table 4.3.). The confidence intervals were, 
however, much larger and the model did not have a better fit (AIC = 16523.00). In the 
adjusted model the two traits shared only 3% of phenotypic variance and 76% of that 
was due to genetic factors (p-value = 0.54). When applying a bivariate model, the point 
estimates yielded in both cases were mostly lower than those from the univariate 
model (0.64 [0.60-0.68]). Such drop in the effect size is frequently observed and may 
happen because adding a variable changes the amount of information about the 
genetic variance component. Alternatively, the drop may also result from measurement 
precision differences between the two variables in the model. The latter is far more 
likely in the case of the analyses presented here.
Table 4.3: Comparison between bivariate heritability estimates obtained using three 
different strategies  
Comparison of bivariate heritability estimates between bivariate Cholesky decomposition, 
Genome-wide Complex Trait Analysis (GCTA) and linkage disequilibrium score regression 
(LDSR) models. VA – % of variance explained by additive genetic factors (h2 in the classical 
model and h2SNP in the other two models); CI – confidence interval; SE – standard error; Rph – 
amount of shared phenotypic variance; C(G) – genetic covariance between 2 traits; h2 – amount 
of shared phenotypic variance explained by genetic factors (h2 in the classical model and h2SNP 
in the other two models); N – number of people used for the analysis; unadjusted – raw scores; 
adjusted – analysis adjusted for age and sex; * adjusted for age and sex; NA$ – not outputted by 
the program; ** calculated using GWAS summary statistics where GWAS analysis were 
analysis type VA  [95%CI] or (SE) Rph  [95%CI] C(G) h2 [95%CI]
nuclear cataract cortical cataract shared
Cholesky decomposition (N=2,464)
unadjusted 34% [23%-45%] 56% [49%-62%] 13% [8%-18%] NA$ 32% [10%-94%]
adjusted 44% [0.3%-59%] 51% [0.4%-66%] 3% [-40%-12%] NA$ 76% [19%-89%]
GCTA (N=1,155)*
both quantitative 28.4% (8.7%) 9.0% (6.8%) NA$ 8.7% (1.7%) 54.7% (12.8%)
both binary 6.9% (3.4%) 5% (4.7%) NA$ 0.5% (2.8%) 9.3% (47.8%)
LDSR (N=2,285)
adjusted** 9.0% (7.2) 5.2% (2.5%) NA$ 0.1% (2.8%) NA***
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adjusted for the effects of age and sex and for relatedness; *** due to very low genetic 
covariance, the amount of shared heritability could not be calculated.
When both traits were treated as quantitative using GCTA (N=1,155), the 
proportion of variance explained by SNPs for nuclear and cortical cataract were 28.4% 
and 9.0% respectively. In this model the genetic covariance between the two traits was 
8.7% and genetic correlation was 54.7%. When both traits were treated as binary,  a 
less powerful model, genetic variance for nuclear and cortical cataract were 6.9% and 
5.0% respectively, while the genetic covariance and the genetic correlation between 
the two traits were 0.5% and 9.3% respectively. The LD-score regression analysis (N = 
2,285) estimated the heritability of nuclear and cortical cataract to be 9.0% and 5.2% 
respectively. The genetic covariance between the two traits was very low (0.1%) and, 
thus, correlation could not be calculated.
Finally, a polygenic risk score for nuclear cataract, calculated using the meta-
analysis results from the International Cataract Genetics Consortium (TwinsUK cohort 
excluded), could predict only a very small amount of variance in cortical cataract in 
TwinsUK (Figure 4.5.)
Figure 4.5. Genome-wide polygenic scores prediction
This figure presents the results of the amount of variance in cortical cataract explained by 
nuclear cataract associated variants. Univariate (purple) and adjusting for age and sex 
(lavender) analysis. The number of SNPs per p-value cut-off are (from left to right): 204, 1,768, 
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16,184, 78,120, 153,800 and 747,352.
4.4.2. Genome-wide association analysis results
In TwinsUK of the 2556 people who had cataract scores, 2285  people had *
genome-wide data imputed against the 1000G project. Of the 9.1 million variants 
(including indels), 9 million variants passed QC (Figures 4.6). The genomic inflation 
factor of the summary statistics was (λ) 1.02 and 1.01 for nuclear and cortical cataract 
respectively, indicating good control of population stratification. In the case of nuclear 
cataract (Table 4.4.), only one variant (rs79717917, MAF=2%, intronic, TDRD3), 
reached genome-wide significance (p-value < 5.8x10-8, Figure 4.7). In addition, 153 
variants at 47 loci were suggestively associated (p-value < 1x10-5) with nuclear 
cataract. These variants were within or in close proximity to 40 protein coding genes, 3 
miRNAs and one lncRNA. Adding smoking status as a covariate did not change the 
results for the existing associations and did not lead to the identification of any 
additional variants. 
In the case of cortical cataract, two variants, rs116848423 (MAF=1%, OR8B8) 
and rs145013270 (MAF=1%, C14ofr177), reached genome-wide significance (p-value 
< 5.8x10-8) and 121 variants at 42 loci were suggestively associated (p-value < 1x10-5) 
with cortical cataract. The suggestively associated variants were within or in close 
proximity to 35 protein-coding and 2 lncRNA-coding genes. In TwinsUK, only variants 
within one gene (SOX5) were associated with both types of cataract. However, the 
variants associated with nuclear cataract were situated within the gene body, and those 
associated with cortical cataract were situated within the gene promotor (Figure 4.8.).
In RSI-III the overlap between genome-wide data imputed against the 1000G 
project (28.7 million variants, excluding indels) and nuclear and cortical cataract was 
1424 and 2410 people respectively. After QC, 10 million variants were associated with 
both types of cataract. The λ equalled 0.99 and 1.02 for nuclear and cortical cataract 
respectively, indicating good control of population stratification. None of the nuclear 
cataract associated variants reached genome-wide significance (Figure 4.6, Table 
4.4.). In addition, 22 variants at 5 loci were suggestively associated (p-value < 1x10-5) 
with nuclear cataract. These variants were within or in close proximity to 5 protein 
coding genes. Adding smoking status as a covariate did no change the results for the 
for the majority of twin pairs one twin per pair at random was included in the imputation; while *
the genotypes of MZ twins could be copied from one twin to the other, that was not possible for 
DZ twins.   
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existing associations and did not lead to the identification of any additional variants.
As opposed to nuclear cataract, three variants within 2 loci, LINC02214 and 
C20orf78, reached genome-wide significance (p-value < 5.8x10-8), and 193 variants at 
30 loci were suggestively associated with cortical cataract (Table 4.4). Furthermore, in 
RSI-III no loci were associated with both nuclear and cortical cataract, and the 
association with SOX5 did not replicate (p-value > 0.05). SOX5 is plays important role 
in various developmental processes but its role in lens development is unclear521.  
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This figure presents the GWAS results for nuclear (A,B) and cortical cataracts (C,D) in the 
TwinsUK (A,C) and RSI-III cohorts (B,D). Q-Q plots: the observed p-values distribution is plotted 
agains the expected p-values distribution under the null hypothesis. Manhattan plots: p-values 
are plotted against the 22 autosomes. red line – genome-wide significance threshold (p-
value=5x10-8); blue line – suggestive significance threshold (p-value=1x10-5). All p-values are -
log10 transformed.
For both traits, over 50% of associated variants in TwinsUK were of low MAF 
(between 1% and 5%) and could not be replicated in RSI-III because the SNPs were 
either insertion-deletions (not considered for RSI-III, see methods), were of low 
imputation quality (< 0.3) or were absent in RSI-III. The most strongly associated loci 
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(Table 4.4.) but for 41% of sentinel variants the direction effect was similar for both 
cohorts. The rest had opposite effect in the two cohorts but for those variants there was 
low statistical confidence in the direction of effect. For example, in the cases where 
there was no statistically significant association in the RSI-III, the effect estimates 
mostly had very wide confidence intervals passing through zero. In the cases where 
was no statistically significant association in the TwinsUK, the confidence intervals 
were tight but the effect was centred on zero. Moreover, as illustrated by Figure 4.7., 
none of the SNPs in LD with the sentinel variant showed association in the replicating 
cohort. Finally, similarly to the shared heritability results, there was no overlap between 
the variants or loci that were associated with nuclear cataract and those that were 
associated with cortical cataract (Table 4.4.).
As the following chapter (Chapter 5) is dedicated to meta-analysis of cataract 
GWAS, I did not attempt to meta-analyse the two cohorts in the present chapter. 
However, the sentinel variants were meta-analysed using fixed effect inverse-variance 
meta-analysis implemented in METAL522 (Table 4.4). These revealed substantial 
heterogeneity of effects between the two cohorts for the majority of sentinel variants 
and resulted in higher meta-analysis p-values (Table 4.4.). The only exceptions were 
two of the variants that were associated with nuclear cataract: rs12991805 (p-
value=7.5x10-9; within LINC01934) and rs149786171 (p-value=1.2x10-7; within PRR11). 
The meta-analyses for these variants produced lower p-values and there was no 
heterogeneity of effects detected in either case. These two loci will be discussed in 
more detail later in this chapter. Here it is worth noting that heterogeneity estimates 
tend to be unstable when the number of cohorts meta-analysed is small and can not be 
used to claim general discordance between TwinsUK and RSI-III. In fact for the 
majority of variants showing at least nominal significance (p-value < 0.05) the direction 
and effect sizes for the two cohorts were comparable. 
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This table lists the sentinel SNPs (dbSNP147 rs-number) per locus for the loci showing the 
strongest association with nuclear and cortical cataracts in each study or which contain 
plausible candidate genes (in bold). Position — chromosomal band and base pair position 
(GRCh37/hg19, positive strand). Gene — closest RefSeq gene (± 2kb from the longest 
transcript start/end sites). Variant location relative to gene: a) exonic/UTR; b) intronic; c) 
upstream; d) downstream; EA – effect allele; OA – other allele; EAF – effect allele frequency; 
the effect (beta), its standard error (SE) and p-value are reported; INFO — information score 
(IMPUTE2 info. for TwinsUK; Minimac R2 for RSI-III), G – genotyped SNP (INFO=1.00); * SNP 
was either absent of badly inputed. When a poxy (r2 >=0.8) that passed QC was available, the 
estimates for the poxy are presented. The meta-analysis estimates were obtained using 
inverse-variance fixed effect meta-analysis using METAL. HetI2 – heterogeneity I2 
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The figure presents the regional association plots for the SOX5 locus where in TwinsUK variants 
were associated with both nuclear (A) and cortical (B) cataract. The plots are centred on the 
sentinel SNP (purple diamond) per locus and flanked by the GWAS results for SNPs in the 
500kb region surrounding it. The shading of the flanking SNPs reflects their pairwise correlation 
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4.4.3. Rare-variant analysis in TwinsUK
Here, I present the association results, obtained using SKAT, for the low 
frequency (MAF<5%) and rare (MAF<1%) exonic genetic variants and nuclear and 
cortical cataract in 905 unrelated individuals from the TwinsUK cohort. The decision to 
focus on exonic variants was driven by the relatively small sample available at the time.
Figure 4.9. Quantile-quantile (Q-Q) and Manhattan plots from the SKAT aggregate tests 
for nuclear and cortical cataract
This figure presents the results from the SKAT aggregate test for nuclear (A) and cortical 
cataracts (B) in the TwinsUK cohort. Q-Q plots: the observed p-values distribution is plotted 
agains the expected p-values distribution under the null hypothesis. Manhattan plots: p-values 
are plotted against the 22 autosomes. red line – genome-wide significance threshold (p-
 115
Q-Q plots Manhattan plots
A
B
Chapter 4: Different genetic variants are associated 
 with nuclear and cortical cataract 
value=2.5x10-6); blue line – suggestive significance threshold (p-value=1x10-5). All p-values are 
-log10 transformed. Each dot is a gene.
There was no correlation between the size of the genes, the number of variants 
analysed per gene or the fraction of individuals harbouring low frequency and rare 
variants and the p-value obtained from the burden test. There was a low positive 
correlation (r2=0.2) between the fraction of people carrying LFRGV in a gene and the 
gene size, moderate correlation between (r2=0.4) the number of variants in a gene and 
the gene size and high positive correlation (r2=0.7) between number of variants per 
gene and the fraction of people carrying low frequency and rare variants.
Only exonic non-synonymous variants were considered for this analysis. After 
QC, 11,263 genes remained and the inflation factors for these analyses were 1.13 in 
the case of nuclear cataract and 1.12 in the case of cortical cataract (Figure 4.9, Table 
4.5.). None of the genes reached genome-wide significance and none of the genes 
associated (P<0.05) with nuclear or cortical cataract has previously been implicated in 
cataractogenesis.
Table 4.5:SKAT results for low-frequency and rare exonic non-synonymous variants
This table lists the most strongly associated genes when only exonic variants were analysed. 
CHR — chromosome; beginning and end of longest ORF, gene — gene name; N — number of 
variants included in final model; FRV% — percentage of people harbouring variants with <5%. 
CHR BEGINIG END GENE N FRV (%) P-value
Nuclear cataract
6 116441813 116446506 COL10A1 4 2.8 2.8E-05
19 39734352 39735517 IL28B 4 5.1 3.1E-05
11 125831724 125871721 CDON 6 5.5 6.5E-05
17 56572427 56586149 MTMR4 4 1.8 9.2E-05
8 144732092 144732488 ZNF623 3 3.4 1.3E-04
Cortical cataract
12 57423517 57441459 MYO1A 9 10.6 1.2E-05
9 132904231 132904267 FLJ46836 3 3.4 2.6E-05
1 228596116 228602816 TRIM17 3 1.4 2.9E-05
1 12004663 12032953 PLOD1 6 4.3 6.8E-05
11 130716857 130731700 LOC100507431 5 4.5 1.8E-04
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4.5. Discussion
4.5.1. Heritability analysis
In this chapter, I first explored whether nuclear and cortical cataract share genetic 
risk factors with each other or with other age-related diseases. The classical heritability 
model yielded results similar to those obtained by Hammond et al in a smaller sample 
of the same population167,169. However, the two traits shared only 13% of phenotypic 
variance and this percentage decreased to 3% when the effect of age was taken into 
account. There was no statistically significant sharing between the two traits 
irrespective of the model used. A bigger sample size is, therefore, needed to accurately 
estimate any shared heritability, given such a low phenotypic sharing. 
The classical heritability modelling uses phenotypic data only and, apart from 
partitioning the variance attributed to genetic factors into variance due to additive and 
variance due to dominant effects, it does not provide in-depth information about the 
genetic architecture of a trait (number of loci involved, strength of effects at a locus). 
SNP-based heritability methods are better suited for elucidating the genetic 
architecture. In line with the “missing” heritability problem495, both SNP-based tests 
yielded lower heritability estimates than the classical twin model. However, GCTA and 
LD-score regression gave very different results even though the same variants were 
used for both types of analysis. Namely, using LD score regression resulted in much 
lower heritability. This results is in line with previous studies where the LD-score 
regression estimates are consistently smaller than those from GREML in the same data 
set523. In addition, using different sets of SNPs (data not shown), I obtained vastly 
different results from no shared heritability to very high estimates which means that the 
GCTA results are very dependent on the sets of SNPs chosen. Indeed, it has been 
previously shown that when a sparser set of variants is used as opposed to a denser 
one, a GREML analysis resulted in a smaller proportion of phenotypic variance 
explained524. 
Using GREML may lead to biased estimates when significant part of the effect is 
explained by rare causal variants, which are unlikely to be well tagged by common 
SNPs, or when causal variants are located in genomic regions with a different LD 
properties from the rest of the genome524. LD-score regression is more robust to 
varying LD structure but it is less well suited to deal with rare variants. Furthermore, 
GCTA-GREML calculates LD from within the sample while LD-score regression uses a 
reference sample to do that. Another limitation of LD-score regression is that its results 
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may be less stable when estimated for smaller samples (overall sample size<50,000). 
Here, it is important to point out that for both the GCTA and LD-score regression 
analyses, only a subset of SNP were used (HapMap3 SNPs) and, given that the 
TwinsUK was imputed to the 1000G panel, this subset may not capture the full extent 
of the genetic effects from the additional non-HapMap3 SNPs. In both cases, using 
more variants and a better reference population, such as UK Biobank, to calculate LD 
may improve the estimates. In addition, models such as LDAK  or GCTA-LDMS may *
afford a better estimation of the underlying LD-architecture525,526.
In conclusion, probably the true shared heritability between nuclear and cortical 
cataract lays somewhere between the GCTA and LD-score regression. GCTA is 
probably overestimating527 while the LD score regression is probably underestimating 
the heritability, but in any case the shared heritability between the two traits seems to 
be still low. This conclusion is still supported by the fact that the polygenic risk score 
analysis showed exceedingly small sharing of genetic risk factors. Thus, nuclear and 
cortical cataract seem to be genetically different diseases, which is interesting given 
they often occur together, but this is similar to the environmental associations which, 
other than age, are also different.
4.5.2. Genome-wide association analysis
In this chapter, the first GWAS results for nuclear and cortical cataracts in two 
European ancestry cohorts have also been presented. The majority of sentinel variants 
were of low frequency and showed a substantial heterogeneity of effects between the 
two cohort. Thus, the two cohorts largely did not replicate each other. Given that both 
cohorts were underpowered these results are not surprising. Meta-analyses of the 
results presented here together with GWAS results from other cohorts would afford the 
better power needed to determine any true association which much greater statistical 
confidante. Despite that, 2 of the variants associated with nuclear cataract show 
evidence for association in both of the cohorts. Furthermore, some of genes within the 
associated loci (p-value < 1x10-5) may be interesting functional candidates for nuclear 
or cortical cataract formation and will be discussed in detail here. As explained in the 
introduction of this chapter (4.2.2. Genome-wide association studies), no fine-
mapping was attempted here, but candidate genes were shortlisted based on the 
following information present in the publicly available literature: the function of the 
 LD-adjusted kinship*
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protein they encode when known; expression patterns concordant with lens or eye 
expression; interaction with genes previously implicated in cataract formation; the gene 
being member of a gene family where other members have been previously implicated 
in cataract formation. 
 LINC01934 and PRR11 loci:
The association between the sentinel variants at both loci and nuclear cataract 
was supported by both cohorts (rs12991805 within LINC01934, meta-analysis p-value 
7.5x10-9; rs149786171 within PRR11, meta-analysis p-value 1.2x10-9). In both cases, 
the sentinel variant mapped to a region of extended LD (Figure 4.7.) but, given their 
low frequency (7% and 1% respectively), the variants themselves were not in strong LD 
with other variants in the region. On bases of their function and expression, none of the 
genes at the two loci were strong candidate genes. Given that lncRNA my be regulating 
gene in trans and that there are a couple of microRNA genes in proximity to the PRR11 
sentinel variant, it may be that the association, if real, is due to target genes in trans. 
CYP7B1 locus:
The sentinel variant within the CYP7B1 locus (rs2884074, p-valueTwinsUK = 
4.1x10-6) mapped to the 5’UTR of one of CYP7B1 isophorms. Similarly to the 
LINC01934 locus, the CYP7B1 sentinel variant was situated in a long LD-block (Figure 
4.7.). Thus, although the pick was located over CYP7B1 it is unclear whether CYP7B1 
is the causative genes. Strong LD with a relatively common allele in a relatively large 
region may indicate a recent mutation event under positive selection528. Furthermore, in 
terms of function, CYP7B1 is a likely candidate. The genes takes part in cholesterol 
metabolism, which may be important in cataract development529, and Mendelian 
mutations in CYP7B1 cause spastic paraplegia in combination with cataracts530.
TRPM3 locus:
In the case of the TRPM3 locus(rs1337010, p-valueTwinsUK = 2.0x10-6), the 
TRPM3 gene and its microRNA were the only two genes in LD with the sentinel variant 
(Figure 4.7). TRPM3 and its regulating microRNA (MIR204) are expressed in lens and 
lens epithelium; and are under the control of PAX6 — a major eye-development 
transcription factor531-533. TRPM3 is a membrane-bound calcium channel, which was 
previously linked to congenital cataracts534-536. The Mir204 is a negative regulator of 
gene expression (including of Sox11) in vertebrate eye537.
TDRD3 locus:
Similarly to the TRPM3 locus, the TDRD3 gene was the only gene in LD with the 
sentinel variant (rs79717917, p-valueTwinsUK = 2.5x10-8) at this locus (Figure 4.7). 
TDRD3 gene encodes for a scaffolding protein in cytoplasmic stress granules538. 
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Mutations in a gene (TDRD7) encoding for another member of the same family of 
proteins, caused paediatric cataracts539. Loss-of-function mutations in the murine Tdrd7 
lead to cataracts and glaucoma539. 
CAV1/2 locus:
A sentinel variant (rs6466582, p-valueRSI-III = 5.0x10-7) in the CAV1/2 locus 
showed suggestive association with cortical cataract. This locus showed similar LD-
structure to the CYP7B1 locus (Figure 4.7). One of the genes in the locus, CAV1, is 
well studied in relation with age-related eye diseases. For example, common CAV1 
variants have been associated with primary open angle glaucoma540. Although the role 
of CAV1 in cataract formation is unclear there is some evidence suggesting that the 
gene may be involved. CAV1 encodes for a scaffolding protein expressed in most cells 
types, including lens fibres. Moreover, knock-out Cav1 mice develop cataract541 and 
heterozygous de-novo CAV1 nonsense mutations have been proposed to cause 
neonatal lipodystrophy with cataract542. 
PALM2/ AKAP2 locus:
In the PALM2/AKAP2 locus there seem to be two independent signals coming 
from two separate LD-block (Figure 4.7). This locus has a complex structure and there 
are naturally occurring read-through products of the PALM2 and its neighbouring gene 
AKAP2. Both genes have been implicated in lens function. In mice, Palm2, a gene 
proposed to be under Pax6 control, is expressed in the lens placode, and this 
expression is maintained in the lens vesicle throughout the formation of the adult 
lens543. In vertebrate, AKAP2 couples MIP to its protein kinase supporting support 
ocular lens transparency544.
TIMP2 locus:
At the TIPM2 locus there are more than 10 genes located in the same LD-block 
(Figure 4.7) where the sentinel variant maps to (rs4789863, p-valueTwinsUK = 3.7 x10-6). 
However only one of the 10 genes (TIMP2) has a known eye-related function. TIMP2 
encodes for an aqueous humor metalloproteinase inhibitor that has been proposed to 
have a relationship with in glaucoma and axial length545,546. Matrix metalloproteinases 
are known mediators of various cataract types547.
Even though the above discussed genes are plausible candidates, the two 
studies largely did not replicate each other. A meta-analysis of those and other 
available studies would afford better power to detect genes that are truly associated 
with ARC. Such an analysis is presented in the following chapter.
Finally, neither the TwinsUK or the RSI-III GWAS analyses detected an 
association between variants in EPHA2 the only gene, to date associated with age-
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related cortical cataract26,122,208,209. There is a simple explanation for that result, namely 
the very different method used between the present and the past EPHA2 studies. Here 
I have used all individuals that had a cataract score and a case-control cut-off at 5%. 
The method I have used here is better powered to detect common variants associated 
with cataract and assumes that cortical cataract is a common polygenic trait.   
The association between the EPHA2 locus and cortical cataract was initially 
discovered using linkage analysis and candidate gene/variants studies26,122,208,209. The 
EPHA2 variants associated with ARC were found using cut-offs for defining case and 
control status 25% of lens area affected and <1% of area affected respectively122; 
effectively cutting off the middle of the score distribution and giving more weight to the 
strongly affected individuals. Such a method is also a way to enrich the right tail of the 
distribution for Mendelian forms of cataract. Indeed, when 25% cut of is used, EPHA2 
is associated with cortical cataract in both TwisnUK and the RSI-III (rs7548209, p-value 
of 2x10-4 and 1x10-3 respectively). Using a similar study design may reveal variants in 
additional genes with moderate to strong effects but will also necessitate much bigger 
sample size.  
4.5.3. Low-frequency and rare variants analysis
Finally, I also explored the effect LFRGV have on ARC in TwinsUK. As pointed 
out in the methods section of this chapter, rare-variants are more susceptible to the 
effects of even subtler population structure517-519. Thus, even though the WGS was 
done in a set of unrelated individuals, I opted for using a kinship matrix. This indeed 
resulted in substantially reduced inflation but the results were still inflated and if 
genomic control was used, none of the genes would be significant at suggestive level 
(p-value < 1x10-5). Moreover, none of the genes previously linked to congenital cataract 
were associated with ARCs (p-value > 0.05). I decided to focus on exonic variants, as 
the sample size of 905 individuals is not sufficient to yield power for whole-genome 
analysis. Making use of the additional WGS samples from the HLI TwinsUK 
collaboration (Table 3.1.) when they become available would increase the sample size 
and will make it possible to explore other groups of functional variants (eg. within 
regulatory regions or non-coding RNA classes). Exploring better powered and more 
versatile tests such as adaptive mixed effect models implemented in MONSTER548 is 
also worthwhile. In addition these and any other results obtained by other methods will 
need to be replicated. The RSI-III has WGS data available which, in combination with 
the fact that phenotyping in RSI-III was done in the same way as TwinsUK, makes this 
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cohort a good replication set. Even then, however, replication may prove problematic 
as rare variants may be population specific and thus difficult to replicate in other 
populations. 
4.5.4. Conclusions 
In conclusion, the shared heritability analysis in this chapter showed that nuclear 
and cortical cataract seem to be genetically different conditions. Those results also 
were supported by the fact that the loci that were found to be associated with nuclear 
and cortical cataract in two European ancestry cohort did not overlap. Better powered 
studies will be needed in order to confidently detect cataract-associated loci and to 
fine-map causative variants and genes. Finally, low-frequency and rare genetic variants 
within coding regions of the genome did not cumulatively show statistically significant 
effects on cataract formation. Again, a better power study will afford better power to 
explore the cumulative effect of non-coding variants, which are much more likely to 
affect a common complex phenotype such as cataract.  
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5.1. Overview
The power of GWAS is heavily dependent on the sample size and, as seen in our 
own data in the previous chapter, small studies are underpowered to find associations 
which would survive correction for multiple testing. In order to increase power and 
reduce false-positive findings, meta-analyses are performed. As described in Chapter 
1, a meta-analysis of GWAS for nuclear cataract in Asian populations led to the 
identification of the first two loci for age-related nuclear cataract27. Here, I perform the 
first meta-analysis of GWAS for nuclear cataract in cohorts of European ancestry and 
combine those with GWAS of Asian ancestry cohorts. First, however, I will briefly 
describe the concept of meta-analysis in genetic studies and the methods traditionally 
used to perform those. 
5.2. Introduction
Meta-analyses are the statistical synthesis of summary-level information from 
multiple independent studies, and have dramatically increased the yield of discovered 
and validated genetic risk loci549. Commonly, meta-analyses are performed using effect 
estimates weighted by the inverse of the standard error so that more weight is given to 
studies with more precision550. More imprecise, sample-size-weighted p-value meta-
analyses are also possible550 and can be used to combine results from a mix of 
quantitative and binary analysis. Meta-analysis usually uses frequentist (fixed or 
random effect) methods. The fixed effect meta-analyses assume a single common 
effect underlying all the studies, while random effects analysis makes the assumption 
that individual studies are estimating different underlying effects550. When between-
study heterogeneity is absent, fixed and random effects calculations yield identical 
point estimates and confidence intervals. With increasing between-study heterogeneity, 
the random effects summary estimates have larger variance (wider confidence 
intervals) and usually, but not always, they have lower statistical significance550. This 
drawback is due to overly conservative null-hypothesis model that assumes 
heterogeneity instead of no association (effect size of 0) under the null hypothesis, and 
can be amended by using Han and Eskin's random effects model551. The test replaces 
the traditional z-score estimation of p-values with a likelihood-ratio test and assume no 
heterogeneity under the null hypothesis551.
In practice, a mixture of fixed effects rather than a true random effect is more 
likely552. In this case, Bayesian models, such as the ones applied in trans-ethnic 
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analysis, may be more suitable. These models apply specific prior probabilities to the 
uncertainty parameters and one can examine the robustness of conclusions based on 
these priors, such as whether different priors may change the results perceptibly550. In 
this chapter both frequentist and Bayesian methods will be explored.
Similarly to meta-analysis in epidemiology, heterogeneity of effects in genetic 
meta-analysis presents a challenge as it decreases the power to detect true effects and 
increases the likelihood of detecting false positives553. Moreover, in presence of 
heterogeneity the effects are smaller in size and that may partially explain the 
discrepancy between the classically calculated heritability and the proportion of 
variance explained by associated genetic variants553. Heterogeneity, may result from 
methodological errors such as: population stratification, different study designs with 
differential ascertainment of phenotype across cohorts, the phenotype of interest being 
correlated with another phenotype with which the SNP is associated, differential 
genotyping errors, or imputation errors leading to breaking of LD patterns between 
tagged markers and causal variants across cohorts554,555. In these cases, 
heterogeneity may lead to false positive findings and it is extremely important that it is 
measured and dealt with. Between-cohort heterogeneity in GWAS effects may reflect 
genuine differences between cohorts that are results from local gene-by-environment 
interactions or, in multi-ethnic studies, from differences in LD556,557. Exploring 
heterogeneity in this case can bring insight about the underlying biology. There are 
different methods to test for and measure the amount of between-study heterogeneity. 
The two most commonly used are Cochran's Q and I2 statistics. Cochran's Q measures 
the weighted differences between the summary effect size and the study-specific effect 
sizes, and it is typically considered significant at the α  =  0.10 level554. This test is 
underpowered, when there are very few studies or when the studies are small studies 
with large confidence intervals554. I2 is a measure of the total variation across studies 
due to heterogeneity beyond chance and is calculated as: (Q-(number of studies - 1))/
Q). This metric is independent of the number of studies and can be compared across 
meta-analyses with different numbers of studies and metrics558,559. The second method 
is the one I have used when performing the meta-analysis. 
As with GWAS, meta-analysis of GWAS can identify associated loci but not the 
causative variants or genes. Therefore, in order for causal variants or candidate genes 
to be identified and prioritised for functional in vitro experiments, meta-analysis is 
followed by bio-informatics analysis of the identified loci. First, the association picks 
can be refined using conditional analysis (GCTA) or credible set analysis (FINEMAP, 
CAVIAR), meaning one variant or a small subset of variants are identified that are most 
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likely to be the causative variants or to tag a unobserved causative variant488,560,561. If 
data from samples with different ethnic backgrounds is available, trans-ethnic meta-
analysis can also help to identify potentially causative variants. This type of analysis 
relies on the fact that if an associated allele is shared between groups with different 
ancestry, can be useful to help fine-map a locus by restricting the credible set of 
variants to those that are in LD with the sentinel variant in all populations562. 
The potential functional consequences of the identified variants or a set of 
variants can next be explored. If the variants map to coding regions their effect on 
protein function or its stability can be predicted using tool such as polyphen2, SIFT and 
CADD which predict likely structural and functional consequence and in addition 
incorporate data on evolutionary site conservation563. Variants are more likely to map 
within non-coding regions in which case one needs to explore whether they are 
disrupting regulatory sequences for or disrupt expression in target tissues (expression 
quantitative trait loci (eQTL) analysis) of any of the neighbouring genes (cis-effects)563. 
Additional levels of evidence such as gene-set enrichment analysis, expression 
patterns of genes in target tissues in humans and model organisms, co-expression and 
co-binding analysis can also be very helpful when prioritising candidate genes563. To 
better understand the functional connection between the meta-analysis identified loci 
and age-related nuclear cataract, some of the here described methods are employed in 
this chapter.
5.3. Materials and Methods 
5.3.1. Cohorts of the International Cataract Genetics Consortium 
Phenotyping, genotyping and imputation procedures used in the different cohorts 
of the International Cataract Genetics Consortium (ICGC) have been discussed in 
detail in Chapter 2 and summarised in the two tables below (Table 5.1. and Table 
5.2.).
5.3.2. Study design
Age-related nuclear cataract GWAS summary statistics from 12 studies 
comprising 19,776 individuals were meta-analysed (Table 5.1.). This was done in 3 
phases: discovery (N=14,151), replication (N=5,625), and all data meta-analysis 
(Figure 5.1.). As LD patterns and causative variants between ancestry groups may 
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differ, in the discovery phase individuals from European (N=7,352) and Asian 
(N=6,799) ancestry were analysed separately, followed by combined analysis.
Table 5.1: Clinical characteristics and cataract phenotyping of participating cohorts
This table summarises the clinical characteristics of the participant in each cohort and the 
phenotyping methods used. AREDS – Age-related Eye Diseases Study (and its grading 
system), BMES – Blue Mountains Eye Study, RSI-III – Rotterdam Study I (follow-up 3), SCES – 
Singapore Chinese Eye Study; SiMES – Singapore Malay Eye Study; SINDI – Singapore Indian 
Eye Study; BDES – Beaver Dam Eye Study; BES – Beijing Eye Study; INDEYE – The India Eye 
Study; SLCCS – South London Case Control Study; N — number of individuals studied, the 
number of case for the replication cohorts is given in brackets after the total number of 
individuals; % F — percentage of females; SD — standard deviation; LPh — lens photography, 
SLB — slit lamp bio-microscopy; CNDS — central nuclear dip score; Wisconsin— Wisconsin 
Cataract Grading System; LOCS III — Lens Opacities Classification System III;
In order to maximise power in the discovery phase (N = 14,151), I selected for 
meta-analysis the GWAS where quantitative nuclear cataract scores were available. In 
these GWAS, all participants underwent detailed eye examination including lens 
photography after pupil dilation, which permitted accurate grading of cataract from lens 






 NC grade 
(mean ± SD)
Discovery (n = 14,151)
  AREDS European 1434 67.4 ± 4.7 59.0 LPh, AREDS 2.2 ± 0.8
  BMES European 2209 66.3 ± 8.8 57.1 LPh, Modified Wisconsin 2.5 ± 0.7
  RSI-III European 1424 71.2 ± 6.2 54.1 LPh, CNDS 89.6 ± 36.9
  TwinsUK European 2285 62.2 ± 6.8 98.0 LPh, CNDS 62.1 ± 18.1
  SCES-610 Asian (Chinese) 1704 57.5 ± 8.9 48.8 LPh, Modified Wisconsin 2.3 ± 0.7
  SCES-
OmniExpress Asian (Chinese) 526 58.7 ± 8.5 48.3
LPh, Modified 
Wisconsin 2.4 ± 0.7
  SiMES Asian (Malay) 2369 58.4 ± 10.9 50.6 LPh, Modified Wisconsin 2.5 ± 0.7
  SINDI Asian (Indian) 2200 56.4 ± 9.1 48.3 LPh, Modified Wisconsin 2.3 ± 0.7
Replication (n = 5,625) N (cases)
  BDES European 1509 (280) 62.3 ± 10.5 53.7 LPh, Original Wisconsin 2.7 ± 0.9
  BES Asian (Chinese) 1528 (769) 57.4 ± 9.4 61.6 LPh, AREDS 2.6 ± 1.1
  INDEYE(S) Asian (Indian) 2284 (373) 66.7 ± 6.0 52.4 LPh, LOCS III 3.7 ± 1.1
  SLCCS European 304 (242) 73.9 ± 10.2 54.9 SLB, LOCS III 2.4 ± 0.7
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photos using standardised grading that provided decimalised grades. Moreover, all 
studies used SNPs imputed to the 1000 Genomes panel (Table 5.2.). Each study 
included in the discovery phase performed per-SNP linear regression (additive genetic 
model) analysis separately following a pre-agreed protocol. All studies adjusted for age, 
sex and, when necessary for principal components of population structure. In addition, 
relatedness was taken into account in the TwinsUK cohort. Furthermore, prior to the 
association analyses nuclear scores were, when necessary, normalised. As different 
cataract grading systems were used, cataract scores were standardised within each 
cohort by subtracting the mean and dividing by the standard deviation.
Table 5.2: Genotyping and imputation platforms in the participating cohorts
The table summarises the genotyping and imputation procedures used by the ICGC cohorts. 
AREDS – Age-related Eye Diseases Study (and its grading system), BMES – Blue Mountains 
Eye Study, RSI-III – Rotterdam Study I (follow-up 3), SCES – Singapore Chinese Eye Study; 
SiMES – Singapore Malay Eye Study; SINDI – Singapore Indian Eye Study; BDES – Beaver 
Dam Eye Study; BES – Beijing Eye Study; INDEYE – The India Eye Study; SLCCS – South 
London Case Control Study; EUR – European ancestry; ALL – all populations in 1000 Genome 
project.




  AREDS Illumina HumanOmni2.5-4v1_B chip IMPUTE2 Phase 1, ALL 2012
  BMES Illumina Human 670-Quadv1 custom IMPUTE Phase 1, EUR 2012
  RSI-III Illumina Infinium II HumanHap550 v3.0 Minimac Phase 1, EUR 2012
  TwinsUK
Illumina HumanHap 300kDuo & 
HumanHap610-Quad IMPUTE2 Phase 3, EUR 2014
  SCES-610 Illumina HumanHap610-Quad Minimac Phase 1, ALL 2012
  SCES-
OmniExpress Illumina OmniExpress Minimac Phase 1, ALL 2012
  SiMES Illumina HumanHap610-Quad Minimac Phase 1, ALL 2012
  SINDI Illumina HumanHap610-Quad Minimac Phase 1, ALL 2012
Replication 
  BDES Illumina Human Exome Array Minimac Phase 1, ALL 2012
  BES Illumina HumanHap610-Quad Minimac Phase 1, ALL 2012
Illumina OmniExpress IMPUTE2 Phase 3, ALL 2014
  INDEYE(S) TaqMan - -
  SLCCS Illumina OmniExpress Exome Array Minimac Phase 3, ALL 2014
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Figure 5.1. Meta-analysis flow-chart
This graph shows the design of the current meta-analysis, the type of analyses and the number 
of individuals used at each stage.
The most strongly associated SNPs in each of the discovery phase loci that were 
associated with age-related nuclear cataract (p-value < 1x10-6) were selected for 
replication in four additional independent cohorts (N=5,625; 1,664 cases and 3,961 
controls). In this phase, the cohorts where the phenotyping was less accurate (BDES, 
BES and SLCCS) or which did not have genome-wide data (INDEYE) were used. 
Because of the less accurate phenotyping, it is problematic to include discrete scores 
as truly quantitative variables in regression models. Therefore, in the replication phase 
age-related nuclear cataract was treated as a binary outcome and logistic regression 
was performed. Case status was determined on the basis of the grading system used 
in each replication study as follows: BES (AREDS grade ≥ 3), INDEYE(S) (LOCS III 
grade ≥ 3), BDES (Wisconsin grade ≥ 4), and SLCCS (LOCS III grade ≥ 3). Controls 
were individuals free of any nuclear opacity and cataract surgery. Finally, in the all data 
meta-analysis (N=19,776), discovery and replication cohorts were meta-analysed 
together.
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5.3.3. Quality control and statistical analysis
The quality control of the summary statistics from the separate GWAS was done 
using a protocol developed by the Genetic Investigation of Anthropometric Traits 
(GIANT) Consortium516, as described in detail in Chapter 4 (section 4.3.3. Statistical 
analysis; subsection: GWAS results QC). Briefly, all variants with MAF <1%, 
information score of <0.3, and HWE p-value <1x10-4 were excluded. As data on 
insertion-deletion polymorphisms was missing for some of the cohorts, single base 
changes only were analysed. Variants present in less than half of the cohorts per 
ancestry group, or in less than 3 of the cohorts in the combined analysis were also 
excluded. 
After QC, between study heterogeneity was calculated using METAL522. As the 
vast majority of variants showed low to moderate heterogeneity, I opted for a fixed 
effect model for all stages (METAL522): inverse-variance (discovery, replication); 
sample-size-weighted p-value (all data meta-analysis). As substantial genomic inflation 
can be present even in the absence of population substructure or technical artefacts564, 
no genomic correction was applied. 
In the discovery phase additional analyses were carried out. For validation 
purposes, a random effect meta-analysis (METASOFT565) and sensitivity analysis were 
performed — excluding cohorts one at a time and re-running the meta-analysis. To 
evaluate sharing between European and Asian Cohorts, trans-ethnic meta-analysis 
(MANTRA566 and MRMEGA ) were performed. Finally, to refine the association loci, *
conditional analysis using GCTA488 was performed as follows. At each locus the least-
squares estimates of the effects of SNPs at the locus conditional on the most strongly 
associated independent SNP at the locus were calculated. The 1000G Phase3 data 
was used to calculate LD patterns at each locus. In this analysis, I explored the effect 
of using different ancestry panels (mixed, European, East Asian, South East Asian). 
GCTA was also used to calculate the amount of genetic variance explained by 
associated SNP488. Shared heritability between age-related nuclear cataract and other 
traits for which GWAS results were available through http://ldsc.broadinstitute.org/, and 
heritability partitioning were explored using linkage disequilibrium score regression489. 
Finally, gene-based meta-analyses (GATES567) were also performed. 
 http://www.geenivaramu.ee/en/tools/mr-mega*
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5.3.4. Gene-set enrichment analysis
Gene-set enrichment analysis were performed using MAGENTA568. For this 
analysis GWAS meta-analysis variants with p-value less than the following cut-offs: 
0.05; 1x10-3; 1x10-4; and 1x10-5, were selected and analysed separately. The number 
of permutations used to calculate the false discovery rate (FDR) adjusted p-value was 
10,000 and, as nuclear cataract is likely to be highly polygenic, FDR of 15% was used. 
Different distances (range 20kb-1MB) from lead SNP to closest gene (start and end 
site of longest transcript) were explored. All gene-sets were adjusted for gene-
clustering: removing all but one gene from a subset of genes assigned the same best 
SNP and keeping the gene with the most significant gene score. Gene-set enrichment 
analyses were also attempted using three additional platforms: WebGestalt GSAT 
(www.webgestalt.org/), DAVID (https://david.ncifcrf.gov/) and Pascal (https://
www2.unil.ch/cbg/index.php?title=Pascal). All three platforms yielded results identical 
to the ones obtained by MAGENTA.
5.3.5. Congenital cataract genes
I explored whether any genes previously linked to congenital cataract harboured 
age-related nuclear cataract association signals. The list of gene linked to congenital 
cataract was assembled using the following databases: OMIM — Online Mendelian 
Inheritance in Human, Cat-Map — Cataract Map; ClinVar — Clinical Variants, HD — in-
house database assembled using extensive literature search and co-curated by Prof. 
Sudha Iyengar. In order to select genes whose involvement in congenital cataract 
pathogenesis was supported by multiple sources, only genes present in 2 or more of 
the database were considered. Genes with insufficient evidence for involvement were 
excluded. Such examples were genes supported by a single study only where a 
mutation present in single family lacked independent replication or any additional 
functional evidence within the report. In addition, genes with well-established 
involvement  in murine cataracts, irrespective of evidence from human studies, were *
also considered. In this manner, a final list of 96 genes was curated. 
Next, I explored whether there was evidence for association between age-related 
nuclear cataract and variants mapping to the 96 genes within the discovery phase 
meta-analysis results. For a congenital cataract gene to be considered associated its 
 multiple articles using a variety of molecular techniques*
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longest transcript had to contain or have in proximity multiple variants that were 
associated with age-related nuclear cataract (p-value < 0.05). Variants were assumed 
to be in proximity if they were located within a 100kb window around the gene or within 
a window demarcated by the two closest recombination hot-spots (recombination rates 
≥ 40), whichever was smaller. For each gene, the p-value assigned to that gene was 
the p-value observed at the sentinel variant assigned to the gene. 
5.3.6. Functional mapping of discover phase association signals 
In order to predict the likely functional consequence of the associated variants 
and/or to predict causal effects, the sentinel SNPs (p-value < 1x10-5) in the discovery 
phase loci were taken forwards to bioinformatic analysis. 
Regulatory elements: Variants were annotated in terms of evidence for 
regulatory functions (enhancer histone modification signals, DNase I hypersensitivity, 
binding of transcription factors or effects on regulatory motifs), using HaploReg569 and 
ENCODE data track in the UCSC genome browser.Data on eye-specific transaction 
factors was also obtained using the Tissue Specific Gene Expression and Regulation 
database (TiGER) . ENCODE (https://www.encodeproject.org/) aims to build a *
comprehensive parts list of functional elements in the human genome, including 
elements that act at the protein and RNA levels, and regulatory elements that control 
cells and circumstances in which genes are active. HaploReg569 intersects a variety of 
functional annotations beyond ENCODE data. Those come mostly from next-
generation sequencing technologies and map DNA methylation, histone modifications, 
chromatin accessibility and small RNA transcripts normal tissues569. TiGER is a 
database, developed by the Bioinformatics Lab at Wilmer Eye Institute, which contains 
tissue-specific gene expression profiles or expressed sequence tag (EST) data, cis-
regulatory module data, and combinatorial gene regulation data (http://
bioinfo.wilmer.jhu.edu/tiger/).
eQTL summary statistics: I explored whether any of the SNPs associated with 
nuclear cataract (p-value < 1x10-5), regulated gene expression of adjacent genes in a 
quantitative manner (eQTLs) by searching publicly available data (GTEx, http://
www.gtexportal.org/home/) and the available literature. GTEx collects and analyses 
multiple human tissues from donors who are also densely genotyped, to assess 
genetic variation within their genomes. GTEx explores the global RNA expression 
 http://bioinfo.wilmer.jhu.edu/tiger/*
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within individual tissues and treats the expression levels of genes as quantitative traits, 
thus identifying variations in gene expression that are highly correlated with genetic 
variation. For the purposes of the current study, eQTL from all available GTEx tissues 
were queried. In addition, I used eQTL summary-level data generated using the 
TwinsUK expression data570,571 (N=856, lymphocytes, subcutaneous fat and skin) and 
genetic data imputed against 1000 Genome Phase 1 genotypes. The eQTL data was 
provided to me by Dr. Kerrin Small and Dr. Alexander Alves.
Gene Expression: Information on expression patterns in the tissue of interest 
can guide the selection of candidate genes in a locus of interest. As there is no in-
house lens expression available, gene expression data was obtained from 4 publicly 
available databases for the gene closest to the most strongly associated variant per 
locus as well as for all other genes in LD (recombination rates ≥ 40). The databases 
used to obtain data gene expression in the human eye and lens were: iSyte572 (https://
research.bioinformatics.udel.edu/iSyTE/ppi/index.php), the Ocular Tissue Database 
(https://genome.uiowa.edu/otdb/), and TiGER. Gene expression data for mouse lens 
was obtained from Mouse Genome informatics (MGI, http://www.informatics.jax.org/). 
In addition, publicly available data on co-expression (CORD) was also queried573. The 
iSyte572 aims to help candidate gene prioritisation relevant to lens development and 
cataract by proving information on transcriptome changes associated with cataract or 
lens defects, and by analysing gene expression in human and mouse embryos. The 
Ocular Tissue Database profiles RNA expression at a resolution of individual exons 
level from donor eye tissues using Affymetrix human Exon 1.0 ST arrays. MGI is an 
international database resource that provides integrated genetic, genomic, and 
biological data on laboratory mouse models in order to facilitate the study of human 
health and disease. Finally, CORD is a meta-analysis program that helps to determine 
gene function by exploring gene expression an co-expression, namely experiments 
where a gene is differentially expressed are identified and the gene network in which 
the gene belongs is determined573. COR also provided a dataset containing gene 
expression data from 9,490 microarray datasets mined from the GEO and 
ArrayExpress databases.
5.4. Results
After removing SNPs which were poorly imputed (info score/r2 < 0.3), were rare 
(MAF < 1%) or out of HWE, 8.3 million variants in the European cohorts (N = 7,352) 
and 6.8 million variants in the Asian cohort (N = 6,799) were retained for analysis. The 
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genomic inflation factors for the different studies were low (λ:0.99-1.04 Figure 5.2.) 
indicating excellent within-study control of population substructure. In the QC-ed subset 
of SNPs, the median standard errors (Figures 5.3.) were in accordance to the ones 
expected given the sample size of the different studies and the betas were normally 
distributed. The majority of associated loci showed low to moderate heterogeneity 
(Figure 5.4), therefore, fixed-effect meta-analysis were employed but validated those 
using a random-effects model.
Figure 5.2. Population stratification diagnostics
The Lambda-N plot (A) show the genomic inflation factor for each study plotted against the 
square root of the maximum sample size in that study; red line denotes threshold for inflation of 
λ=1.1. The meta-analyses Q-Q plots (B to D) show the observed distribution of p-values for 
association (-log10 transformed) plotted against the expected distribution of p-values under the 
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Figure 5.3. SE-N diagnostic plots for trait distribution issues
This plot shows the results from the standard error (SE) versus sample-size (N) diagnostics 
analysis in European (A) and Asian (B) cohorts. X-axis: c/median SE where c is a constant 
calculated using the appropriate 1000G minor allele frequency data. Y-axis: the square root of 
the maximum sample size in each study.
Figure 5.4. Distribution of the meta-analysis heterogeneity (I2) scores
This graph shows the frequency distribution plots of meta-analysis heterogeneity scores (I2) of 
for variants (p-value < 0.05) associated with nuclear cataract in the European (pink) and Asian 
(green) ancestry cohorts (A) and the meta-analysis of all cohorts (B). 
5.4.1. Discovery phase
Eighteen variants within the SOX2-OT locus and a variant within LOC440704 
reached genome-wide significance in the cohorts of European origin (Figure 5.5.). The 
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value = 4.4x10-9) and it was also associated in Asians (p-value = 2.5x10-5). The variant 
within LOC440704, rs147580522 (MAF=2%, p-value = 4.4x10-8) appeared to be driven 
by the TwinsUK cohort (Table 5.6.). Moreover, it was absent in the Asian cohorts and in 
one of the two European replication cohorts. In the remaining BDES cohort, the variant 
did not replicate (p-value = 0.93, Table 5.8.). In addition, 118 variants were 
suggestively (p-value < 1x10-5) associated with nuclear cataract. These variants were 
within or in close proximity to 18 protein-coding genes, including CRYAB (rs10502150, 
p-value = 2.2x10-6) — a gene which encodes for an important structural lens protein. 
Moreover, CRYAA and KCNAB1, the two loci previously found to be associated with 
nuclear cataract in Asians574, were also associated in Europeans (CRYAA: p-value = 
5.3x10-6 at rs7278468; KCNAB1: p-value = 0.02 at rs55818638 (MAF=3%)). In Asian 
cohorts (N=6,799) nineteen variants in CRYAA (rs7278468, p-value = 9.8x10-13) and 
GJA3 (rs4769087, p-value = 2.2x10-8) loci, reached genome-wide significance (Figure 
5.5.). In addition, 59 variants within 24 loci were suggestively associated with nuclear 
cataract (p-value < 1x10-5), including SNPs within KCNAB1 (rs7615568, p-value = 
3.9x10-6). 
When the European and Asian ancestry cohorts were combined (Nvariants=8.5 
million), SNPs at three loci reached genome-wide significance (Figure 5.5.). Two of the 
loci, CRYAA (rs7278468, p-value = 3.6x10-17) and SOX2-OT (rs9842371, p-value = 
2.6x10-12) were the most strongly associated in each ethnic group, while variants within 
TMPRSS5 (rs4936279, p-value = 4.2x10-11) reached genome-wide significance only 
after combining the two ancestry groups. In addition, rs62149908 (within COMMD1) fell 
short of reaching genome-wide significance (p-value = 6.5x10-8). Moreover, 30 loci 
were suggestively associated with nuclear cataract (p-value < 1x10-5, Table 5.3), 
including GJA3 (p-value = 6.6x10-6) and CRYAB (p-value = 8.4x10-6). The gene-based 
analysis (Table 5.4) did not yield additional associated genes. The common variants 
we found associated with age-related nuclear cataract (p-value < 1x10-5) explained 3% 
of genetic variance.
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Figure 5.5. Discovery phase Manhattan plots
This figure presents Manhattan plots for the European ancestry (A), Asian ancestry (B) and 
combined (C) meta-analyses: the -log10 transformed p-values for association are plotted 
against the 22 autosomes. The red line denotes the genome-wide significance threshold (p-
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Table 5.4: Gene-based analysis of the Discovery phase loci
The table shows the results from the gene-based analysis (GATES) of the summary statistics 
from the Discovery phase: combined analysis of European and Asian ancestry cohorts. Both the 
raw p-value and the p-value corrected for number of genes tested are presented. 
5.4.2. Validation, trans-ethnic and conditional analyses 
In order to ensure that by selecting a fixed-effect model no loci were missed, 
random-effect meta-analysis were also performed (Table 5.5.). The random-effect 
model produced similar results to the fixed effect model and no additional loci were 
identified. Next, leave-one-out sensitivity analyses were performed to evaluate the 
robustness of the association results (Table 5.6). The effect size and direction of effect 
stayed stable, thus the results did not support a disproportionate influence of any of the 
participating cohorts. The only exception was the sentinel variant at the 2p24.1 where 
BMES strongly influenced the association. This locus however did not replicate (Table 
5.8). 
To further evaluate the sharing of genetic factors between the European and 
Asian cohorts, trans-ethnic meta-analysis were performed (Table 5.7) in two different 
ways, both of which use a Bayesian framework but employ different methods to 
calculate the population relatedness. The first method, implemented in MANTRA566, 
assigns studies to population clusters and the effect of each study is compared to the 
cluster effect. The distance between the cluster centre and each study is calculated on 
the basis of allele frequency dissimilarity. Due to the fact that this method is 
computationally intensive and data formatting is cumbersome, only a subset of the 
SNPs (p-value < 1x10-4) were used to calculate the distance between clusters. The 
second method, implemented in MR-MEGA , calculates distance matrixes using the *
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mean pairwise differences between effect allele frequencies across a set of thinned 
SNPs. The matrices are then subjected to multidimensional scaling in order to calculate 
principal components, which are in turn used as covariates in a linear inverse-variance 
weighted model. In addition, the heterogeneity between studies is partitioned into 
ancestry-related heterogeneity and residual heterogeneity.  
The results from the trans-ethnic meta-analysis (Table 5.7) again reinforced the 
observation that, with two exceptions (the GJA3 and CRYAB loci), the observed 
genetic effects on nuclear cataract were ancestry-independent; and no additional loci 
reached genome-wide significance. The LD-structure of the GJA3 locus differs 
between European and Asian ancestry populations (Figure 5.6). Moreover, the 
posterior betas calculated by MANTRA had opposite direction of effect in the two 
populations. There was some evidence for ancestry-independent heterogeneity in this 
locus, too. There were no differences in LD-structure for the CRYAB locus between the 
two ancestry groups. Due to allele frequencies, however, for every associated variant 
the effect was much stronger in Europeans as opposed to Asians. The COMMD1 locus 
showed statistically significant heterogeneity that could not be explained by ancestry 
effects. At this locus the source of heterogeneity was the TwinsUK cohort which 
showed opposite direction of effect to the rest of the cohorts. The result was not due to 
genotyping errors, imputation errors or outlier effects. Interestingly, RNA sequencing 
analysis in human lenses with or without nuclear cataract performed by Dr. Chaolong 
Wang (data not shown), suggested COMMD1 expression differences between females 
and males pointing to an opposite direction of effect in females. Given that 98% of 
TwinsUK participants are female the result may reflect a genuine biological effect.
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Figure 5.6. Ethnic differences at the GJA3 locus
This graphs shows the differences in LD-structure (A) between Europeans and Asians for the 
GJA3 locus, and regional association plots where instead of plotting the p-value for association, 
the p-values for heterogeneity due to ancestry (B) and residual heterogeneity (C) are plotted.
5.4.3. Replication and all data meta-analysis
The most strongly associated variant per locus at ten discovery phase loci (p-
value < 10-6) were selected for replication. Four of the variants replicated (p-value < 
0.05) and three SNPs, although not reaching nominal significance, had the same 
direction of effect as that in the discovery phase (Table 5.8.). Finally, the discovery and 
replication phase results were combined (all data meta-analysis) using sample-size-
weighted p-value of the different studies (Table 5.8.). This resulted in total of 7 loci 
reaching genome-wide significance. Regional association and forest plots for those loci 
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Figure 5.7. Regional association and forest plots for the loci associated with age-related 
nuclear cataract at the All Data meta-analysis phase 
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This figure shows the regional association and forest plots for the 7 loci association with age-
related nuclear cataract at the All Data meta-analysis phase. The regional association plots are 
centred on the sentinel meta-analysis SNP (purple diamond) per locus. The shading of the 
adjacent SNPs (±400kb) reflects their pairwise correlation (r2) with the sentinel SNP. Blue lines 
— estimated recombination rates (1000G phase3 reference). The forest plots show: the effect 
size (the linear regression beta from the discovery phase or the ln(odds ratio) from the 
replication phase) and its standard error (bars). The squares are proportional to weights used in 
meta-analysis; European ancestry — no shading; Asian ancestry — grey shading. Black 
diamond — overall effect. A) COMMD1 locus; B) LINC01412 locus; C) SOX2-OT locus; D) 
TMPRSS5 locus; E) MMAB locus;F) GLTSCR1 locus; G) CRYAA locus
5.4.4. Common variants in congenital cataract genes 
Given that mutations in CRYAA, CRYAB, GJA3 and SOX2 are known to cause 
congenital cataracts, I explored whether common variants within other congenital 
cataract genes were associated with age-related nuclear cataract (Figure 5.8.). Using 
publicly available data, I selected 96 genes (⍺=5x10-4) and found multiple variants at 47 
of these to be associated (P<0.05) with nuclear cataract. The most strongly associated 
variants were in BFSP1 (P=3.5x10-5), LIM2 (P=1.4x10-4), MIP (P=3.4x10-4), TFAP2A 
(P=3.7x10-4) and CHMP4B (P=3.8x10-4). The associated variants within or in proximity 
to congenital cataract genes explained 2% of variance in age-related nuclear cataract.
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Figure 5.8: Common variants in congenital cataract genes. 	
This Manhattan plot shows the association results for the congenital cataract genes. The -
log10(p-value) of the sentinel variant per gene is plotted against the gene location. The colour 
code represents the strength of association in terms of p-value. 	
5.4.5. Gene-set enrichment analysis
No pathways or gene sets were statistically significantly enriched after correction 
for multiple testing. Below are presented the pathway and gene sets that (Table 5.9): 
have connection to cataract formation; were detected by multiple databases; or that 
were nominally associated at P ≤ 0.01 according to at least one database.
5.4.6. Functional fine mapping at the associated loci
In order to identify plausible candidate genes within the associated loci, functional 
fine mapping at each locus focusing on regulation and expression was performed.
Regulatory elements: First, I explored whether the sentinel variant at each 
associated locus (P < 1x10-5), or variants in high LD with it mapped to H3K27ac sites 
(Table 5.10). The presence of H3K27ac accurately marks active enhancers as 
opposed to inactive/poised enhancer elements containing H3K4me1 modification 
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alone575. The presence of H3K27ac and other enhancer markers (H3K4me1, 
H3K4me3, H3K9ac) was also queried through HaploReg and if the variant mapped to a 
binding sequence for any of these, the affected tissues or the number of affected 
tissues tissues was noted (Table 5.10). H3K4me3 and H3K9ac co-localize on active
Table 5.9. Gene set enrichment analysis
The table shows the results from the gene set enrichment analysis performed using MAGENTA. 
The gene-set and the database from which the gene-set was obtained as well as the raw and 
p-value p-value
Gene-set Databases raw adj. Gene-set Databases raw adj.
lens structural 
constituents GOTERM 3.0E-03 0.86
glucose regulation of 
insulin secretion REACTOM 0.01 0.91
ephrin receptor 
signalling Ingenuity 0.03 1.00
Glycosphingolipid 
biosynthesis KEGG 0.01 0.33
peptidase activity GOTERM 0.01 0.88 histone deubiquitination GOTERM 0.01 0.62
proteasome 
complex GOTERM 0.01 0.66 Immunity and defence Panther 0.01 0.55
Proteolysis Panther 0.01 0.44
integration of energy 




receptor group III Panther 0.01 0.10
Panther 0.03 0.68
negative regulation of 
cell growth GOTERM 0.01 0.76
Cysteine protease Panther 0.01 0.74
neural crest cell 




GOTERM 0.04 0.98 Neurotransmitter release Panther 4.0E-03 0.31
Panther 0.04 0.91
nuclear chromosome, 
telomeric region GOTERM 0.01 0.61
cell cycle BIOCARTA 0.02 1.00
P53 signaling 
KEGG 0.02 0.50
GOTERM 0.01 0.97 REACTOM 0.04 0.70
cell division GOTERM 3.0E-03 0.68 Panther 0.01 0.17
mitosis
BIOCARTA 0.04 1.00 protein/AA glycosylation GOTERM 0.01 0.92
REACTOM 0.01 0.71
protein/AA 
autophosphorylation GOTERM 3.0E-04 0.67
Panther 4.0E-03 0.45
regulation of insuline 
secretion REACTOM 0.01 0.90
G1 phase REACTOM 0.01 1.00
response to hydrogen 
peroxide GOTERM 0.01 0.79
dephosphorylation GOTERM 1.0E-03 1.00 response to starvation GOTERM 0.01 0.74




protein Panther 0.01 0.73
Panther 0.01 0.66 transport GOTERM 0.003 0.76
endosome GOTERM 3.0E-03 0.65 ubiquitin ligase complex GOTERM 0.001 0.64
Extracellular 
transport/import Panther 0.01 0.33 WNT signalling GOTERM 0.01 0.79
G-protein GOTERM 0.01 0.39 KEGG 0.02 0.65
Panther 0.01 0.39
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FDR of 15% adjusted p-values (adj.) for each gene-set are listed.
gene promoters and are associated with active transcription576. Similarly to the 
enhancers it was also noted whether the variant mapped to a DNAse hypersensitivity 
site at one or more tissues (Table 5.10). DNAse hypersensitivity sites are regions of 
the genome where chromatin has lost its condensed structure, exposing the DNA and 
making it accessible for transcription factors. Finally, I explored whether presence of 
the non-reference allele at each sentinel SNP changes any transcription factor binding 
motifs (Table 5.10). 
In five cases, sentinel variants fell within clusters of H3K27ac and 50% of sentinel 
variants mapped to other enhancer marks in many different tissues. Moreover, 
partitioning the heritability estimated by the LD-score regression resulted in significant 
enrichment (after adjusting for the number of independent tests) of repressor 
sequences (0.002) and H3K9ac enhancer picks (0.005). Variants also mapped to a 
couple of regulatory motifs that may function in lens, cataract or eye development. For 
example, early embryonic disruption of Klf4 resulted in a smaller lens and nuclear 
opacity577. OTX2 is an important transcription factor for head structure development 
and mutations in OTX2 cause anophthalmia/ microphthalmia102,578. Interestingly, CTCF 
binding sites were also predicted to be affected. CTCF is one of the key players in the 
organisation of insulator elements579. Finally, according to TiGER, the motifs HaploReg 
predicted to be affected by the risk allele at the sentinel SNP, point to members of eye 
specific cis co-regulation networks (POU3F2-FOXJ2-PAX2-PAX6-MEF2-HNF1; SRF-
CHX10-PITX2) or cis co-regulation networks with function in the eye (ERalpha-a-
GATA6-SMAD3-TGIF, Lmo2_complex-alphaCP1-MEF2-NFY-STATA4). These results 
may be suggestive of a role for impaired gene regulation in age-related nuclear 
cataract formation.
Lens expression: Next, I explored whether any of the genes at the associated 
(P<1x10-5) loci were expressed in human and mouse lens, using publicly available data 
(Table 5.11). Multiple transcripts of genes within those loci were expressed in the 
human eye and or in human or murine lens, but in terms of relative expression the 
levels were in general low, as measured by both normalised probe intensities (PLIER 
values) and/or normalised EST counts. However, some of the genes were expressed at 
moderate to high levels (PLIER/EST  enrichment scores): 12800.8/18.49 for CRYAA, *
for 2860.40/5,46 CRYAB, 289.7/1.92 for SOX2, 192.9/1.72 for COMMD1, 160.5/- for 
ZEB2, for 222.93/0.86 MAF. Some of those genes also showed eye-specific 
 higher values mean higher expression relative to the mean expression level for genes in the *
tissues
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enrichment (TiGER, Table 5.11) and/or were expressed in the human embryonic lens 
(iSyte, Table 5.11): CRYAA, CRYAB, ZEB2, MAF, SOX2, GJA3, CRX. Thus, in terms of 
expression, the above listed genes are plausible functional candidates. 
eQTL summary data: Further, the relationship between the alleles present at 
most sentinel SNP per locus (and the variants in high LD with those (r2>0.8) and all 
transcripts within 1MB of the lead SNP were explored (Table 5.12). As expression 
levels in the ocular lens are not available to conduct eQTL analysis, eQTL effects at the 
associated loci were queried in all of the tissues available from the GTEx database and 
the TwinsUK Expression data, under the assumption that a statistically significant effect 
in any of them would demonstrate the capacity of that locus to regulate transcription 
albeit in other cell lines or tissues. Although effects over transcription may be tissue 
and age-specific, others are shared across tissues (mean π1=0.73 of cis-eQTLs)580,581. 
Eight of the SNPs altered expression (or were in LD with the top eQTL) in at least one 
tissue. For example, the most strongly associated variant in CRYAA was also the most 
significant eQTL for the gene in liver (Pliver=4.8x10-8, rGTEx=-0.57). Apart from the lens, 
CRYAA is expressed only in liver and kidney but, given the small sample size for 
kidney in GTEx, reliable eTQL for the gene in kidney could not be established. The 
sentinel SNP (rs10502150, Pfat=7.6x10-22, rTwinsUK=-0.35) at the CRYAB locus in the 
European cohorts was in perfect LD (r2=0.95/D’=1.0) with the top eQTL variant 
(rs11214027) for CRYAB in fat. The eQTL results suggest that these polymorphic loci 
are capable of affecting genetic expression, at least in some tissues and cell lines, 
which may suggest that the association of these variants with cataract may be due to 
an eQTL effect. 
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Table 5.10: Regulatory elements data (ENCODE, HaploReg) for the sentient SNPs 
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Table 5.11: Publicly available expression data in human and mice for the genes closest to 
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The table reports the summary eQTL data obtained from GTEx and TwinsUK (purple) for the 
sentinel SNP at each locus.For GTEX only cis effects are shown. For TwinsUK both cis and 
trans-effect are reported. The sentinel SNPs (dbSNP147 rs-number) at each locus is listed as 
follows: position — chromosomal band (CHR) and base pair position (GRCh37/hg19, positive 
strand); Gene — closest RefSeq gene (± 2kb from the longest transcript start/end sites); variant 
location relative to gene: a) exonic/UTR; b) intronic; c) upstream; d) downstream; P value – P-
value from the Discovery phase meta-analysis (European and Asian cohorts combined); Locus 
here means a region between two recombination hot-spots (recombination rates ≥ 40) or a 1MB 
window, whichever was smaller; SNPs with no eQTL effect and SNPs not in LD (r2>0.8) with the 
top eQTL per gene are omitted. eGene – the gene whose expression is dependent on sentinel 
SNP, eSNP – the eQTL SNP for each gene. eTissues – the tissues where the eSNP exerts its 
effect on expression; N –number of eQTL-eGene-eTissues associations; LD between sentinel 
SNP and eSNP is reported as calculated on bases of 1000 Genomes LD parameters (r2 and D’ 
according to SNAP (https://www.broadinstitute.org/mpg/snap/ldsearchpw.php) or LD calculator ( 
https://caprica.genetics.kcl.ac.uk/~ilori/ld_calculator.php; in the cases SNP were > 500kb 
apart)), as is the distance between the two SNPs in kilo-bases (kb); LCL: lymphoblastoid cell 
line;
5.4.6. Candidate genes identification
At each locus (p-value < 1x10-5), whenever possible, a candidate gene or a set of 
candidate genes was identified. This was done on bases of:
•  the bioinformatics work described above;
• functional work in samples from human lens nuclei (RNA sequencing and 
protein expression and localisation work) that was carried by our collaborators in the 
labs of Dr. Chaolong Wang and Dr. Anita Chan (data not shown);
• extensive search of the published literature to date. 
The reasoning behind selecting candidate genes at each locus will be described 
here. Loci that did not replicate or where there was insufficient data to pinpoint a likely 
candidate are omitted. 
COMMD1 locus: There were several genes mapping to the COMMD1 locus, a 
locus of extended high-LD (Figure 5.7.). The publicly available expression data and the 
eQTL summary data were not informative for this locus but the sentinel SNP was 
predicted to disrupt an estrogen receptor binding site with function in the eye (Table 
5.10.). Two of the genes in the locus (COMMD1 and EHBP1) were associated with 
cataract severity in the RNA sequencing data provided by of Dr. Wang and the 
immunocytochemistry analysis provided by Dr. Chan suggested reduction in 
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expression levels of both genes. The CORD analysis showed COMMD1 to be co-
expressed with many of the subunits of the mitochondrial protein synthesis machinery, 
while EHBP1 was co-expressed with cell adhesion proteins. Both genes were treated 
as plausible candidates at this locus. 
LINC01412 locus: The sentinel variant at this locus mapped to an enhancer 
active at 5 different tissues (Table 5.11). From the genes in the LINC01412 locus, 
ZEB2 had the highest expression(Table 5.10) in human lens and its expression was 
elevated with increased cataract severity according to the RNA sequencing analysis. 
CORD analysis showed ZEB2 to be co-expressed with extracellular matrix receptor 
and focal adhesion proteins (including VIM: p-value=6.8x10-36). VIM encodes for a type 
III intermediate filament protein and mutations in this gene are a known cause of 
Mendelian cataracts.
SOX2-OT locus: The sentinel variant at the SOX2-OT was located within intron 5 
of SOX2-OT gene, a non-coding RNA gene that regulates the expression of SOX2582. 
As described above, the sentinel variants in not predicted to be an eQTL (Table 5.12.) 
but it is predicted to fall within a site for OTX2 transcription factor binding site. SOX2 
was expressed in the lens (Table 5.10.) but, according to the RNA sequencing results, 
its expression in lens epithelium was not associated with cataract severity. However, 
SOX2 protein concentration was elevated in epithelial nuclei of cataractous lenses 
compared to control lenses.
CRYAB locus: There were again many genes in high-LD at this locus (Figure 
5.7). However, the only one strongly expressed in lens was CRYAB (Table 5.10.). The 
sentinel variant at this locus was the eQTL SNP for CRYAB in fat (Table 5.12.). CRYAB 
encodes for a subunit of the most abundant structural lens protein (α-Crystallin). 
GJA3 locus: This locus showed complicated recombination patterns but only 
one gene, GJA3, was in LD (recombination rates <20). The gene was expressed in 
lens (Table 5.10.) and the sentinel variant was predicted to disrupt the binding of 
members of the SOX family of transcription factors. GJA3 encoded for a structural lens 
protein and as discussed further in this chapter, mutations in this gene cause 
Mendelian forms of cataract60,583,584.
GLTSCR1 locus: Pinpointing a likely candidate in at the GLTSCR1 locus was not 
straightforward. The sentinel variant was not predicted to affect gene regulation (Table 
5.10.) or to be an eQTL SNP (Table 5.12.). According to publicly available data 
GLTSCR2 and CRX showed eye-specific expression, while CRX was expressed in the 
human embryonic lens (Table 5.11.). The RNA sequencing analysis showed that 
GLTSCR1 expression was not associated with cataract severity but the expression of 
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both GLTSCR2 and NAPA decreased with increase in cataract severity. There was also 
a shift from cytoplasmic to nuclear NAPA expression in the cataractuos eye. The 
CORD analysis did not yield any additional information either. CRX encodes for a 
transcription factor, NAPA encodes for a vesicle docking protein and the protein 
encoded by GLTSCR2 is involved in ribosomal biogenesis. Additional functional work is 
needed to more accurately pinpoint the causative gene at this locus. 
CRYAA locus: At this locus only one gene, CRYAA, was in LD with the sentinel 
variant (Figure 5.7.). This gene showed eye- and lens-specific expression (Table 
5.11.). As described above, the sentinel variant at this locus was also the eQTL SNP for 
CRYAA in liver (Table 5.12.). Furthermore, the sentinel variant at this locus is predicted 
to fall within Klf4 regulatory motifs (Table 5.10.). Klf4 is a transcription factor that 
important for lens maturation577. The RNA sequencing analysis suggested that increase 
in cataract severity score was associated with decrease in CRYAA expression, while 
the immunohistochemistry assays suggested differences in localisation of CRYAA 
protein between cataractous and normal lenses. All this, together with the fact that 
CRYAA encodes for a subunit of the most abundant structural lens protein, points to 
CRYAA having a function in the formation of ARC. 
5.5. Discussion
In this chapter I have presented the largest to date meta-analysis of GWAS for 
age-related nuclear cataract. As estimated using GCTA and LD-score regression, the 
variants identified through the meta-analysis explained 9% of phenotypic variance in 
age-related nuclear cataract, of which 3% was attributable to the common variants that 
achieved p-values < 1x10-5 and 2% to genetic variants within congenital cataract loci. I 
also explored whether there was genetic sharing between age-related nuclear cataract 
and any of the traits (N = 219) for which GWAS results were available through LDHub, 
a platform that also uses LD-score regression. However, no statistically significant 
genetic sharing between nuclear cataract and LDHub phenotypes was detected, 
probably due the fact the LDHub uses only a subset of variants for the analysis (only 
the common HapMap 3 imputed SNPs as opposed to the full 1000G imputed set of 
SNPs).
After replication, 7 loci were associated with age-related nuclear cataract (Table 
5.8., Figure 5.7.) at genome wide significance level and will be discussed below. Many 
more (p-value < 1x10-5) loci contained genes that are potentially interesting functional 
candidates and will also be discussed here. In terms of function, the candidate genes 
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identified in this chapter can be divided broadly into two groups: structural lens proteins 
and transcription factors regulating the expression of those.
Little is known about the genetic aetiology of ARC but oxidation is thought to play 
a role in nuclear cataract formation through the denaturation/aggregation of crystallins 
— the structural lens proteins126,585. In this study, variants in proximity to CRYAA (p-
value = 3.6x10-17) and CRYAB (p-value = 8.4x10-6), encoding for the two forms of α-
crystallin, were associated with age-related nuclear cataract. α-Crystallins contribute to 
the clarity and refractive properties of the lens in two ways: when bound they are an 
integral part of the lens protein structures; in the free state they are molecular 
chaperones that prevent protein damage and protect against oxidative stress370,586,587. 
Moreover, Mendelian mutations in both genes cause congenital cataracts57,59,588,589. 
CRYAA and CRYAB are proposed to be down-regulated in lens epithelia of patients 
with age-related nuclear cataract27,590,591. If this is also true during nuclear fibre 
formation, that would imply that people who have lower expression of crystallins are 
likely more susceptible to oxidative stress-related protein depletion. The eQTL results 
we obtained for those two genes together with the lens epithelium expression data are 
also in agreement with a crystallin depletion hypothesis. Further modulators of 
crystallin expression, such as SOX2 may also play a role. SOX2-OT (p-value = 
4.8x10-20) encodes for a highly conserved long noncoding RNA expressed in the 
lens582. SOX2-OT regulates a transcription factor (SOX2) with an important role for lens 
and eye development, which when mutated, is known to cause microphthalmia592-594. 
During murine lens placode formation, Sox2 is regulated by Six3 and Pax6; and 
combination of Pax6/c-Maf with Sox2 generates synergistic effects in crystallin 
regulation66,595. In chicks Sox2 regulates δ-crystallins expression596. Another 
transcription factor, ZEB2 (a.k.a. SIP1), identified here, suppresses E-cadherin, up-
regulates FOXE3 and is important for fibre cell migration and organisation and cataract 
formation79,597,598.  
The results also support a role for protein clearance — a mechanism previously 
suggested to be important for cataract formation145,599. GJA3 (p-value = 6.2x10-6) 
encodes for a gap-junction connexin (Connexin-46, CXA46) involved in intercellular 
communication and cellular trafficking; and rare mutations in the gene cause congenital 
cataracts60,583,584. In animal models, alterations in ubiquitination lead to depletion of 
CXA46, accumulation of CXA43 and increase in Ca2+ levels and cataract600. COMMD1 
(p-value = 5.2x10-8) regulates, among others, copper homeostasis and is involved in 
ubiquitination of various substrates601,602. Copper concentration is higher in ARCs159. 
The COMMD1 locus contains another plausible candidate gene EHBP1 the expression 
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of which showed even stronger association with cataract severity. EHBP1 may play a 
role in endocytosis of glucose and lipids and is a binding partner of EHD1 —  a protein 
required for lens development603-605. The candidate genes at the COMMD1 locus seem 
to be under estrogen control, and the RNA sequencing analysis pointed to COMMD1 
expression differences between females and males with opposite direction of effect in 
females to males. These results need further refinement but if true are in support of the 
estrogen hypothesis of cataract formation discussed in detail in Chapter 1.  
The strengths and limitation of the study are discussed below. This study used 
the largest sample to date for genetic analysis of nuclear cataract and, in the discovery 
phase, of precisely and quantitatively phenotyped cohorts, resulting in the identification 
of 6 new loci associated with age-related nuclear cataract and the replication of the 
association with CRYAA variants. Although this is the biggest study to date many more 
genetic loci will be discovered by further increasing the sample size, as power to detect 
genetic associations is a function of the number of individuals included in the analysis. 
We also could not detect statistically significantly enriched gene-sets or pathways, 
possibly because of the relatively small number of known genetic loci compared to the 
potentially plurigenic architecture of nuclear cataract. This can also be remedied by 
better-powered analyses. 
Another power-limiting source is heterogeneity. The GWAS used in the study 
employed a variety of grading systems, which may have increased heterogeneity and 
therefore, decreased power to detect associations. To minimise the importance of 
phenotypic heterogeneity to the results the scores were standardised prior to the 
GWAS. Similarly, the population diversity inherent to a multi-ethnic meta-analysis 
design606, presents with both advantages and disadvantages. While replication of 
association signals among individuals with different ethnic background leads to more 
precise results and increases the confidence in the veracity of those results, variation in 
risk allele frequency or underlying differences in linkage disequilibrium between 
different ancestral groups may decrease statistical power. For the same reason, 
although the conditional analysis did not suggest the presence of secondary signals in 
the genome-wide associated loci, this result needs to be taken with caution, as the 
analysis depended on the assumption that the 1000G LD data are able to capture the 
LD patterns in the participating cohorts. The 1000G participants are predominately of 
European dissent and the Asian ancestry populations are not well covered.
Another important contribution of the study is that it provides evidence of sharing 
of genetic mechanisms between congenital and ARC, and shows the importance of 
common genetic variants in maintaining crystalline lens integrity in the ageing eye. 
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Several congenital cataract genes where common variants were associated with age-
related nuclear cataract, deserve particular attention in the future. In particular the 
structural lens proteins: α-crystallins and the β-crystallin and γ-crystallin clusters, 
where variants were nominally associated with nuclear cataract, as well as GJA3, 
SOX2, BFSP1, LIM2, MIP, TFAP2A and CHMP4B. 
Not all associated loci (P<1x10-5) candidate genes known to relate to cataract 
formation or lens biology (eh. GLTSCR1 locus) and, therefore, functional work that can 
shed light on the likely candidate genes in those loci and their role in lens function and 
cataract formation will be worthwhile. 
Another strength of this study is the use of human lens samples for RNA and 
protein analysis which show a link between genetic variation and transcription 
regulation, suggesting a role for the latter in age-related nuclear cataract causation. 
Other aspects of the functional work presented here were limited by the lack of lens 
tissues. Although, the results showed a likely consistency of findings in all tissues 
studied, a contextual interpretation of results, taking into account issues of tissue 
specificity, will be necessary.  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6.1. Overview
In Chapter 1, I discussed in detail the role of dietary factors in cross-sectional 
cataract prevalence and in cataract progression and concluded that, we know relatively 
little about the role dietary factors play in cataract progression. In this chapter, it was 
also noted that, although the roles of separate nutrients are well studied, diets as a 
whole are not. Finally, it is also not known whether the effect of dietary nutrients or 
diets on cataract is direct or mediated by changes in metabolism or in gut microbiome 
composition. Therefore, in this chapter I aimed to fill these gaps in the current 
knowledge by:
a) applying a classical twin model to separate the role of genetic and 
environmental factors in cataract progression, followed by conducting an 
epidemiology study to evaluate the role of dietary micronutrient intake on cataract 
progression.
b) conducting an epidemiology study on the relationship between healthy diet, 
as represented by two different indexes (Mediterranean diet score (MDS), Healthy 
Eating Index (HEI)), and cross-sectional cataract measurements.
c) assessing the blood metabolome and the gut microbiome associated with 
habitual food intake; and exploring whether the association between diet and 
cataract is mediated by the associated metabolites or the gut microbes. 
Given the wide variety of dietary scores607,608 it is necessary to briefly introduce 
the rationale behind choosing to focus on the MDS and HEI. Next metabolomic and 
microbiome analysis will be introduced in relation to the health of the eye and the lens. 
The different hypotheses underlying the analysis presented in this chapter will also be 
discussed.
6.2. Introduction
The Mediterranean diet has been widely promoted as one of the healthiest 
dietary patterns, not least because of it being rich in antioxidants. This diet is 
characterised by high consumption of vegetables and olive oil and moderate 
consumption of protein, and is based on the traditional foods and drinks of the 
countries surrounding the Mediterranean Sea609. The protective effect of this diet 
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against chronic disease, including eye conditions610-612 has been extensively studied. 
The Mediterranean diet has been robustly associated with reduced the risk of overall 
mortality, cardiovascular diseases, coronary heart disease, myocardial infarction, 
overall cancer incidence, neurodegenerative diseases and diabetes609. Although 
adherence to Mediterranean-type diet is a plausible candidate in terms of cataract 
protection, the TwinsUK cohort individuals are mostly elderly British women adhering to 
a more traditional British Diet. For this reason an additional diet score (the Healthy 
Eating Index), which is perhaps better suited for studying a western European diet, was 
evaluated613. This score (range 0-100), originally developed in the USA, has ten 
components of which the first five are nutrient intake per major food group (grains, 
fruits, vegetables, meat and alternates and milk) and the next five relate to dietary 
guidelines (total fat, saturated fat, cholesterol, sodium and variety). The score 
correlates with a range of nutrient intakes, with the person’s body mass index (BMI) 
and with the individual’s self-perception of their diet quality613. 
The effect of diet on cataract can be either direct, meaning changes in 
concentration of certain micronutrients (e.g. vitamins) affect the lens physiology leading 
to cataract (Figure 6.1.), or indirect, for instance nutrients would change the 
concentration or types of metabolites in blood which in turn could affect the lens. 
Metabolites are low-weight molecules that are a products of or intermediates of 
metabolic processes. From a systems biology prospective, metabolites are thought to 
be closer to the phenotype of interest than either genetic variation or mRNA/protein 
expression; and may also be affected by environmental influences such as diet, 
lifestyle choices, disease-related changes, medication, etc614,615. Thus metabolites are 
a powerful tool for identifying diagnosis, prognosis, prediction or treatment efficacy 
biomarkers616,617. 
Metabolomics is a high-throughput technology that captures the global metabolic 
state of an individual at a given point in time by simultaneously assaying an extensive 
set of metabolites614. Metabolomics profiles can be obtained from a variety of different 
biological samples, with blood and urine being the two most often used. There are two 
types of approaches used for metabolome analysis. The first is an untargeted 
hypothesis-free approach where hundreds of metabolites are measured, including 
unknown metabolites, with the idea of obtaining a global view of the metabolome and 
detecting previously unsuspected or unknown metabolic perturbations associated with 
a certain disease and novel mechanisms or pathways, akin to GWAS615. The 
disadvantage is the semi-quantitative nature of the methods and the need to validate 
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any identified compounds. Various methodologies, including clustering, pathway 
analysis and the use of genetic information can help with the identification of unknown 
compounds. Targeted approaches rely on small, predefined sets of metabolites and 
typically focus on a few pathways of interest615. The advantages of this kind of 
approach, apart from easier identification of compounds, include a higher degree of 
sensitivity (low detection limit) than untargeted approaches and most importantly 
absolute instead of relative quantification618.
Figure 6.1. Direct and indirect effects of diet on the eye
The figure shows the possible direct (solid lines) and indirect (dotted line) effects of dietary 
foods on the eye.
The main methods employed for detecting metabolites in biological samples are 
nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). NMR 
is a high-throughput, high-speed, low-cost technology that provides information on 
molecular structures based on atom-centred nuclear interactions619. NMR detection is 
quantitative, non-discriminating, non-destructive, highly reproducible approach for 
metabolite detection that requires minimal  sample preparation619. However, NMR *
spectroscopy has a relatively low level of sensitivity and can detect only metabolites at 
medium-to-high levels of abundance620. MS-based profiling is also quantitative but it is 
highly-selective, sensitive and comprehensive with the potential to identify individual 
 in the case of soluble molecules*
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metabolites621. Prior to MS, metabolites within a sample usually  need to be separated *
(e.g. using gas (GC) or liquid (LC) chromatography) which requires long and elaborate 
preparation that can result in metabolite loss622.
Little is known about the eye metabolome, its similarities and differences with the 
blood metabolome or how circulating metabolites would affect it, especially given the 
presence of aqueous-blood and retina-blood barriers. Studies in animal models have, 
however, shown the utility of exploring the changes in metabolites in context of eye 
conditions623. Studies in humans are generally lacking but the few that exist presented 
encouraging results. The metabolite profile of the lens differs from that of other eye 
tissues, which may be related to the fact that the aqueous humor is the main nutrient 
source for the lens624. The most abundant aqueous humor metabolites, however, seem 
also to be present in serum at either similar or lower concentration to the aqueous 
humor625. Serum and vitreous humor metabolite profiles, have also been useful in 
distinguishing case from controls in eye conditions with known systemic risk factors 
(e.g. neovascular AMD, diabetic retinopathy, glaucoma, etc.)626-628.
Another possible indirect mechanism is that diet causes changes in the type of 
bacteria present in the gut and those changes cause systemic effects that extend to 
lens (Figure 6.1.). The gut hosts almost 100 trillion microorganisms (bacteria, archaea 
and viruses) that share symbiotic properties with humans629. It is estimated that these 
organisms contain in total close to 10 million genes and only about 36% of those are 
commonly (> 5%) shared between humans630. However, there is a substantial 
redundancy in bacterial genes and functions631. At present there are two methods for 
measuring the metagenome: targeted sequencing of nine highly variable regions of the 
bacterial 16S ribosomal RNA (rRNA) gene, or shotgun whole genome sequencing632. 
The latter method is more expensive and computationally intensive but it is better at 
detecting bacterial species and bacterial diversity and is better at bacterial gene 
prediction632.  
Intestinal microbiota regulate part of the host’s metabolic and energy balance, 
including regulation of cytokines’ secretion from adipose tissue and insulin signalling629. 
Furthermore, gut bacteria produce a substantial proportion (90-95%) of the body’s 
short-chain fatty acids, help humans digest plant fibres and bio-activate lignans and 
flavonoids633,634. The gut microbiome also modulates intestinal motility, regulates 
immune system maturation and confers protection against pathogens and toxins629. 
 except for some of the Biocrates platforms which use direct sampling from plates instead of *
pre-separation
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Consequently, the disruption of the normal balance between the gut microbiota and 
host (dysbiosis), has been associated with variety of diseases including obesity, 
malnutrition, inflammatory bowel diseases, neurological disorders, and cancer635-641. 
Studies on the role of dysbiosis in eye diseases are lacking but a very small recent 
case-control study found that patients with age-related macular degeneration had a 
significant increase in bacterial gene products linked to L-alanine fermentation, 
glutamate degradation and arginine biosynthesis pathways and a decrease in the 
expression of genes of the fatty acid elongation pathway642. Abnormalities in glutamate 
and arginine metabolism have been linked to retinal disease through an ability to 
promote oxidative stress643,644, while the role of alanine metabolism is not well studied. 
The human retina has unique lipid profiles enriched in long-chain and very-long chain 
polyunsaturated fatty acids that appear to promote normal retinal structure and 
function645,646. Mutations in genes for elongating long-chain polyunsaturated fatty acid 
cause early onset autosomal dominant retinopathy with similar clinical picture to 
AMD645. 
The structure of the human microbiome is constantly shifting due to the various 
environmental (e.g. diet, medication, influx of transient species) and host-related 
factors (host age and genetics)631,647. However, samples obtained over time from the 
same individual are more similar to one another compared to those obtained from other 
individuals472,648,649. This suggests that each person has a relatively distinct, stable 
community and there is also the idea of a “core” microbiome representing whatever 
may be in common among the microbiomes of all humans in terms of functional 
relationships between the microbiome and the host647. Of the environmental factors, 
diet is perhaps the most significant one for the human gut microbiome, and its role has 
been supported by both population-based observation studies650-652 and dietary 
intervention studies653,654. In brief, all macronutrients (protein, fats, digestible and non-
digestible carbohydrates), as well as probiotics and polyphenols, can induce shifts in 
the microbiome with secondary effects on host immunologic and metabolic markers 
(Figure 6.2.). For example, intake of animal protein increases overall microbial 
diversity (including total anaerobic microflora) as well as the abundance of bile-tolerant 
organisms (e.g. Bacteroides, Alistipes); and simultaneously reduces representation of 
the Roseburia/E. rectale group655. A diet rich in high-saturated fat results in increase in 
Actinobacteria and Lactic acid bacteria, while intake of carbohydrates enriches the gut 
with Bifidobacterium and suppress Clostridia, Lactobacillus, Ruminococcus and 
others655.
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Figure 6.2: Example of the impact of three common diets on the gut microbiome
This graph is adopted from Singh et al., J Transl Med. 2017655 and shows the effect of three 
common diets (Western diet, Mediterranean diet, and Gluten free diet) on intestinal microbiota 
and on cardio-metabolic traits. CVD — cardiovascular disease, DM2 — type 2 diabetes mellitus.
6.3. Material and Methods 
6.3.1. Subjects and phenotyping 
Of the 2,556 twins for whom cataract data was available, only 41 were males and 
most of those did not complete a FFQ. In addition, only female participants contributed 
data on cataract progression. Therefore, the male participants were excluded from the 
analysis presented in this chapter. Nuclear and cortical cataract at baseline 
(1998-1999, 2006-2010)167 were measured in 2,515 white female twins (mean age, 
62.3 years; range, 50.1–83.1 years) from the TwinsUK cohort, 2,054 of whom had also 
completed a FFQ around the time of their eye examination (median = 2 years). Nuclear 
and cortical cataract was measured as detailed in Chapter 4 (4.3.2. Phenotyping). The 
461 twins with cataract data but without FFQ data were younger by 2.5 years on 
average. As a result they were also less affected by cataract. 
Cataract progression was measured in 324 twins (151 MZ and 173 DZ pairs) with 
a mean age at follow-up of 69.8±5.4 years (range, 58.3–83.6 years) as part of the 
2006-2010 recruitment period of Healthy Ageing in Twins (HATS) study464. The mean 
time between baseline and second visits was 9.4 years (range, 7–12 years). Nuclear 
and cortical cataract progression was measured in two ways: a) as a differences: 
Δscore = score at follow-up − score at baseline; b) as a rate: Δscore = (score at follow-
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up − score at baseline)/score at baseline. As both measures yielded the same results, I 
present the results from the difference score only. 
The smaller number of individuals with follow-up data is a result of the fact that 
the HATS study was not designed specifically as a cataract follow-up study. In HATS, 
individuals (≥ 40 years of age) who had previously attended clinical phenotyping were 
invited to participate and this was done irrespective of whether they had an eye 
examination prior to HATS (Figure 6.3.). Thus for 1,523 individuals (aged ≥50 years) 
the HATS study formed their baseline cataract assessment. Additional reasons for non-
participation of the original cohort participants who had cataract measurements in 
1998/9 were: death (N = 52), withdrawal of participation from the TwinsUK registry (N = 
169), noncontactable (N = 30), refusal of further phenotyping (N = 82), bilateral cataract 
surgery (N = 11), and refusal of dilating drops or unavailability of ophthalmic testing at 
the HATS visit (N = 344).
Figure 6.3: Consort digram of the cataract progression part of the study
The figure shows the number of individuals who participated in the different parts of the study 
and reasons for non-participation at follow-up. FFQ = food frequency questionnaire; HATS = 
Healthy Ageing in Twins. This figure is adopted from Yonova-Doing et al. Ophthalmology. 2016 
Jun; 123(6): 1237–1244656. 
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6.3.2. Nutrient intake and dietary scores
The intake data of nutrients and food groups was originally calculated by by Alex 
MacGregor and Sue Fairweather-Tait, nutritional epidemiology experts from the 
University of East Anglia, who have analysed DTR FFQs over 20 years. Briefly, intake 
of micronutrients (vitamins and minerals) and supplements was estimated at the 
baseline visit using self-administered EPIC FFQ657. This questionnaire explored the 
average frequency of intake of 131 foods and supplements over a 1-year period657,658. 
Intake per nutrient and per food group was calculated using an established nutrient 
database659, and the dietary variables were adjusted for calorie intake, yielding an 
energy-adjusted mg/μg of each nutrient per person per day658,660. The following 
micronutrients were considered in the analysis: sodium, potassium, calcium, 
magnesium, phosphorus, iron, copper, zinc, chloride, manganese, iodine, retinol, 
carotene, vitamin D, vitamin E, thiamine, riboflavin, niacin, tryptophan, vitamin B6, 
vitamin B12, folate, pantothenate, biotin, and vitamin C. High vitamin K has been found 
to protect against cataract surgery415 and is, therefore, another nutrient worth 
considering. Vitamin K was missing from the original nutrient intake calculations and to 
obtain data on its intake I used the energy-adjusted food groups data and the latest 
edition of the nutrient database661. 
Data on supplement intake for 33 different supplements was also available. 
However, the percentage of individuals taking any single supplement was 10% or less. 
Supplements were therefore grouped as follows: any supplements; micronutrient 
supplements (vitamins and minerals in any combination); micronutrient supplements 
excluding multivitamins (e.g., vitamin C only, vitamin D only, iron only, ACD complex); 
minerals only (e.g., iron only, calcium only); and other supplements (e.g., aloe vera, 
Echinacea, Ginkgo, omega-3). Each supplement group was coded as a binary variable, 
with “yes” indicating that the person took 1 or more of the supplements in a specific 
group.
There are a lot of different ways to calculate MDS607. The alternative MDS was 
used here662. There were two reasons for that choice: the score uses median intake 
which is slightly more accurate than number of portions; the score does not take into 
account a component of the Mediterranean diet that was not assessed in TwinsUK, 
namely olive oil consumption. The score assumes that only people with above median 
intake are protected but that there is no difference between low and median intake and, 
therefore, that low intake does not confer any risk. To avoid making such an 
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assumption, score was modified by giving -1 point to people whose consumption was 
below the median for every component hypothesised to benefit health (vegetables, 
fruits, nuts, grains, legumes, fish, ratio of monounsaturated to saturated fat intake) and 
-1 point was above the median for every component be detrimental to health (red meat, 
dairy, dairy products). Thus the score used here ranges between -9 and 9. No points 
were given to people with median intake (Figure 6.4.). As opposed the MDS, the HEI, 
gives a score using all food groups (fruit, vegetables, grains, milk, meat, legumes, oils, 
sodium, and percentage of energy from saturated fat, alcoholic beverages, and added 
sugars). In each group different amount of points are given dependent on how much of 
each food is consumed. The HEI was calculated by Ruth Bowyer as previously 
described663. 
Figure 6.4: Comparison between the classic and modified MDS 
This box plot shows the relationship between the classic and the modified MDS.
6.3.3. Metabolite and microbiome measurements
The methods used to acquire metabolite and microbiome measurements are 
discussed in detail in Chapter 3 (Section 3.2.2. Omics data). 
 174
Chapter 6: Dietary factors and cataract progression.  
Diet-related changes in metabolites  
and gut flora in relationship with cataract. 
6.3.4. Statistical analysis
All analyses were carried using the STATA10 or STATA14  statistical packages.*
Heritability analysis: The heritability analysis were conducted on 155 twin pairs 
(72 MZ and 83 DZ pairs) for nuclear and 148 twin pairs (75 MZ and 73 DZ pairs) for 
cortical cataract using a classical twin modelling implemented in OpenMX (http://
openmx.ssri.psu.edu/). In both cases the differences between the follow-up and the 
base-line measurement was used. In the case of cortical cataract, both people who 
progressed and people who did not were included in the analysis. 
Data transformation: The central nuclear dip score and the nuclear and cortical 
cataract progression variable were not normally distributed and, therefore, were 
transformed using natural logarithm before the analysis. The cortical cataract score 
was treated as binary variable with case-control cut of 5% lens area affected by cortical 
spokes.
Group comparisons: Means and proportions between groups of individuals 
(with or without follow-up data, MZ and DZ twins, etc.) in terms of age, cataract scores, 
and nutritional variables were performed using 2-sample, 2-tailed t-tests or z-tests, 
assuming equal variance.
Regression analysis: 
1. Micronutrient, supplements, dietary scores
A) Initially, the associations between baseline cataract scores and micronutrients 
or supplement groups were assessed using age-adjusted univariable linear regression 
models of the kind: 
y = α + β1x + β2age + ε, cluster (family_id) (nuclear cataract)
odds(y) = exp( α + β1x+ β2age + ε) , cluster (family_id) (cortical cataract)
where: (y) is cataract score; (x) is a predictor of interest (a nutrient or a supplement 
groups); age is age at baseline; and α is the intercept term. The association between x 
and y is given by β1, defined as the amount of change that occurs with one unit change 
in x.  All formulas presented in this section use the same notation as presented here.
All nutrients or supplement groups showing significant univariable association (p-
value < 0.05) were then included in a multivariable linear regression model. 
Independent variables were identified using a stepwise backward procedure with 
threshold for removal set at 0.05.
 StataCorp LP, College Station, TX; www.stata.com*
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Factors showing significant (P < 0.05) association at baseline in the multivariable 
models were tested for association with progression using the above presented 
formulas but with adjusted for both age at baseline and Δage (age at follow-up − age at 
baseline). 
The results presented below are for models where the micronutrients were not 
standardised and were, therefore, on their original scale. Standardisation of nutrients 
did not yield different results in terms of association (data not shown). 
B) In the case of both cross-sectional and progression nuclear cataract scores, 
the use of transformed scores makes clinical interpretation more difficult. To facilitate 
the clinical interpretation of the results, relative risk ratios (RRs) were calculated using 
multinomial regression:
RR (category 2 versus reference)=exp(α + β1(2)x1 + … + βi(2)(xi+1) + … + βk(2)xk)/
exp(α1 + β1(2)x1 + … + βi(2)xi + … + βk(2)xk), cluster (family_id)
RR (category 3 versus reference)=exp(α + β1(3)x1 + … + βi(3)(xi+1) + … + βk(3)xk)/
exp(α2 +β1(3)x1 + … + βi(3)xi + … + βk(3)xk), cluster (family_id)
In this case, the nuclear cataract score, the nuclear cataract progression scores, 
and the associated nutrients were divided into tertiles, and the first tertile was set as 
reference. Supplement intake per supplement group was kept binary. 
C) Dietary scores: 
The following regression models were used to assess the association between 
the two diet scores and the nuclear and cortical cataract scores respectively were: 
y = α + β1dietary score + β2ageeye_visit + β3Δage + ε, cluster (family_id)
odds(y) = exp(α + β1dietary score + β2ageeye_visit + β3Δage + ε), cluster (family_id) 
where y in cataract score and Δage = absolute difference between the age at eye visit 
and the age at which the FFQ was filled in. 
2. Metabolites, diets, and cataract  
The association between diet scores and single-point metabolite measurements 
was assessed using the following mixed effects (REML) model:   
y = α +βX + uZ + ε
where: y is the relative concentration of each metabolite; α is the intercept term; β 
represents the fixed effects of a fixed-effect matrix (X). The following variables were 
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considered to have fixed effect: dietary score, age, body mass index (BMI), ΔT= age at 
FFQ response - age at metabolite sampling. Only samples where ΔT ≤ 5 years were 
considered. The u term represents the random effect of a random-effect matrix (Z). The 
following predictors were included as having random effect: family id, blood source 
(serum/plasma), batch and run-day. In order to exclude the possibility that the results 
were confounded by diabetes-related metabolic changes, an additional model with 
diabetes status as covariate was also considered.   
As technical covariates were accounted for in the initial data normalisation step, 
the association between diet scores and the mean of the relative metabolite 
concentrations over several visits was assessed using the following models:  
y = α + β1dietary score + β2BMI + β3ageFFQ + ε, cluster (family id) 
y = α + β1dietary score + β2BMI + β3 diabetes status + β4 ageFFQ + ε, cluster (family id).
Metabolites that were significantly associated with diet scores at p-value less 
than the Bonferroni threshold (0.05/number of independent tests) for multiple testing 
were evaluated for association with cataract. As majority of metabolites are correlated, 
a multiple testing threshold was calculated using the number of effective tests 
method664. This resulted in α=0.0004 (0.05/120 ) for single-point metabolites versus *
diet analysis and in α=0.0003 (0.05/182*) for the mean concentration of the metabolites 
over time versus diet analysis. 
The association between single-point relative metabolite concentrations and 
cataract was calculated as follows:  
y = α + βX + uZ + ε (nuclear cataract)
odds(y)= exp (α + βX + uZ + ε) (cortical cataract)
where y is either ln(central nuclear dip score) or cortical cataract case-control status, β 
represents the fixed effects of a fixed-effect matrix (X). The following variables were 
considered to have fixed effect: relative metabolite concentration (either or mean 
concentration), age, BMI, diabetes status, ΔT= age at eye visit - age at metabolite 
sampling. Only samples where ΔT ≤ 5 years were considered. The u term represents 
the random effect of a random-effect matrix (Z). The following predictors were included 
as having random effect: family id, blood source (serum/plasma), batch and run-day.
The association between mean relative metabolite concentrations and nuclear 
and cortical cataract respectively was calculated as follows:  
 number of independent tests*
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y = α + β1metabolite + β2 BMI + β3 ageeye_visit  + ε, cluster (family id) 
odds(y) = exp (α + β1metabolite + β2 BMI + β3 ageeye_visit + ε), cluster (family id) 
3. Microbiome, diets, and cataract
The association between relative abundance of OTUs and diet was assessed as 
follows: y = β1dietary score + β2BMI + β4ageFFQ + β4Δage + ε, cluster (family id), where 
Δage = age at which the FFQ was filled - age at microbiome sampling (only sample 
where Δage ≤ 5 years were considered). The p-value for associations between 
microbes and diet score were FDR5%-adjusted. All OTUs associated with diet scores 
were than tested for association with cataract: 
y = α + β1OTU + β2 BMI + β3 ageeye_visit + β4Δage + ε, cluster (family id) 
odds(y)= exp (α + β1OTU + β2BMI + β3 ageeye_visit + β4Δage + ε), cluster (family id)
where Δage = age at eye visit - age at microbiome sampling. Only sample where Δage 
≤ 5 years were considered. The Bonferroni threshold was again calculated using 
number of independent test664, which resulted in α = 0.003 (0.05/17 ). Finally, mediation *
analysis of the relationship between cataract, diet and OTUs were performed using the 
Sobel-Goodman test and structural equation modelling as implemented in STATA665. 
The mediation analyses were performed in one twin per pair and were adjusted for the 
effects of age and BMI.
Metabolite enrichment analysis: Metabolite enrichment analysis were carried 
for all metabolites that were associated (p-value < 0.05) with any of the diet scores or 
with nuclear cataract using MetaboAnalyst v3.0  and any pathways were considered †
significantly enriched if their q value (FDR5% adjusted p-value) was < 0.05.
6.4. Results  
6.4.1. Micronutrients and the heritability of cataract progression 
Baseline characteristics: Baseline characteristics and nutrient and supplement 
intake for twins with and without follow-up data are presented in Tables 6.1 to 6.3. At 
baseline, the twins with follow-up data (N=324) when compared to the twins without 
follow-up (N=1730) were one on average a year younger (60.4 vs. 61.5 years, p-value 
 number of independent tests *
 http://www.metaboanalyst.ca†
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> 0.05) and had lower nuclear cataract scores (p-value > 0.05; mean nuclear score of 
55.3 vs 60.4). Conversely to nuclear cataract, the prevalence of cortical cataract was 
significantly higher (p-value < 0.0001, 25% vs 15%) in the twins with follow-up data. 
Finally, the twins with follow-up data consumed on average 0.2mg (p-value = 0.02) less 
iron and 0.1mg (p-value = 0.04) less thiamine and 0.1mg more biotin (p-value = 0.01).
There were no statistically significant differences (p-value > 0.05) between MZ 
and DZ twins, except for the MZ twins with cross-sectional data only who had a slightly 
higher nuclear cataract score (61.6 vs. 59.3; p-value = 0.02). The MZ twins with follow-
up data had slightly higher prevalence of cortical cataract (27% vs 23%) but the 
difference was not statistically significant (p-value = 0.39).
Table 6.1. Baseline sample characteristics in individuals with or without follow-up data
This table presents the baseline characteristics of the participant with and without follow-up 
data. DZ — dizygotic; MZ — monozygotic; NDS — central nuclear dip score; CC — cortical 
cataract; *Denotes statistically significant difference (p-value < 0.05) between subjects with and 
without and without follow-up. The table is adapted from Yonova-Doing et al Ophthalmology. 
2016 Jun;123(6):1237-44656. 
Heritability of cataract progression: Nuclear cataract scores progressed in all 
participants (Figure 6.5). The mean (SD, [range]) CNDS at baseline was 55 (11, 
[32-99]) and it increased by 19.9 (16.9, [1–137]) over the period of follow-up. Cortical 
cataract score progressed in only 32% of participants (Table 6.4).
The intraclass correlation coefficient for nuclear cataract progression in MZ and 
DZ twins was 0.22 and 0.26 respectively. The heritability analysis showed that the best-
fitting model for both progression phenotypes was one explained by additive genetic 
factors and unique environmental factors. The AIC values for the different model were: 
1987.77 for ACE; 1985.82 for AE; 1986.46 for CE and 1992.35 for E. In the case of 
nuclear cataract, 35% [95%CI: 13%-54%] of variance was due to genetic and 65% 
[95% CI: 46%-87%] of variance was due to unique environmental factors, while the 
Subjects without Follow-up Subjects with Follow-up
Total MZ DZ Total MZ DZ
No. of individuals 1730 827 916 324 151 173
Zygosity ratio (MZ:DZ) 01:01.1 - - 01:01.2 - -
Age (mean ± SD) 61.5±6.5 61.7±6.7 61.4±6.4 60.4±5.1 60.8±5.5 60.0±5.2
CNDS (mean ± SD) 60.4±17.2 61.3±17.4 59.0±14.2 55.3±11.2 55.3±11.4 55.3±11.1
% with CC 15.7 14.9 16.2 25.0 27.2 23.1
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heritability estimate for cortical cataract progression was 17% [0%-34%], with individual 
environmental factors explaining 83% of variance [0%-100%].
Table 6.2. Baseline micronutrient intakes in individuals with or without follow-up data
This table presents the micronutrient intakes (mean ± standard deviation (SD))at baseline for 
people with and without follow-up data. DZ — dizygotic; MZ — monozygotic; *Denotes 
statistically significant difference (p-value < 0.05) between subjects with and without and without 
follow-up. The table is adapted from Yonova-Doing et al Ophthalmology. 2016 Jun;123(6):
1237-44656.
Subjects without Follow-up Subjects with Follow-up
Total MZ DZ Total MZ DZ
Sodium (mg) 2262.8±508.7 2265.3±476.3 2258.7±535.6 2237.4±456.4 2227.7±444.4 2247.2±444.4
Potassium (mg) 4013.5±637.4 3997.0±622.4 4026.9±650.6 4033.7±580.5 4094.5±588.4 3972.5±469.4
Calcium (mg) 1117.1±284.7 1118.5±284.9 1125.1±284.6 1118.9±291.5 1138.3±295.0 1099.4±568.0
Magnesium (mg) 347.3±56.4 347.3±56.8 347.2±56.0 343.8±55.0 347.0±58.0 340.6±287.5
Phosphorus (mg) 1527.1±247.0 1527.1±234.9 1527.1±257.8 1522.0±239.3 1532.0±251.0 1512.1±227.5
Iron (mg)∗ 13.1±3.0 13.2±3.2 13.0±2.8 12.6±2.6 12.5±2.7 12.7±2.5
Copper (mg) 1.5±0.5 1.5±0.6 1.5±0.4 1.5±0.4 1.5±0.4 1.6±0.5
Zinc (mg) 10.2±1.7 10.2±1.8 10.1±1.7 10.2±1.7 10.2±1.8 10.1±1.6
Chloride (mg) 3629.6±792.9 3633.6±749.4 3623.0±828.6 3578.0±721.3 3566.7±690.3 3589.4±753.3
Manganese (mg) 4.2±1.2 4.1±1.1 4.2±1.2 4.2±1.1 4.3±1.1 4.2±1.1
Iodine (mg) 225.0±75.8 224.2±75.2 225.8±76.5 229.2±64.2 230.0±61.4 228.5±67.2
Retinol (μg) 579.5±817.8 569.1±570.6 554.8±496.6 611.8±472.9 588.2±422.6 635.6±519.0
Carotene (μg) 5343.4±3067.4 5503.7±3263.8 5200.4±2874.9 5305.6±3915.4 5663.8±4823.8 4945.0±2679.4
Vitamin D (μg) 2.7±1.4 2.7±1.1 2.6±1.5 2.8±1.1 3.0±1.0 2.6±1.0
Vitamin E (mg) 11.5±3.2 11.6±3.4 11.4±3.1 11.7±3.4 11.9±3.6 11.5±3.2
Thiamine (mg)∗ 1.8±0.4 1.8±0.4 1.8±0.4 1.7±0.3 1.7±0.3 1.7±0.3
Riboflavin (mg) 2.5±0.7 2.4±0.7 2.5±0.7 2.4±0.6 2.5±0.6 2.4±0.7
Niacin (mg) 22.0±5.7 22.2±5.1 21.8±6.2 21.3±4.5 21.3±4.6 21.2±4.4
Tryptophan (mg) 17.4±3.0 17.5±2.7 17.3±3.3 17.2±2.5 17.3±2.5 17.1±2.6
Vitamin B6 (mg) 2.6±0.6 2.6±0.6 2.5±0.5 2.5±0.5 2.5±0.5 2.5±0.5
Vitamin B12 (μg) 6.5±3.2 6.7±3.6 6.4±2.9 6.7±2.3 6.7±2.3 6.7±2.4
Folate (μg) 402.2±113.1 400.7±114.0 403.2±112.3 395.7±98.9 402.0±95.9 389.4±101.8
Pantothenate (mg) 7.4±16.0 7.5±21.3 7.2±8.6 6.8±4.2 6.5±2.1 7.1±5.6
Biotin (mg)∗ 48.1±10.5 47.7±10.3 48.5±10.8 49.7±10.3 50.6±10.2 48.7±10.3
Vitamin C (mg) 165.1±73.9 167.6±74.2 163.0±73.7 166.8±65.0 166.9±68.1 166.7±65.0
Vitamin K
(energy-adjusted mg) 20.6±14.4 19.7±13.8 21.6±15.0 21.1±14.7 19.0±10.8 23.2±17.6
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Table 6.3. Baseline supplements intakes in individuals with or without follow-up data
This table presents baseline supplements intake per supplement group (% of users) in 
individuals with and without follow-up data. The supplement groups studied are: any 
supplement, micronutrient supplements (vitamins and mineral in any combination), 
micronutrient supplements excluding multivitamins (e.g., vitamin C only, vitamin D only, iron 
only, ACD complex), minerals only (e.g., iron only, calcium only), and other supplements (e.g., 
aloe vera, Echinacea, Ginkgo, omega-3). DZ — dizygotic; MZ — monozygotic; *Denotes 
statistically significant difference (p-value < 0.05) between subjects with and without and without 
follow-up. The table is adapted from Yonova-Doing et al Ophthalmology. 2016 Jun;123(6):
1237-44656.
Figure 6.5. Progression of nuclear between the 2 visit dates
This figure shows a graphical representation of the progression of nuclear cataract between the 
2 visits, presented as deltaNDS (deltaNDS = NDS at follow-up − NDS at baseline) where NDS 
stands for nuclear dip score. The y-axes show frequency of deltaNDS per bins with width of 
6.25 points. The figure is adopted from Yonova-Doing et al Ophthalmology. 2016 Jun;123(6):
1237-44656.
Subjects without Follow-up Subjects with Follow-up
Total MZ DZ Total MZ DZ
Any supplement (%) 55.1 54.8 55.4 55 54.1 55.9
Micronutrients (%) 32.57 32.4 33.2 31.7 32.8 30.8
Micronutrients excluding 
multivitamins (%) 23.6 24.1 23.2 21.6 24.2 19.3
Minerals only (%) 7.4 7.8 7 6.9 6.4 7.2
Other supplements (%) 44.9 46.2 44.4 47.1 44.2 49.5
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Table 6.4. Cortical cataract progression between baseline and follow-up visits
This table shows the number of people whose cortical cataract progressed between the 
baseline and the follow-up visits, as well as the number of people who showed no measurable 
progression. The cortical cataract score presented here is the modified Oxford grading system 
score.
Cross-sectional associations between age-related nuclear cataract and 
micronutrient intake: Results from univariable cross-sectional regression models are 
presented in Table 6.5. Eight micronutrients (potassium, magnesium, manganese, 
phosphorus, vitamins C, E and K, and folate) were significantly associated (p-value < 
0.05) with nuclear cataract, while only vitamin D was associated with cortical cataract 
(p-value = 0.04). Only vitamin C (β= −0.0002; SD = 6.3E-05; p-value = 0.01) and 
manganese (β = −0.009; SD = 0.04; p-value = 0.03) stayed associated with nuclear 
cataract in the multivariable regression model. Two supplement groups, micronutrient 
supplements and minerals only, showed a significant (p-value < 0.05) association with 
nuclear cataract (Table 6.6.), but only micronutrient supplements stayed significant in 
the multivariate model (β=−0.03; SD = 0.01; p-value = 0.01).   
The nuclear cataract results from the multinomial regression analysis are 
presented in Figure 6.6.. Here the reduction in relative risk (1 - relative risk ratio (RR)) 
has been plotted. The RR in this case means the probability that subjects in the highest 
tertile of nutrient intake would fall in the 2nd or 3rd tertile of CNDS. For example people 
in the highest tertile of vitamin C intake were 11% less likely to have moderate cataract 
scores and 19% less likely have high cataract scores. The highest tertile of CNDS 
encompasses moderate and clinically significant cataracts and, therefore, this result is 
equivalent to 19% reduction in baseline risk of developing clinically significant cataract.
Associations between age-related nuclear cataract progression and 
micronutrient intake: Vitamin C was the only nutrient associated with nuclear cataract 
progression (β = -0.001; SD = 0.001; p-value = 0.03). Individuals in the highest tertile of 





Number of people 
per score group 
Number of people who 
did not progress
Number of people 
who progressed
Controls 
0 166 166 0
(0-0.25) 67 28 39
Cases [0.25-5] 84 22 62
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Table 6.5. Results from univariable regression models between age-related cataracts and 
micronutrient intakes
This table, adapted from Yonova-Doing et al. Ophthalmology. 2016 Jun;123(6):1237-44656, 
shows the results of the univariable linear regression analysis between the nuclear dip score or 
binarised cortical cataract score (cut-off: 5% of area with opacity) and energy-adjusted 
micronutrient intakes. Statistically significant associations (p-value < 0.05) are denoted in bold. 
Analyses were adjusted for age and family structure. SE – standard error; OR – odds ratio.
Nuclear cataract Cortical cataract(358 case/1710 controls)
Beta SE p-value OR SE p-value
Sodium (mg) 5.4E-06 9.6E-06 0.56 1.00 1.0E-04 0.34
Potassium (mg) −1.6E-05 7.5E-06 0.04 1.00 1.0E-04 0.60
Calcium (mg) −2.0E-05 1.5E-05 0.2 1.00 2.0E-04 0.90
Magnesium (mg) −0.010 0.004 0.01 1.00 0.001 0.90
Phosphorus (mg) −4.0E-05 1.9E-05 0.04 1.00 3.0E-04 0.53
Iron (mg) −1.2E-04 0.002 0.95 1.00 3.0E-04 0.95
Copper (mg) 0.001 0.008 0.86 0.79 0.020 0.09
Zinc (mg) −7.8E-04 0.003 0.77 0.98 0.107 0.51
Chloride (mg) 3.8E-06 6.1E-06 0.53 1.00 0.037 0.39
Manganese (mg) −0.010 0.004 0.01 0.97 1.0E-04 0.59
Iodine (mg) −1.1E-04 6.1E-05 0.07 1.00 0.053 0.21
Retinol (μg) 2.4E-06 3.9E-06 0.55 1.00 0.001 0.94
Carotene (μg) −1.7E-06 1.4E-06 0.23 1.00 2.0E-05 0.40
Vitamin D (μg) −0.004 0.003 0.22 1.11 0.040 0.01
Vitamin E (mg) −0.003 0.001 0.04 1.01 0.019 0.77
Thiamine (mg) −0.013 0.013 0.3 0.91 0.152 0.58
Riboflavin (mg) −0.011 0.006 0.08 0.96 0.087 0.64
Niacin (mg) −1.1E-04 8.3E-04 0.89 1.00 0.012 0.87
Tryptophan (mg) −0.001 0.001 0.27 1.02 0.195 0.45
Vitamin B6 (mg) −0.002 0.009 0.81 0.97 0.109 0.81
Vitamin B12 (μg) −0.001 0.001 0.5 1.00 0.021 0.68
Folate (μg) −9.9E-05 4.1E-05 0.02 1.00 0.001 0.27
Pantothenate (mg) −2.8E-05 1.9E-04 0.88 0.98 0.010 0.11
Biotin (mg) −3.0E-04 4.2E-04 0.47 1.00 0.006 0.51
Vitamin C (mg) −1.7E-04 6.2E-05 0.01 1.00 0.001 0.55
Vitamin K (mg) -0.001 3.0E-04 0.03 0.99 0.005 0.19
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Excluding the subjects with the greatest progression (>100 units of change) did not 
alter the results. Vitamin D, the only nutrient associated with cortical cataract score at 
baseline, was not associated with progression (p-value = 0.32).
Table 6.6. Results from univariable regression models between cataract and supplement 
intakes
This table shows the results of the univariable linear regression analysis between the natural 
logarithm-transformed central nuclear dip score or binarised cortical cataract score (cut-off: 5% 
of area presenting with opacity) and supplement intakes per supplement group. Statistically 
significant associations (p-value < 0.05) are denoted in bold. † supplement intakes per 
supplement groups were coded as binary traits (0/1). All analyses were adjusted for age and 
family structure. SE – standard error; OR – odds ratio. The table is adapted from Yonova-Doing 
et al. Ophthalmology. 2016 Jun;123(6):1237-44656.
6.4.2. Diets, cataract and the metabolome
The numbers of samples with ARC measurements were much smaller than the 
number of measured metabolites or OTUs resulting in a multiple testing problem. For 
this reason the following strategy was used. The association between diet scores and 
metabolites and between diet scores and microbiome was explored in everyone who 
had FFQ data (2/3 FFQ questioners) : cross-sectional metabolite measurements (N = *
3000), longitudinal metabolite measurements (N = 2049); microbiome data (N = 1514). 
Only the associated variants after these analyses were tested for association with ARC 
in the number of individuals described above. Of the 2054 individuals who had both 
Nuclear cataract Cortical cataract  (358 case/1710 controls)
Beta SE p-value OR SE p-value
Any supplement −0.015 0.009 0.12 1.20 0.194 0.27
Micronutrients −0.032 0.013 0.01 1.21 0.211 0.27
Micronutrients 
excluding multivitamins −0.023 0.012 0.06 1.19 0.195 0.29
Minerals only −0.038 0.016 0.02 0.96 0.232 0.86
Any other supplement 0.005 0.014 0.72 0.90 0.205 0.65
Not all metabolites or OTUs were present in all individuals. Metabolites or OTUs were 
considered only when the sample size for those was more than 100 individuals.  
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ARC scores and FFQ data: all had metabolites measured crosse-sectionally; 1835 had 
metabolite measurements at multiple times; and 757 had their gut microbiome 
sequenced.
Figure 6.6. Relative risk reduction of nuclear cataract risk
This figure shows the results from the multinomial regression analysis. Relative risk reduction is 
plotted as a percentage. Diamonds denote vitamin C at baseline (C-B) and in relation to 
progression (C-P). Circles denote manganese. Triangles denote micronutrient supplements. 
Lighter colours and darker colours denote - 2nd and 3rd tertile of central nuclear dip score 
(CNDS) respectively. * — p-value < 0.01; ** — p-value < 0.001. Baseline CNDS tertiles: 1st 
[34.5-53.2] — reference; 2nd — [53.3-54.5]; 3rd — [54.6-229.2]. ΔCNDS tertiles: 1st [1.0-12.6] 
— reference; 2nd — [12.7-19.3]; 3rd — [19.4-137.1]. 
Distribution plots for both scores, as well as a scatter plot showing the 
relationship between the two scores are presented below (Figure 6.7.). In this analysis 
the median MDS score was 1 (IQR: 3) and the mean (SD) HEI score was 59.1 (9.8). 
Both dietary scores were associated with nuclear cataract, independently of age and 
higher index score was associated with lower cataract score (β (se), p-value): -0.006 
(0.002), 0.01 for the MDS; and -0.003 (0.001) for the HEI. Only the HEI score was 
associated with cortical cataract but with a small negative effect OR=1.06, p-value = 
0.02. The single point metabolite analysis considered 274 metabolites and of those 71 
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the sets of metabolites associated with the two dietary scores largely did not overlap. 
The following pathways were nominally enriched within the MDS association: protein 
biosynthesis (p-value = 0.01), α-linolenic and linoleic acid metabolism (p-value = 0.02), 
aspartate metabolism (p-value = 0.04). Only one pathway, glycerolipid metabolism was 
nominally enriched (p-value = 0.02) within the HEI associations. None of these 
pathways survived correction for multiple testing (q-value=1.0 for all).
Figure 6.7. Distribution plots for the MDS and HEI scores and a scatter plot showing the 
correlation between the two scores
This plots show: the distribution of the Mediterranean diet score (MDS, A) and the Healthy 
Eating Index (HEI, B) score; the correlation between the two score (C). 
After correcting for multiple testing, only 20 MDS-associated and 3 HEI-
associated metabolites were still significantly associated with cataract (p-value < 
0.0004, Table 6.7). Diabetes status did not affect the association between diet scores 
and metabolites, except for the association between MDS and DHA and the 
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Table 6.7. Results of the single-point metabolite analysis and nuclear cataract
This table shows the linear mixed effect model results (beta, standard error (SE), p-value and p-
value with diabetes status as covariate (p-value2)) from the diet scores ~ metabolite (A) and 
nuclear cataract ~ metabolite (B) models. HEI result with p-value > 0.05 are omitted. HEI results 
A) Diets and Metabolites B) metabolites and nuclear cataract
Mediteranean Diet HEI
beta se p-value p-value2 beta se p-value p-value2 beta se p-value
pipecolate (amino acid)
0.01 0.002 1.0E-04 4.0E-05 - - - - -0.07 0.02 0.005
glycerate (carbohydrate)
0.01 0.002 6.3E-08 2.7E-07 - - - - -0.02 0.04 0.647
 eicosapentaenoate (EPA) 20:5n3 (lipid)
0.01 0.002 1.5E-12 9.1E-11 0.003 0.001 8.0E-04 5.0E-03 -0.03 0.03 0.250
proline (amino acid)
-4.0E-03 0.001 1.0E-04 2.0E-04 - - - - 0.13 0.05 0.016
docosahexaenoate (DHA) 22:6n3 (lipid)
0.02 0.002 8.0E-09 8.9E-16 - - - - -0.04 0.03 0.20
1,5-Anhydroglucitol (1,5-AG, carbohydrate)
-0.01 0.002 5.0E-05 5.0E-05 -0.002 0.001 7.0E-03 1.0E-05 0.05 0.04 0.20
threonate (co-factors/vitamins)
0.01 0.002 2.0E-04 5.8E-05 -0.001 0.002 1.0E-02 1.0E-02 -0.02 0.03 0.41
keto leucine (amino acid)
0.001 0.001 1.6E-06 4.6E-06 - - - - -0.01 0.05 0.76
3-carboxy-4-methyl-5-propyl-2-furanpropanoate (carbohydrate)
0.04 0.004 2.2E-12 2.2E-12 - - - - -0.01 0.01 0.18
2-amino butyrate (amino acid)
0.01 0.001 4.4E-05 2.7E-05 0.01 0.002 1.5E-07 1.5E-06 -0.09 0.05 0.06
n3 docosapentaenoate (DPA) 22:5n3 (lipid)
0.01 0.002 7.9E-07 1.1E-05 0.001 4.0E-04 5.0E-03 3.0E-03 -0.02 0.03 0.48
X - 02269
0.03 0.004 2.6E-12 9.0E-12 - - - - -0.04 0.02 0.03
X - 11299
0.03 0.007 1.7E-04 3.9E-04 0.01 0.002 1.3E-07 1.4E-06 -0.01 0.01 0.69
X - 11315
0.01 0.002 1.6E-07 5.3E-07 - - - - -0.01 0.04 0.88
3-dehydrocarnitine* (lipid)
-0.01 0.001 6.6E-05 1.8E-04 - - - - -0.04 0.05 0.36
C-glycosyl tryptophan* (amino acid)
-3.0E-03 0.001 4.9E-05 3.7E-05 -0.001 3.0E-04 1.9E-02 1.9E-02 0.04 0.07 0.54
X - 11372
-0.01 0.002 5.5E-05 9.3E-05 - - - - -0.02 0.04 0.57
X - 11469
0.03 0.004 7.0E-11 3.3E-10 0.01 0.002 3.7E-08 4.8E-07 -0.04 0.02 0.05
1-docosahexaenoylglycerophosphocholine (lipid)
0.01 0.002 1.6E-06 6.1E-06 0.002 0.001 2.0E-03 2.0E-03 -0.04 0.03 0.16
1-oleoylglycerophosphoethanolamine (lipid)
-0.01 0.002 9.9E-05 2.9E-05 -0.002 0.001 4.0E-03 4.0E-03 0.01 0.03 0.71
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surviving correction for multiple testing are underlined; Metabolites associated with nuclear 
cataract are denoted in bold; X denotes metabolites quantified by Metabolon which are currently 
chemically unidentified.
Of the metabolites associated with the MDS, three were associated with nuclear 
cataract (Table 6.7.), and one was associated with cortical cataract (glycerate, 
OR(SE)=3.33 (1.68); p-value=0.02). Association between HEI-associated metabolites 
and nuclear or cortical cataract were not observed. Given these results, I next checked 
if any of the measured metabolites, irrespective of whether they were associated with 
diet, were associated with nuclear or cortical cataract. Fourteen additional metabolites 
were associated with nuclear cataract but the strongest association remained the one 
with pipecolate. No additional metabolites were found to be associated with cortical 
cataract (data not shown).
The single-point metabolite analysis assumes stable metabolite concentrations 
over time when in reality metabolite concentrations are quite variable. A way to deal 
with this is attempting to calculate a steady state concentration, reflecting an average 
concentration over several visits. In this way possible effects of measurement error and 
diurnal/seasonal/other variation are reduced. The analysis of the mean metabolite 
concentration over time considered 738 metabolites  (182 independent metabolites, α  * †
= 0.0003). Of those 199 were associated with the MDS but only 74 survived Bonferroni 
correction for multiple testing: 26 lipids, 13 Xenobiotics, 6 amino-acids, 2 
carbohydrates, 6 vitamins/cofactors, 1 energy-related metabolite, and 20 unknown 
metabolites. One pathway, protein biosynthesis, was statistically significantly enriched 
(p-valueadjusted = 1.9x10-4) within the 199 metabolites associated with the MDS. Finally, 
101 metabolites were associated with the HEI but only 21 survived correction for 
multiple testing and no pathways were found to be enriched. The associated 
metabolites (p-value < 0.0003 for at least one of the scores) overlapping between the 
two diet scores are presented in Table 6.8.. Similarly to the single-point analysis, there 
was no strong evidence for association between metabolites, irrespective of their 
association with diet, and nuclear or cortical cataract. Adjusting for diabetes status did 
not significantly change the results of any of the models.
 the increase in number of metabolites is duo to fact that a more comprehensive Metabolon *
platform was used to assay the samples included in the longitudinal study. This platform gives 
more information on lipid subspecies.
 multiple testing threshold†
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Table 6.8. Results of the metabolite analysis using the mean metabolite concentration 
over several visits
This table shows the linear model results (beta, standard error (SE), p-value and p-value with 
diabetes status as covariate (p-value2)) from the diet scores ~ mean metabolite concentration 
(A) and nuclear cataract ~ mean metabolite concentration (B) models. HEI result with p-value > 
0.05 are omitted. HEI results surviving correction for multiple testing are underlined; Metabolites 
Mediteranean Diet HEI metabolites & cataract
beta se p p2 beta se p p2 beta se p
ergothioneine (xenobiotics)
0.09 0.01 7.6E-15 1.8E-13 0.02 0.004 2.6E-07 3.3E-06 -0.001 0.01 0.95
pipecolate (amino acid)
0.08 0.01 1.3E-13 2.0E-11 0.02 0.004 2.7E-08 2.4E-07 0.01 0.01 0.34
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) (lipid)
0.08 0.01 2.1E-13 6.2E-13 0.02 0.004 4.5E-08 1.3E-07 -0.02 0.01 0.83
docosahexaenoate (DHA; 22:6n3) (lipid)
0.08 0.01 1.3E-12 2.5E-11 0.02 0.003 3.9E-06 2.9E-05 0.01 0.01 0.44
oxalate (ethanedioate, co-factors/vitamins
0.07 0.01 1.6E-11 3.2E-11 0.01 0.003 6.5E-06 4.3E-06 0.004 0.01 0.67
1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPE (P-16:0/22:6)* (lipid)
0.07 0.01 6.1E-10 4.5E-09 0.02 0.004 3.7E-05 2.3E-04 0.001 0.01 0.97
1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (P-16:0/22:6)* (lipid)
0.08 0.01 1.7E-09 1.7E-08 0.02 0.004 4.1E-06 1.4E-05 0.002 0.01 0.80
4-allylphenol sulfate (xenobiotic)
0.06 0.01 3.8E-09 1.1E-08 0.01 0.003 1.9E-06 7.0E-06 -0.14 0.01 0.22
1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)* (lipid)
0.06 0.01 4.6E-09 4.3E-08 0.01 0.003 1.0E-05 4.7E-05 0.002 0.01 0.80
1-docosahexaenoyl-GPC (22:6)* (lipid)
0.07 0.01 9.0E-09 2.0E-08 0.02 0.003 2.3E-07 7.5E-07 -0.001 0.01 0.61
eicosapentaenoate (EPA) 20:5n3 (lipid)
0.06 0.01 3.4E-08 6.7E-07 0.01 0.003 4.9E-05 4.2E-04 0.002 0.01 0.84
X - 23765
0.06 0.01 6.2E-08 1.4E-06 0.01 0.004 2.7E-05 5.2E-05 -0.003 0.01 0.67
1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6, lipid) 
0.06 0.01 1.0E-07 4.1E-08 0.02 0.004 7.9E-06 8.4E-06 0.003 0.01 0.67
1-docosahexaenoyl-GPE (22:6)* (lipid)
0.06 0.01 2.6E-07 4.8E-07 0.01 0.003 8.0E-05 2.9E-04 0.01 0.01 0.34
1-eicosapentaenoyl-GPC (20:5)* (lipid)
0.05 0.01 7.7E-07 6.0E-06 0.01 0.003 2.1E-06 1.4E-05 0.01 0.01 0.34
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)* (lipid)
0.05 0.01 1.8E-06 2.0E-06 0.02 0.004 1.1E-05 6.1E-06 0.01 0.01 0.06
X - 11315
0.05 0.01 1.5E-05 1.5E-04 0.02 0.004 1.2E-06 3.8E-06 0.01 0.01 0.48
phosphocholine (18:0/20:5, lipid) 
0.05 0.01 2.2E-05 8.7E-05 0.01 0.003 4.6E-05 1.6E-04 -0.003 0.01 0.75
1-(1-enyl-stearoyl)-2-docosahexaenoyl-GPC (P-18:0/22:6)* (lipid)
0.05 0.01 2.8E-05 6.4E-05 0.01 0.004 2.5E-04 1.0E-03 0.003 0.01 0.68
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associated with nuclear cataract are denoted in bold; X denotes metabolites quantified by 
Metabolon which are currently chemically unidentified.
6.4.3. Diets, cataract and the microbiome
Of the 560 taxonomy collapsed OTUs, 20 OTUs were associated with the MDS 
and 60 OTUs were associated with HEI (Table 6.9., Figures 6.8. and Figure 6.9). HEI 
associations were observed within all bacteria classes called in the sample, while 
Mediterranean diet was associated almost exclusively with changes in the clostridia 
class of bacteria. 
None of the MDS-associated OTUs were associated with nuclear cataract (p-
value > 0.05). Only three of the HEI associated OTUs, two belonging to the 
Ruminococcaceae family (β(SE) = -0.002(0.01) p-value = 0.004 and β(SE) = 
-0.002(0.01) p-value = 0.02 respectively) and one belonging to the Mogibacteriaceae 
family (β(SE) = 0.002(0.01); p-value = 0.01) were associated with nuclear cataract. 
None of the HEI-assocaited bacteria were associated with cortical cataract. No OTUs 
were found to be associated with cortical cataract (p-value > 0.05). Finally, alpha-
diversity (the mean bacterial species diversity per individual) was positively associated 
with both dietary scores (p-value = 0.01 and p-value = 0.003 for the MDS and HEI 
respectively) but not with any of the cataract scores. Finally, mediation analysis were 
also attempted. The results of those are presented in Figure 6.9. There was no 
evidence for mediation by both OTUs when using the Sobel-Goodman test but he 
structural equation modelling test suggested a mediation effect for both OTU (p-value = 
0.049 and p-value = 0.024 for Ruminococcaceae and Mogibacteriaceae OTUs 
respectively.)
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Table 6.9. Associations between diet scores and operational taxonomy units (OTUs)
This table presents the 10 strongest association between diet scores (Mediterranean diet score 
and Healthy eating index score (HEI)) and operational taxonomy units (OTUs), resulting from 
the linear regression analysis (beta, its standard error (SE), and adjusted p-value — FDR of 5% 
adjusted p-value). o — order; f — family; g — genre; s — species; Bold text denotes cases 
where the same OTU was associated with both scores. 
top 10 Mediterranean diet associated OTUS
beta se adjusted p-value
o__Clostridiales; f__; g__; s__ 0.05 0.012 2.7E-05
o__Clostridiales; f__; g__; s__ 0.05 0.013 2.7E-05
o__Clostridiales; f__Ruminococcaceae; g__; s__ 0.05 0.012 1.7E-05
o__Clostridiales; f__Ruminococcaceae; g__; s__ 0.05 0.012 7.1E-05
o__Clostridiales; f__Ruminococcaceae; g__; s__ 0.05 0.012 6.4E-05
o__RF32; f__; g__; s__ 0.05 0.012 1.4E-04
o__Clostridiales; f__Ruminococcaceae; g__Faecalibacterium; s__prausnitzii 0.04 0.012 1.4E-04
o__Clostridiales; f__Ruminococcaceae; g__Oscillospira; s__ 0.04 0.012 1.4E-04
o__Desulfovibrionales; f__Desulfovibrionaceae; g__; s__ 0.04 0.011 1.8E-04
o__Clostridiales; f__Ruminococcaceae; g__; s__ 0.04 0.012 1.7E-04
top 10 HEI associated OTUs
 o__Clostridiales; f__Lachnospiraceae; g__Lachnospira; s__ 0.14 0.012 5.6E-06
 o__Clostridiales; f__; g__; s__ 0.13 0.013 2.0E-05
 o__Clostridiales; f__; g__; s__ 0.14 0.013 3.4E-05
 o__Clostridiales; f__Ruminococcaceae; g__Oscillospira; s__ 0.13 0.014 3.6E-05
 o__Clostridiales; f__Ruminococcaceae; g__Oscillospira; s__ 0.12 0.012 6.4E-05
 o__Clostridiales; f__Lachnospiraceae; g__[Ruminococcus]; s__gnavus -0.12 0.013 1.5E-04
 o__Clostridiales; f__Lachnospiraceae; g__Lachnospira; s__ 0.11 0.013 1.7E-04
 o__Clostridiales; f__[Mogibacteriaceae]; g__; s__ -0.13 0.013 2.7E-04
 o__Clostridiales; f__; g__; s__ 0.11 0.013 3.0E-04
 o__Clostridiales; f__; g__; s__ 0.11 0.013 3.0E-04
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Figure 6.8. Associations between HEI and OTUs per bacterial class
This figure shows the associations between Healthy Eating Index (HEI) and operation 
taxonomy units (OTUs) per bacterial class (outer ring). The inset shows a Manhattan 
plot of the association between Clostridia OTUs and nuclear cataract (black) in 
comparison with all other tested OTUs
6.5. Discussion  
In order to elucidate the relationship between diet and the two most common 
types of cataract, the following questions were addressed in this chapter: 1) What 
proportion of variance in cataract progression is explained by genetic factors?; 2) Do 
micronutrients play a role in ARC progression?; 3) Is the association between diet and 
the ARC mediated by changes in metabolite concentration? 4) Is the association 
between diet and the ARC mediated by changes in the gut microbiome?
The results revealed that the progression of nuclear and cortical cataract over a 
10-year period in a group of UK female twins was influenced primarily by environmental 
factors with genetic factors explaining just 35% of 17% of variance respectively. The 
heritability estimates of cataract progression were lower than previous cross-sectional 
estimates published for the same population167,169. This was not due to some sort of 
selection bias for those 324 subjects in the follow-up group who contributed the
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Figure 6.9. Mediation analysis of diet, cataract and HEI associated OTUs.
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This figure presents the results from the mediation analysis exploring whether the effect of diet 
on cataract is mediated by operational taxonomy units (OTUs). In this analysis only one twin per 
pair was included. Betas and p-values from Sobel-Goodman test (A) and structural equation 
modelling (B) are presented for the separate paths and the whole model. In both cases the 
analyses were adjusted for the effects of age and BMI. 
progression data as these estimates are half as large as the baseline heritability 
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estimates that were recalculated in this group (61% [95%CI: 45%-72%] for nuclear and
50% [95%CI:35-65] for cortical cataract respectively). These findings were, however, 
consistent with previous studies showing that heritability generally is lower when 
examining change, compared with cross-sectional studies666-668. A variety of other 
factors might play a role in determining change during ageing than genetic factors. For 
example, environmentally driven differences in response to stressors in early 
development or in adulthood may be important, as well age-related accumulation of 
somatic mutation or epigenetic remodelling668.
The heritability findings are also dependent the ability of the grading methods 
used here to detect change. In the case of nuclear cataract a highly quantitative and 
reproducible  measure of cataract from digital images was used. The fact that every *
subject measured showed progression suggested that the central nuclear dip score is 
sensitive to change. CNDS may also be better in capturing change than the widely 
used LOCSIII system that was developed to increase steps between scores to allow 
greater sensitivity to change, accepting a lower inter-grader reproducibility36. 
Longitudinal studies using the LOCS III scale show relatively little change. For 
example, in the Longitudinal Study of Cataract, only 24% of participants had an 
increase in nuclear opacities over an average of 4.6 years385. Although CNDS is not the 
same measure, it is highly correlated with average nuclear opalescence graded 
digitally or using a slit lamp167. 
Regarding cortical cataract, 32% of participants progressed in 10-years, thus with 
324 participants the study was underpowered to estimate heritability. If everyone would 
have progressed, 100 pairs would have power of 80% to detect a heritability of 20%. 
This rate of progression observed here is comparable to those found in other studies, 
namely close to twice the 5-year progression found in BAES and MVIP and close but 
slightly higher than the 10-year progression of 20% found in BMES232,233,669. 
Furthermore, none of the participants with grade of 0 at base line developed cortical 
spokes at follow-up. This implies that women, who by the age of 60 have not 
developed cortical cataract, are less likely to ever develop cortical cataract. Therefore, 
for case-control analysis, selecting older controls could prevent misclassification by 
labelling as controls people who are likely to develop cataract in the future. 
Next the role micronutrients play in cataract progression was explored. Those 
participants who contributed follow-up data (N = 324) were seen as part of the HATS 
 intraclass correlation coefficient for the worse eye in 30 subjects who came for a repeat *
measurement as part of the original nuclear cataract heritability study (Hammond et al, N Engl J 
Med. 2000 Jun 15;342(24):1786-90) was 0.93
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study, which was not designed as a cataract follow-up study. This reduced the amount 
of data available for analysis and, therefore, the power of the study. For that reason, in 
the single nutrient analysis I focused on micronutrients only. According to the available 
literature discussed in detail in Chapter I, those were more likely to yield strong signal 
that, if present, could be detected in the progression analysis. Furthermore, only 
nutrients that were associated with nuclear cataract score at baseline were tested for 
association with progression.
 Vitamin C was found to be inversely associated with nuclear cataract 
progression; and the previous findings in other population cohorts of association 
between cross-sectional cataract and vitamin C intake were replicated. Vitamin C 
intake has been extensively studied in relation to ARC because it is the L-enantiomer of 
ascorbate — one of the metabolites with the highest concentration in aqueous humor 
and the lens that reduces oxidation products670-672. However, the conclusions of the 
many studies of the effects of ascorbate on cataract development are inconsistent and 
often conflicting272,375-381,387. Many of these have studied relatively well-nourished 
populations and are cross-sectional. Cross-sectional studies in India, where overall 
antioxidant levels may be lower, have found an inverse relationship between vitamin C 
and cataract378,409. These results are in agreement with the CAREDS  and BMES  * †
studies where dietary vitamin C was inversely associated with 10-years prevalence and 
incidence respectively377,387. Dietary manganese was found to be protective against 
cross-sectional nuclear cataract independent of vitamin C. This association may be a 
type I error, given that there was no association between dietary manganese and 
nuclear cataract progression and the lack of a dose response (Figure 6.6.), although 
factors associated with incidence and progression do not always overlap. Manganese 
is an important antioxidant present in the human lens; manganese concentration in the 
lens drops as a result of cataractogenesis673-676. Finally, similarly to the finding in 
BMES677, there was also an association between supplemental intake of micronutrients 
and cross-sectional nuclear cataract but not between supplemental nutrients and 
cataract progression. As only 10% or less of the participants in our study took any 
single supplement, supplements had to be grouped together; therefore, drawing 
conclusions on the effect of any single supplement or of components of supplements 
(e.g., supplemental vitamin C) is not possible. 
Most likely due to lack of power, no association was detected between any of the 
 FFQ*
 intake and plasma concentrations†
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micronutrients and cortical cataract progression. Vitamin D was marginally associated 
with increased risk of developing cortical cataract but that association would not survive 
a correction for multiple testing. Given the association between cortical cataract and 
T2D and obesity, exploring the role of macronutrients (e.g. carbohydrates) may be 
more fruitful in terms of associations. However, given that diet plays a much greater 
role in nuclear as opposed to cortical cataract formation, very larger sample sizes may 
be needed in order to detect any subtler effects important for cortical cataract 
formation. 
The low power also restricted the number of covariates that could be explored. 
Three covariates in particular need mentioning: BMI, diabetes status and smoking. In 
TwinsUK, neither nuclear nor cortical cataract were cross-sectionally associated with 
BMI or with the presence of diabetes (p-value > 0.05). That was also true for the 
nutrients studied except for manganese, and, therefore, the analysis were not adjusted 
for BMI and diabetes status. In the case of manganese, adjusting for one or both 
factors did not result in a change in the beta and standard error estimates but the p-
value increased (from 0.01 to 0.02). Of note, only 10% of TwinsUK participants had 
diabetes or were diabetes suspects, and this percentage fell to 6% within the 
individuals with cataract measurements. Because 85% of participants who contributed 
to the progression analyses have never smoked, there was also lack of power to 
explore the effects of smoking on cataract progression. Cross-sectionally, there was no 
association between smoking status and intake of micronutrients. Therefore smoking 
status is unlikely to have confounded the association between vitamin C and cataract. 
Next, I explored whether a healthy diet, as represented by two different indexes 
(modified MDS, HEI) was associated with changes in blood metabolites and the 
microbiome. Despite the fact that the FFQ data and the metabolite/microbiome 
samples were obtained on average 2.4 years apart, both indices were associated with 
differences in blood metabolites and the microbiome. A possible reason for this is the 
relative stability of dietary patterns over tine; also supported by the fact that many food 
intake patterns and preferences are heritable678-680. Somewhat unexpectedly, the sets 
of metabolites and OTUs largely did not overlap which would suggest that the two 
indices reflect different aspects of the healthy diet. The MDS was better in capturing 
differences in metabolite concentration than HEI: higher number of metabolites both in 
the single point and in the mean concentration analysis were associated with MDS as 
opposed to HEI; the associations with MDS also reached higher significance. These 
results are probably due to the differences in food groups that are included in the two 
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scores. Conversely, more OTUs (60 vs. 20) were associated with HEI and the 
associations spanned all the bacterial classes. It is not clear why MDS and HEI give 
such different results. A varied diet is associated with high microbiome diversity681. The 
HEI measures more food groups than MDS and is probably better at measuring such 
diversity. HEI was also more strongly associated with alpha-diversity as opposed to 
MDS. 
The observed associations with both scores also make biological sense. Increase 
in one or both scores was associated with increase in relative concentration in blood 
metabolites such as omega-3 fatty acids (EPA, DHA), glycerol (glycerate) and 
docosapentaenoate which are linked to consumption of olive/fish oil intake682,683; and 
threonate linked to consumption of nuts . There was also a decrease in: 1,5-*
anhydrosorbitol concentration which is a marker of good glycemic control684,685; and of 
the carnitine metabolism by-product 3-dehydrocarnitine — a marker of reduced red 
meats  consumption. Of note, both scores were associated with increase in 2-†
aminobutyrate in the single-point and mean metabolite analysis. This metabolite is a 
key intermediate in the synthesis of a glutathione analog in the lens known as 
ophthalmic acid or ophthalmate686. The role that ophthalmic acid plays in the human 
lens is very poorly studied. The observed direction of effect, however, was not always 
consistent with what would be expected given a positive effect on health. For example 
increase in diet score was associated with increase in relative concentration of 
pipecolate and ketoleucine. The first metabolites is of bacterial origin and accumulates 
in patients with chronic liver diseases and pyridoxine-dependent seizures, while the 
second is a marker of compromised brain energy metabolism. 
Some of metabolite associated with MDS and HEI may also be a marker of the 
intake of certain foods687: decreased relative concentration of pipecolate has been 
associated with intake of jam/confectionary; increased relative concentration of 
glycerate has been associated with tomatoes intake; increased relative concentration 
of EPA, DHA and DPA has been associated with various foods, including oily fish, wine, 
avocado; decreased relative concentration of 1,5-anhydroglucitol has been associated 
with intake of non-oily fish and sea food; increased relative concentrations of 2-
aminobutyrate and 3-dehydrocarnitine have been associated with intake of wine and 
low-fat milk respectively; finally, increased relative concentration of 1-
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green leafy vegetables and avocado.
Three metabolites, pipecolate, proline and un unknown compound (X - 02269), 
showed association with cataract (p-value < 0.05) but none of this associations would 
survive correction for multiple testing. How these metabolite would affect cataract 
formation is unclear. 
In terms of microbiome, both scores were associated with increase in total 
microbiome diversity with increase in both scores. HEI was associated with an increase 
in the Ruminococcaceae family of bacteria, which is important for digestion of plant 
material. The score was also associated with a decrease in Mogibacteriaceae family 
whose function in the gut is not well understood but some of its species are pathogens 
linked to gum inflammation and allergies. In this chapter weak evidence pointing to 
OTUs mediating the effect of diet on cataract was also presented. Two test were used, 
a Sobel-Goodman test and a structural equation modelling. Only the latter test detected 
mediation. This test is more powerful as it uses a more complex model fitting that is 
less susceptible to none-normality. 
There may be several reasons for explaining why significant associations 
between metabolites/microbiome and cataract were not observed. It may be that 
differences in metabolites or bacterial concentrations have either no effect on the lens 
or the effects are sufficiently small that this study was underpowered to detect them. 
Another reason is that, largely only cross-sectional data was available, forcing the 
assumption that diet, metabolite profiles and microbiome are stable in time. In this 
cohort, the dietary patterns are relatively stable but if the metabolome/microbiome are 
not, the timing between the metabolome/microbiome sampling and the eye measures 
might reduce power to detect effects. Moreover, for the majority of subjects both 
metabolome and microbiome were sampled after the eye test. A tighter sampling time-
frame might therefore be needed. 
A robust association between metabolites/microbiome and cataract needs to be 
established before causation or mediation analysis can be tested. Finding such 
associations, however, will lead to better understanding of the systemic and molecular 
causes of cataract; and the mechanism behind the diet-cataract association. What is 
more, if blood metabolites mirror the metabolome of the aqueous humor, we could use 
blood as a model system instead of the difficult to obtain lens tissue. Changes in 
metabolites or the gut flora are likely to be a much faster read-out of environmental 
changes and thus might be used prior to disease detection or in its early stages. 
Therefore a relationship between those and cataract should also be studied 
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longitudinally. Finally, dietary interventions that target the metabolome or the 
microbiome may be the more powerful in preventing disease onset or progression and 
have other benefits rather than a cataract-specific drug therapy.
Finally, all the results presented here need replication. In addition, the TwinsUK 
cohort is predominantly a female cohort, and assess any gender differences in risk 
factors could not be assessed. The findings of this study can be generalisable only to 
Caucasian women of similar age because they reflect cataract progression in a group 
of white British women between, on average, the ages of 60 and 70 years, and so may 
not reflect other population groups or age ranges. The fact that a lot of individuals were 
lost of follow-up may have introduced a selection bias. The individuals who declined 
participation were of lower socioeconomic status, had higher self-rated health status, 
and were less health aware464. Any introduced bias probably would have resulted in 
loss of power because this group of individuals are more likely to have less healthy 
diets and more cataract. Those with follow-up data were on average 1.8 years younger 
than the original cohort, but in general they were not significantly different in other 
respects or in nutrient or supplement intake, hopefully reducing potential selection bias 
in the progression data. As in any observational study, this one is potentially 
susceptible to residual confounding, missing data, or misspecification of variables.
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7.1. Overview
The PhD thesis presented here aimed to elucidate the genetic factors and some 
of the environmental factors underlying the two most common forms of ARC. In this 
chapter the strengths and limitations of the findings presented in the previous chapters 
of this thesis will be summarised. The contribution this thesis makes to the existing 
literature will be explored and future direction of research will be considered.
7.2. General discussion
At present cataract surgery is the only form of treatment for ARC but it is not 
widely accessible in big parts of the world, particularly sub-Saharan Africa. In more 
developed economies, it is the most common operation and costs health services 
significant amounts of money. If a much cheaper, non-invasive treatment or a 
preventive strategy is to be developed, we need a better understanding of how genetic 
and environmental risks interplay. High-throughput 'omics' technologies can enable the 
discovery of the molecular changes and biological pathways that are involved in 
cataract formation and progression. The thesis focused on studying the genetics of 
ARC and a potentially modifiable risk factor — diet. The results of this thesis further the 
field of cataract research as follows. First, based on the genetic, environmental and 
dietary analyses, it can be concluded that nuclear and cortical cataract appear to be 
two separate diseases. Second, this thesis elucidates common genetics variants 
associated with nuclear cataract and proposes a list of plausible functional candidate 
genes that may underlay this condition. Third, the results presented in Chapter 6 show 
that vitamin C intake is protective against cataract progression. Finally, the thesis 
attempted to address the mechanisms behind the association between diet and nuclear 
cataract. Below I will discuss the contribution these findings make to the literature, what 
implications they have for future research and care; what are the limitations; and 
possible future directions.
7.2.1. Age-related cataract: umbrella term for ethnologically separate 
conditions   
A fascinating question that was addressed as part of the research presented 
here, and that, has never been addressed before, was whether the two common types 
of ARC, nuclear and cortical cataract, share genetic risk factors. In Chapter 1, the 
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different environmental risk factors that underlie nuclear and cortical cataract were 
discussed and it was concluded that apart from age they do not share many 
environmental predictors. For example, smoking and diet are associated with nuclear 
but not with cortical cataract, while UV radiation, T2D and being female are associated 
with cortical but not with nuclear cataract. The results from the diet, metabolome and 
microbiome analysis presented in Chapter 6 provide further support for differences in 
risk profiles between the two types of cataract. However, a difference in environmental 
risks is not necessarily equal to difference in genetic risk. Given that both cataracts are 
common with advancing age, and commonly co-exist, it is widely assumed that they 
are related. Therefore, it was hypothesised that both common types of ARC would 
share at least some genetic risk factors but that the phenotypic expression will depend 
on environmental factors. 
Here, the thinking behind this hypothesis will be explained further as it may not 
be immediately clear. With the exception of the embryonic nucleus, all other lens fibres 
are derived from the lens epithelium; and in the mature lens fibres there is no 
transcription but only stabilised mRNA molecules67. This will mean that fibres are 
genetically the same irrespective of their position within the lens. However, fibres in the 
nucleus and cortex differ in age, meaning a difference in cumulative exposures and 
stress-related damage, and differences in extracellular environment. Below a 
hypothetical example is discussed. A person is a smoker and spends a lot of time 
outdoors for his work. He also carries an eQTL variant that causes a decrease in 
concentration of a chaperon that will result in both nuclear and cortical fibres having 
reduced amount of the chaperon compared to non-carriers. The chaperone molecules 
get damaged with age and, although the same amount was present in all fibres, there 
are fewer molecules effective in the lens nucleus. The smoking results in additional 
damage and nuclear cataract but not cortical as the cortex has enough of active 
chaperone molecule to prevent misfolding. On the other hand, in the inferonasal 
quadrant area of cortex UV radiation causes damage resulting in fewer working copies 
of the same chaperone, misfolding and cortical cataract. In this case both cataract 
types share the same genetic risk but different environmental triggers.
The results of the heritability analysis presented in Chapter 3 of this, shown that 
this hypothesis is incorrect. Age-related nuclear and cortical cataract are genetically 
distinct conditions, as shown by the results of three different approaches: a residual 
maximum likelihood model implemented in GCTA, linkage disequilibrium regression 
analysis and polygenic risk score. A strategy that could have been adopted but would 
have probably yielded similar results is a bivariate GWAS analysis such as the network 
inference in matrix-variate Gaussian models type implemented in PHENIX688. A 
 203
Chapter 7: General Discussion and Conclusions
 
problem with this model, one that is also shared with GCTA and to a certain extent with 
the classical bivariate heritability estimation, is that analysis of a mixture of quantitative 
and binary traits results in lower power to detect association comported to two 
quantitative traits or two binary traits. Cortical cataract is not easily transformable due 
to a high number of unaffected individuals (score of 0) as using rank transformation 
which usually works for log tailed data results in people with scores of zero getting a 
positive ranking. 
The question is then what makes nuclear and cortical cataract genetically 
different. One possibility is that very different sets of genes are active in young and old 
fibres but studies of molecular differences between the human lens nucleus and the 
cortex are lacking, probably due to the difficulty of physically separating the two. A 
more interesting possibility is that somatic mutations accumulate in the lens epithelium 
as the eye ages and are passed to the fibres689. Whatever the reason, an implication is 
that the same prevention strategy or a future non-operative treatment is unlikely to 
work for both. Further, another research question arises, namely, if the two common 
types of cataract do not share genetic risk factors, do each of them share risk factors 
with other common-age related diseases? For example, does cortical cataract shares 
genetic risk factors with diabetes and metabolic syndrome; or does nuclear cataract 
share genetic risk factors with telomere length?
These findings would benefit from a larger sample size for a more accurate 
estimation and also from a replication in an independent cohort. However, given that 
there are almost no variants, loci or genes overlapping between the two types of age 
related cataract, neither in the TwinsUK, nor between the age-related nuclear cataract 
meta-analysis and similar meta-analyses of genetic studies of age-related cortical 
cataract, the results are not expected to change substantially. Finally, this also means 
that cataract surgery cannot be used as a surrogate for either nuclear or cortical 
cataract diagnoses. Neither can self-reported status of either having the disease or 
having had cataract surgery be used. For example, in TwinsUK, about 50% of 
volunteers who responded that they did not have cataract actually were affected with 
“clinically significant” nuclear or cortical cataract, or with both types of cataract. 
Unfortunately, the large population-base studies such as UK Biobank, do not have 
information on cataract types or cataract grading. Due to lack of time in busy clinics, 
such information is often missing from the clinical record too. That also makes it 
extremely difficult to obtain large sample sizes unless a cataract-specific study is 
designed to do that. All that said, it might be possible to exploit the differences in risk 
(both genetic and environmental) between the two conditions two differentiate between 
nuclear and cortical cataract in patients diagnoses of cataract where information on 
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cataract type is not available. How that can be done is discussed in the Future Studies 
section below.  
7.2.2. Genetic risk factors for nuclear cataract 
Age-related cataracts are common complex diseases and as such arise from the 
interplay of genetic and environmental factors. In the case of ARC, environmental risk 
factors have been studied extensively, as summarised in Chapter 1, but apart of 
couple of heritability studies167-170, little focus has been given to genetic risk 
factors122,574. Thus, in Chapters 4 and 5, it was hypothesised that there exist genetic 
variants (common and rare in terms of effect allele frequency) that are associated with 
the two common forms of ARC, nuclear and cortical cataract. Through my efforts and 
those of my colleagues of the International Cataract Genetics Consortium, new 
susceptibility loci for nuclear and cortical cataract have been identified. As my efforts 
were primarily devoted on elucidating the genetic risk factors for nuclear, rather then 
cortical cataract, the following discussion will be focused this on nuclear cataract. 
In terms of nuclear cataract genetics, main contribution to knowledge this thesis 
makes, is the identification of 6 new loci (SOX2-OT, TMPRSS5, COMMD1, LINC01412, 
MMAB, GLTSCR1) associated with age-related nuclear cataract and the replication of 
the previously reported association with variants in the CRYAA gene574 (Chapter 4). 
Apart from MIP (P=2.4x10-4), none of the ARC candidate genes put forwards by various 
small studies64,178-205 were found to be associated with nuclear cataract (p-value < 
0.05). These results again prove that many studies adopting a candidate gene strategy 
are poorly powered to detect true associations and there is likely a positive publication 
bias. In this thesis it was also shown for the first time that, unlike most age-related eye-
phenotypes, there is a genetic link between age-related and congenital forms. Coding 
mutations in genes such as CRYAA, CRYAB, SOX2 and GJA3 cause congenital 
cataracts59,60,588,592, while, similarly to other age-related diseases690,691, variants 
associated with age-related nuclear cataract (Chapter 5) are more likely to affect gene 
expression. It is likely that while mutations in crystallins or other lens proteins cause 
rapid and direct protein aggregation and result in congenital cataract, common 
polymorphisms may increase or decrease gene expression and thus susceptibility to 
environmental insults, such as oxidative stress, and result in ARC by altering the pool 
of available molecules28,126,692. The functional work (RNA sequencing and protein 
expression) carried by our collaborators had only a small set of human lens tissues 
(predominantly epithelial cells) available and would benefit from a further replication. 
Nonetheless it provided supportive evidence for cataract-related differences in RNA 
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and protein expression for genes at the identified loci. Given that lens fibres arise from 
the epithelial cells and that mature fibres are transcriptionally incompetent and 
relatively inactive metabolically28, altered expression patterns of key genes in lens 
epithelial cells are likely to propagate to the mature lens fibres. Although nuclear 
cataract has onset in the 5th decade of life and nuclear scatter detectable prior early 
adulthood, the lens nucleus is already present at birth and, therefore, subtle 
dysregulation of the development process described in Chapter 1 (Section 1.4. 
Anatomy and embryonic development of the lens) may be of very important but might 
not be detectable adult lens epithelium. 
Based on the bioinformatics work presented in Chapter 5, together with evidence 
from the existing literature, plausible candidate gene list for nuclear cataract can now 
be drawn. The lens gene signature693 (relative to other eye tissues) will be used as a 
starting point to explain a possible role of these candidate genes in nuclear cataract 
formation. The idea being that if a gene is strongly (or exclusively) expressed in lens it 
should be important for its function. In this discussion genes will also be include that, 
due to lack of power, did no reached suggestive or genome-wide significance but have 
strong a priori probability to be important for cataract formation and showed (in the 
meta-analysis) statistical evidence of association of varying strength. Due to the 
number of multiple tests performed, strict Bonferroni correction was applied which is 
generally very conservative if the independence assumption does not hold, potentially 
overlooking true associations.
Within the associated loci there were genes (CRYAA, CRYAB, and genes within 
the CRYB and CRYG clusters) that fall within the structural lens proteins. It is easy to 
see how genetic variants that cause differences in expression levels or protein 
instability, or in the case of free form of CRYAA and CRYAB, a decrease in chaperone 
activity, may cause protein unfolding and lens clouding370,586,587,694. Regarding the other 
structural protein encoding genes (LIM2, BFSP2, SPTBN2, ABLIM, EPB49, EPB41L1, 
EPB41L4), enriched in the lens signature, variants in close proximity to LIM2 and 
BFSP2 were also found to be associated here. LIM2 encodes for a protein with a key 
role in cell-cell adhesion, while BFSP2 encodes for a protein that, along with filensin, 
composes the beaded filaments – lens cell-specific intermediate filaments695,696. 
Although not signature proteins, but still very important for lens function64,584 variants 
altering the function of genes (GJA3 and GJA8) encoding for gap junction proteins also 
may be involved in formation of age-related nuclear cataract. Another notable feature of 
the lens signature is the enrichment of genes encoding proteins involved in 
endocytosis, including clathrin (CLTCL1, PICALM) and caveolin (CAV1). None of those 
genes were found associated with nuclear cataract. Of note, of the genes in the 
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GLTSCR1 locus, NAPA expression was associated with cataract severity. NAPA 
encodes for a protein of the SNAP family of vesicle docking proteins697. 
Given that two (SOX2, ZEB2) of the candidate genes found to be associated with 
nuclear cataract are transcription factors, regulating the transcription of lens genes 
(structural and others), transcriptional regulation may also play an important role in the 
formation of nuclear cataract593-595,597,698. Furthermore, the current study suggest that 
the gene encoded by EHBP1 is Eps15 homology domain binding protein that interacts 
with EHD1 – a protein important for regulation of lens development603,604, may also play 
a role in nuclear cataract pathogenesis. The involvement of transcription factors may 
mean that prenatal and early-life exposure might affect the way the lens ages. 
Alternatively, transcription factors may be re-expressed in the lens epithelia which in 
turn might affect the lens fibres derived from the epithelia. Such is the is the case with 
SOX2 which is activated in a specific population of adult lens epithelial cells and is 
required for their self-renewal699.  
The majority of the previous candidate gene studies focused on genes important 
for protection against oxidative stress in line with the oxidative stress hypothesis of 
cataract formation126. Several classes of such genes are also within the lens 
expression signature set: heath-shock proteins (HSPA6, HSPA8, HSPB1), proteasome 
complex subunits (PSMA6, PSMA7, PSMB6, PSMB7, PSMB9, PSMD13), and 
scavenging of free radicals (GSS, GSR, SOD1, AOP2)693. The oxidative stress 
hypothesis was formed based on functional studies in animal models and cell culture 
experiments; and more rarely human lens samples. An additional compelling piece of 
evidence however is the fact that patients develop nuclear cataracts secondary to 
treatment with hyperbaric oxygen700. According to this hypothesis, ROS are formed in 
the lens either endogenously (as result of the function of mitochondria (lens 
epithelium), peroxisomes, lipooxygenases, NADPH oxidase and cytochrome P450, 
lens specific forms of NADPH oxidase located in the plasma membrane of lens fibres) 
or exogenously (sources include: ultraviolet light, ionising radiation, chemotherapeutics, 
inflammatory cytokines and environmental toxins)157. When the lens anti-oxidation 
mechanisms are overwhelmed or do not function properly, ROS can damage various 
lens fibre components. For example ROS oxidise lens proteins and makes them 
insoluble or impair membrane stability by oxidising membrane lipids157,700-702. ROS can 
also increase ion balance in the lens epithelium if it damages the Na/K-ATPase 
pumps703. When metals such as Fe and Cu that have been found to be elevated in 
advanced cataract react with H2O2 that also can lead to the production of extremely 
potent ROS700. Apart from variants in close proximity to SOD1 (p-value = 5.4x10-4), 
none of the above listed genes that when mutated have been proposed to decrease 
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the lens ability to defend agains ROS, were found to be associated in the meta-
analysis of GWAS of nuclear cataract. Although we did not find association with those 
genes, variants in these and other genes with anti-oxidative function may still play 
some role and may be detected with a better-powered study. 
All these results, and the fact that the associated genes in general are not known 
risk factors for other systemic conditions, point to more eye-specific genetic causes for 
nuclear cataract as opposed to genes associated with general body ageing and 
metabolic imbalance. As with the genes linked to oxidative stress, this observation may 
be due to insufficient power to detect effects. 
Although the International Cataract Genetics consortium has the largest to date 
sample size and some of the best phenotypically defined studies, it lacked the power to 
elucidate additional loci which will lead to better understanding of both types of 
cataract. In addition, reducing the heterogeneity of grading system by re-grading 
studies and using qualitative (e.g. central nuclear dip score167, dynamic light 
scattering694) rather than semi-qualitative grading systems may afford additional power.
Finally, more functional work is needed to point with certainty the causative 
genes, the possible regulatory or other effects mediated by the variant (or variants in 
LD), in each of the loci identified in this thesis. Even though functional work in the 
human lens is made difficult by the fact that modern cataract surgery operations do not 
provide intact lens tissues, it still is likely to add to the usefulness of animal models. 
Any insight from model systems will need validation in human tissue. Pioneering work 
is exploring the possibility of growing a lens from an individual’s own stem cells, 
including lens epithelium stem cells704,705. If those prove to be close in biochemical 
priorities to the person’s own lens, lenses derived from pluripotent stem cells might 
prove to be a valuable and easier alternative to post-mortem lens material.
7.2.3. Diets and cataract 
The focus of my research prior to pursuing a PhD degree has always been 
primarily in different aspects of human genetics (including molecular genetics, clinical 
genetics, genetic epidemiology). Thus, my first year rotation project was in the field of 
evolutionary genetics and dealt with the question of human adaptation to Neolithic 
dietary change. Apart of a valuable experience in a field of genetics I have never before 
worked in, this project sparked in me a fascination with the role diet plays in health and 
disease. In my PhD project I combined this fascination with eye research. There is 
plenty of evidence (discussed in detail in Chapter 1) in the literature showing that high 
intake of antioxidant micronutrients protects against cataract formation. Whether this is 
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also true about cataract progression is not certain. A small subset of the TwinsUK 
cohort had both baseline and follow-up cataract measurements, and those could be 
used this data to answer two questions: 1) what is the heritability of cataract 
progression; 2) does micronutrient intake protect against cataract progression. I 
showed in this thesis that genetic factors explained 35% of the variation in 10-year 
progression of nuclear cataract that dietary vitamin C intake at baseline protected 
against 10-year cataract progression. The meta-analysis of GWAS of nuclear cataract 
is probably the best achievement (in scientific terms) presented in this thesis but the 
vitamin C work is the one with the biggest public impact. The article656 presenting the 
results of the vitamin C work was extensively covered in the British and international 
media, including in the New York Times. The reason for such impact is that a simple 
intervention, in this case increasing the intake vitamin C, can protect not only against 
cataract formation but also against cataract progression. 
Given that the different diet components are correlated and that dietary patterns 
or preferences706, as opposed to single nutrients, may reflect better the effect of diets 
as a whole, next the following questions were explored: whether “healthy” diet has an 
effect on nuclear cataract and whether the effect is mediated by metabolites or the 
microbiome. The rationale behind exploring those questions was that if diet or dietary 
factors protected against cataract formation and or progression, and that effect was 
mediated by changes of metabolites or the microbiome, then it could be explored 
whether any of the genetic risk factors for ARC interact either with diet (dietary factors) 
directly or indirectly through the metabolome or the microbiome. Assuming that such 
interaction exists and can be detected in blood, one could devise a treatment that 
modify the effect of one or more cataract-related genes by modifying a person’s diet 
and, thus, to stop formation or slow progression of ARC. 
The results showed that “healthy diet” as measured by two different indices was 
protective against cataract formation. Moreover, diet was also associated with changes 
in metabolites and the microbiome. Unfortunately, there was not a strong evidence of 
association between diet-related metabolites/OTUs and age-related nuclear cataract. 
There may be a number of different reasons for that. First, it might be that due to the 
blood-eye barrier the metabolic environment of the eye is very different from that in 
blood and so blood is the wrong tissue to measure. However, as long as the 
concentration gradient is not reversed or absent an effect should still be detectable. For 
example, the concentration of ascorbic acid is substantially higher in the aqueous 
humor than in blood but an association between plasma ascorbic acid and cataract is 
detectable. Probably a stronger factor is the gap between the metabolome/microbiome 
sampling and the eye test where the latter was done up to 5 years after the former. 
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Although dietary patterns, metabolites and the gut microbiome seem stable in the long-
term707 and cataract is not reversible, other factors that affect both cataract and 
metabolites/microbiome might confound a possible association. For example during the 
eye visit the participant would have been made aware of their cataract status and that 
could have resulted in change of exposure patterns (e.g. stopped smoking) that were 
not taken into account. The change could have caused concentration differences in 
metabolites but not in cataract status which will prevent an association being detected. 
A tighter matching of sampling dates would afford better power to detect association. 
Further to that, using platforms measuring more metabolites or doing so with increased 
accuracy (eg NMR-based platforms) will likely generate additional findings and will 
make it possible to explore the links between diet either as a whole per nutrient (e.g. 
vitamins), metabolites and cataract. Although the lack of statistically significant 
associations between metabolites/microbiome and ARC is disappointing, further 
studies are worthwhile because if a pathway linking diet and cataract through 
metabolites is established this could pave the way for new interventions. If diet/dietary 
patterns as a whole have more influence that separate nutrients, it might also explain 
why randomised controlled trials for supplemental vitamin intake largely failed. A 
different approach can also be taken, for example by exploring whether genetic 
variants linked to cataract are also associated with metabolites or OTUs. Alternatively, 
multivariate approaches such as building networks of diets, metabolite and OTUs and 
associating those with cataract may prove more fruitful albeit much less straight 
forward to interpret.  
Finally, the results of the dietary epidemiology part of this thesis need replication 
in an independent dataset and a bigger sample size would afford power to study the 
role diet in cataract progression. In addition, the TwinsUK cohort is predominantly a 
British female cohort which reduces generalisation to other population groups or age 
ranges. One of the most important limitations of the analysis presented in Chapter 6 is 
the fact that they dealt with associations which is very different from causations. 
Associating one latent variable with another does not imply causation or its direction. 
Therefore, in the case of the association between diet, microbiome and cataract, 
mediation analyses were attempted but due to lack of power the results were 
inconclusive. A larger study would afford the power to perform not only mediation 
analysis but also Mendelian randomisation. And of course, a randomised clinical trial 
would be in a better position to elucidate causality. The TwinsUK is a representative 
population cohort but as any observational cohort, the results presented here are 
potentially susceptible to residual confounding, missing data, or misspecification of 
variables. This is especially true for the progression part of the study.
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7.3. Future directions
As discussed in this chapter, nuclear and cortical cataract seem to be driven by 
distinct combinations of genetic and environmental risk factors while in majority of 
cases clinical records contain only a diagnose of cataract without its type being 
specified. Similarly, records on cataract surgery that do not mention the type of cataract 
observed before the surgery are also of little use. These ambiguities seriously limit the 
power of any cataract related studies. However, cataract is not the only field suffering 
from problems relating to discrimination of cases. For example, close to half of all type 
1 diabetes (T1D) cases have onset over 30 years of age that overlaps with the onset of 
T2D. Those two groups of patients are difficult to distinguish clinically. Recent studies 
however, have shown the utility of genetic risk score for distinguishing between adult 
onset T1D and T2D708,709. A similar technique could be used in the case of nuclear and 
cortical cataract as described below.  
As part of the UK Biobank imaging study (N = 100,000), lens photos could be 
obtained and both types of cataract graded using, ideally, objective grading systems. 
As these research participants are already genotyped, a genetic risk score can be 
derived either from well measured common SNPs or from SNPs that are conditionally 
independently associated with each type of cataract. The effects of rare variants from 
the sequencing data that would soon be available for all UK Biobank participants could 
also be added. The score can be augmented by data on environmental risks. A score 
that discriminate well between nuclear and cortical cataract cases using a reasonably 
small set of genetic variants and is replicated in large independent cohorts such as the 
cohorts from the International Cataract Genetics Consortium, can open the doors to 
using almost any population or hospital-based study irrespective of how cataract 
presence was recorded. That would includ studies such as the Kayser Permanente 
GERA study in California or the Million veterans program, that use the advent of huge 
electronic medical record studies linked to DNA. It will also make it possible to use 
studies that do not have any eye data at all but have a wealth of molecular phenotyping 
data available such as INTERVAL (www.intervalstudy.org.uk/). In such cases the score 
could predict whether a person is likely to develop cataract of each type and controls 
can be individuals who scores low on both cataract scores. In terms of ethnic 
differences, the trans-ethnic meta-analysis of age-related nuclear cataract presented in 
this thesis do not support differences in genetic risk between European and Asian 
ancestry cohorts and thus a genetic risk score might be generalisable to other 
ethnicities.
All this will make it possible to study the genetics of ARC in large cohorts and 
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perform a much more comprehensive and hugely-powered analysis of genetic variation 
through the entire frequency spectrum including also CNVs or poorly explored parts of 
the genome such as the X chromosome and mitochondrial DNA variants. Other various 
types of analysis that require big sample sizes will be possible such as gene by gene or 
gene by environment interaction studies. Studying gene-by-environment and gene-by-
gene interactions requires huge sample sizes that are prohibitive for hypothesis-free 
approaches and require prior knowledge about underlying genetic and environmental 
risk factors710-712.
When more loci can be identified and causative genes precisely fine-mapped in 
conjunction with metabolomics and proteomic data that would afford deeper knowledge 
of molecular mechanisms underlying ARC and hopefully point to better preventive and 
therapeutic strategies.
7.4. Potential cataract therapies
Potential therapeutic and preventive compounds for ARC are actively explored 
but there have been two main problems. First, the limited knowledge on the 
mechanisms underlying the disease and the lack of genetic studies has made it difficult 
to guid drug targeting or re-purposing. Thus there are just a few examples of 
therapeutic agents that show some promise. In recent studies, triterpenoids (lanosterol 
and a related compound named compound 29) improved lens transparency by 
reducing aggregation of crystalline proteins713,714. A later study however showed that 
lanosterol did not reverse opacification in patients with age-related nuclear cataract715. 
More recently, ghrelin, the so called hunger hormone, has also been shown to protect 
rat lens epithelial cells agains oxidative stress716.
Lanosterol was identified in a congenital cataract genetic study thus showing the 
promise of using genetics tools for drug discovery714. Other fields, where association 
studies in very large sample have been possible have had much more success in 
inferring drug properties from genetic association results in combination with Mendelian 
randomisation approaches. A good examples is darapladib, an inhibitor of a LDL-bound 
enzyme expressed by inflammatory cells in atherosclerotic plaques, and thus a 
promising anti-coronary heart disease drug717. Darapladib failed tree clinical trials but it 
was only later that a large-scale human genetic study found that none of a series of 
enzyme-lowering alleles was causally related to coronary heart disease risk717.
It remains to be seen however whether any new cataract therapeutic approach, 
unless derived from repurposing, can reduce cataract-related visual impairment 
globally, given that new agents may have limited application in developing countries 
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due to drug pricing and access issues, which may place them out of reach of those 
who are most in need. In the developing world preventive treatments may, therefore, be 
more successful. In the past decade an enormous effort has been made to elucidate 
the anti-oxidant properties of plant extracts in experimental systems with the hope to 
create preventive, possibly dietary, interventions for cataract718. Compounds extracted 
form vast variety of plants, from every-day foods (apricots, garlic, curcuma) to exotic 
plants (silk-cotton tree, drumstick tree, Chinese chaste tree) have been tested719-724. 
But it is still unclear how effective those can be when administered to humans and in 
majority of cases the precise mechanisms underpinning the observed protective effects 
are unknown. As with a lot of other nutrient-based interventions, there is not an easy 
read out available in terms of the target or systemic effects once the compound is 
ingested. A better understanding of the human blood metabolome and gut microbiome 
and their connection to the eye, however, may possibly provide such read outs and 
such studies are thus worth perusing. 
7.5. Conclusion 
In conclusion this PhD thesis elucidated some of the genetic factors underlying 
ARC and especially age-related nuclear cataract. It also attempted to find the 
mechanisms behind the association between diet and cataract and showed that vitamin 
C protects against cataract progression. The work presented in this thesis together with 
the other projects pursued during my postdoctoral studies is not the end of a road but a 
stepping stone for future research. Cataract is the leading cause of world blindness but 
the complex interplay between the multitude of common genetic variants that are likely 
to confer cataract risk and environmental factors is still a terra incognita. In order to 
study this interplay we will need better powered purpose-designed studies as well as 
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Appendix I: Eye examination protocols
VISIONIX VX120 
3.8.7. VISIONIX measurements
A. Starting and turning off the VISIONIX
1. Switch on the socket switches for the VISIONIX and for the table on 
which the VISIONIX is placed
2. Switch on VISIONIX by switching on the on button on the touch screen 
3. In the end of the day, press the shut down button on the Home screen
4. When the VISIONIX is off, switch off the socket switches for the 
VISIONIX and for the table 
B. Inputting volunteer data
1. Tap the Add Patient button on the Home Screen (left icon on 9 o’clock)
2. Fill in the information fields
3. If the volunteer is already sitting in front of the camera press Scan & 
Diagnose, otherwise press save
4. If the next person whose data you are inputting has the same family 
name press Save & New
C. Finding volunteers’ records
1. Tap the Patient screen button on the Home Screen (right icon on 3 
o’clock)
2. Type Surname or Name in the Search Field above
3. Select the patient name on the left-hand side by taping on it and press 
New Diagnostics
4. If patient is not present add patient by pressing the add patient button 
(first button on the left in the bottom panel)   
D. Editing volunteers’ information
1. To edit information, select the patient name and tap Modify patient 




2. After making modification press save
3. If you have taken measurement on the wrong name: 
a. tap the measurement on the right hand side of the screen
b. press cut
c. go to the right name
d. press paste 
E. Positioning the volunteer
1. Explain to the volunteer what you are going to do
2. Have the volunteer sit comfortably
3. Adjust the table high to the sitting high of the volunteer so that the 
camera is on the level of the volunteer’s face and his/her eyes are on the 
level of mark lines on the head rest
4. Ask them to put their chin on the chin rest and to firmly press their 
forehead to the head rest
5. Ask the volunteer to look at the balloon and to try and keep their eyes 
wide open
F. Taking measurements 
1. Select the name of the patient by taping on it on the left hand side of the 
screen
2. Tap New Diagnostics
3. Make sure the name of the patient is written on top of the diagnostic 
screen 
4. Make sure that the eye of the volunteer is in the middle of the screen. To 
centre tap on top of the eye on the screen
5. Make sure that the option ALL is selected from the menu of available 
diagnostics (right top cornet of the screen)
6. Press Go
7. When the machine starts moving down, tell the volunteer that they will 
fell 3 puffs of air
8. If you cannot take a measurement or the machines struggles to measure 




9. If the tonometer struggles to focus on the eye do the following:
a. Make sure the volunteer is positioned correctly 
b. If the target is not aligned with the black circle in the middle tap on 
the target till it aligns
c. If the target is fuzzy and out of focus, zoom in by pressing the plus 
sign on the zoom on the upper right-hand side of the screen
d. If the 4 lines of the target look double, zoom out by pressing the 
minus sign on the upper right-hand side of the screen
10.When the measurements are finished press Continue 2x to access the 
Results Summary screen
11.  Advise the volunteer about their refraction, cornea and pressure 
readings
12.Press exit to save the results 
OPTOVUE 
3.8.6. OCT and Fundus measurements
NB. Imaging order: all OCT imagines for both eyes are taken first and then move 
to taking Fundus images
NB. All images are taken in with the lights in the room switched off
NB. You need to take 5 scans each eye with the OCT (retina map, retina 3D, ONH, 
disk 3D, GCC) and 2 photos each eye with the fundus camera (macula, ONH)
NB. If in doubt concerning eye pathology and always before referring volunteers 
to a specialist ask an ophthalmologist  
A. Starting and turning off the camera and computer
1. Make sure that the main black switch on the back of the control box is 
switched on
2. Switch on the computer by switching on the socket switch on the wall




4. Switch on the iCam by pressing the button on the iCam camera 
5. Wait 30 seconds
6. Switch on the computer screen
7. Wait for the operating system to initialise 
8. Press the iView and iCam icons to start the software 
9. When finished for the day:
• Close the iView and iCam programs
• Select the shut down option from the main computer menu
• When the screen switches off, switch off the socket switch on the 
wall
B. Inputting volunteer data: can be done on either of the programs, as the two 
programs share one database, you need to input the data once only
1. Go to Patient Menu
2. Press Add Patient button
3. Fill out the information fields
4. If the volunteer is already sat in front of the camera and you see the OCT 
menu press Scan otherwise press Save and press the iVew tab (on the 
left) to go to the OCT menu
C. Finding volunteers’ records
1. Go to Patient Menu
2. Look for the name of the volunteer in the Patient list
3. OR input volunteer name in the search field and press Search
D. Editing volunteers’ information
1. To edit information, select the patient name and click the Edit button




3. To add additional comments such as reasons why taking photos was 
difficult or unsuccessful select the patient name, click the Edit button and 
fill in the comments box
E. Deleting data – NB data once deleted can not be retrieved back
1. For OCT data – review the scan in the review window, any scan with low 
quality due to blinking or other factors should be deleted so that there are 
only 10 scans per person. For that right-click on the scan you want to 
discard and press delete
2. For the Fundus data – look at the photos in the review window, any 
photos with low quality due to blinking or other factors should be deleted 
so that there are only 4 photos per person. For that remember the 
position in the taking order of the photo you want to discard and go back 
to the main iCam menu. Right-click on the photo you want to discard and 
press delete
F. Positioning the volunteer
1. Explain to the volunteer what you are going to do
2. Have the volunteer sat comfortably
3. Adjust the table high to the sitting high of the volunteer so that the 
camera is on the level of the volunteer’s face
4. Ask them to put their chin on the chin rest and to firmly press their 
forehead to the head rest
5. Their eyes should be on the level of the black lines which are visible on 
both sides of the head rest
6. The chin rest should be adjusted to be very slightly lower so that the 
volunteer leans forwards 
7. Tell the volunteer that they can blink until you tell them to stare 
G. Taking OCT measurements 




2. Move the camera close to the eye you want to measure and use the 
joystick to focus 
3. Perform all measurements on the right eye first and then move to the left 
eye
4. Press Step 1
5. Select an eye (Right/OD for the right eye or Left/OS for the left eye) - the 
eye selected will be shown below the video screen
6. Selecting Retina
7. Press Retina Map
8. Ask the volunteer to look at the “X” in the centre of the target which 
should be straight-ahead. This is true for all retinal images  
9. Press Auto-Adjust button to enhance the OCT image
10.The image should be in-between the red lines on the measurement 
screen
11. To adjust the image position use the mouse scroll 
12.When ready to take the image ask the volunteer to blink one last time 
and then repeat three times “Stare”
13.After the last “Stare” press the capture button on the screen or the black 
button on top of the joystick
14. If you are happy with the quality of image (the bar on the right sight of 
the image is green and the percentage given is high >60%) go back to 




15.Press retina 3D (done for everyone on their first measurement with 
the machine) (not needed for follow up)
16.Make sure that the image is under the higher red line
17.Ask the volunteer to blink one last time and then repeat three times 
“Stare”
18.After the last “Stare” press the capture button on the screen or the black 
button on top of the joystick
19.Skip the Cross Line measurement
20.Press Nerve Fiber 
21.Press ONH 
22.Ask the volunteer to look at the “+” which should appear slightly on the 
left of the volunteer for her/his right eye and slightly on the right for her/
his left eye
23.Press Auto-Adjust button to enhance the OCT image
24.Make sure the optic nerve head is in the middle of the green circle on the 
screen below the video screen
25.To adjust click on the centre of the optic nerve on the screen below the 
video screen
26.Make sure the image is in-between the red lines on the measurement 
screen





28.After the last “Stare” press the capture button on the screen or the black 
button on top of the joystick
29.The 3D disk option should appear automatically at this point, if it 
doesn’t go to Step 1 and select it from the Nerve Fiber menu
a. NB. 3D disk must always done for everyone on their first ever 
measurement with this machine (not needed for follow up)
30.Make sure the optic nerve head is in the middle of the green circle on the 
screen below the video screen
31.To adjust tap with the mouse on the optic nerve on the screen below the 
video screen
32.Make sure the image is in-between the red lines on the measurement 
screen
33.Ask the volunteer to blink one last time and then repeat three times 
“Stare”
34.After the last “Stare” press the capture button on the screen or the black 
button on top of the joystick
35.Press GCC
36.Advise the volunteer that the target will move to slightly off-centre 
37.Press Auto-Adjust button to enhance the OCT image
38.Make sure the optic nerve head is in the middle of the green circle on the 
screen below the video screen
39.To adjust tap with the mouse on the optic nerve on the screen below the 
video screen
40.Make sure the image is in-between the red lines on the measurement 
screen





42.After the last “Stare” press the capture button on the screen or the black 
button on top of the joystick
H. Taking Fundus measurements
1. Press the iCam bar on the left
2. Show the volunteer the drawing of the target and explain to them what they will 
be looking at: When photographing their right eye they should be looking at the 
small triangle which is in the big circle for the first photo (macula) and at the 
square for the second photo (ONH). The square will be far on their left (direction 
their nose) and out of the big circle. When photographing their left eye they 
should be looking at the small circle which is in the big circle for the first photo. 
For the second photo they will need to look at the diamond which will be far on 
their right (direction their nose) and out of the big circle.
3. Press Right/OD
4. Move forward the camera till you see the two bright focus bars. Use the 
focus knob to align the bars on top of each other 
5. Move forward till you see the working distance dots. Move forward and 
backwards, up and down till they become small and clear and are equally 
spaced on both sites of the central line
6. Ask the volunteer to look at the triangle
7. Tell the volunteer not to blink




9. If you are happy with the photo press save if not press discard and 
repeat the procedure
10.Ask the volunteer to look at the square 
11. Tell the volunteer not to blink
12.Take a photo by pressing capture or the black button on the joystick
13. If you are happy with the photo press save if not press discard and 
repeat the procedure
14.Press Left/OS
15.Move forward the camera till you see the two bright focus bars. Use the 
focus knob to align the bars on top of each other
16.Move forward till you see the working distance dots. Move forward and 
backwards, up and down till they become small and clear and are equally 
spaced on both sites of the central line
17.Ask the volunteer to look at the small circle
18.Tell the volunteer not to blink
19.Take a photo by pressing capture or the black button on the joystick
20. If you are happy with the photo press save if not press discard and 
repeat the procedure
21.Ask the volunteer to look at the diamond
22.Tell the volunteer not to blink
23. If you are happy with the photo press save if not press discard and 
repeat the procedure 
I. When finished ask the volunteer if they want to see the results. If the answer 
is yes guide the volunteer trough the results
1. Go to the review bar and guide the volunteer trough the iCam results first




3. If there is no visible pathology according to your understanding tell to the 
volunteer one of the two below (dependent on your status):
a. you are not a trained ophthalmologist but as far as you can see 
there are no problems. The photos will be checked by a specialist 
and we will contact the volunteers if we find anything wrong 
b. you are an ophthalmologist and as far as you can see there are no 
problems     
4. If there is time also show the volunteer the results from the OCT: the 
retina map and ONH only and guide them through these results too
5. If you have observed a problem with the eye that needs attention do one 
of the options below (dependent on your knowledge): 
a. If you are absolutely confident that you know what the problem is 
but you are not an ophthalmologist, explain to them that what you 
found and if needed arrange a letter of referral to be sent to their 
GP but double-check with the ophthalmologist first. 
b. If you do not know what the problem is explain that you are not a 
trained ophthalmologist and that you will ask a specialist to look at 
the results and we will contact them if they need referring or if they 
need further attention
c. If you are ophthalmologist explain what is wrong with them and 
write them referral to the GP immediately if needed
d. In general we do not refer dry AMD, drusen, epiretinal membrane 
detachment, small splits. We refer wet AMD and glaucoma, 
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Genetic and Environmental Factors AssociatedWith the
Ganglion Cell Complex in a Healthy Aging British Cohort
Edward Bloch, MBBS; Ekaterina Yonova-Doing, MSc; Eneh Jones-Odeh, MBBS; Katie M.Williams, FRCOphth;
Diana Kozareva, BSc; Christopher J. Hammond, MD
IMPORTANCE Measurement of ganglion cell complex (GCC) thickness may bemore sensitive
than current methods for glaucoma diagnosis and research. However, little is known about
the factors influencing GCC thickness in the general population.
OBJECTIVES To investigate the heritability of and factors associated with GCC thickness in a
healthy aging population.
DESIGN, SETTING, AND PARTICIPANTS A cross-sectional twin studywas conducted from
August 27, 2014, to March 31, 2016, among 1657 participants of white British ancestry from
the TwinsUK study cohort without ocular pathologic conditions. Heritability analyses were
conducted in 1432 twins (426monozygous and 290 dizygous pairs). Association analyses
were performed using univariable andmultivariable stepwise linear regressionmodels, taking
family structure into account. Heritability analyses were conducted using maximum
likelihood structural equation twin modeling.
MAIN OUTCOMES ANDMEASURES Parametersmeasured included GCC thickness,
autorefraction, intraocular pressure, blood pressure, bodymass index, and cholesterol,
creatinine, glucose, insulin, triglycerides, and urea levels. Estimated glomerular filtration rate
was calculated using theModification of Diet in Renal Disease formula.
RESULTS Among the 1657 participants (mean [SD] age, 56.0 [15.3] years; 89.5%women and
10.5%men), the mean [SD] inner GCC thickness was 96.0 [7.6] μm (95% CI, 95.1-96.2). In
multivariable modeling, the mean inner GCC thickness was associated with advancing age
(β, –0.14; P < .001), increased bodymass index (β, –0.15; P = .001), spherical equivalent
(β, 0.70; P < .001), and higher estimated glomerular filtration rate (β, 0.03; P = .02). A 1-U
increase in age or bodymass index was associated with a 0.14-µm and 0.15-µm decrease in
GCC thickness, respectively (P < .001), while a 1-U increase in spherical equivalent or
estimated glomerular filtration rate was associated with a 0.70-µm (P < .001) and 0.03-µm
(P = .02) increase in GCC thickness, respectively. Ganglion cell complex thickness was not
associated with sex, intraocular pressure, or diabetes. Age-adjusted GCC thickness was highly
heritable, with additive genetic effects explaining 81% (95% CI, 78%-84%) of phenotypic
variance and individual environmental factors explaining the remaining 19% (95% CI,
16%-22%).
CONCLUSIONS AND RELEVANCE Ganglion cell complex thickness appears to be highly
heritable and further genetic analysis may help identify new biological pathways for
glaucoma. The results suggest it may be important to account for age, bodymass index,
refractive error, and sex when using GCC thickness as a diagnostic tool. Replication of their
results is required, as is further research to explain the association between renal function
and GCC thickness.
JAMA Ophthalmol. 2017;135(1):31-38. doi:10.1001/jamaophthalmol.2016.4486
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G laucoma is the second leading cause of blindnessworldwide, affecting up to 3% of the global popula-tionolder than40years, and is forecasted toaffect79.6
million people worldwide by 2020.1,2 Glaucoma comprises a
group of optic neuropathies characterized by progressive, ir-
reversible visual field loss. Impaired retrograde neurotrophic
transport causes dysfunction of retinal ganglion cells and, ul-
timately, apoptosis with axonal atrophy.3-5
As loss of retinal ganglion cells is not visible on ophthal-
moscopy, glaucoma is traditionallydetectedusingoptic nerve
examination and visual field tests. These tests have low sen-
sitivity,areproneto interobservervariation,anddetectchanges
that occur relatively late in the disease process, leading to a
diagnosticdelayofup to 10years.6-9Theadventof spectral do-
main-optical coherence tomography(SD-OCT)hasaffordedthe
opportunity toacquirenoninvasive invivohigh-resolutionseg-
mentationof the inner retinal layers.10-12Since themacula con-
tains up to 50%of retinal ganglion cells, it is very sensitive to
early glaucomatousdamage.13Spectral domain-optical coher-
ence tomographymeasurements of themacular ganglion cell
complex (GCC) thickness, comprising the ganglion cell layer,
the inner plexiform layer, and the retinal nerve fiber layer
(RNFL), correlate closelywith histologic data.14Various stud-
ies have investigated the diagnostic ability and validity of
SD-OCT parameters, concluding that both GCC and peripap-
illary RNFL thickness have high sensitivity, specificity, and
positive predictive value for disease.15-27
It iswell established that older age andhigher intraocular
pressure (IOP) are risk factors for primary open-angle glau-
coma (POAG).28 It also has been suggested that factors such
as vascular dysregulation29-32 and diabetes33may play an im-
portant role in the development of POAG. In addition, family
history isknowntocontribute to the riskofdevelopingPOAG28
and genetic variants have been identified that play a role in
POAG and its endophenotypes.34,35
Theextent towhichanyof these factorsmay influenceGCC
thickness in a healthy population is unclear. We undertook a
cross-sectionalobservational studytoexplore thesystemicand
ophthalmicfactors influencingGCCthickness inahealthypopu-
lation of European ancestry. In particular,we focused onpara-
metersthatmightbeassociatedwithmicrovasculardamage,such
as blood pressure, diabetes, and renal function. To investigate
towhatextentgenetic factors influenceGCCthickness,weused
a twinmodel design to perform a heritability study.
Methods
Participants
Allmonozygousanddizygous twinpairswerevolunteers in the
TwinsUKstudy,anunselectedpopulation-basedtwincohortrep-
resentative of the broader population in terms of disease-
associated and lifestyle characteristics.36We assessed 1753 in-
dividuals for eligibility and included those of European ances-
try and who were 18 years or older and excluded 39 not of
Europeanancestry,33with treatedglaucoma,4withocularhy-
pertension, 7 with other pathologic conditions affecting the
retina, 12withpoor-qualitySD-OCTimages,and 1with incorrect
data.Zygositywasdeterminedbyastandardizedquestionnaire
and confirmed using genome-wide genotyping of single-
nucleotide polymorphisms or short tandem repeats in some
monozygous twin pairs forwhomgenome-wide datawere not
available.ThestudywasapprovedbytheGuy’sandSt.Thomas’
ethics committee and all the participants providedwritten in-
formedconsent inaccordancewiththeDeclarationofHelsinki.37
Clinical Examination
Data were collected between August 27, 2014, and March 31,
2016. Eachparticipant completed aquestionnaire to elicit any
previousophthalmichistory.Nonophthalmicparameterswere
assessed, including height, weight, blood pressure, and stan-
dard bloodmarkers relevant tomicrovascular disease (ie, lev-
elsofcholesterol, creatinine,glucose, insulin, triglycerides,and
urea). Estimated glomerular filtration rate (eGFR) was calcu-
latedusing theModificationofDiet inRenalDisease formula.38
Ophthalmic examination on both eyes included autore-
fraction, pachymetry, and noncontact measurement of IOP
(Visionix120;TheLuneauTechnologyGroup).Sphericalequiva-
lent (SphE) was calculated using the standard formula of
sphere + (cylinder/2). Fundus photography and SD-OCT,
including mapping of GCC thickness, were performed
(iVue SD-OCT; Optovue).18,19,39-41 Scans were reviewed by an
ophthalmologist (E.B.) and poor-quality scans (n = 59, con-
firmed by K.M.W.) were excluded from the final analyses. As
therewas a high correlation between left and right eyes for all
measurements (Pearsoncorrelationcoefficient, >0.7),weused
themean of the 2 eyes when both eyes were available.
Statistical Analysis
Differences betweenmonozygous and dizygous twins, or be-
tween any other group (eg, participantswith hypertension or
diabetes vs controls),were comparedusing2-sample,2-tailed
t tests or z tests, assuming equal variance. Associations were
assessed between GCC thickness and the following 14 fac-
tors: age, sex, body mass index (BMI; calculated as weight in
kilograms divided by height inmeters squared), diabetes sta-
tus, bloodpressure (systolic anddiastolic),2ophthalmicpara-
meters (SphE and IOP), and6 bloodmarkers (levels of choles-
terol, creatinine, glucose, insulin, triglycerides, and urea).
Key Points
Question What are the genetic and environmental factors
associated with ganglion cell complex thickness in a healthy aging
British cohort?
Findings In a cross-sectional twin cohort study of 1657
participants, ganglion cell complex thickness was associated with
age, bodymass index, and refractive error, as well as estimated
glomerular filtration rate. Ganglion cell complex thickness was
highly heritable, with additive genetic effects explaining 81% of
phenotypic variance.
Meaning Ganglion cell complex thickness appears to be a highly
heritable trait and adjustment for age, bodymass index, and
refractive error is important when using it as a diagnostic
parameter.
Research Original Investigation Genetic and Environmental Factors AssociatedWith the Ganglion Cell Complex
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Univariable linear regression analyses were performed, fol-
lowed by a multivariable linear regression model for factors
with an association significant at P < .05 in the univariable
model. Independent variableswere identified using stepwise
backwardprocedurewitha threshold for removal setatP < .05.
Variables that, in the multivariable model, would survive
Bonferroni correction for multiple testing (P ≤ .004; 0.05 di-
vided by 14, where 14 is the number of independent variables
tested),were consideredassociatedwithGCC thickness.Mean
arterial pressure and eGFR are not independent variables, as
they are calculated from these variables, so they donot affect
theBonferroni correction threshold. In all regressionmodels,
family structure was taken into account.
All analyses, except for the heritability, were carried out
using STATA, version 14, statistical package (StataCorp).Heri-
tability analyses were performed using maximum likelihood
structural equation twin modeling implemented in the
OpenMx package in R (http://openmx.psyc.virginia.edu). We
compared thephenotypic variancebetweenmonozygous and
dizygous twins to estimate the extent towhichGCC thickness
was a result of additive or dominant genetic effects and
commonoruniqueenvironmental factors. Thegoodnessof fit
of the full and reduced additive, common, and unique (ACE)
oradditive,dominant,andunique (ADE)modelswascompared
with theobserveddataandthebest-fittingmodelwasselected.
Before the heritability analysis, GCC thickness was adjusted
for age by linear regression of GCC and age and applying the
models to the residuals.
Results
Data on GCC thickness were acquired from 3235 eyes of 1657
predominantly female (89.5%) participants, whose demo-
graphic andclinical characteristics arepresented inTable 1.We
excluded 39 individuals of non-European ancestry, 44 with
ocular pathologic conditions, and 13 for other reasons. The in-
dividuals who were excluded for ocular pathologic condi-
tions or other reasonswere ameanof 14.3years older than the
remainingparticipants,whowereamean (SD)ageof56.0 (15.3)
years (range, 18-90 years). Monozygous twins were on aver-
age younger than the dizygous twins (54 vs 59 years) and had
thickermeanGCC (96.4vs95.3µm;P = .01).Monozygous and
dizygous twins alsohaddifferentmean (SD) values for the fol-
lowingparameters:BMI (25.6 [0.16] vs26.5 [0.21]), SphE (–0.21
[0.08] vs 0.15 [0.10] diopters), systolic blood pressure (126.3
[0.58] vs 128.9 [0.66] mm Hg), and serum cholesterol level
(206.95 [1.54] vs 212.36 [1.54] mg/dL [to convert to milli-
moles per liter,multiply by0.0259]) (P ≤ .01 for all). After lin-
ear age adjustment, therewerenodifferences betweenmono-
zygous and dizygous twins for these variables.
The mean (SD) inner GCC thickness of the study popula-
tionwas96.0 (7.6)μm(95%CI,95.1-96.2),withmean (SD) su-
perior thickness of 95.4 (7.7) μm (95%CI, 95.1-95.7) and infe-
rior thicknessof96.6 (8.0)μm(95%CI,96.2-96.8).Thesuperior
and inferior thicknesseswerehighly correlatedwith themean
inner GCC thickness (Pearson correlation coefficient,0.97 for
both) and yielded similar results in all analyses.
Table 2 summarizes the results from the univariable and
multivariable stepwise regression analyses. On univariable
analysis, themeanGCCwas thinnerwithadvancingage (β [SE],
–0.12 [0.02]; P < .001), increased BMI (β [SE], –0.19 [0.04];
P < .001), andhigher systolic (β [SE], –0.06 [0.01];P < .001) and
diastolic blood pressures (β [SE], –0.06 [0.02]; P = .003). The
association with systolic and diastolic blood pressure sur-
vivedadjustment forhypertension status (β [SE], –0.05 [0.01];
P < .001; andβ [SE], –0.04 [0.02];P = .02, respectively).Of the
ocular parameters, only SphEwas associatedwith GCC thick-
nessonunivariableanalysis (β [SE],0.45 [0.09];P < .001),with
a thinner GCC associated with a more myopic refraction. Re-
garding blood parameters, on univariable analysis GCC thick-
nesswasnegativelyassociatedwithan increase in levelsof cre-
atinine (β [SE], –2.69 [1.28]; P = .01), glucose (β [SE], –0.27
[0.003];P = .01), insulin (β [SE], –0.02 [0.01];P = .01), triglyc-
eride (β [SE], –0.01 [0.004]; P = .01), and urea (β [SE], –3.42
[0.90]; P < .001) levels (Table 2). In multivariable modeling,
themean inner GCC thickness was independently associated
withadvancingage (β [SE], –0.14 [0.02];P < .001), SphE(β [SE],
Table 1. Demographic and Clinical Characteristics of the Study Population
Characteristic Value
Age, mean (SD), y 56.0 (15.3)
Height, mean (SD), m
Women 1.6 (0.1)
Men 1.7 (0.1)
Weight, mean (SD), kg
Women 68.6 (13.2)
Men 82.6 (16.4)
Body mass index, mean (SD)a 26.2 (5.1)
Women 26.1 (4.9)
Men 27.3 (4.5)
Blood pressure, mean (SD), mm Hg
Systolic 127.3 (17.4)
Diastolic 75.8 (10.6)
Female sex, No. (%) 1483 (89.5)
Diabetes, No. (%) 190 (11.5)
Hypertension, No. (%) 290 (17.5)
Receiving antihypertensive treatment, No. (%) 213 (12.9)
IOP, mean (SD), mm Hg 13.3 (2.6)
SphE, mean (SD), diopters −0.1 (2.4)
CCT, mean (SD), μm 536.2 (35.6)
Total cholesterol, mean (SD), mg/dL 208.5 (42.5)
Creatinine, mean (SD), mg/dL 0.83 (0.15)
Glucose, mean (SD), mg/dL 86.5 (10.8)
Insulin, mean (SD), μIU/mL 49.1 (32.2)
Total triglycerides, mean (SD), mg/dL 88.5 (53.1)
Urea, mean (SD), mg/dL 32.43 (6.6)
Abbreviations: CCT, central corneal thickness; IOP, intraocular pressure;
SphE, spherical equivalent.
SI conversion factors: To convert cholesterol to millimoles per liter, multiply by
0.0259; creatinine to micromoles per liter, multiply by 88.4; glucose to
millimoles per liter, multiply by 0.0555; triglycerides to millimoles per liter,
multiply by 0.0113; and urea to micromoles per liter, multiply by 59.485.
a Calculated as weight in kilograms divided by height in meters squared.
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0.70 [0.09];P < .001), and increasedBMI (β [SE], –0.15 [0.04];
P = .001) only; these associationswould survive correction for
multiple testing (Bonferroni threshold, P ≤ .004).
Given thepossible connectionbetweenGCCthickness and
both blood pressure42-44 and kidney function,45we explored
associated parameters even though they did not survive the
multivariable analysis.We first examined ifmeanarterial pres-
sure, which is considered to be a better marker of organ
perfusion,46 was associated with GCC thickness. The mean
arterial pressure in our study was a mean (SD) of 92.9
(12.1)mmHg. Similar to systolic and diastolic blood pressure,
mean arterial pressurewas associatedwithGCC thickness, ir-
respective of hypertension status (β, –0.06; P < .001), but not
when adjusted for age (β, –0.03; P = .13). Next, we looked at
whether GCC thickness was associated with the eGFR. In our
study, the mean (SD) eGFR was 82.5 (19.6) mL/min/1.73m2.
Higher eGFRwas associatedwith a thicker GCC, independent
of age, hypertension, and diabetes status (β, 0.03; P = .02).
Finally, we calculated the heritability of GCC thickness in
1432 twins (426monozygous and 290 dizygous pairs), as 225
individuals had their twinmissing. We found the best-fitting
model tobe theadditivegenetic anduniqueenvironment (AE)
model, in which 81% (95% CI, 78%-84%) of variance in age-
adjustedGCC thicknesswas explainedbyadditive genetic fac-
tors and the remaining 19% (95%CI, 16%-22%) by unique en-
vironmental factors.
Discussion
Many cross-sectional and longitudinal studies have investi-
gated the effects of age, sex, race/ethnicity, IOP, and axial
length on RNFL thickness.47-54 As GCC incorporates RNFL,
the 2 variables are correlated (Pearson correlation coeffi-
cient, 0.76 in this sample) and likely share risk factors. How-
ever, we set out to examine the associations in a large
population-based epidemiologic study of GCC thickness in
healthy European individuals and found it to be strongly and
independently associated with age, BMI, SphE, and eGFR.
Except for eGFR, all the other parameters survived correc-
tion for multiple testing.
With respect to age, our results are similar to those previ-
ously found forRNFL.55-57Wefound, cross-sectionally, a thin-
nerGCCwith older age (ameandecrease of0.14µmper year).
The effect we found is comparable with that found by Zhang
etal54 in92controls (0.17µmperyear) in theAdvancedImaging
forGlaucomaStudy. Incontrast, theassociationbetweenRNFL
andBMI ismore variable.Morbid obesity had a significant in-
fluence on RNFL, retinal ganglion cells, and choroidal thick-
ness in 1 study,58while others suggest that BMI plays a role in
RNFL thickness only inmen55 or not at all.59 The UK Biobank
study founda significant negative associationbetweenmacu-
lar thickness and both BMI and male sex,56which is in keep-
ingwith our study findings of a reduction in GCC thickness of
0.15 µm per 1-U increase in BMI. Owing to the small number
of male participants in this study, we were underpowered to
detect sexeffects;however, thedirectionofeffectwas thesame
in the 2 groups (β, –0.19 andP < .001 forwomen; β, –0.28 and
P = .20 for men).
Studies of RNFL thickness from the European Prospec-
tive Investigation IntoCancerandNutrition (EPIC)-Norfolkand
UKBiobank cohorts foundRNFL andmacular thickness to be
thinner inmen than inwomen.55,56Wanget al60 foundno sex
differences in the mean thickness of GCC and ganglion cells
and the inner plexiform layer in a Chinese cohort. However,
while Mwanza et al61 did not find a difference between the
sexes formean thickness of ganglion cells and the inner plexi-
form layer (P = .36), they did find that male sex was associ-
ated with GCC thickness in multivariate analysis with RNFL
thickness, age, andaxial length (β, –1.62;P = .005).Wedidnot
observe a difference inmean (SD) GCC thickness between the
174 men (95.7 [7.98] µm) and 1483 women (96.1 [7.45] µm;
P = .69) in our study.
Of the ophthalmic parameters, GCC thickness was asso-
ciated only with SphE, withmoremyopic eyes having a thin-
ner GCC and amean increase in thickness of0.70µmper 1-di-
opter increase in SphE. Previous studies have proposed that
longer axial length is associatedwith thinnerRNFL.62-64How-
ever, Khawaja et al,55 using scanning laser polarimetry in the
EPIC-Norfolk study, found that longer axial length appeared
to be associated with a thicker RNFL. There is some contro-
versy as to the possible magnification effects of the eye with
increasing ametropia, which is not routinely corrected for by
SD-OCT software.55,65,66 Some studies using SD-OCT have
found that this association reversed once ocular magnifica-
tion was mathematically corrected.65,67 Patel et al56 demon-
strated that, on results of SD-OCT, increasingmyopia was as-
sociated with increased central macular thickness but a
decrease in the other macular subfield thicknesses, resulting
in an overall positive association with refractive error. Opti-
cal coherence tomographyalsohas been shown tobemore re-
peatable and sensitive than glaucoma diagnoses by scanning
laser polarimetry at detecting glaucoma in cases of high
myopia.40,68-72 Irrespectiveofwhether theeffect isphysiologi-
cal or owing to optics, we propose that future studies of GCC
Table 2. Univariable andMultivariable Linear Regression Analysis
Characteristic
β (SE)
Univariable P Value Multivariable P Value
Age −0.12 (0.02) <.001 −0.14 (0.02) <.001
Sex 0.31 (0.77) .69
Body mass index −0.19 (0.04) <.001 −0.15 (0.04) .001
Blood pressure
Systolic −0.06 (0.01) <.001
Diastolic −0.06 (0.02) .003
Diabetes −0.91 (0.47) .05
Spherical equivalent 0.45 (0.09) <.001 0.70 (0.09) <.001
Intraocular pressure 0.05 (0.08) .51
Total cholesterol −0.01 (0.01) .27
Creatinine −2.69 (1.28) .01
Glucose −0.27 (0.03) .01
Insulin −0.02 (0.01) .01
Total triglycerides −0.01 (0.004) .01
Urea −3.42 (0.90) <.001
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should consider adjusting for SphEor axial length, given their
strong association with GCC thickness.
Although IOP is a known risk factor for POAG, we were
not able to identify an association between IOP and GCC
thickness in our study. However, this is in agreement with
the findings from RNFL association studies, such as the
EPIC-Norfolk, UK Biobank, and Advanced Imaging for Glau-
coma Study groups.54-56 It is possible that our exclusion of
individuals taking IOP-lowering medication diminished the
association with GCC thickness, although we excluded only
37 individuals on this criterion. Furthermore, there is
increasing evidence for the role of the association between
IOP and intracranial pressure, known as the translaminar
pressure difference, in the pathophysiologic cause of
glaucoma.73,74 It may be that the IOP does not damage reti-
nal ganglion cell axons at the lamina cribrosa until it reaches
a given threshold, which would, in part, further explain the
pathophysiologic cause of normal-tension glaucoma.
Vascular dysregulation has been proposed to play an im-
portant role in POAG29-32 and several recent studies have sug-
gested that systemichypertension is associatedwithRNFLand
GCC thinning, which may represent an important consider-
ationwhenusing retinal SD-OCTmeasurements as a diagnos-
tic tool.42-44Therefore, in this study,we explored the associa-
tion between GCC thickness and blood pressure (systolic,
diastolic, and mean arterial pressure). We did find GCC to be
thinner in individuals with hypertension (94.3 µm) vs those
with normal blood pressure (96.3 µm; P < .001), and an in-
crease in any of the blood pressure parameters was associ-
atedwithGCCthickness inunivariable analyses.However, this
associationwas small (β, –0.06µm)andnot independent from
the effect of age.
Similarly, some studies have shown diabetes to have an
early neurodegenerative effect on the retina, causing neuro-
nal dysfunction, leading to thinning of both the RNFL and
GCC, with associated functional visual deficits.75-82
Chhablani et al79 showed that inner retinal thinning was
present in patients with type 2 diabetes, even before signs of
retinopathy were visible, while Salvi et al80 showed a signifi-
cant association of GCC thinning in patients with diabetic
polyneuropathy but not in those with retinopathy. We did
not find an association between a diagnosis of diabetes and
GCC thickness, nor with fasting serum glucose and insulin
levels. The participants in the TwinsUK study cohort are
generally healthy, so we may be underpowered to detect
effects specific to hypertension or diabetes, although our
study did include 290 and 190 participants with these
respective diagnoses.
Finally, we found eGFR to be associated with mean GCC
thickness. The association survived correction for the effects
of age, diabetes, and hypertension, accounting for a 0.03-µm
change in GCC thickness per 1-U change in eGFR. This find-
ing suggests that there may be an association between renal
function and retinal neuropathy. Srivastav et al83 found an
association between increased serum urea and creatinine
levels and decreased RNFL thickness in patients with diabe-
tes, while Shim et al84 recently demonstrated that low eGFR
levels are independently associated with POAG. However,
there is a paucity of data regarding this potential association
in the absence of diabetes. One study, by Demir et al,45
evaluated the RNFL thickness in patients with chronic renal
failure without diabetes, concluding that it was significantly
thinner than normal. Our data are consistent with this
notion, but further investigation is required to elucidate the
underlying association. It is accepted that the kidneys and
retina share common developmental pathways and struc-
tural similarities, such as the vascular configuration and
type IV collagen basement-membrane composition.85 There-
fore, if renal function correlates with retinal neuronal
anatomy in a healthy population, it may become a factor to
consider in the interpretation of GCC thickness as a diagnos-
tic parameter.
This is the first study, to our knowledge, that explores the
heritability of GCC thickness. We found GCC thickness to be
highly heritable, with additive genetic effects accounting for
81% of variance, while unique environmental effects ex-
plained the remaining 19% of variance. This finding is com-
parablewith theheritability estimates for central retinal thick-
ness (90%)andRNFL thickness (between48%and82%).86-88
It would be interesting to explore whether any of the known
genetic risk factors forPOAGand itsotherendophenotypesalso
influenceGCC thickness.Alleles inSIX1-SIX6 (GenBank:6495
and4990, respectively)havebeenassociatedwithPOAG inge-
nome-wide association studies, andwith a decrease in global
and sectoral RNFL thickness in individuals of European and
Asian descent.89-91
Limitations
This studycontains some limitations.First, theTwinsUKstudy
cohort is predominantly females of European ancestry, limit-
ingourability todrawconclusionsas to theeffectof sexor race/
ethnicity on GCC thickness. As this is a cross-sectional study,
we cannot draw any conclusions on causation and, as an ob-
servational study, we are potentially susceptible to residual
confounding and missing data. As we relied on self-reported
ocular and systemic disease, as well as drug history, we may
be liable to misspecification of variables. Our novel findings
require replication.
Conclusions
Ganglion cell complex thickness is a highly heritable trait.We
identified anassociationbetweenSD-OCT–derivedGCC thick-
ness measurements and age, refractive error, BMI, and eGFR
in a healthy, aging, predominantly female cohort of Euro-
pean descent. The associations between SphE, BMI, and age
are strong and therefore adjustment is likely to be relevant if
GCC thicknesswere to be used as a clinical parameter. Future
studies of GCC and its association with glaucoma or neuro-
logic disease should take these associations into account.We
didnot findGCCthickness tobe independentlyassociatedwith
sex, diabetes, blood pressure, or IOP. Further studies are re-
quired toestablish theprecise associationbetween renal func-
tion and inner retinal structures and to investigate the ge-
netic factors underlying GCC thickness.
Genetic and Environmental Factors AssociatedWith the Ganglion Cell Complex Original Investigation Research
jamaophthalmology.com (Reprinted) JAMAOphthalmology January 2017 Volume 135, Number 1 35




Copyright 2017 American Medical Association. All rights reserved.
ARTICLE INFORMATION
Accepted for Publication: September 28, 2016.
Published Online:November 17, 2016.
doi:10.1001/jamaophthalmol.2016.4486
Author Contributions:Dr Bloch andMs Yonova-
Doing had full access to all the data in the study and
take full responsibility for the integrity of the data
and the accuracy of the data analysis. Dr Bloch and
Ms Yonova-Doing contributed equally to this work.
Study concept and design: Bloch, Yonova-Doing,
Williams, Hammond.
Acquisition, analysis, or interpretation of data: All
authors.
Drafting of the manuscript: Bloch, Yonova-Doing,
Hammond.
Critical revision of the manuscript for important
intellectual content: All authors.
Statistical analysis: Bloch, Yonova-Doing,
Jones-Odeh, Williams, Hammond.
Obtained funding:Hammond.
Administrative, technical, or material support:
Bloch, Williams, Kozareva.
Study supervision:Hammond.
Conflict of Interest Disclosures: All authors have
completed and submitted the ICMJE Form for
Disclosure of Potential Conflicts of Interest and
none were reported.
Funding/Support: This study received funding
from the International Glaucoma Association. The
Wellcome Trust and the European Community’s
Seventh Framework Programme (FP7/2007-2013)
supported the TwinsUK study. The study also
received support from the National Institute for
Health Research–funded BioResource, Clinical
Research Facility, and Biomedical Research Centre
based at Guy’s and St. Thomas’ National Health
Service Foundation Trust in partnership with King’s
College London. Ms Yonova-Doing received funding
from the Biotechnology and Biological Sciences
Research Council and the London Interdisciplinary
Doctoral Program. MsWilliams received funding
from theMedical Research Council Clinical Research
Training Fellowship.
Role of the Funder/Sponsor: The funding sources
had no role in the design and conduct of the study;
collection, management, analysis and
interpretation of the data; preparation, review or
approval of themanuscript; and decision to submit
themanuscript for publication.
Additional Contributions:We thank all the twin
volunteers for their participation.
REFERENCES
1. Varma R, Lee PP, Goldberg I, Kotak S. An
assessment of the health and economic burdens of
glaucoma. Am J Ophthalmol. 2011;152(4):515-522.
2. Quigley HA, Broman AT. The number of people
with glaucomaworldwide in 2010 and 2020. Br J
Ophthalmol. 2006;90(3):262-267.
3. Quigley HA. Neuronal death in glaucoma. Prog
Retin Eye Res. 1999;18(1):39-57.
4. McKinnon SJ. Glaucoma, apoptosis, and
neuroprotection. Curr Opin Ophthalmol. 1997;8(2):
28-37.
5. Weinreb RN, Aung T, Medeiros FA. The
pathophysiology and treatment of glaucoma:
a review. JAMA. 2014;311(18):1901-1911.
6. Harwerth RS, Carter-Dawson L, Shen F, Smith EL
III, CrawfordML. Ganglion cell losses underlying
visual field defects from experimental glaucoma.
Invest Ophthalmol Vis Sci. 1999;40(10):2242-2250.
7. Cordeiro MF, Guo L, Luong V, et al. Real-time
imaging of single nerve cell apoptosis in retinal
neurodegeneration. Proc Natl Acad Sci U S A. 2004;
101(36):13352-13356.
8. Balendra SI, Normando EM, Bloom PA, Cordeiro
MF. Advances in retinal ganglion cell imaging. Eye
(Lond). 2015;29(10):1260-1269.
9. Tatham AJ, Weinreb RN, Zangwill LM, Liebmann
JM, Girkin CA, Medeiros FA. The relationship
between cup-to-disc ratio and estimated number of
retinal ganglion cells. Invest Ophthalmol Vis Sci.
2013;54(5):3205-3214.
10. WangM, Hood DC, Cho JS, et al. Measurement
of local retinal ganglion cell layer thickness in
patients with glaucoma using frequency-domain
optical coherence tomography [published
correction appears in Arch Ophthalmol.
2010;128(9):1150]. Arch Ophthalmol. 2009;127(7):
875-881.
11. Ishikawa H, Stein DM,Wollstein G, Beaton S,
Fujimoto JG, Schuman JS. Macular segmentation
with optical coherence tomography. Invest
Ophthalmol Vis Sci. 2005;46(6):2012-2017.
12. Chen TC, Cense B, Pierce MC, et al. Spectral
domain optical coherence tomography: ultra-high
speed, ultra-high resolution ophthalmic imaging.
Arch Ophthalmol. 2005;123(12):1715-1720.
13. Curcio CA, Allen KA. Topography of ganglion
cells in human retina. J Comp Neurol. 1990;300(1):
5-25.
14. Hood DC, Raza AS, deMoraes CG, Liebmann
JM, Ritch R. Glaucomatous damage of themacula.
Prog Retin Eye Res. 2013;32:1-21.
15. Yang Z, Tatham AJ, Weinreb RN, Medeiros FA,
Liu T, Zangwill LM. Diagnostic ability of macular
ganglion cell inner plexiform layer measurements in
glaucoma using swept source and spectral domain
optical coherence tomography. PLoS One. 2015;10
(5):e0125957.
16. Tan O, Chopra V, Lu AT, et al. Detection of
macular ganglion cell loss in glaucoma by
Fourier-domain optical coherence tomography.
Ophthalmology. 2009;116(12):2305-14.e1, 2.
17. Kim NR, Lee ES, Seong GJ, Kim JH, An HG, Kim
CY. Structure-function relationship and diagnostic
value of macular ganglion cell complex
measurement using Fourier-domain OCT in
glaucoma. Invest Ophthalmol Vis Sci. 2010;51(9):
4646-4651.
18. Schulze A, Lamparter J, Pfeiffer N, Berisha F,
Schmidtmann I, Hoffmann EM. Diagnostic ability of
retinal ganglion cell complex, retinal nerve fiber
layer, and optic nerve headmeasurements by
Fourier-domain optical coherence tomography.
Graefes Arch Clin Exp Ophthalmol. 2011;249(7):
1039-1045.
19. Garas A, Vargha P, Holló G. Diagnostic accuracy
of nerve fibre layer, macular thickness and optic
disc measurements made with the RTVue-100
optical coherence tomograph to detect glaucoma.
Eye (Lond). 2011;25(1):57-65.
20. Medeiros FA, Zangwill LM, Bowd C, Vessani
RM, Susanna R Jr, Weinreb RN. Evaluation of retinal
nerve fiber layer, optic nerve head, andmacular
thickness measurements for glaucoma detection
using optical coherence tomography. Am J
Ophthalmol. 2005;139(1):44-55.
21. Tan O, Li G, Lu AT, Varma R, Huang D; Advanced
Imaging for Glaucoma Study Group. Mapping of
macular substructures with optical coherence
tomography for glaucoma diagnosis.Ophthalmology.
2008;115(6):949-956.
22. Jeoung JW, Choi YJ, Park KH, Kim DM.Macular
ganglion cell imaging study: glaucoma diagnostic
accuracy of spectral-domain optical coherence
tomography. Invest Ophthalmol Vis Sci. 2013;54(7):
4422-4429.
23. Mwanza JC, Durbin MK, Budenz DL, et al.
Glaucoma diagnostic accuracy of ganglion cell-inner
plexiform layer thickness: comparison with nerve
fiber layer and optic nerve head.Ophthalmology.
2012;119(6):1151-1158.
24. Oddone F, Lucenteforte E, Michelessi M, et al.
Macular versus retinal nerve fiber layer parameters
for diagnosingmanifest glaucoma: a systematic
review of diagnostic accuracy studies.
Ophthalmology. 2016;123(5):939-949.
25. Loewen NA, Zhang X, Tan O, et al; Advanced
Imaging for Glaucoma Study Group. Combining
measurements from three anatomical areas for
glaucoma diagnosis using Fourier-domain optical
coherence tomography. Br J Ophthalmol. 2015;99
(9):1224-1229.
26. Nouri-Mahdavi K, Nowroozizadeh S, Nassiri N,
et al. Macular ganglion cell/inner plexiform layer
measurements by spectral domain optical
coherence tomography for detection of early
glaucoma and comparison to retinal nerve fiber
layer measurements. Am J Ophthalmol. 2013;156
(6):1297-1307.e2.
27. Meira-Freitas D, Lisboa R, Tatham A, et al.
Predicting progression in glaucoma suspects with
longitudinal estimates of retinal ganglion cell
counts. Invest Ophthalmol Vis Sci. 2013;54(6):
4174-4183.
28. Coleman AL, Miglior S. Risk factors for
glaucoma onset and progression. Surv Ophthalmol.
2008;53(suppl 1):S3-S10.
29. Osborne NN, Melena J, Chidlow G,Wood JP.
A hypothesis to explain ganglion cell death caused
by vascular insults at the optic nerve head: possible
implication for the treatment of glaucoma. Br J
Ophthalmol. 2001;85(10):1252-1259.
30. Moore D, Harris A, Wudunn D, Kheradiya N,
Siesky B. Dysfunctional regulation of ocular blood
flow: a risk factor for glaucoma? Clin Ophthalmol.
2008;2(4):849-861.
31. Hayreh SS. The role of age and cardiovascular
disease in glaucomatous optic neuropathy. Surv
Ophthalmol. 1999;43(suppl 1):S27-S42.
32. Lawrenson JG. Histopathology and
pathogenesis of glaucomatous optic neuropathy.
In: Edgar DF, Rudnicka AR, eds. Glaucoma
Identification and Co-management. Philadelphia, PA:
Elsevier Limited; 2007:27-35.
33. ZhouM,WangW, HuangW, Zhang X. Diabetes
mellitus as a risk factor for open-angle glaucoma:
a systematic review andmeta-analysis. PLoS One.
2014;9(8):e102972.
Research Original Investigation Genetic and Environmental Factors AssociatedWith the Ganglion Cell Complex
36 JAMAOphthalmology January 2017 Volume 135, Number 1 (Reprinted) jamaophthalmology.com




Copyright 2017 American Medical Association. All rights reserved.
34. Charlesworth J, Kramer PL, Dyer T, et al.
The path to open-angle glaucoma gene discovery:
endophenotypic status of intraocular pressure,
cup-to-disc ratio, and central corneal thickness.
Invest Ophthalmol Vis Sci. 2010;51(7):3509-3514.
35. Abu-Amero K, Kondkar AA, Chalam KV.
An updated review on the genetics of primary open
angle glaucoma. Int J Mol Sci. 2015;16(12):
28886-28911.
36. Moayyeri A, Hammond CJ, Valdes AM, Spector
TD. Cohort Profile: TwinsUK and healthy ageing
twin study. Int J Epidemiol. 2013;42(1):76-85.
37. World Medical Association. World Medical
Association Declaration of Helsinki: ethical
principles for medical research involving human
subjects. JAMA. 2013;310(20):2191-2194.
doi:10.1001/jama.2013.281053
38. Levey AS, Coresh J, Greene T, et al; Chronic
Kidney Disease Epidemiology Collaboration. Using
standardized serum creatinine values in the
modification of diet in renal disease study equation
for estimating glomerular filtration rate. Ann Intern
Med. 2006;145(4):247-254.
39. Mori S, Hangai M, Sakamoto A, Yoshimura N.
Spectral-domain optical coherence tomography
measurement of macular volume for diagnosing
glaucoma. J Glaucoma. 2010;19(8):528-534.
40. Bertuzzi F, Benatti E, Esempio G, Rulli E,
Miglior S. Evaluation of retinal nerve fiber layer
thickness measurements for glaucoma detection:
GDx ECC versus spectral-domain OCT. J Glaucoma.
2014;23(4):232-239.
41. Takagi ST, Kita Y, Takeyama A, Tomita G.
Macular retinal ganglion cell complex thickness and
its relationship to the optic nerve head topography
in glaucomatous eyes with hemifield defects.
J Ophthalmol. 2011;2011:914250.
42. Gangwani RA, Lee JW, Mo HY, et al. The
correlation of retinal nerve fiber layer thickness
with blood pressure in a Chinese hypertensive
population.Medicine (Baltimore). 2015;94(23):e947.
43. Akay F, Gündoğan FC, Yolcu U, Toyran S, Tunç
E, Uzun S. Retinal structural changes in systemic
arterial hypertension: anOCT study. Eur JOphthalmol.
2016;26(5):436-441.
44. Sahin OZ, Sahin SB, Ayaz T, et al. The impact of
hypertension on retinal nerve fiber layer thickness
and its association with carotid intimamedia
thickness. Blood Press. 2015;24(3):178-184.
45. Demir MN, Eksioglu U, Altay M, et al. Retinal
nerve fiber layer thickness in chronic renal failure
without diabetes mellitus. Eur J Ophthalmol. 2009;
19(6):1034-1038.
46. Brzezinski WA. Blood pressure. In: Walker HK,
Hall WD, Hurst JW, eds. Clinical Methods: The
History, Physical and Laboratory Examination. 3rd ed.
Boston, MA: Butterworths; 1990:95-97.
47. Zhao L, Wang Y, Chen CX, Xu L, Jonas JB.
Retinal nerve fibre layer thickness measured by
Spectralis spectral-domain optical coherence
tomography: the Beijing Eye Study. Acta Ophthalmol.
2014;92(1):e35-e41.
48. Patel NB, LimM, Gajjar A, Evans KB, Harwerth
RS. Age-associated changes in the retinal nerve
fiber layer and optic nerve head. Invest Ophthalmol
Vis Sci. 2014;55(8):5134-5143.
49. Girkin CA, McGwin G Jr, Sinai MJ, et al.
Variation in optic nerve andmacular structure with
age and race with spectral-domain optical
coherence tomography.Ophthalmology. 2011;118
(12):2403-2408.
50. Budenz DL, Anderson DR, Varma R, et al.
Determinants of normal retinal nerve fiber layer
thicknessmeasured by Stratus OCT.Ophthalmology.
2007;114(6):1046-1052.
51. Leung CK, YuM,Weinreb RN, et al. Retinal
nerve fiber layer imaging with spectral-domain
optical coherence tomography: a prospective
analysis of age-related loss.Ophthalmology. 2012;
119(4):731-737.
52. Leung CK, Ye C, Weinreb RN, YuM, Lai G, Lam
DS. Impact of age-related change of retinal nerve
fiber layer andmacular thicknesses on evaluation of
glaucoma progression.Ophthalmology. 2013;120
(12):2485-2492.
53. Ueda K, Kanamori A, Akashi A, TomiokaM,
Kawaka Y, Nakamura M. Effects of axial length and
age on circumpapillary retinal nerve fiber layer and
inner macular parameters measured by 3 types of
SD-OCT instruments. J Glaucoma. 2016;25(4):
383-389.
54. Zhang X, Francis BA, Dastiridou A, et al;
Advanced Imaging for Glaucoma Study Group.
Longitudinal and cross-sectional analyses of age
effects on retinal nerve fiber layer and ganglion cell
complex thickness by Fourier-Domain OCT. Transl
Vis Sci Technol. 2016;5(2):1.
55. Khawaja AP, ChanMP, Garway-Heath DF, et al.
Associations with retinal nerve fiber layer measures
in the EPIC-Norfolk Eye Study. Invest Ophthalmol
Vis Sci. 2013;54(7):5028-5034.
56. Patel PJ, Foster PJ, Grossi CM, et al; UK Biobank
Eyes and Vision Consortium. Spectral-domain
optical coherence tomography imaging in 67 321
adults: associations with macular thickness in the
UK Biobank study.Ophthalmology. 2016;123(4):
829-840.
57. Knight OJ, Girkin CA, Budenz DL, Durbin MK,
FeuerWJ; Cirrus OCT Normative Database Study
Group. Effect of race, age, and axial length on optic
nerve head parameters and retinal nerve fiber layer
thickness measured by Cirrus HD-OCT. Arch
Ophthalmol. 2012;130(3):312-318.
58. Dogan B, Kazim Erol M, Dogan U, et al. The
retinal nerve fiber layer, choroidal thickness, and
central macular thickness in morbid obesity: an
evaluation using spectral-domain optical coherence
tomography. Eur Rev Med Pharmacol Sci. 2016;20
(5):886-891.
59. Zhu BD, Li SM, Li H, et al; Anyang Childhood
Eye Study Group. Retinal nerve fiber layer thickness
in a population of 12-year-old children in central
China measured by iVue-100 spectral-domain
optical coherence tomography: the Anyang
Childhood Eye Study. Invest Ophthalmol Vis Sci.
2013;54(13):8104-8111.
60. Wang J, Gao X, HuangW, et al. Swept-source
optical coherence tomography imaging of macular
retinal and choroidal structures in healthy eyes.
BMCOphthalmol. 2015;15(15):122.
61. Mwanza JC, Durbin MK, Budenz DL, et al; Cirrus
OCT Normative Database Study Group. Profile and
predictors of normal ganglion cell–inner plexiform
layer thickness measured with frequency-domain
optical coherence tomography. Invest Ophthalmol
Vis Sci. 2011;52(11):7872-7879.
62. Wang YX, Pan Z, Zhao L, You QS, Xu L, Jonas
JB. Retinal nerve fiber layer thickness: the Beijing
Eye Study 2011. PLoS One. 2013;8(6):e66763.
63. Zhao JJ, ZhuangWJ, Yang XQ, Li SS, XiangW.
Peripapillary retinal nerve fiber layer thickness
distribution in Chinese with myopia measured by
3D-optical coherence tomography. Int J Ophthalmol.
2013;6(5):626-631.
64. Alasil T, Wang K, Keane PA, et al. Analysis of
normal retinal nerve fiber layer thickness by age,
sex, and race using spectral domain optical
coherence tomography. J Glaucoma. 2013;22(7):
532-541.
65. Kang SH, Hong SW, Im SK, Lee SH, AhnMD.
Effect of myopia on the thickness of the retinal
nerve fiber layer measured by Cirrus HD optical
coherence tomography. Invest Ophthalmol Vis Sci.
2010;51(8):4075-4083.
66. Weinreb RN. Evaluating the retinal nerve fiber
layer in glaucomawith scanning laser polarimetry.
Arch Ophthalmol. 1999;117(10):1403-1406.
67. Savini G, Barboni P, Parisi V, Carbonelli M. The
influence of axial length on retinal nerve fibre layer
thickness and optic-disc size measurements by
spectral-domain OCT. Br J Ophthalmol. 2012;96(1):
57-61.
68. Garas A, TóthM, Vargha P, Holló G. Comparison
of repeatability of retinal nerve fiber layer thickness
measurement made using the RTVue
Fourier-domain optical coherence tomograph and
the GDx scanning laser polarimeter with variable or
enhanced corneal compensation. J Glaucoma.
2010;19(6):412-417.
69. Michelessi M, Lucenteforte E, Oddone F, et al.
Optic nerve head and fibre layer imaging for
diagnosing glaucoma. Cochrane Database Syst Rev.
2015;11(11):CD008803.
70. Choi YJ, Jeoung JW, Park KH, Kim DM.
Glaucoma detection ability of ganglion cell–inner
plexiform layer thickness by spectral-domain
optical coherence tomography in highmyopia.
Invest Ophthalmol Vis Sci. 2013;54(3):2296-2304.
71. Shoji T, Sato H, Ishida M, Takeuchi M, Chihara E.
Assessment of glaucomatous changes in subjects
with highmyopia using spectral domain optical
coherence tomography. Invest Ophthalmol Vis Sci.
2011;52(2):1098-1102.
72. Kim NR, Lee ES, Seong GJ, et al. Comparing the
ganglion cell complex and retinal nerve fibre layer
measurements by Fourier domain OCT to detect
glaucoma in highmyopia. Br J Ophthalmol. 2011;95
(8):1115-1121.
73. Jonas JB. Role of cerebrospinal fluid pressure in
the pathogenesis of glaucoma. Acta Ophthalmol.
2011;89(6):505-514.
74. Siaudvytyte L, Januleviciene I, Daveckaite A,
et al. Literature review andmeta-analysis of
translaminar pressure difference in open-angle
glaucoma. Eye (Lond). 2015;29(10):1242-1250.
75. Skarf B. Retinal nerve fibre layer loss in
diabetes mellitus without retinopathy. Br J
Ophthalmol. 2002;86(7):709.
76. van Dijk HW, Verbraak FD, Kok PH, et al.
Decreased retinal ganglion cell layer thickness in
patients with type 1 diabetes. Invest Ophthalmol Vis
Sci. 2010;51(7):3660-3665.
77. van Dijk HW, Verbraak FD, Stehouwer M, et al.
Association of visual function and ganglion cell layer
Genetic and Environmental Factors AssociatedWith the Ganglion Cell Complex Original Investigation Research
jamaophthalmology.com (Reprinted) JAMAOphthalmology January 2017 Volume 135, Number 1 37




Copyright 2017 American Medical Association. All rights reserved.
thickness in patients with diabetes mellitus type 1
and no or minimal diabetic retinopathy. Vision Res.
2011;51(2):224-228.
78. Demir M, Oba E, Sensoz H, Ozdal E. Retinal
nerve fiber layer and ganglion cell complex
thickness in patients with type 2 diabetes mellitus.
Indian J Ophthalmol. 2014;62(6):719-720.
79. Chhablani J, Sharma A, Goud A, et al.
Neurodegeneration in type 2 diabetes: evidence
from spectral-domain optical coherence
tomography. Invest Ophthalmol Vis Sci. 2015;56(11):
6333-6338.
80. Salvi L, Plateroti P, Balducci S, et al.
Abnormalities of retinal ganglion cell complex at
optical coherence tomography in patients with type
2 diabetes: a sign of diabetic polyneuropathy, not
retinopathy. J Diabetes Complications. 2016;30(3):
469-476.
81. Barber AJ. A new view of diabetic retinopathy:
a neurodegenerative disease of the eye. Prog
Neuropsychopharmacol Biol Psychiatry. 2003;27
(2):283-290.
82. Kern TS, Barber AJ. Retinal ganglion cells in
diabetes. J Physiol. 2008;586(18):4401-4408.
83. Srivastav K, Saxena S, Mahdi AA, Kruzliak P,
Khanna VK. Increased serum urea and creatinine
levels correlate with decreased retinal nerve fibre
layer thickness in diabetic retinopathy. Biomarkers.
2015;20(6-7):470-473.
84. Shim SH, Sung KC, Kim JM, et al; Epidemiologic
Survey Committee of the Korean Ophthalmological
Society. Association between renal function and
open-angle glaucoma: the Korea National Health
and Nutrition Examination Survey 2010-2011.
Ophthalmology. 2016;123(9):1981-1988.
85. Savige J, Ratnaike S, Colville D. Retinal
abnormalities characteristic of inherited renal
disease. J Am Soc Nephrol. 2011;22(8):1403-1415.
86. Chamberlain MD, Guymer RH, Dirani M,
Hopper JL, Baird PN. Heritability of macular
thickness determined by optical coherence
tomography. Invest Ophthalmol Vis Sci. 2006;47(1):
336-340.
87. van Koolwijk LM, Despriet DD, van Duijn CM,
et al. Genetic contributions to glaucoma: heritability
of intraocular pressure, retinal nerve fiber layer
thickness, and optic disc morphology. Invest
Ophthalmol Vis Sci. 2007;48(8):3669-3676.
88. Hougaard JL, Kessel L, Sander B, Kyvik KO,
Sørensen TI, LarsenM. Evaluation of heredity as a
determinant of retinal nerve fiber layer thickness as
measured by optical coherence tomography. Invest
Ophthalmol Vis Sci. 2003;44(7):3011-3016.
89. Kuo JZ, Zangwill LM, Medeiros FA, et al.
Quantitative trait locus analysis of SIX1-SIX6 with
retinal nerve fiber layer thickness in individuals of
European descent. Am J Ophthalmol. 2015;160(1):
123-30.e1.
90. Carnes MU, Liu YP, Allingham RR, et al;
NEIGHBORHOOD Consortium Investigators.
Discovery and functional annotation of SIX6
variants in primary open-angle glaucoma.PLoSGenet.
2014;10(5):e1004372.
91. Cheng CY, Allingham RR, Aung T, et al.
Association of common SIX6 polymorphisms with
peripapillary retinal nerve fiber layer thickness: the
Singapore Chinese Eye Study. Invest Ophthalmol Vis
Sci. 2014;56(1):478-483.
Research Original Investigation Genetic and Environmental Factors AssociatedWith the Ganglion Cell Complex
38 JAMAOphthalmology January 2017 Volume 135, Number 1 (Reprinted) jamaophthalmology.com




1Scientific RepoRts | 6:34116 | DOI: 10.1038/srep34116
.re./sereprs
The correlation between cognitive 
performance and retinal nerve fibre 
layer thickness is largely explained 
by genetic factors
Eneh Jones-Odeh1,*, Ekaterina Yonova-Doing1,*, Edward Bloch1, Katie M. Williams2, 
Claire J. Steves1 & Christopher J. Hammond1,2
Retinal nerve fibre layer (RNFL) thickness has been associated with cognitive function but it is unclear 
whether RNFL thinning is secondary to cortical loss, or if the same disease process affects both. We 
explored whether there is phenotypic sharing between RNFL thickness and cognitive traits, and 
whether such sharing is due to genetic factors. Detailed eye and cognitive examination were performed 
on 1602 twins (mean age: 56.4 years; range: 18–89) from the TwinsUK cohort. Associations between 
RNFL thickness and ophthalmic, cognitive and other predictors were assessed using linear regression 
or analysis of variance models. Heritability analyses were performed using uni- and bivariate Cholesky 
decomposition models. RNFL was thinner with increase in myopia and with decrease in disc area 
(p < 0.001). A thicker RNFL was associated with better performance on mini mental state examination 
(MMSE, F(5,883) = 5.8, p < 0.001), and with faster reaction time (RT, β = −0.01; p = 0.01); independent 
of the effects of age, refractive error and disc area (p < 0.05). RNFL thickness was highly heritable (82%) 
but there was low phenotypic sharing between RNFL thickness and MMSE (5%, 95% CI: 0–10%) or RT 
(7%, 95% CI: 1–12%). This sharing, however, was mostly due to additive genetic effects (67% and 92% of 
the shared variance respectively).
Cognitive function has been defined as the ability to appropriately identify and manage complex external or inter-
nal stimuli, and encompasses many mental abilities and processes, including decision making, memory, attention, 
and problem solving1. The retinal nerve fibre layer (RNFL) has been shown to be thinner in people with memory 
loss and cognitive decline in certain neurodegenerative conditions such as Alzheimer’s disease (AD) and multiple 
sclerosis (MS)2. The retina forms as a functional extension of the central nervous system (CNS), developing as a 
result of diencephalic evagination of pluripotent cells during embryogenesis3 and shares similar morphological 
properties with other neurons in the CNS4. These properties allow the opportunities for studying the retina as a 
model of the CNS, and provide window for accessible and direct observation of the CNS using ocular imaging 
techniques such as optical coherence tomography (OCT).
OCT is now the most commonly used optical imaging technique for structural assessment of the retina, allow-
ing for accessible, inexpensive and non-invasive in vivo quantitative measurement of the optic nerve head (ONH) 
and RNFL. With similar principles to that of ultrasound, OCT uses low-coherence interferometry to measure 
optical backscattering of light from the retina and a reference mirror and calculates RNFL thickness (RNFLT) 
from generated two-dimensional data sets.
At a population level, a thinner RNFLT has been associated with lower cognitive performance5–7 in 
cross-sectional analysis, although the Erasmus Rucphen Family (ERF) Study only found this association in 
younger individuals6 and the association was reversed in the older Lothian Birth Cohort Study when corrected 
for IQ at age 115. It is also well-described in populations with mild cognitive impairment2. However it is unclear 
whether RNFL thinning is secondary to cortical loss (retrograde damage), or if the same disease process affects 
both brain and retina.
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A twin and a family study have demonstrated heritability of the RNFLT8,9, but to date, to our knowledge, no 
studies have explored whether this phenotypic sharing is due to shared genetic or environmental factors.
The aim of this large twin study was to examine whether the RNFLT measured by OCT was associated with 
cognitive function and whether this association was driven by shared genetic factors. A further objective of this 
study was to explore associations between RNFLT and age, sex, spherical equivalent (SphE), and other factors 
known to influence glaucoma such as intraocular pressure (IOP) and optic disc size.
Results
Association analysis. We initially explored associations between RNFL thickness and various ophthalmo-
logical and cognitive measures (Table 1). 1602 twins of 908 families (mean age 56.4 years; range 18–89) from the 
TwinsUK cohort were included (Fig. 1). There was no difference between monozygotic (MZ) and dizygotic (DZ) 
twins except for the following variables (p < 0.05): age, reaction time (RT), MMSE score and recall (RC) (Table 1). 
The MZ twins were on average slightly younger than DZ twins (55 versus 59 years of age) and had better reaction 
times, MMSE score and recall. When adjusted for age, however, the three cognitive parameters did not differ 
between MZ and DZ twins. The inferior quadrant had the highest RNFL thickness followed by superior, nasal and 
All subjects (N = 1602) MZ twins (N = 947) DZ twins (N = 655)
Mean (SD) Range Mean (SD) Range Mean (SD) Range
Age(years)* 56.4 (15.2) 18.2–89.8 54.5 (16.0) 18.2–88.8 59.1 (13.4) 19.1–89.8
Average RNFL (µ m) 96.8 (9.2) 66.6–123.2 97.1 (9.1) 70.1–123.2 96.3 (9.3) 66.6–120.3
Superior (µ m) 118.2 (13.4) 74.7–158.9 118.3 (13.4) 74.4–155.5 118.1 (13.5) 74.7–158.9
Nasal (µ m) 75.1 (10.8) 40.0–112.5 75.3 (10.9) 40.0–112.5 74.7 (10.7) 46.0–110.9
Inferior (µ m) 121.4 (13.7) 73.3–167.5 122.0 (13.6) 76.4–167.5 120.5 (13.8) 73.3–159.7
Temporal (µ m) 72.4 (8.7) 43.6–102.3 72.8 (8.9) 43.6–102.3 71.8 (8.4) 48.5–101.1
SphE (D) − 0.1 (0.1) − 11.3–9.3 − 0.2 (2.4) − 11.3–7.5 0.1 (2.3) − 9.3–9.3
IOP (mmHg) 13.4 (2.7) 6.7–23.8 13.4 (2.7) 7.0–23.8 13.5 (2.7) 6.6–22.5
Corneal Thickness (µ m) 538 (38.3) 221.2–752.3 537.7 (38.3) 221.3–752.3 538.4 (38.4) 343.0–745.6
Reaction time (ms)* 586.7 (87.9) 341.1–928.3 566.7 (101.7) 341.1–967.9 583.7 (95.5) 368.7–1049.5
% % %
Gender
 Female/Male 88.6/11.4 87.9/12.1 90.9/9.1
Education*
 Primary 19.1 16.4 22.4
 Secondary 53.4 51.5 55.7
 Higher 27.5 32.0 21.9
IMD
 Q1 6.9 7.4 6.2
 Q2 12.0 11.8 12.2
 Q3 18.6 19.1 18.1
 Q4 26.9 27.5 26.3
 Q5 35.7 34.3 37.3
MMSE score*
 ≤ 25 1.3 0.8 2.1
 26 2.1 2.3 1.9
 27 5.0 4.0 6.5
 28 12.5 11.7 13.5
 29 29.8 27.9 32.6
 30 49.2 53.2 43.3
Recall*
 ≤ 1 5.4 4.1 3.0
 2 21.9 20.3 10.0
 3 72.6 75.6 68.4
Verbal fluency 
 < 11 16.4 16.6 16.0
 ≥ 11 83.6 83.4 84.0
Table 1.  Characteristics of the study population. Legend: This table shows summary data for the different 
variables studied for the whole sample population and by zygosity status. The *denotes variables which were 
significantly different (p < 0.05) between monozygotic (MZ) and dizygotic (DZ) twins. RNFL –retinal nerve 
fibre layer; µ m – micrometers; SphE – spherical equivalent; IOP – Intraocular pressure. ms – milliseconds,  
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temporal quadrants. The differences in thickness between quadrants were statistically significant (p < 1 × 10−4). 
All of the RNFL parameters were approximately normally distributed.
Table 2 summarises the univariable (A) and multivariable (B) results from association analysis for the quan-
titative predictors. Increase in age was associated with decrease in RNFL thickness for the average of the four 
quadrants and in each quadrant individually (p < 0.001). Education was nominally associated with average RNFL 
thickness and with the inferior and temporal quadrants in the univariable analysis only (p < 0.05). Increase in 
SphE (more hyperopic refraction) and in disc area (larger optic discs) were strongly associated (p < 0.001) with 
increase in RNFL thickness for the average of the four quadrants and in each quadrant, except for SpheE in the 
temporal quadrant (p = 0.41). Disc area remained strongly associated (p < 0.001) in the multivariable analysis 
with the average of the four quadrants and in all the quadrants separately, while age and SphE were associated 
with RNFLT for all but the temporal quadrant (Table 2). There was no association between sex, index of multiple 
deprivation (IMD) or IOP corrected for central corneal thickness (CCT) and RNFLT (Table 2).
None of the cognitive parameters were associated with SphE, education or IMD, independently of age 
(p < 0.05). A faster reaction time was associated with a thinner RNFL thickness (p < 0.001) and this stayed sig-
nificant in the multivariable model for average RNFL (p = 0.01), and for the inferior and temporal quadrants 
(p = 0.01 and p = 0.04 respectively). As cataract surgery has been reported to improve reaction times10, we com-
pared the reaction time in the 63 pseudophakic participants to that of 126 age-matched individuals without 
cataract surgery (case:control ratio of 1:2). There was no difference between the two groups (mean of 630 ms and 
632 ms respectively, p = 0.8). Cataract surgery status was associated with RNFL thickness in univariable analysis 
(β = − 3.29, p = 0.02), but not in the multivariable analysis (likely to due to the association between cataract sur-
gery and age).
There were significant differences in RNFL thickness between MMSE groups (ptrend < 0.003). The one-way 
ANOVA results for MMSE were as follows: average RNFL – F(5, 883) = 5.8, p < 0.001; Superior quadrant – F(5, 
883) = 4.0, p = 0.001; Inferior quadrant – F(5, 883) = 5.9, p < 0.001; Temporal quadrant – F(5, 883) = 2.5, p = 0.02; 
Nasal quadrant – F(5,883) = 2.8, p = 0.02. These differences were still significant after taking age, SphE and disc 
area into account, as determined by MANOVA for all but the temporal quadrant: average RNFL – F(5,615) = 4.2, 
p = 0.001; Superior quadrant – F(5,615) = 3.1, p = 0.01; Inferior quadrant – F(5,615) = 3.8, p = 0.002; Nasal 
quadrant – F(5,474) = 2.6, p = 0.02. Recall was associated with RNFL thickness only in the inferior quad- 
rant –F(5,886) = 5.2, p = 0.01, however this effect was not independent from the effects of age, SphE and disc area 
F(2,618) = 2.9, p = 0.06. No statistically significant association was detected between RNFL thickness and verbal 
fluency (VF) (data not shown).
Heritability analysis. The results of the univariate heritability models are reported in Table 3. In all cases 
the best fitting model was the AE (addictive genetic effects/unique environment) model. As can be seen from the 
table, RNFL thickness is highly heritable with additive genetic effects accounting for 65% (Nasal quadrant) to 83% 
(the average of the four quadrants) of variance. As pointed above, due to the fact that the MZ twins were younger 
than the DZ twins, there were differences between the two groups in terms of MMSE, RC and RT. For this reason 
we adjusted those predictors for the effect of age prior to the heritability analysis. The measurements of cognitive 
function were moderately heritable (MMSE = 32%, RT = 44% and VF = 48%), with the exception of recall which 
showed low heritability (19%).
Figure 1. Consort diagram of the study. Legend: This figure presents a consort diagram of the study showing 
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When taking into account the effect of age, RNFL thickness shared 5% (95% CI: 0− 10%) of phenotypic vari-
ance with MMSE and 7% with RT (95% CI: 1–12%) (Fig. 2). Additive genetic effects accounted for 67% (95% CI: 
61–81%) and 87% (95% CI: 82–99%) of the shared variance for MMSE and RT respectively and rest was explained 
by environmental factors. Adjusting for SphE and disc area did not substantially change the results: phenotypic 
sharing between MMSE and RNFL was 8% (95% CI: 2–15%) and of those 93% (72–96%) was due to additive 
genetic factors; phenotypic sharing between RT and RNFL was 11% (95% CI: 4–7%) and of those 82% (75–94%) 
was due to additive genetic factors.
Discussion
This study, based on an unselected twin population, has confirmed an association between thinner RNFL and 
lower cognitive scores, and suggests this phenotypic sharing is largely due to shared genetic factors. This raises the 
possibility that the processes involved in cognitive decline and ultimately dementia are similar to those resulting 
in loss of RNFL, and the latter could therefore be a biomarker of dementia. However, the degree of phenotypic 
sharing (8% for MMSE score and 11% for reaction time, when adjusted for age, refractive error and optic disc 
size) is relatively small, and given other factors such as glaucoma influence RNFL thickness, it remains to be seen 
if this will have enough specificity and sensitivity to act as a biomarker of disease progression in dementia.
(A) Univariable
Average RNFL Superior quadrant Nasal quadrant Inferior quadrant Temporal quadrant
 beta se p beta se p beta se p beta se p beta se p
Age − 0.15 0.02 < 0.001 − 0.21 0.03 < 0.001 − 0.13 0.02 < 0.001 − 0.19 0.03 < 0.001 − 0.07 0.02 < 0.001
Sex 0.46 1.56 0.76 0.32 2.17 0.88 − 0.85 1.89 0.65 1.61 2.48 0.52 0.77 1.36 0.57
Education 0.97 0.46 0.04 1.06 0.68 0.12 0.43 0.54 0.43 1.33 0.65 0.043 1.05 0.42 0.01
IMD 0.19 0.24 0.42 − 0.05 0.35 0.90 0.25 0.28 0.37 0.24 0.34 0.47 0.32 0.22 0.14
SphE 1.14 0.13 < 0.001 1.49 0.19 < 0.001 1.43 0.15 < 0.001 1.54 0.21 < 0.001 0.12 0.15 0.41
IOP − 0.10 0.15 0.50 − 0.24 0.22 0.13 0.10 0.17 0.61 − 0.06 0.21 0.77 − 0.22 0.13 0.09
IOPc − 0.06 0.11 0.59 − 0.01 0.16 0.93 0.02 0.12 0.85 − 0.15 0.16 0.33 − 0.09 0.10 0.36
Disc area 8.53 0.79 < 0.001 10.16 1.17 < 0.001 8.32 1.00 < 0.001 11.93 1.54 < 0.001 3.68 0.82 < 0.001
Reaction time − 0.02 0.003 < 0.001 − 0.02 0.004 < 0.001 − 0.01 0.003 < 0.001 − 0.02 0.004 < 0.001 − 0.01 0.003 < 0.001
(B) Multivariable
Average RNFL Superior Nasal Inferior Temporal
beta se p beta se p beta se p beta se p beta se p
Age − 0.16 0.02 < 0.001 − 0.27 0.03 < 0.001 − 0.19 0.02 < 0.001 − 0.20 0.04 < 0.001 — — —
Education — — — — — — — — — — — — — — —
SphE 1.18 0.13 < 0.001 1.43 0.22 < 0.001 1.33 0.16 < 0.001 1.84 0.19 < 0.001 — — —
Disc area 6.03 1.01 < 0.001 6.43 1.19 < 0.001 5.39 0.98 < 0.001 7.70 1.20 < 0.001 3.59 0.85 < 0.001
Reaction time − 0.01 0.004 0.01 — — — — — — − 0.01 0.01 0.01 − 0.01 0.003 0.002
Table 2.  Univariable and Multivariable Linear Regression Analyses of RNFL thickness and ophthalmic, 
wcognitive and other predators. Legend: This table shows the results from the univariable (A) and 
multivariable (B) analysis. RNFL – retinal nerve fibre layer; IMD – Index of multiple deprivation; SphE 
– spherical equivalent; IOP – Intraocular pressure; IOPc – IOP corrected for corneal thickness by adding 
thickness as predictor in the regression; se – standard error, p – p value. Results for the variable with 
p-value > 0.05 in the stepwise regression are not reported.
 average RNFL Superior quadrant Nasal quadrant Inferior quadrant Temporal quadrant
 estimate 95% CI estimate 95% CI estimate 95% CI estimate 95% CI estimate 95% CI
A 0.83 0.66–0.85 0.74 0.58–0.77 0.65 0.60–0.69 0.75 0.72–0.79 0.74 0.63–0.78
C 0.00 0.0–0.0 0.00 0.0–0.0 0.00 0.0–0.0 0.00 0.0–0.0 0.00 0.0–0.0
E 0.17 0.15–0.20 0.26 0.23–0.31 0.35 0.31–0.40 0.25 0.21–0.29 0.26 0.22–0.30
 MMSE score* Recall* Reaction time* Verbal fluency
 estimate 95% CI estimate 95% CI estimate 95% CI estimate 95% CI
A 0.32 0.23–0.40 0.19 0.09–0.28 0.44 0.37–0.51 0.48 0.41–0.54
C 0.00 0.0–0.0 0.00 0.0–0.0 0.00 0.0–0.0 0.00 0.0–0.0
E 0.68 0.60–0.77 0.81 0.79–0.91 0.56 0.49–0.63 0.52 0.46–0.59
Table 3.  Univariate Heritability estimates of RNFL thickness and cognitive variables. Legend: This table 
presents the results from univariate heritability modelling for the different RNFL and cognition parameters. 
RNFL –retinal nerve fibre layer; A –additive genetic factors; C –common/shared environmental factors;  
E –unique environmental latent factors; MMSE – mini-mental state examination. *Scores were adjusted for age 
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Our findings are similar to another UK-based aging cohort from the Norfolk EPIC study by Khawaja et al.7, 
which showed significant, albeit weaker, associations with MMSE and also the Hopkins Verbal Learning Test 
(testing recognition, learning and memory) and the National Adult Reading Test (NART, testing premorbid 
intelligence). Similarly, the Dutch ERF study6 showed better cognitive function associated with thicker RNFL 
across various measures, with 2.8% of cognitive scores explained by RNFLT, although somewhat surprisingly 
the strongest effects seemed to be in the younger age groups (below 40 years). Some of these differences may be 
due to measurement techniques, and these studies used HRT (Heidelberg Retina Tomograph) and scanning laser 
polarimetry (the GDx VCC) rather than the current gold standard used in this study, of OCT. The Lothian study5 
using OCT in only 96 subjects aged 73 years, found that while cognitive decline seemed to be associated with 
thinner RNFL, when corrected for IQ at age 11, those with thicker RNFL had worse cognition, again somewhat 
counterintuitively. We do not have historic IQ data on the TwinsUK cohort, but did not observe any relationship 
between the educational and socio-economic status and either RNFL or the cognitive parameters in this study. 
The cognitive measures used in each study differed, which may also explain some of the differences; we selected 
MMSE, RT and VF because these tests are commonly used in clinical settings11–14.
Our results showed that the average RNFL was significantly thinner with increasing age, lower spherical 
equivalent (i.e. myopia) and with smaller optic disc size. Similar findings have been confirmed in other studies15,16 
and an inverse relationship between RNFLT and SphE identified in a small twin study of 50 pairs8. We found the 
phenotypic sharing between RNFL and cognition was greater when these factors were accounted for, suggesting 
future studies examining RNFLT variation should measure refractive error or axial length, which is was measured 
in the Khawaja et al. study7 but is not commonly done in non-ophthalmic studies, in addition to adjusting for age 
and disc size (which is measured by OCT).
Figure 2. Bivariate heritability model showing the amount of shared genetic variation for average RNFL 
thickness and MMSE (A) and Reaction time (B). Legend: This figure presents the bivariate heritability models 
for RNFL thickness and the associated cognitive parameters. All traits were adjusted for age prior to the 
analysis. RNFL – retinal nerve fibre layer; MMSE – mini-mental state examination; A – additive genetic factors; 
C – common/shared environmental factors; E – unique environmental latent factors; Ra – genetic correlation;  
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Our community-based study confirms the relationship between RNFL and cognitive decline in clinic-based 
studies which found a thinner RNFL in patients even with mild cognitive impairment17–20. In particular, the infe-
rior quadrant has been proposed to be more susceptible to neuronal loss2,14,21,22. Certainly in our data, and others5, 
the inferior quadrant showed the strongest relationships with cognitive tests, although as the quadrant with the 
thickest RNFL it is unsurprising that the effect size is largest in ANOVA analyses, but despite this, the inferior 
(along with the temporal) quadrant was the only quadrant which remained significantly associated with reaction 
time when age, spherical equivalent and disc size were included in the multivariable model. Histological studies 
have shown significant correlation between retinal layers determined by OCT and retinal histology23 demon-
strated reduced RNFL thickness in patients with AD when compared with normal controls24, however individual 
quadrants of the RNFL were not examined separately. It is unclear why the inferior RNFL might be preferentially 
affected but it may be due to the fact that nerve fibers with larger diameter atrophy more rapidly and those fibers 
are more abundant in inferior and superior quadrants25.
RNFL thickness was shown in this large twin study of 730 pairs to be highly heritable, while MMSE score 
and RT were moderately heritable with additive genetic effects accounting for 82%, 32% and 44% of variance 
respectively. These results are in line with previous twin studies8,26, and as expected, higher than found using other 
family-based study designs9. Many quantitative traits that can be measured accurately are highly heritable, such 
as refractive error and height, and both these traits appear to be influenced by hundreds of common genetic vari-
ants27–29. Genome-wide association studies (GWAS) of RNFL are in progress, and we await with interest whether 
genes or pathways identified in these analyses are common to dementia GWAS.
This study is not without its limitations. First, as the TwinsUK cohort consists mainly of white British 
middle-aged females (mean 56.2 years, SD 15.4) we were not able to look at gender or ethnicity differences. 
However, our baseline measurements of average RNFL thickness (96.2 ± 9.1 µ m) are similar to those obtained in 
healthy controls of other studies11,12,30 that have investigated the cognitive associations of RNFL thickness using 
OCT (91.5 ± 7.1 µ m), (98.6 ± 1.67 µ m), (94.3 ± 11.3 µ m) respectively, and quadrant thickness distribution (ISNT 
rule: inferior RNFL thickest, followed by superior, nasal and temporal) comparable to those obtained in similar 
studies5,14,31. We found no differences between genders for RNFL (and with 183 males the sample size in not 
insignificant). We therefore believe that these data are generalisable to the wider European population. Second, 
we do not have longitudinal cognitive or RNFL data on these subjects, so causality cannot be applied to any of the 
cross-sectional analyses, and these results may still be due to residual confounding by age, or refractive error, not 
fully corrected in linear models, or other confounders. Third, due to the low phenotypic sharing we observed, the 
bivariate heritability results were of borderline statistical significance, and larger studies might be needed for fur-
ther analyses, including examining the amount of variance explained by known genetic variants from dementia 
genome-wide association studies.
In conclusion, we have shown RNFL thickness to be associated with MMSE and reaction time cognitive per-
formance in a healthy adult population, and the phenotypic sharing was largely due to shared genetic factors. 
However, given the relatively low phenotypic sharing, RNFL thickness is probably a poor predictor of cognitive 
decline in an unselected population, although it remains to be determined in longitudinal studies, combining sev-
eral and different cognitive tests, how predictive RNFL thickness might be. Further genetic studies may provide 
insight into shared pathophysiology between loss of RNFL and cognitive impairment.
Methods
Subjects. The TwinsUK cohort is a volunteer twin registry of 11,000 British adults, recruited from the general 
population through national media campaigns in the United Kingdom, and representative to the broader popula-
tion in terms of disease-related and lifestyle characteristics32. All subjects were unaware of the hypotheses in this 
study at the time of enrolment. The studies in the TwinsUK cohort were performed with the approval of the Guys 
and ST Thomas’ Ethics Committee, and participants signed a written informed consent in accordance with the 
Declaration of Helsinki. All methods were performed in accordance with the relevant guidelines and regulations.
Between August 2014 and March 2016, 1756 twins from 974 families underwent detailed eye examination 
which included RNFL thickness measurements using spectral domain optical coherence tomography (Optovue 
iVue system, Fermont, California), non-cycloplegic autorefraction, non-contact IOP and central corneal thick-
ness (CCT) measurements (Visionix120, The Luneau Technology group) of both eyes. Of the 1756 individuals, 
154 were excluded, leaving 1602 twins of 908 families in the final analysis (Fig. 1). The reasons for exclusion 
were as follows: 37 individuals were of non-white British ethnicity; 44 individuals had self-reported diagnoses 
of glaucoma or were on treatment for ocular hypertension; 23 had poor quality OCT scans; and 50 individuals 
were outliers (fell outside the range of mean ± 3 SD) in terms of RNFL thickness (either average RNFL or in one 
of the 4 quadrants). For 25 out of the 50 outliers there was no obvious explanation why their measurements were 
so different to the mean and the scans for those individuals were deemed of good quality by an ophthalmologist. 
Of the remaining outliers, 12 individuals were described as having difficulty with target fixation, 6 presented with 
retinal pathology and 7 reported having cataracts in the eye/eyes with the aberrant RNFL measurement. From the 
1602 twins included in the study, 63 (3.9%) reported having had cataract surgery previously.
In addition, data on age, sex, education (primary, secondary and higher) and socio-economic status (Index of 
Multiple Deprivation - IMD) were also collected.
Cognitive assessment. As part of the visit, the twins also underwent cognitive assessment including the 
standardised mini-mental state examination (MMSE), verbal fluency (VF), and reaction time (RT). Recall (RC), 
a subtest included in the MMSE was extrapolated as an individual test and results obtained from this subtest were 
analysed separately. Cognitive data was available for 1593 individuals for the VF, MMSE and recall tests, and 1563 
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The MMSE is used widely in clinical settings as a standard screening tool for global measurement of cognitive 
function33. It contains 20 subtests with a maximum score of 30 and helps facilitate detection of cognitive impair-
ment or change in mental status34. We decided to analyse RC scores separately as it has been shown to provide a 
good measure of episodic memory, and some other components of the full MMSE may not adequately discrimi-
nate healthy individuals in a population with mild cognitive impairment35.
The verbal fluency tasks assesses the speed and ease at which individuals can access words from memory36, 
and performance has been associated with both temporal and frontal lobe activity37,38. VF was tested by examin-
ers instructing participants to name as many words beginning with a given letter of the alphabet, excluding names 
of people or places, and a further test required participants to name as many animals beginning with any letter. 
Participants were given 1 minute for each component of the VF test and were marked out of 7 for each task, where 
0 = 2 answers or less and 7 = 17 answers or more. The scores from the two tasks were summed and individuals 
were categorised into two groups (normal performance, low performance) with cut-off score of 11.
RT was measured using the ‘Deary-Liewald Reaction Time Tester’ on a Windows 7 computer and was meas-
ured in milliseconds39. The test comprises of two components, the simple reaction time test (pressing a key any-
time a target appears) and the choice reaction time test (pressing a key corresponding to 1 of 4 boxes where a 
target appears). Participants had 8 practice trials and 20 experimental trials for each component of the test. In the 
present study we analysed the mean of the two tests.
Statistical Analysis. Association analysis. Comparisons of means and proportions for all variables 
between Monozygotic (MZ) and Dizygotic (DZ) twins or between RNFL quadrants were performed using 
two-sample two-tailed t-tests or z-tests, assuming equal variance. Associations between RNFL (either average or 
per quadrant) and age, sex, SphE, IOP and reaction time was assessed using univariable linear regression analy-
ses, followed by multivariable linear regression model for factors showing significant (p < 0.05) association in the 
univariable model. Independent variables were identified using stepwise backwards procedure with threshold for 
removal set at 0.05. In all regression models family structure was taken into account.
Associations between RNFL thickness (either average or per quadrant) and MMSE, verbal fluency and recall 
were assessed using one-way ANOVA, followed by MANOVA that included age, SphE and disc area into the 
model. For these analyses only one twin per pair was selected at random. As there was strong correlation between 
the two eyes, we used the mean measurements of the two eyes for all eye phenotypes. All analyses were carried 
using STATA14 statistical package (www.stata.com).
Modelling of Heritability. Heritability analyses were performed on 730 twin pairs (438 monozygotic and 292 dizy-
gotic) as data was missing on 178 co-twins. Zygosity was determined by a standardised questionnaire and confirmed 
using genome-wide single nucleotide polymorphism genotyping data or DNA short tandem repeat fingerprinting.
Univariate and bivariate Cholesky decomposition heritability models of RNFL thickness and the associated 
cognitive phenotypes were calculated using maximum likelihood structural equation twin modelling imple-
mented in the OpenMx package (http://openmx.psyc.virginia.edu). The univariate method separates phenotypic 
variation in additive (A) genetic factors and common/shared (C) or unique environmental (E) latent factors, 
while bivariate model defines the amount of shared genetic variation that explains a given amount of shared 
phenotypic variance between two or more traits. In cases where the intraclass correlation coefficient for MZ twins 
was more than twice that of the DZ twins, ADE models were also computed (D stands for Dominant factors). The 
goodness of fit of the full and reduced ACE/ADE models were compared with the observed data and the best fit-
ting model was selected. Two different bivariate models were explored. In Model 1 RNFL thickness was adjusted 
for age prior to the analysis, while in Model 2 RNFL was also adjusted for SphE and disc area in addition to age. 
In both models the cognitive traits were adjusted for age only.
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Re: Sitko et al.: Pitfalls in the use of
stereoacuity in the diagnosis of
nonorganic visual loss
(Ophthalmology 2016;123:198-202)
TO THE EDITORS: The study by Sitko et al1 improves our
understanding of the use of the Titmus Stereotest in helping to
conﬁrm nonorganic visual loss. However, in cases with possible
medicolegal consequences, we believe that testing should be
performed with the 3 lines of animals rather than the circles because
the asymmetric circles provide monocular clues that can allow
subjects to make a selection indicating stereopsis without stereopsis
actually present, confounding the test.2 The 3 rows of animals cannot
discriminate higher levels of stereopsis, but testing for profound
feigned visual loss with them reduces the chance of ﬁnding “false-
positive” stereopsis, because they do not present any monocular clues.
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REPLY: We appreciate the recent critical reading of and
response to our paper1 by Chronopoulos and Schutz. They
correctly note in their letter that the Wirt circles portion of
the test provides the subject with monocular cues that can aid in
making the correct choice, regardless of stereoacuity. We agree
and mention in our paper that this is a limitation of the Titmus
test, but chose it for our study given its wide use and prominent
role in the diagnosis of nonorganic visual loss. However,
Chronopoulos and Schutz also suggest that the animal ﬁgures
section of the test does not suffer from the same limitations
related to monocular cues that the circles section does, but this is
not the case. The ﬁrst 2 animals (400 and 200 arcseconds) have
similar “double printing” monocular cues to those of the ﬁrst
through third circles and can be easily guessed monocularly.
Furthermore, the maximal stereoacuity that can be determined
from the animals is only 100 arcseconds. This level of
stereoacuity corresponds to the ﬁfth Wirt circle, which we found
to correspond with a 95% probability of visual acuity of about
20/80, about one-half the acuity prediction of someone who can
correctly identify 9/9 circles. We would encourage the use of
alternative tests without such monocular cues (e.g., random dot
stereotests) for the evaluation of nonorganic visual loss because
they will likely help to reduce variability in the prediction of
visual acuity. However, those tests should also be evaluated
rigorously in a fashion similar to our evaluation of the Titmus
test owing to other sources of variability.
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Re: Datiles et al.: Longitudinal study
of age-related cataract using dynamic
light scattering: loss of a-crystallin
leads to nuclear cataract development
(Ophthalmology 2016;123:248-54)
TO THE EDITORS: We read with great interest the recent article by
Datiles et al1 exploring whether a longitudinal dynamic light scatter
measurement of changes in unbound a-crystallin concentration
within the lens predicts cataract progression. This study is built on
a previous cross-sectional study for early detection of a-crystallin
changes in lens using the same method.2 We wondered whether
brunescence and nuclear opalescence were graded separately,
because they both are reﬂected within the term “nuclear cataract”
and whether dynamic light scatter measurements reﬂect one more
than the other, or are inﬂuenced by brunescence? Similarly, the
published paper does not comment on smoking status, which is a





wondered whether the authors had any insights into whether
smoking status differed in each tertile of the a-crystallin index,
and might increase unbound a-crystallin, thereby causing cataract?
Given that common genetic variants in the CRYAA gene were
recently associated with nuclear cataract formation in Asians,3 we
were wondering whether the authors have DNA or genetic data
available for the participants in the study, to explore associations
between depletion of a-crystallin and genetic variants in CRYAA
gene. We have measured nuclear cataract in 324 female twins
(TwinsUK cohort) at 2 time points (on average 9.7 years apart)
by calculating the pixel density in the center of the nucleus from
Scheimpﬂug images as previously described.4 We have
previously nominally replicated the association between CRYAA
variants and cross-sectional nuclear cataract (P ¼ 0.01 at
rs870137).5 We explored whether this same variant was also
associated with cataract progression in the 324 twins. This was
done using a score-based test (MERLIN), adjusting for age. We
report here that we also ﬁnd an association between rs870137 and
cataract progression (P ¼ 0.01). Our data suggest that common
variants in the CRYAA gene may inﬂuence the prevalence and
progression of nuclear cataract, and it would be fascinating to ﬁnd
out whether these variants inﬂuence the a-crystallin index.
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REPLY: We thank Drs Ekaterina Yonova-Doing and
Christopher J. Hammond for their interest in our paper1
and would like to respond to their questions.
With regard to lens brunescence, we used the Age-Related Eye
Disease Study Cataract Clinical Grading System, which in contrast
with the Lens Opacities Classiﬁcation System, does not grade
brunescence separately from opalescence. Brunescence is typically
a later feature in nuclear cataract. The advantage of the dynamic
light scattering system is that it can detect lens protein changes in
the precataractous stages, when the lens is still transparent. Thus, at
the time when dynamic light scattering is most useful, brunescence
will generally not be an issue.
We agree that smoking is associated with increased risk of
nuclear sclerosis and we would expect smoking to be associated
with a decrease in a-crystallin index. However, we did not assess
risk factors and did not know the smoking status of the individual
patients. We did not perform genetic analysis in this study, but it
could be an important feature in future studies.
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Re: Jabbarvand et al.: Endophthalmitis
occurring after cataract surgery:
outcomes of more than 480000
cataract surgeries, epidemiologic
features, and risk factors
(Ophthalmology 2016;123:295-301)
TO THE EDITORS: This correspondence concerns the results of the
study by Jabbarvand et al.1 As per the results, 112 of 480 104 cases
that underwent cataract surgery at a single hospital between 2006
and 2014 developed endophthalmitis. However, of the 25 920
cases where intracameral cefuroxime was injected, none
developed endophthalmitis. This study also found that short-term
pretreatment with topical or systemic antibiotics or postoperative
subconjunctival injection of antibiotics reduced the odds of
endophthalmitis by 40% to 50%, but the difference was not sig-
niﬁcant (P ¼ 0.2). The authors concluded from their results that
intracameral cefuroxime was 100% effective in preventing post-
cataract surgery endophthalmitis. We would like to put forth our
observations regarding 2 statistical concepts, sample size, and risk
reduction.





Genetic and Dietary Factors Inﬂuencing the
Progression of Nuclear Cataract
Ekaterina Yonova-Doing, MSc,1 Zoe A. Forkin, BSc,1,3 Pirro G. Hysi, MD, PhD,1
Katie M. Williams, MPhil, FRCOphth,2 Tim D. Spector, MD, PhD,1 Clare E. Gilbert, FRCOphth, MD,4
Christopher J. Hammond, MD, FRCOphth1,2
Purpose: To determine the heritability of nuclear cataract progression and to explore prospectively the effect
of dietary micronutrients on the progression of nuclear cataract.
Design: Prospective cohort study.
Participants: Cross-sectional nuclear cataract and dietary measurements were available for 2054 white
female twins from the TwinsUK cohort. Follow-up cataract measurements were available for 324 of the twins (151
monozygotic and 173 dizygotic twins).
Methods: Nuclear cataract was measured using a quantitative measure of nuclear density obtained from
digital Scheimpﬂug images. Dietary data were available from EPIC food frequency questionnaires. Heritability was
modeled using maximum likelihood structural equation twin modeling. Association between nuclear cataract
change and micronutrients was investigated using linear and multinomial regression analysis. The mean interval
between baseline and follow-up examination was 9.4 years.
Main Outcome Measures: Nuclear cataract progression.
Results: The best-ﬁtting model estimated that the heritability of nuclear cataract progression was 35% (95%
conﬁdence interval [CI], 13e54), and individual environmental factors explained the remaining 65% (95% CI,
46e87) of variance. Dietary vitamin C was protective against both nuclear cataract at baseline and nuclear
cataract progression (b ¼ "0.0002, P ¼ 0.01 and b ¼ "0.001, P ¼ 0.03, respectively), whereas manganese and
intake of micronutrient supplements were protective against nuclear cataract at baseline only (b ¼ "0.009, P ¼
0.03 and b ¼ "0.03, P ¼ 0.01, respectively).
Conclusions: Genetic factors explained 35% of the variation in progression of nuclear cataract over a
10-year period. Environmental factors accounted for the remaining variance, and in particular, dietary vitamin C
protected against cataract progression assessed approximately 10 years after
baseline. Ophthalmology 2016;123:1237-1244 ª 2016 by the American Academy of Ophthalmology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Age-related cataract is the leading cause of blindness in the
world, affecting approximately 20 million people, particu-
larly in sub-Saharan Africa.1 Its prevalence increases from
2.9% in the 43- to 54-year age group to 40% in those
older than 75 years of age.2 As the world’s population ages,
cataract will remain a serious healthcare and socioeconomic
burden, in terms of both healthcare provision and blindness
in less-developed countries.
Nuclear cataract is the most common form of age-related
cataract.2 Apart from age, other factors associated with
nuclear cataract are smoking, oxidative stress, and dietary
antioxidant intake.3e5 However, studies of the effect of
dietary vitamin C intake,6e11 serum vitamin C concen-
trations,6,9,11e13 and vitamin C supplementation6,10,14 on
nuclear cataract formation often have given conﬂicting re-
sults. Case-control studies7,11,12,14 and some cohort
studies6,9,10 have found protective effects. Other prospective
cohort studies have found no effect overall8,13,15 or protective
effects only in subgroups.8,15 Similarly to vitamin C, di-
etary6,16 and supplemental14,17 vitamin E intake and vitamin
E blood concentrations6,13 have been shown to be related
inversely with nuclear cataract. Randomized clinical trials of
vitamins C and E supplementation alone or in combination
with other vitamins failed to ﬁnd an effect.18,19 Vitamin A has
been associated with a reduced risk of nuclear cataract,9,20,21
as have lutein and zeaxanthin.22e24 The studies exploring
dietary nutrients and cataract progression have ﬁndings
similar to those looking at prevalent cataract, with cohort
studies ﬁnding a protective effect.16,25 However, supplement
trials largely have failed to ﬁnd an effect.18,26,27
As opposed to vitamins and micronutrients,28 the role of
minerals in cataract formation in general and in nuclear
cataract in particular is poorly studied. Together with
epidemiologic factors, genetic factors also play a role in
cataract formation. We previously reported that genetic
factors explain 48% of cross-sectional variance in age-related
nuclear cataract.29 In a recent genome-wide meta-analysis,
variants in 2 genes, CRYAA and KCNAB1, were found to be
associated with nuclear cataract in Asian populations,30 but no
ﬁndings are available for populations of European origin. In
comparison with epidemiologic factors, little is known about
genetic susceptibility factors in age-related cataract.
1237! 2016 by the American Academy of Ophthalmology
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Factors that lead to the development of a phenotype may
be different from factors underlying change, such as pro-
gression of lens opacity. Therefore, we set out to establish
the relative importance of genes on progression of nuclear
cataract using a classic twin model with a highly quantita-
tive measure of nuclear cataract. We also examined how
intake of micronutrients and supplements associated with
nuclear cataract at baseline affects nuclear cataract pro-
gression over a decade.
Methods
Subjects
Nuclear cataract data at baseline were available for 2515 white female
twins (mean age, 62.3 years; range, 50.1e83.1 years) from the
TwinsUK cohort, 2054 of whom had also completed a food frequency
questionnaire (FFQ) around the time of their eye examination. The
median time interval between an eye test taking place and a FFQ
completion was 2 years. The 461 twins with cataract data but without
FFQ data were 2.5 years younger on average and less affected by
cataract. Cataract progression datawere collected from324 twins (151
monozygotic [MZ] and 173 dizygotic [DZ]) with a mean age at
follow-up of 69.8!5.4 years (range, 58.3e83.6 years) as part of the
Healthy Ageing in Twins (HATS) study between 2006 and 2010.31
Individuals included in the follow-up were all part of our original
cataract heritability study of 1012 twin participants assessed in 1998
and1999.29Themean timebetweenbaseline and second visitswas 9.4
years (range, 7e12 years). The smaller number of individuals with
follow-up data is mainly due to the fact that the HATS study (in
which the follow-up datawere collected)was not designed speciﬁcally
as a cataract follow-up study and had different selection criteria:
Participants were aged more than 40 years and had to have previously
attended clinical phenotyping irrespective of whether they had an eye
examination or not (N¼ 4610) (Fig 1). The TwinsUK study started in
1992, but eyemeasureswere performed only on subjectsmore than 50
years of age in 1998e1999, and subsequently from 2006. That meant
that individuals (aged #50 years) who attended the HATS visit and
who did not have eye examinations in 1989e1999 had their
baseline cataract assessment during HATS (2006e2011;
N ¼ 1523). Reasons for having only longitudinal data for 324 of
the original 1012 twins included death (N ¼ 52), withdrawal
of participation from the TwinsUK registry (N ¼ 169),
noncontactable (N ¼ 30), refusal of further phenotyping (N ¼ 82),
cataract surgery (N ¼ 11), and refusal of dilating drops or
unavailability of ophthalmic testing at the HATS visit (N ¼ 344).
Both the baseline study and the HATS study received local
research ethics approval and were conducted according to the
tenets of the Declaration of Helsinki. All the participants gave
written informed consent.
Phenotyping
Nuclear Cataract Scores. Digital black and white lens photo-
graphs were taken using a Scheimpﬂug camera (Case 2000;
Marcher Enterprises Ltd., Worcester, UK), and the same camera
was used at both baseline and follow-up. Nuclear cataract was
measured quantitatively by calculating the pixel density in the
center of the lens nucleus, also known as the central nuclear dip
score (NDS).29 This score measures the amount of white scatter
(opalescence), and more opaciﬁcation results in higher pixel
density. Because NDS uses black-and-white images, it does not
assess the brunescence of the lens. Nuclear cataract progression
was measured as the difference in measurements between the
visits: DNDS ¼ NDS at follow-up $ NDS at baseline. Both NDS
and DNDS were not normally distributed and therefore were
transformed using natural logarithm before the analysis.
Nutrient Intake. Intake of micronutrients (vitamins and minerals)
and supplements was estimated using the EPIC FFQ, which was self-
administered at the baseline visit. This questionnaire explored the
average frequency of intake of 131 foods and supplements over a
1-year period.32,33 Nutrient intake was calculated using an established
nutrient database, and the dietary variables were adjusted for calorie
intake, yielding an energy-adjusted mg/mg of each nutrient per person
per day.32,34,35 We considered the following micronutrients in the
analysis: sodium, potassium, calcium, magnesium, phosphorus, iron,
Figure 1. Consort diagram of the study showing the number of individuals who participated in the different parts of the study and reasons for no
participation at follow-up. FFQ ¼ food frequency questionnaire; HATS ¼ Healthy Ageing in Twins.





copper, zinc, chloride, manganese, iodine, retinol, carotene, vitamin
D, vitamin E, thiamine, riboﬂavin, niacin, tryptophan, vitamin B6,
vitamin B12, folate, pantothenate, biotin, and vitamin C.
Data on supplement intake were available for 33 different sup-
plements. However, the percentage of individuals taking any single
supplement was 10% or less. Supplements were grouped as follows:
any supplements;micronutrient supplements (vitamins and minerals
in any combination); micronutrient supplements excluding multivi-
tamins (e.g., vitamin C only, vitamin D only, iron only, ACD
complex); minerals only (e.g., iron only, calcium only); and other
supplements (e.g., aloe vera, Echinacea, Ginkgo, omega-3). Each
supplement group was coded as a binary variable, with “yes” indi-
cating that they took 1 ormore of the supplements in a speciﬁc group.
Statistical Analysis
Modeling of Heritability. Heritability was analyzed in 310 twins
(155 pairs: 72 MZ and 83 DZ) because data were missing on 14 co-
twins. Zygosity was determined by a standardized questionnaire
and conﬁrmed using genome-wide single nucleotide poly-
morphism genotyping data or DNA short tandem repeat
ﬁngerprinting.
Twin studies are able to estimate the heritability of a trait (the
amount of variance explained by genetic factors) using maximum
likelihood structural equation modeling. The variance of the trait and
the covariance within twin pairs are used to estimate additive genetic
effects (A), shared/family environmental effects (C), and individual
environmental effects (E). We implemented the modeling in the
OpenMx package (http://openmx.psyc.virginia.edu). The goodness of
ﬁt of the full ACE model and submodels were compared with the
observed data and the best ﬁtting model was selected.
Nutrient Factor Analysis. Comparisons of means and pro-
portions for all variables between individuals with or without
follow-up data, or between MZ and DZ twins per group in terms of
age, nuclear cataract scores, and nutrient and supplement intake
were performed using 2-sample, 2-tailed t tests or z tests, assuming
equal variance.
Association was assessed using linear regression analyses.
Univariable linear regression was ﬁrst carried out where each factor
or supplement group was individually regressed against NDS at
baseline. All nutrients or supplement groups showing signiﬁcant
univariable association (P < 0.05) were then included in a multi-
variable linear regression model; independent variables were iden-
tiﬁed using a stepwise backward procedure with threshold for
removal set at 0.05. Factors showing signiﬁcant (P < 0.05) asso-
ciation in the multivariable model were tested for association with
progression. We used linear models to establish the relationship
between NDS (continuous variable) and nutrients, but because NDS
had to be normalized, giving a clinical interpretation of the betas
becomes more difﬁcult. Therefore, in addition to the linear models,
we calculated risk reduction by calculating relative risk ratios
(RRRs) using multinomial regression. In this case, NDS, DNDS,
and the associated nutrients were divided into tertiles, and the ﬁrst
tertile was set as reference while supplement intake per supplement
group was kept binary. In all cases, models were adjusted for family
structure and age at the ﬁrst visit only (baseline analysis) or for both
age at baseline and Dage (age at follow-up ! age at baseline). All
analyses were carried using the STATA10 statistical package (Sta-
taCorp LP, College Station, TX; www.stata.com).
Results
Cross-sectional data were available for 2054 white female twins
(827 MZ and 916 DZ), 324 (151 MZ and 173 DZ) of whom also
had nuclear cataract measured at follow-up. Baseline characteris-
tics and nutrient and supplement intake are shown in Table 1, and
an example of a lens image is available in Figure 2. The twins with
follow-up data were on average 1.1 years younger at baseline (60.4
vs. 61.5 years) and, given their younger age, had less cataract
(mean NDS scores of 55.3 and 60.4, respectively) compared with
those with only cross-sectional data. In both cases, these differ-
ences were not statistically signiﬁcant (P > 0.05). The MZ and DZ
twins with follow-up data were similar in terms of age and NDS
scores (P > 0.05). The MZ and DZ twins with cross-sectional data
only were similar in terms of age, but the MZ twins had a slightly
higher NDS score (61.6 vs. 59.3; P ¼ 0.02).
There were also no statistically signiﬁcant differences between
groups in terms of micronutrient intake except for iron (P ¼ 0.02),
thiamine (P ¼ 0.04), and biotin (P ¼ 0.01). The twins with follow-
up data had slightly lower iron and thiamine intake (mean of 12.6
and 1.7 mg, respectively) and slightly higher biotin intake (mean of
49.7 mg) compared with individuals without follow-up data. There
were also no signiﬁcant differences in supplement intake between
the 2 groups (P > 0.05). There were no statistically signiﬁcant
differences between MZ and DZ twins in terms of nutrient or
supplement intake (P > 0.05).
As expected, nuclear cataract scores progressed in all partici-
pants (Fig 3). The mean baseline central NDS was 55#11 (range,
32e99) with the score increasing by an average of 19.9#16.9
(range, 1e137) over the period of follow-up. The heritability
analysis, conducted on 155 twin pairs (72 MZ and 83 DZ pairs),
showed that the best-ﬁtting model was one explained by additive
genetic factors and the unique (individual) environment, with no
signiﬁcant effect of a common environment or nonadditive genetic
factors. Calculations estimated the heritability to be 0.35, meaning
that genetic factors explained 35% of variance (95% conﬁdence
interval [CI], 13e54) in progression of nuclear cataract, with in-
dividual environmental factors accounting for the remaining 65%
(95% CI, 46e87).
To test associations between micronutrient intake and cataract
progression, we used univariable regression (Table 2) followed
by stepwise regression in 2054 female twins who had baseline
data on nutrient intake. Seven micronutrients showed a
signiﬁcant association (P < 0.05) with NDS and were used in
multivariable analysis: potassium, magnesium, manganese,
phosphorus, vitamins C and E, and folate. After stepwise
multivariable regression, 2 factors remained signiﬁcantly
associated with NDS at baseline: vitamin C (b ¼ !0.0002;
standard deviation [SD] ¼ 6.3E-05; P ¼ 0.01) and manganese
(b ¼ !0.009; SD ¼ 0.04; P ¼ 0.03). From these 2 nutrients,
only vitamin C showed association with cataract progression
(b ¼ !0.001; SD ¼ 0.001; P ¼ 0.03). A sensitivity analysis
excluding subjects with greatest progression (>100 units of
change) did not alter the result. Comparing people in the
highest and lowest tertiles of vitamin C intake was associated
with a 19% risk reduction at baseline (RRR, 0.81; 95% CI,
0.68e0.96) and a 33% risk reduction of cataract progression
(RRR, 0.66; 95% CI, 0.47e0.91) (Table 3). Manganese intake
was associated with 20% risk reduction (RRR, 0.80; 95% CI,
0.67e0.95) at baseline (Table 3).
Two supplement groups, micronutrient supplements and minerals
only, showed a signiﬁcant association with NDS (P< 0.05) (Table 2),
but only micronutrient supplements stayed signiﬁcant in the
multivariate model (b¼!0.03; SD ¼ 0.01; P ¼ 0.01), and their
intake led to an 18% risk reduction in people within the highest
compared with the lowest tertile of nutrient intake (RRR, 0.82;
95% CI, 0.57e1.20) (Table 3). We found no statistically signiﬁcant
association between taking micronutrients in supplemental form and
progression of nuclear cataract.






This study found that progression of nuclear cataract over a
10-year period in a group of UK female twins is inﬂuenced
by genetic factors that explain 35% of variance. The herita-
bility estimate of cataract progression is lower than our
previous cross-sectional estimates of susceptibility to
development of nuclear cataract in this cohort,29 and it is also
lower than the heritability estimated in the 324 individuals
estimated from the nuclear score measurement at follow-up
(61%; 95% CI, 45e72). This is consistent with previous
studies showing that heritability generally is lower when
examining change, compared with cross-sectional stud-
ies.36e38 In addition to early developmental differences and
the body’s response to environmental factors in adulthood,
environmentally driven processes or accumulated “errors”
(e.g., somatic gene mutation and epigenetic remodeling)
might play a greater role in determining change during aging
than genetic factors.38
This study also identiﬁed vitamin C as a micronutrient
affecting nuclear cataract progression. We also replicate the
previously found association between cross-sectional cata-
ract and vitamin C intake. Vitamin C intake has long been
studied in relation to age-related cataract because it is the
L-enantiomer of ascorbate. A signiﬁcant concentration of
ascorbate is present in the aqueous humor that bathes the
lens and may reduce oxidation products in the lens, thus
reducing oxidative stress.39,40 However, the conclusions of
the many studies of the effects of ascorbate on cataract
development are inconsistent and often conﬂicting.6e15
Many of these have studied relatively well-nourished pop-
ulations and are cross-sectional, although cross-sectional
studies in India, where overall antioxidant levels may be
lower, have found an inverse relationship between vitamin
Table 1. Baseline Sample Characteristics and Nutrient Intakes in Individuals with or without Follow-up Data
Subjects without Follow-up Subjects with Follow-up
Total MZ DZ Total MZ DZ
No. of individuals 1730 827 916 324 151 173
Zygosity ratio (MZ:DZ) 1:1.1 - - 1:1.2 - -
Age (mean ! SD) 61.5!6.5 61.7!6.7 61.4!6.4 60.4!5.1 60.8!5.5 60.0!5.2
NDS (mean ! SD) 60.4!17.2 61.3!17.4 59.0!14.2 55.3!11.2 55.3!11.4 55.3!11.1
Sodium (mg) 2262.8!508.7 2265.3!476.3 2258.7!535.6 2237.4!456.4 2227.7!444.4 2247.2!444.4
Potassium (mg) 4013.5!637.4 3997.0!622.4 4026.9!650.6 4033.7!580.5 4094.5!588.4 3972.5!469.4
Calcium (mg) 1117.1!284.7 1118.5!284.9 1125.1!284.6 1118.9!291.5 1138.3!295.0 1099.4!568.0
Magnesium (mg) 347.3!56.4 347.3!56.8 347.2!56.0 343.8!55.0 347.0!58.0 340.6!287.5
Phosphorus (mg) 1527.1!247.0 1527.1!234.9 1527.1!257.8 1522.0!239.3 1532.0!251.0 1512.1!227.5
Iron (mg)* 13.1!3.0 13.2!3.2 13.0!2.8 12.6!2.6 12.5!2.7 12.7!2.5
Copper (mg) 1.5!0.5 1.5!0.6 1.5!0.4 1.5!0.4 1.5!0.4 1.6!0.5
Zinc (mg) 10.2!1.7 10.2!1.8 10.1!1.7 10.2!1.7 10.2!1.8 10.1!1.6
Chloride (mg) 3629.6!792.9 3633.6!749.4 3623.0!828.6 3578.0!721.3 3566.7!690.3 3589.4!753.3
Manganese (mg) 4.2!1.2 4.1!1.1 4.2!1.2 4.2!1.1 4.3!1.1 4.2!1.1
Iodine (mg) 225.0!75.8 224.2!75.2 225.8!76.5 229.2!64.2 230.0!61.4 228.5!67.2
Retinol (mg) 579.5!817.8 569.1!570.6 554.8!496.6 611.8!472.9 588.2!422.6 635.6!519.0
Carotene (mg) 5343.4!3067.4 5503.7!3263.8 5200.4!2874.9 5305.6!3915.4 5663.8!4823.8 4945.0!2679.4
Vitamin D (mg) 2.7!1.4 2.7!1.1 2.6!1.5 2.8!1.1 3.0!1.0 2.6!1.0
Vitamin E (mg) 11.5!3.2 11.6!3.4 11.4!3.1 11.7!3.4 11.9!3.6 11.5!3.2
Thiamine (mg)* 1.8!0.4 1.8!0.4 1.8!0.4 1.7!0.3 1.7!0.3 1.7!0.3
Riboﬂavin (mg) 2.5!0.7 2.4!0.7 2.5!0.7 2.4!0.6 2.5!0.6 2.4!0.7
Niacin (mg) 22.0!5.7 22.2!5.1 21.8!6.2 21.3!4.5 21.3!4.6 21.2!4.4
Tryptophan (mg) 17.4!3.0 17.5!2.7 17.3!3.3 17.2!2.5 17.3!2.5 17.1!2.6
Vitamin B6 (mg) 2.6!0.6 2.6!0.6 2.5!0.5 2.5!0.5 2.5!0.5 2.5!0.5
Vitamin B12 (mg) 6.5!3.2 6.7!3.6 6.4!2.9 6.7!2.3 6.7!2.3 6.7!2.4
Folate (mg) 402.2!113.1 400.7!114.0 403.2!112.3 395.7!98.9 402.0!95.9 389.4!101.8
Pantothenate (mg) 7.4!16.0 7.5!21.3 7.2!8.6 6.8!4.2 6.5!2.1 7.1!5.6
Biotin (mg)* 48.1!10.5 47.7!10.3 48.5!10.8 49.7!10.3 50.6!10.2 48.7!10.3
Vitamin C (mg) 165.1!73.9 167.6!74.2 163.0!73.7 166.8!65.0 166.9!68.1 166.7!65.0
Any supplement (%) 55.1 54.8 55.4 55.0 54.1 55.9
Micronutrients (%) 32.57 32.4 33.2 31.7 32.8 30.8
Micronutrients excluding multivitamins (%) 23.6 24.1 23.2 21.6 24.2 19.3
Minerals only (%) 7.4 7.8 7.0 6.9 6.4 7.2
Other supplements (%) 44.9 46.2 44.4 47.1 44.2 49.5
DZ ¼ dizygotic; MZ ¼ monozygotic; NDS ¼ nuclear dip score; SD ¼ standard deviation.
The baseline characteristics of the participants and the baseline intake of micronutrients (mean ! standard deviation [SD]) and supplements per supplement
group (% of users) are shown. The supplement groups studied are as follows: any supplement, micronutrient supplements (vitamins and mineral in any
combination), micronutrient supplements excluding multivitamins (e.g., vitamin C only, vitamin D only, iron only, ACD complex), minerals only (e.g.,
iron only, calcium only), and other supplements (e.g., aloe vera, Echinacea, Ginkgo, omega-3).
*Denotes statistically signiﬁcant difference (P < 0.05) between subjects with and without and without follow-up.





C and cataract.9,20 Our results are similar to those of the
Carotenoids in Age-Related Eye Disease Study that showed
vitamin C intake, assessed with an FFQ 10 years before
cataract assessment, to be protective of nuclear cataract
prevalence.15 The Blue Mountains Eye Study also found
that vitamin C intake, through both diet and supplements
together, resulted in a lower nuclear cataract incidence
over 10 years.10 This study is the ﬁrst, to our knowledge,
to show that dietary vitamin C intake protects against
progression of nuclear lens opacity.
We also found dietary manganese to be protective against
cross-sectional nuclear cataract independent of vitamin C.
We cannot exclude that this association was a type I error,
given we did not ﬁnd an association between dietary
manganese and nuclear cataract progression and the lack
of a dose response (Table 3), although factors associated
with incidence and progression do not always overlap.
Manganese is an important antioxidant present in the
human lens,41e43 and its concentration has been reported
to be lower in cataractous lenses in comparison with normal
lenses.43,44 This study was not designed to elucidate the
causeeeffect relationship underlying the associations we
found; therefore, we cannot distinguish whether manganese
depletion is a cause or effect of cataractogenesis. Further
studies are needed to answer this question. We also detected
an association between supplemental intake of micro-
nutrients and cross-sectional nuclear cataract but not be-
tween supplemental nutrients and cataract progression.
These results are similar to those reported in the Blue
Mountains Eye Study.45 Because only 10% or less of the
participants in our study took any single supplement, we
had to group supplements together; therefore, we could not
draw conclusions on the effect of any single supplement
or of components of supplements (e.g., supplemental
vitamin C).
We used a highly quantitative measure of cataract from
digital images (NDS), which essentially measures the nuclear
opalescence (or “white scatter”) of the lens. The measure also
was highly reproducible: the intraclass correlation coefﬁcient
for the worse eye in 30 subjects from our original study29 who
came for repeat measurements was 0.93. The fact that every
subject measured showed progression suggests that NDS is
sensitive to change. Many epidemiologic studies have used
the Lens Opacity Classiﬁcation System (LOCS) grading
scale, comparing phenotype with standardized photographs of
6 stages of lens opaciﬁcation, which includes both nuclear
opalescence and nuclear color or brunescence.4 The LOCS III
Figure 2. Black-and-white Scheimpﬂug lens images of a healthy lens (left) and a lens with nuclear cataract (right). The center of the lens (lens nucleus) on
the right is much whiter than the one on the left.
Figure 3. Progression of nuclear cataract between the 2 visit dates.
Graphical representation of the progression of nuclear cataract (deltaNDS)
between the 2 visits. The y-axes show frequency of deltaNDS per bins with
width of 6.25 points. deltaNDS ¼ NDS at follow-up " NDS at baseline;
NDS ¼ nuclear dip score.





was developed to increase steps between scores to allow greater
sensitivity to change, accepting a lower intergrader
reproducibility.46 Longitudinal studies using the LOCS III
scale show relatively little change: In the Longitudinal Study
of Cataract, only 24% of participants had an increase in
nuclear opacities over an average of 4.6 years.25 Although
our central NDS is not the same measure, it is highly
correlated with average nuclear opalescence graded digitally
or using a slit lamp.29 Digital imageederived NDSs using
pixel density counts may be better suited for measuring pro-
gression and allowed our study the power to detect associations
with a relatively small sample size.
Study Limitations
A potential limitation is that our cohort is based on twin
volunteers rather than a population study, but they are unse-
lected and from across the United Kingdom and are unlikely to
signiﬁcantly differ from the UK general population.47 Twin
studies use the “equal environment assumption” that the
degree of shared family environment is the same for both
MZ and DZ twin pairs. This is generally found to be true,
although there are few studies of elderly subjects that
explore this assumption. In addition, the TwinsUK cohort is
predominantly a female cohort, and we could not assess any
gender differences in risk factors. The ﬁndings of this study
can be generalizable only to Caucasian women of similar
age because they reﬂect cataract progression in a group of
white British women between, on average, the ages of 60
and 70 years, and so may not reﬂect other population groups
or age ranges. In this article, we explored the effect of all
micronutrients on nuclear cataract formation; however, we
had no data on carotenoid (lutein and zeaxanthin) intake.
We also lacked power to explore the effects of smoking on
cataract progression because 85% of participants have never
smoked.
Those participants with follow-up data collected were
seen as part of the HATS study, which was not designed as a
cataract follow-up study. This meant that the number of
subjects decreased to 324 individuals, thus reducing the
amount of data we could analyze and our power. The in-
dividuals who were lost to follow-up in HATS were in
general of lower socioeconomic status, had higher self-rated
health status, and were less health aware.31 Any introduced
bias probably would have resulted in loss of power because
this group of individuals are more likely to have less healthy
diets and more cataract. For this reason, we decided to test
the association with progression only for nutrients that
were associated with NDS at baseline. Those with follow-
up data were on average 1.8 years younger than the
Table 3. Results of Multinomial Regression Analysis for Factors
Associated with Cross-Sectional Nuclear Cataract and Nuclear
Cataract Progression
Cross-Sectional Results
Vitamin C RRR 95% CI P Value
NDS Tertiles 34.5e53.2 reference
53.3e54.5 0.89 0.77e1.02 0.09
54.6e229.2 0.81 0.68e0.96 0.01
Manganese RRR 95% CI P Value
NDS Tertiles 34.5e53.2 reference
53.3e54.5 0.76 0.66e0.87 0.001
54.6e229.2 0.8 0.67e0.95 0.01
Micronutrients RRR 95% CI P Value
NDS Tertiles 34.5e53.2 reference
53.3e54.5 0.82 0.60e1.12 0.82
54.6e229.2 0.82 0.57e1.20 0.82
Progression Results
Vitamin C RRR 95% CI P Value
DNDS Tertiles 1.0e12.6 reference
12.7e19.3 0.75 0.54e1.04 0.09
19.4e137.1 0.66 0.47e0.91 0.01
CI ¼ conﬁdence interval; NDS ¼ nuclear dip score; DNDS ¼ NDS at
follow-up " NDS at baseline; RRR ¼ relative risk ratio.
The results from the multinomial regression analysis for factors associated
with cross-sectional (vitamin C and manganese) and progression (vitamin
C) are shown. The RRR with its 95% CIs for each tertile of NDS or
progression (DNDS) is reported. The minimum and maximum NDS score
per tertile are reported.
Table 2. Results from Univariable Regression Models
Beta Standard Error P Value
Micronutrients
Sodium (mg) 5.41E-06 9.58E-06 0.56
Potassium (mg)* "1.58E-05 7.54E-06 0.04
Calcium (mg) "1.95E-05 1.52E-05 0.20
Magnesium (mg)* "0.010 0.004 0.01
Phosphorus (mg)* "4.01E-05 1.94E-05 0.04
Iron (mg) "1.15E-04 0.002 0.95
Copper (mg) 0.001 0.008 0.86
Zinc (mg) "7.76E-04 0.003 0.77
Chloride (mg) 3.79E-06 6.10E-06 0.53
Manganese (mg)* "0.010 0.004 0.01
Iodine (mg) "1.10E-04 6.07E-05 0.07
Retinol (mg) 2.36E-06 3.90E-06 0.55
Carotene (mg) "1.67E-06 1.40E-06 0.23
Vitamin D (mg) "0.004 0.003 0.22
Vitamin E (mg)* "0.003 0.001 0.04
Thiamine (mg) "0.013 0.013 0.30
Riboﬂavin (mg) "0.011 0.006 0.08
Niacin (mg) "1.10E-04 8.26E-04 0.89
Tryptophan (mg) "0.001 0.001 0.27
Vitamin B6 (mg) "0.002 0.009 0.81
Vitamin B12 (mg) "0.001 0.001 0.50
Folate (mg)* "9.91E-05 4.06E-05 0.02
Pantothenate (mg) "2.81E-05 1.87E-04 0.88
Biotin (mg) "3.01E-04 4.17E-04 0.47
Vitamin C (mg)* "1.742E-04 6.19E-05 0.01
Supplement Groupsy
Any supplement "0.015 0.009 0.12




Minerals only* "0.038 0.016 0.02
Any other supplement 0.005 0.014 0.72
The results of the univariable linear regression analysis between nuclear
cataract (natural logarithm-transformed NDS) and energy-adjusted
micronutrient intakes and between nuclear cataract and supplement
intake per supplement group are shown.
*Denotes statistically signiﬁcant associations at P < 0.05.
yDenotes that in the case of supplement groups, supplement intake was
coded binary (presence vs. absence of intake of at least 1 of the components
in the group). All analyses were adjusted for age and family structure.





original cohort, but in general they were not signiﬁcantly
different in other respects or in nutrient or supplement
intake, hopefully reducing potential selection bias in the
progression data. As in any observational study, ours is
potentially susceptible to residual confounding, missing
data, or misspeciﬁcation of variables.
In summary, this study has shown that progression of nu-
clear cataract over a 10-year period is inﬂuenced by genetic
factors with a heritability of 35%. Dietary vitamin C and
manganese, both factors related to oxidative stress, seem to
inﬂuence cross-sectional nuclear cataract, and vitamin C intake
also signiﬁcantly inﬂuences nuclear cataract progression.
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